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Abstract  
 
 Tetraspanin proteins are a family of transmembrane proteins that are broadly expressed 
on different tissues and in multi-cellular organisms. Their main characteristic is the 
ability to organize multi-molecular complexes through their association with different 
proteins and lipids to form tetraspanin enriched microdomains or TEMs. These 
microdomains have important roles in many cell functions, cancer malignancy and 
infectious diseases. However relatively few studies have investigated tetraspanin 
proteins in bacterial infection. Recently, tetraspanins have been shown to be involved in 
bacterial adhesion and invasion of human epithelial cell lines and human primary 
monocyte derived macrophages (MDMs). Specific monoclonal antibodies (mAb) and 
soluble recombinant versions of the large extracellular domains (EC2s) of tetraspanins 
were shown to inhibit adhesion of various bacterial species to human cells, possibly by 
disrupting TEM (Green et al., 2011). Therefore, treatments that target tetraspanins could 
offer a potential therapeutic alternative to antibiotics, in infections where resistance is an 
increasing problem. 
In this study, we further investigate the role of tetraspanin proteins in Salmonella 
enterica serovar Typhimurium NCTC12023 and LT2 strains using mouse and human 
phagocytic and human epithelial cell line models. As macrophage models, the well-
characterised mouse cell lines J774, RAW247 were used, along with macrophage cell 
lines established from CD9 KO and wild type mice. In addition, macrophages derived 
from THP-1 cells were used as a human cell line model. The human epithelial cell line 
HEC-1- B and HeLa were similarly investigated. Assays were developed to assess 
infection by flow cytometry (FACS) analysis in addition to conventional microscopy. 
Additionally, the role of syntenin, a CD63 tetraspanin partner protein, on Salmonella 
infection of HeLa cells was investigated. 
Different patterns of tetraspanin expression were observed on the cell lines by flow 
cytometry, with CD9 and CD81 generally highly expressed. Interestingly, tetraspanin 
CD63 showed high expression in human THP-1 derived macrophages, but was present at 
very low levels on mouse macrophage cell lines. Salmonella expressing green and red 
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fluorescent protein were also successfully generated to facilitate the investigation of 
infection.  
 Pre-treatment of mouse macrophage cells with anti-CD9, anti-CD81 monoclonal 
antibody (mAb) significantly decreased Salmonella infection. Comparable results were 
obtained using both immunofluorescence microscopy and FACS analysis. Anti-CD63 
mAbs had no effect, which is likely to relate to the low expression of the tetraspanin by 
these cells. By contrast, anti-CD63 mAb inhibited infection of human THP1 derived 
macrophages, whereas anti-CD9 mAb had no effect, which is similar to previously 
reported findings for human MDM (Hassuna, PhD thesis, University of Sheffield, 2010). 
In this study, no significant effect on Salmonella infection of epithelial cell lines HEC-1- 
B and HeLa cells was observed on pre-treatment with individual tetraspanin-specific 
mAbs. This suggests less involvement of tetraspanins in Salmonella infection of non-
phagocytic cells. Pre-treatment of J774 cells with soluble recombinant versions of 
human or mouse CD9- EC2 showed no effect on Salmonella association. This difference 
in activity between mAb and EC2s may indicate that Salmonella binding to J774 cells is 
not reliant on TEMs and the antibodies have a different mechanism of action here. 
Differences in the infectivity of the CD9KO and wild type mouse macrophage cell lines 
were noted, although this varied depending on the virulence of the Salmonella strain. 
CD9 KO cells also showed some differences in expression of other tetraspanins at 
protein, but not mRNA level as determined by microarray analysis. HeLa cells stably 
knocked down for syntenin expression were more susceptible to Salmonella infection 
than control cells; however, no changes were observed in early stages of Salmonella 
binding. The effects of syntenin KD could relate to alternative syntenin partner proteins 
such as syndecan. 
This study suggests a prominent role for tetraspanin CD9 and other tetraspanins in 
Salmonella infection of mouse macrophages and confirms a role for tetraspanins in 
infection of human macrophages. The different effects observed between cell lines when 
targeting tetraspanins could be related to differences in bacterial types, strains and mode 
of uptake, as well as differences in tetraspanin expression. 
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Chapter 1:  General introduction 
1.1 Tetraspanin proteins 
Tetraspanins are a large family of transmembrane proteins; this family consists of thirty three 
members in mammals, which can be subdivided into four subfamilies: the CD family, the 
CD63 family, the Uroplakin family and the RDS family (Table 1.1) (Kashef, Diana et al. 
2012, DeSalle, Sun et al. 2013). These transmembrane proteins have four hydrophobic 
regions and two extracellular loops. The tetraspanins were discovered first on human 
leukocyte surfaces, but it was quickly found that they had a broad expression on tissues and 
organisms including on human melanoma (CD63) and Schistosoma (Sm 23). The specific 
functions of many tetraspanins are unknown, but data from biochemical studies or knockout 
mice suggest an important role in membrane structure. Their unique characteristic is their 
ability to form a complicated multimolecular net, the "tetraspanin web ", which includes 
proteins such as integrins (Fan and Brindley 1998, Boucheix and Rubinstein 2001, Pols and 
Klumperman 2009). It has also been suggested that their ability to interact with proteins and 
lipids leads to the formation of a specialized type of microdomain; tetraspanin enriched 
microdomains or TEM (Hemler, 2003). The significant variety in the dynamics and 
composition of tetraspanin complexes lends the proteins a great deal of flexibility to 
contribute to various biological roles (Yunta and Lazo 2003), for instance cellular motility,  
activation, adhesion, invasion of cancer (Tarrant, Robb et al. 2003) and apoptosis 
(Lapalombella, Yeh et al. 2012). The emerging genetics and studies on tetraspanin function 
and biochemistry powerfully supports the importance of tetraspanins (Hemler 2001, Stipp, 
Kolesnikova et al. 2003, Hemler 2005, Wang, Li et al. 2011, Hemler 2014). 
 
Some tetraspanin protein that have been identified in mammals show particular functions and 
limited expression, but the distribution of many is very wide with many cells expressing 
multiple tetraspanins on the surface or interior membranes (Monk and Partridge 2012). In 
addition, analysis of the evolution of all known tetraspanins has shown that they include 20 
members in the genome of Caenorhabditis elegans (nematode); also 37 members of the group 
are present in the genome of the fruit fly Drosophila melanogaster (Shi, Ke et al. 2010), in a 
certain set of eighteen contiguous genes of the genome (Todres, Nardi et al. 2000) and there 
are at least 47 members in zebrafish (Garcia-España, Mares et al. 2009). Tetraspanins are also 
found in plants (Wang, Vandepoele et al. 2012), sponge (Garcia-España, Mares et al. 2009) 
and fungi (Lambou, Tharreau et al. 2008). 
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Table 1.1: The identified human tetraspanins members with their alternative names.  
HGM-2005 
Tetraspanin 
name 
Tetraspani
n 
 
Family 
Protein 
(Gen Pept) 
DNA 
(Gen Bank) 
Alternative 
Name(s) 
1 TSPAN-1 CD NP_005718 NM_005727 
TM4-C, 9030418M05Rik, RP11-322N21.1, 
NET1 
2 TSPAN-2 CD NP_005716 NM_005725 FLJ12082, RP4-666F24.2, 6330415F13Rik 
3 
TSPAN-3 
-isoform 2 
CD63 
NP_005715 
NP_944492 
NM_198902 
NM_005724 
TM4SF8.1, TM4-A,  
TM4SF8.2 
4 TSPAN-4 CD NP_003262 NM_003271 TM4SF7, NAG-2 
5 TSPAN-5 RDS NP_005714 NM_005723 
2810455A09Rik, 4930505M03Rik, TM4SF9, 
NET-4 
6 TSPAN-6 CD63 NP_003261 NM_003270 TM4SF6, T425, TM4-D, A15 homologue 
7 CD231 CD63 NP_004606 NM_004615 
A15, MXS1, CCG-B7, TALLA-1, TM4SF2b, 
DXS1692E, MRX58 
8 CO-029 CD NP_004607 NM_004616 D6.1, TM4SF3 
9 NET5 CD NP_006666 NM_006675 PP1057 
10 Oculospanin RDS NP_114151 NM_031945 FLJ39607 
11 TSPAN11 RDS NP_001073978 NM_001080509 UNQ1971, VSSW1971 
12 NET2 Uroplakin NP_036470 NM_012338 TM4SF12 
13 NET6 CD63 NP_055214 NM_014399 TM4SF13, FLJ22934 
14 DC-TM4F2 RDS NP_112189 NM_030927 BC002920, NEW2, TMSF14 
15 NET7 RDS NP_036471 NM_012339 2700063A19Rik, TMSF15 
16 TM4B CD NP_036598 NM_012466 TM-8, TMSF16 
17 CAD35489 RDS NP_569732 NM_130465 F-Box23, SB134, BC067105, NEW3, TMSF17 
18 BAB55318 CD NP_570139 NM_130783 AK027715.1, UP1 homologue 
19 
Tetraspanin 
19 
CD NP_001094387 NM_001100917 FLJ44351 
20 
Uroplakin 
Ib 
Uroplakin NP_008883 NM_006952 UPIB, UPK1 
21 Uroplakin Ia Uroplakin NP_008931 NM_007000 UPIA, UP1A, UPKA 
22 Peripherin RDS NP_000313 NM_000322 
RDS, RP7, AVMD, PRPH, AOFMD, PRPH2, 
RD2 
23 Rom1 RDS NP_000318 NM_000327 ROSP1 
24 
 
CD151 -
UTR variant 
CD 
NP_004348 
NP_620599 
NM_004357 
NM_139030 
PETA3, SFA1, gp27, RAPH, MER2 
25 CD53 CD NP_000551 NM_000560 MOX44 
26 CD37 CD NP_001765 NM_001774 GP52-40 
27 CD82 CD NP_002222 NM_002231 
Kangai1, R2, 4F9, C33, IA4, ST6, GR15, 
KAI1, SAR2 
28 CD81 CD NP_004347 NM_004356 TAPA-1, S5.7 
29 CD9 CD NP_001760 NM_004356 
BA2, p24, GIG2, MIC3, MRP-1, BTCC-1, 
DRAP-27, 5H9 
30 CD63 CD63 NP_001771 NM_001769 
MEL1, ME491, granulophysin, LAMP3, 
OMA81H, MLA1, neuroglandular Ag (Hara-
Kaonga and Pistole), LIMP 
31 SAS CD63 NP_005972 NM_005981  
32 TSSC6 Uroplakin NP_620591 NM_139022 PHEMX, ART1, FLJ17158, FLJ97586 
33 MGC50844 CD NP_848657 NM_178562 PEN 
This table was kindly provided by P.N. Monk, Department of Infection and Immunity, University of 
Sheffield, and modified  according to  (DeSalle, Sun et al. 2013). 
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1.1.1 Tetraspanin structure 
The four transmembrane domains are the main characteristic of tetraspanins and the proteins 
consist of 204 (SAS) - 355 (oculospanin) amino acids. The proteins have two different sized 
extracellular loops, the small one (EC1) composed of  20-28 amino acids, and the other 
extracellular loop (EC2) composed of 76-131 amino acids (Boucheix and Rubinstein 
2001).These unequal loops separate the four transmembrane regions (TM1-TM2 and TM3- 
TM4)  with a small intracellular domain lying between TM2 and TM3 (Figure 1.1). The EC2 
shows the greatest variability in sequence but also has highly conserved residues that include 
a CCG motif. This motif and two other cysteine residues are the only signature residues. 
Disulphide bonding between 2 of these cysteines creates a subdomain in the EC2 (Figure 
1.1).  
 
There is variability in the number of cysteine residues in the EC2 sequence with tetraspanins 
showing either 4, 6 or 8. This variety of cysteine number in the EC2 is a feature that has been 
used to divide tetraspanins into three groups: group1 have four cysteines and consequently 
have two disulfides. Group 2 have six cysteines and may form three disulphide bonds. Group 
3 consists of a small number of tetraspanins that have an extra two cysteine residues in the 
EC2 which are close relative to one another and they may form a fourth disulfide bond 
(Seigneuret, Delaguillaumie et al. 2001). 
 
The X-ray structure of tetraspanin CD81 EC2, which acts as co-receptor for hepatitis C virus 
(HCV), was solved and shown to consist of an umbrella-shaped structure organized from 5 
alpha-helices placed in "stalk" and "head" sub-domains. The stalk sub-domain was suggested 
to gather on the cell membrane into homodimers and/or heterodimers via a preserved 
hydrophobic region,  whereas the head sub-domain may be responsible for interacting with 
other ligand proteins such as HCV E2 (Kitadokoro, Bordo et al. 2001). In studies on CD81and 
its interaction with HCV, it was found that the EC1 is important to the expression of EC2 in 
mediating translocation of entire CD81 to the surface of the cells (Masciopinto, Campagnoli 
et al. 2001). However, recently the CD81 EC2 structural characterization by NMR has been 
reported. The HCV-E2 glycoprotein interaction with tetraspanin CD81 is mediated through a 
dynamic loop on the helical region that appears to have a different structure from that which 
was shown in the crystal structure. A membrane binding site is also postulated adjacent to the 
interaction area of HCV in the extracellular loop of tetraspanin CD81 (Figure1.2) (Rajesh, 
Sridhar et al. 2012).  
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From modelling studies, the transmembrane domains are predicted to form four left handed 
coiled coil strands that connect directly to the two EC2 helices. The small extracellular 
domain EC1 has a mostly hydrophobic small beta- strand, which may interact with an EC2 
conserved hydrophobic groove. The hypervariable subdomain of EC2 and the cytoplasmic  
 
regions are the sites in which the variability in construction generally occurs (Seigneuret 
2006). Generally, the EC2s homology between family members varies by 5 - 40%.  
There are high homologies of tetraspanin transmembrane domains between human and zebra 
fish orthologues (83%), and this similarity indicates essential functional roles. The 1, 3 and 4 
transmembrane domains show 70-90% conservation of extremely polar residues (asparagine, 
glutamine and glutamate) between all tetraspanins and the conservation is 100% between four 
human and zebrafish tetraspanin orthologues. The molecular pattern of polar residues of TM 
1, 2 and 3 of CD82 are suspected to rest at internal TM-TM connections instead of outer TM 
lipid connections. It has been suggested that these residues might participate in strong 
hydrogen bonds within TMs or with other molecules (Stipp, Kolesnikova et al. 2003). More 
recent studies indicate that the polar residues are important in interactions between the TM 
regions and maintaining conformational stability of the tetraspanins (Bari, Zhang et al. 2009). 
 
Tetraspanins are commonly palmitoylated at inner juxta-membrane cysteines and this helps 
form and/or stabilize tetraspanins interactions (Charrin, Manie et al. 2002). Almost all 
tetraspanins have preserved residues of cys at least at some similar sites. The intracellular N 
and C tails and the small intracellular domain altogether have 72-78% similarity between 
mammalian and zebrafish tetraspanins.  
 
Many attempts have been made to relate the structural features of tetraspanins to specific 
functions. As mentioned above, the EC2 domain has a variable sub-region, which moderates 
interactions particularly with different polypeptides and in addition has a more conserved 
area thought to be involved in homodimerisation. The four transmembrane domains are 
involved in intra- and inter-molecular interactions which are essential throughout synthesis 
and interactions of tetraspanin proteins to form what it is known as the "tetraspanin-web" 
(Charrin, Le Naour et al. 2001). The intracellular juxta-membrane palmitoylation sites are 
also involved in tetraspanin-web regulation (Charrin, Manie et al. 2002). 
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Whilst most specific tetraspanin protein functions are linked to the extracellular domains, the 
cytoplasmic regions are important for some functions. For example the intracellular C-tail 
region might act as a cytoskeleton and protein signaling bridge in some tetraspanins, as seems 
to be the case for CD82 in activated T cells (Stipp, Kolesnikova et al. 2003) and discussed 
further below. Also, mutations induced in the CD9-C- terminus led to a change of CD9 
function in cell adhesion and spreading (Wang, Kolesnikova et al. 2011). In addition, recently 
an association between tetraspanin CD9 and metalloprotease CD10 was identified and the 
involvement of TM4 and the C terminal of CD9 in this interaction was determined (Mazurov, 
Barbashova et al. 2013). In another study, the CD9 C-tail has been shown to have a role in 
RAC1 activation and actin remodeling as a response to CXCL12 (Arnaud, Vallee et al. 2015). 
The Gly-Try-Glu-Val-Met sequence in the cytoplasmic C-tail of CD63 is essential for 
targeting to intracellular compartments (Stipp, Kolesnikova et al. 2003) and the role of this 
lysosomal targeting motif is discussed further below. Furthermore, the tetraspanin C- 
terminus is shown to play an important role in tetraspanin - associated cytoplasmic protein 
interactions; deletion of the last two amino acids from the CD63 C-tail eliminated the entire 
CD63-Syntenin-1 interaction (Latysheva, Muratov et al. 2006).  
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Figure 1.1. The structure of tetraspanins: The diagram shows a tetraspanin protein which is composed 
of four transmembrane protein (TM) residues (1-4), a large extracellular loop (LEL or EC2), and cysteines 
that form a di-sulfide bond to create a subdomain in the large extracellular loop, a small extracellular loop 
(SEL or EC1), a short intracellular loop and two intracellular termini (N and C). The EC2 is composed of 
two regions, a variable region with a conserved CCG motif and a constant region that contains A, B and E 
α helices. 
 
 
Figure 1.2: A model of the large extracellular domain (LEL) of CD81 monomer showing the binding 
of ligand residues. (Left) monomer of CD81 acquired by using crystal structure of CD81-EC2 with the 
small extracellular loop EC1 shaped from the full length CD81model. The red color shows the Hepatitis C 
protein E2 binding SNLFK motif, while the green color shows the dodecylphosphocholine (DPC) binding 
interface and the pink color shows the Plasmodium sporozoites interacting site (VVDDD). (Right): 120º 
rotation around vertical axis of the left image focusing of HCV-E2 and membrane binding border, adapted 
from (Rajesh, Sridhar et al. 2012).  
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1.1.2 Tetraspanin enriched microdomains (TEMs) and the tetraspanin 
web 
The general effect of anti-tetraspanin antibodies on cell behaviour reflects their importance 
in cell functions. However, results that were obtained from knockout mice did not meet the 
predictions found using antibodies. This could be because the antibodies that were used are 
not only targeted a particular tetraspanin, but also disrupt their associated proteins, in contrast 
to knocking-out a specific tetraspanin which tends to keep other components integrated 
(Hemler 2005). This revealed the importance of tetraspanin proteins in organizing cell 
membranes by engaging associated proteins into specialized tetraspanin enriched 
microdomains (TEMs) that regulate many cellular events (Bailey, Herbert et al. 2011, 
Charrin, Jouannet et al. 2014). Looking at proteins that co-immunoprecipited with 
tetraspanins in different types of detergents gave rise to the ideas of primary, secondary and 
tertiary tetraspanin interactions (reviewed in Hemler 2003, Yanez-Mo et al 2009, Charrin et 
al 2014). 
 
Chemical cross-linking studies indicate that tetraspanin homodimers or higher multitimers 
may form the basic units inside TEMs. The tetraspanins may interact with other tetraspanins 
members homogeneously or heterogeneously to form tetraspanin-tetraspanin complexes and 
the EC2 is suggested to play a vital role in homodimerization (Hemler 2005). In addition, 
direct interactions between tetraspanins and non-tetraspanin proteins occur (Boucheix and 
Rubinstein 2001, Martin, Roth et al. 2005, Charrin, Jouannet et al. 2014) such as CD151 with 
integrins, CD9 and CD81 with EWI proteins (members of the immunoglobulin superfamily), 
uroplakins UP1a with UPll and other hetero-interactions. These direct interactions have been 
classed as primary interactions (Hemler, 2003; Hemler, 2005). This protein assembling may 
serve as a basis for other tetraspanin interactions, for instance those linking to CD151, CD9, 
CD81 and their associates. These interactions are classed as secondary interactions and the 
propensity of tetraspanins to link heterophilically is important for this. Various associated 
proteins can then be engaged by tetraspanins into functionally essential compositions through 
indirect interactions, preserved only in mild detergents, termed tertiary interactions. There 
are various possible tetraspanins partners such as immunoglobulin (Ig) supergene family 
proteins, integrins, proteoglycans, complement regulatory proteins, proteases, cadherin, 
membrane proteases, signaling enzymes and others.  Tetraspanins can thus construct an 
interacting net or so called "tetraspan-web" on the cell surface  (Figure 1.3) (Charrin, le Naour 
et al. 2009). 
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Furthermore, the importance of tetraspanins association has been shown in many studies; in 
an early study of tetraspanin CD63 association in melanoma cell lines, CD9 and CD81 were 
shown to be associated with CD63, in addition, CD9 and CD63 associated with integrins. 
This tetraspanin- tetraspanin and tetraspanin- tetraspanin partner protein linkage gives the 
ability to form proteins interactions clusters (Radford, Thorne et al. 1996). The association of 
CD9 and CD81 with α3β1 and α6β1integrins was also observed (Berditchevski, Zutter et al. 
1996). In addition to cluster formation, TEMs may have an important roles in signaling; for 
example in C. elegans, a recent study showed that TEMs are involved in bone morphogenetic 
protein signaling (Liu, Shi et al. 2015). TEMs have also been shown to be exploited by some 
pathogens and have important roles in different stages of viral infections. A recent study, for 
example, showed that proteases present in TEM facilitate Corona virus infection and targeting 
CD9 disturbed the viral receptor binding and protease cleavage needed prior to virus:cell 
membrane fusion (Earnest, Hantak et al. 2015). Overall, tetraspanin proteins appear to play a 
central role in organizing their associated proteins in the cell membrane (Hemler 2005), 
explaining why these proteins are involved in so many activities including cell differentiation, 
adhesion, cell activation, cancer invasion (Pols and Klumperman 2009), angiogenesis 
(Takeda, Kazarov et al. 2007), development of the embryo (Kashef, Diana et al. 2012), cell 
migration (Powner, Kopp et al. 2011) and infections (Silvie, Franetich et al. 2007, Artavanis-
Tsakonas, Kasperkovitz et al. 2011, Gui, Wang et al. 2012). 
 
 
Figure 1.3.  The potential structure of the tetraspanin web. The main connections of TEMs are through 
primary connections that involve the interaction of TEM proteins directly. The various connections between 
different tetraspanins is included in secondary connections which are less strong and enhances interaction 
indirectly of primary tetraspanins protein complexes. Tertiary connections are the weakest complexes and 
are considered  to represent significant coalescence of the advanced organized connections into big 
signaling domains, figure modified from (Martin, Roth et al. 2005).  
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High resolution microscopy has been used to add more understanding to tetraspanins pattern 
of association and tetraspanin web construction. Earlier fluorescence microscopy studies of 
single molecules of tetraspanin dynamics within TEMs revealed that the tetraspanin web was 
distinct from lipid raft microdomains and that palmitoylation of CD9 and plasma membrane 
cholesterol have a role in tetraspanin CD9 movement and segregation in the membrane 
(Espenel, Margeat et al. 2008). Recently, a high resolution microscopy technique called dual 
color stimulated emission (STED) was used to observe 4 tetraspanins and their partner 
proteins distribution in the plasma membrane. CD53 appeared to be arranged in clusters of 
approximately 10 molecules, and only slight overlap was shown between CD53 and CD37 
clusters with CD81or CD82 containing complexes.  CD81 and CD53 were shown to closest 
to their MHC II and CD19 partner proteins, rather than other tetraspanins. This was taken to 
indicate that rather than containing multiple tetraspanins, as widely thought, the basic unit of 
TEM is made up of clusters of individual tetraspanins and their partner proteins. These may 
then form dynamic secondary interactions with other tetraspanin clusters or partners in the 
plasma membrane (Zuidscherwoude, Gottfert et al. 2015). 
 
1.1.3 Palmitoylation  
Palmitoylation is responsible for tetraspanin function and web or TEMs organization and has 
been shown to have an impact on cell phenotype and signaling (Stipp, Kolesnikova et al. 
2003, Montpellier, Tews et al. 2011). Palmitoylation of tetraspanin proteins occurs in the 
Golgi apparatus or post Golgi compartment (Yang, Claas et al. 2002). Tetraspanin CD82 
subcellular distribution and interaction with other family members is organized by 
palmitoylation (Zhou, Liu et al. 2004). This precise function is also important for stabilizing 
the CD9/CD21/CD81 complex raft function (Cherukuri, Carter et al. 2004) and 
palmitoylation of CD9 was shown to be essential in the CD9-CD81 interaction (Charrin, 
Manie et al. 2002). Palmitoylation has an impact on protein-protein interaction as mutation 
of cysteines involved in palmitoylation changed the contact between CD81 and other proteins 
(Delandre, Penabaz et al. 2009). Palmitoylation of CD9 and CD151 also encouraged the 
physical relationship between CD9 and CD151 and between α3 integrin and other proteins. 
It is also important in protein interaction with cholesterol-rich domains (Zhu, Luo et al. 2012). 
Palmitoylation also protects CD151 and CD9 from enzyme digestion in lysosomes and 
enhances cell-cell contact (Sharma, Yang et al. 2008). Studying the role of palmitoylation of 
CD9 and CD63 confirmed the need for palmitoylation for tetraspanins interaction with other 
tetraspanin or with integrins in platelets (Israels and McMillan-Ward 2010). Also, β4 integrin 
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palmitoylation enhanced CD151-α6β4 integration into secondary tetraspanin interactions 
with CD9, CD81, CD63 (Yang, Kovalenko et al. 2004). 
1.1.4 Glycosylation 
In eukaryotic cells, the most common post-translation modification of proteins is 
glycosylation (Zhao, Takahashi et al. 2008). Glycosylation occurs in most tetraspanins (Levy 
and Shoham 2005) and CD63 is shown to be highly N-glycosylated (Tominaga, Hagiwara et 
al. 2014), with three N-linked glycosylation sites. In contrast to other tetraspanins, however, 
tetraspanin CD81 is non-glycosylated (Levy 2014). The glycosylation occurs mainly in the 
large extracellular domain (EC2) on putative N-glycosylation sites. Nevertheless, 
glycosylation could also occur in the small extracellular loop (EC1) of CD9 (Boucheix and 
Rubinstein 2001). In glycosylated tetraspanins, the glycosylation may be needed to obtain 
correct protein folding and successful tetraspanin passing from the endoplasmic reticulum 
(ER) (Scholz, Sauer et al. 2009). Furthermore, it could be essential for tetraspanin function 
and association with partner proteins: disruption of N-linked -glycosylation sites of CD82 
affected cell motility and association with α5 integrin (Ono, Handa et al. 2000). On the other 
hand, α3β1 integrin glycosylation was shown to be vital in tetraspanin CD151 action 
(Baldwin, Novitskaya et al. 2008) and has an impact on its association with tetraspanin 
CD151 and cell motility (Ranjan, Bane et al. 2014). The importance of CD63 glycosylation 
was indicated in lateral association; CD63-CXCR4 receptor interaction was decreased as a 
consequence of CD63 glycosylation interruption and consequently led to reduced cell surface 
level of CXCR4 (Yoshida, Ebina et al. 2009). 
1.1.5 Tetraspanin trafficking 
The production of tetraspanin proteins, as for many proteins, occurs in the endoplasmic 
reticulum (ER) (Tsai and Weissman 2010); the transmembrane regions plays a part in the exit 
of the tetraspanins from the ER. Any alterations in the transmembrane regions of CD9, CD82, 
CD151and uroplakins (lb) leads to ER retention and prevents the tetraspanin protein reaching 
cytoplasmic membranes or the plasma membrane (Toyo-oka, Yashiro-Ohtani et al. 1999, 
Berditchevski, Gilbert et al. 2001, Cannon and Cresswell 2001, Zhou, Liu et al. 2004, Tu, 
Kong et al. 2006). In some cases, the interaction of tetraspanins with partner proteins in the 
ER plays a role in their trafficking to the plasma membrane (Berditchevski and Odintsova 
2007). 
The tetraspanins were first recognized as cell surface  markers, but now it is obvious that 
several tetraspanins are related to the endosomal pathway, for example early and late 
endosomes, multi-vesicular bodies (MVBs) and lysosomes and also with many type of 
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secretory vesicles. (Berditchevski and Odintsova 2007, Andreu and Yanez-Mo 2014). The 
internalization of tetraspanins may occur by endocytosis and transfer into intracellular 
vesicles. On the other hand, the fusion of these secretory tetraspanin containing vesicles with 
the cytoplasmic membrane can occur. In the same manner, the fusion of late endosomes and 
multi-vesicular bodies with the cell membrane may also occur and release tetraspanin protein-
enriched exosomes (Andreu and Yanez-Mo 2014). 
Tetraspanin internalisation could occur through a tyrosine-based motif YXXØ (where Y 
indicates tyrosine, X indicates any amino acid and Ø indicates a hydrophobic amino acid) 
that is found in the CD63 C-tail domain. This motif interacts with adaptor protein (AP) 
complexes that are involved in CD63 internalisation (Rana and Zoller 2011). However, not 
all tetraspanins have this motif (e.g. CD9). In addition to CD63, this motif is found in another 
12 tetraspanins members. Nevertheless, in about half of these tetraspanins, this motif may be 
located too close to the plasma membrane spanning regions, which may inhibit the interaction 
with the AP complex. Other potential sorting motifs are present in some  tetraspanins (e.g. 
di-leucine  motifs in tetraspanin RDS, oculospanin and CD231), as reviewed in  
(Berditchevski and Odintsova 2007).  Removing the signal of the supposed tyrosine-based 
sorting in some tetraspanins did not inhibit their internalisation, however, so the trafficking 
of these tetraspanins could be independent of the  AP pathway or involve the non-cytoplasmic 
region, for example TM domains, to associate them into appropriate cargo for AP adaptors 
(Berditchevski and Odintsova 2007). Moreover, it has been hypothesised that the tetraspanins 
without a tyrosine-based motif or those that cannot mediate  tyrosine-based motif/AP 
complex interactions could rely on their associated partners that have functional YXXØ motif 
to obtain internalisation (reviewed in (Rana and Zoller 2011). 
 
Tetraspanin CD63 synthesis has been well studied and the role of tetraspanin CD63 in 
endocytosis was identified early (Marks, Ohno et al. 1997, Bonifacino and Traub 2003). Due 
to the presence of the GYEM lysosomal targeting/internalisation motif, the C-terminal 
intracellular domain interacts with various subunits of adaptor proteins (µ2, µ3A, µ3B and 
µ4). In consequence, CD63 trafficking is linked with the clathrin dependent route and 
alteration of tyrosine to alanine in this tetraspanin in a rat fibroblast cell line completely 
abolished CD63 trafficking to lysosomes (Rous, Reaves et al. 2002). Furthermore, syntenin-
1, that is associated with CD63, can prevent the AP-2 dependent internalization pathway; 
moreover, syntenin-1 was shown to interact directly with CD63, and this interaction is driven 
by the cytoplasmic CD63 C-tail. Increased expression of syntenin-1 lowered constitutive 
tetraspanin internalization and expressing syntenin-1 mutants in cells completely abolished 
CD63 internalization (Latysheva, Muratov et al. 2006). More details on this will covered in 
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the Introduction section of chapter 7. The tetraspanin CD63 is present and transferred between 
many cellular compartments such as lysosomes, late endosomes, secretory vesicles and the 
plasma membrane. A number of studies have indicated that CD63-mediated internalization 
of associated partner proteins may regulate their cell surface expression and activity. For 
example, it associates with the H-K-ATPase proton pump found in gastric parietal cells and 
enhances its internalization (Duffield, Kamsteeg et al. 2003). Other tetraspanins may also 
control expression of their partner proteins by inducing their internalization, as noticed in 
CD151 and integrins, CD82 and EGFR, reviewed in (Berditchevski and Odintsova 2007). 
1.1.6 Tetraspanin function 
TEMs have been associated with various cell events including primarily adhesion, motility, 
cell:cell fusion, intracellular signaling and cell: cell interactions  (Figure 1.4) (Yanez-Mo, 
Barreiro et al. 2009) as well as invasion of cancer (Tarrant, Robb et al. 2003) and apoptosis 
(Lapalombella, Yeh et al. 2012). Furthermore, tetraspanin proteins are found to be involved 
in infectious disease pathology (Martin, Roth et al. 2005, Hassuna, Monk et al. 2009, van 
Spriel and Figdor 2010, Monk and Partridge 2012), for instance viral diseases (Pileri, 
Uematsu et al. 1998, Shanmukhappa, Kim et al. 2007, Thali 2011, Gui, Wang et al. 2012), 
prion infection (Griffiths, Heesom et al. 2007), fungal diseases (Rittenour and Harris 2008), 
parasitic diseases (Yalaoui, Huby et al. 2008, Dang, Yagi et al. 2012, Piratae, Tesana et al. 
2012) and bacterial diseases (Tham, Gouin et al. 2010, Green, Monk et al. 2011). In this 
section, the main implications of tetraspanin proteins involvement in different biological cell 
functions will be highlighted in more detail.  
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Figure 1.4: Functions of tetraspanin-enriched microdomains (TEMs). TEMs promote adhesion 
receptor clustering or segregation to mediate different cellular events such as invasion and cell migration, 
related cell membrane fusion function, intracellular trafficking events. This figure is reproduced with 
permission from Trends in Cell Biology (Yanez-Mo, Barreiro et al. 2009). 
 
1.1.6.1 Cell adhesion and motility 
Tetraspanin microdomains are associated with many of the cellular events related to 
intercellular adhesion and migration (Mazzocca, Carloni et al. 2002, Barreiro, Yanez-Mo et 
al. 2005, Yanez-Mo, Sanchez-Madrid et al. 2011). The tetraspanins such as CD9, CD63, 
CD53, CD82, CD81, CD151 and Tspan-4 (NAG2) engage in primary and secondary 
interactions with laminin binding integrins including α7β1, α3β1, α6β1, α6β4 and α4 
integrins. There is no indication, however, that tetraspanins change the conformation of 
integrins or their affinity for ligand and the tetraspanins commonly show no effect on 
stationary cell adhesion, whereas they have significant impact on integrin dependent 
migration, spreading and cell morphology (Hemler 2003). The best characterized interaction 
is that of CD151 with α3β1 integrin; this is a direct, primary interaction and it has been studied 
via site-directed mutagenesis (Berditchevski, Gilbert et al. 2001, Kazarov, Yang et al. 2002). 
CD151 is also reported to associate with α6 integrin (Kazarov, Yang et al. 2002). Mutations 
in EC2-CD151 altered primary integrin interactions with α3 and α6 integrins; this did not 
affect integrin dependent cell adhesion but altered cell spreading and cellular morphology. 
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Deletion of palmitoylation sites had less impact on primary interaction with α6β3 integrin, 
but the secondary interactions with other tetraspanins were reduced.  
 
The tetraspanin-web also provides a means for engaging phosphatases, kinases and other 
signaling molecules which are linked with tetraspanins that might regulate integrin dependent 
activities. Thus, a variety of tetraspanins were shown to interact with phosphatidylinositol 4- 
kinase (PI(4)K) and protein kinase C (PKC) isoform, that can enhance aggregation of 
signaling compounds via binding these enzymes with integrin hetero-dimers (Berditchevski 
2001). 
 
Some membrane proteases have been confirmed to reside in TEMs and their location is 
essential for their co-recruitment with integrins and proteolysis of the extracellular matrix 
during cell migration (Yanez-Mo, Barreiro et al. 2009). A disintegrin and metalloprotease 
(ADAM) are another TEMs associated group of proteins which have important roles in cell 
adhesion and shedding of a rising number of common substrates including adhesion proteins, 
cytokines, receptors and growth factors, and thus impact on many different types of cell 
activities (Yanez-Mo, Sanchez-Madrid et al. 2011). 
 
 The action of tetraspanins members as adhesion regulators with other associated proteins has 
been studied. CD9 plays an important role in cell adhesion and is directly associated with 
ALCAM (a member of the immunoglobulin superfamily of cell adhesion molecules (Ig-
CAMs)) on the surface of leukocytes. CD9 was shown to enhance ALCAM function by 
facilitating clustering of the protein and up-regulating its surface expression (Gilsanz, 
Sanchez-Martin et al. 2012). Furthermore, it was found that tetraspanin CD151 engages Ras, 
Ras1, and Cdc42 to the plasma membrane area promoting production of α3β1/ α6β1 integrin-
CD151-GTPase complexes that enhance adhesion (Hong, Jeoung et al. 2012). In another 
study, a role for CD151 in epithelial cell-cell adhesion as a regulator of PKC and Cdc42- 
dependent actin cytoskeletal reorganization was described (Shigeta, Sanzen et al. 2003). In 
addition, tetraspanins CD9 and CD151 associate with and have a critical role in the 
appropriate adhesion function of ICAM-1 and VCAM-1 during trans-endothelial migration 
and adhesion of white blood cells (WBCs) (Barreiro, Yanez-Mo et al. 2005). Tetraspanin 
CD63 is also associated with two other proteins MMP-3 and Cdc42 involved in cell adhesion 
and migration processes (Lee, Hadi et al. 2005). 
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1.1.6.2 Tetraspanins and the cytoskeleton 
The tetraspanin-enriched microdomains can be linked with the cytoskeleton and are 
associated especially with microvilli and cell to cell contact structures  (Yanez-Mo, Barreiro 
et al. 2009). Binding between tetraspanin CD81 C- terminal domain and the actin linker ezrin-
radoxin-moesin (ERM) has been proved and this direct connection works as a linker to 
connect the actin cytoskeleton with tetraspanin microdomains to regulate cell mobility and 
division (Sala-Valdes, Ursa et al. 2006). Furthermore, there is evidence for a role for 
tetraspanins in organizing the formation of large tubular structures in the cell membrane. 
Tetraspanins and their related proteins localize at tubular structures (adhesion zipper, 
microvilli, penetration peg and foot processes). It has been suggested that tetraspanins may 
act as constructional and/or developmental regulators of tubular structures such as microvilli 
or nanovilli, cell-matrix and cell-cell interfaces membranes tubules and intracellular 
membrane compartment tubules (Zhang and Huang 2012). Furthermore, CD9 has been found 
in egg membrane microvilli, which is important in sperm-egg fusion and targeting CD9 leads 
to changes in the density, length and thickness of microvilli, that lead to sperm losing fusion 
ability (Runge, Evans et al. 2007). Tetraspanins CD63 and CD9 have been found in 
"filopodia" of platelets activated by thrombin (Israels and McMillan-Ward 2007). 
Tetraspanin CD81 is also found in microvilli of the interior side of retinal pigment epithelium 
cells (Pan, Brown et al. 2007).  
 
Signaling through CD82 in T-cells produces long-term adhesion and membrane extension 
development and there is an inducible association between CD82 and the cytoskeleton matrix 
(Lagaudriere-Gesbert, Lebel-Binay et al. 1998). CD82 was shown to regulate the association 
of lipid rafts with the actin cytoskeleton in T cells which is important for T-cell co-stimulation 
(Delaguillaumie, Harriague et al. 2004). Finally, in a model of aortic smooth muscle, 
knocking down CD9 led to cells that were smaller, rounder and less contractile than controls 
as a result of changes in actin fiber arrangement. This appeared to be related to a role for CD9 
in RhoA activation, since levels of GTP-bound (active) Rho were also lowered in the CD9 
KD cells. (Herr, Mabry et al. 2014). 
 
1.1.6.3 Fusion  
There are essential biological events underlying cell membrane fusion such as sperm-egg 
fusion, myofibril formation, cell invasion by viruses, formation of multinucleated giant cells 
and osteoclasts from macrophages and trafficking of intracellular proteins (Le Naour, 
Rubinstein et al. 2000, Horsley and Pavlath 2004, Fanaei, Monk et al. 2011). Many 
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researchers have considered the importance of tetraspanins in cell:cell fusion. CD9-/- female 
mice show an extreme decline in fertility, because sperm lack the ability to integrate with the 
ovulated eggs in CD9-/- females (Le Naour, Rubinstein et al. 2000). Also, sperm-oocyte 
fusion is entirely blocked by targeting CD9 with monoclonal anti-CD9 antibody (Miller, 
Georges-Labouesse et al. 2000). It has also been suggested that the capability of the zona 
pellucida to merge with sperm could be controlled by production of CD9 by the oocyte 
(Komorowski, Baranowska et al. 2006). The EC2 region of CD9 is suggested to have a crucial 
role in male and female gametocytes binding and fertilization (Longhurst, Jacobs et al. 2002, 
Zhu, Miller et al. 2002, Higginbottom, Takahashi et al. 2003).  Several proteins known to 
associate with tetraspanins may play a role in sperm-oocyte adhesion and fertilization. It was 
found that the sperm ADAMs and oocyte β1 integrin-associated proteins are involved in 
sperm-oocyte adhesion and fertilization, and it has been suggested the female gametocyte 
tetraspanin-web enhances fertilization and promotes connections between ADAMs and 
integrin (Evans 2001, Takahashi, Bigler et al. 2001, Wong, Zhu et al. 2001). It has also been 
proposed that the role of CD9 might be to regulate the redistribution of several proteins on 
the cell membrane in clusters with α6/β1-integrin (Ziyyat, Rubinstein et al. 2006). Other 
studies have shown a complementary effect of CD9 and CD81 in fertilization events 
(Sutovsky 2009). In mice, by deleting the CD81 gene, the female fertility was reduced, 
because of loss of the oocyte ability to bind with sperm, whereas knock out of both CD9 and 
CD81 lead to complete female sterility (Rubinstein, Ziyyat et al. 2006, Tanigawa, Miyamoto 
et al. 2008, Sutovsky 2009). 
 
The formation of multinucleated muscle fibers from myoblast fusion is essential for muscle 
development (Taylor 2000). The tetraspanins CD9 and CD81were shown to be essential to 
support myotube fusion and maintenance in vitro (Tachibana and Hemler 1999). 
Furthermore, CD9 and CD81 appear to be involved in controlling muscle cell fusion during 
muscular regeneration (Charrin, Latil et al. 2013). 
 
Tetraspanins have also been implicated in the fusion of mononuclear phagocytes to form 
osteoclasts (involved in bone homeostasis) and multinucleated giant cells associated with 
chronic inflammation or infection, reviewed in (Fanaei, Monk et al. 2011). By targeting CD9 
and CD81via mAbs, the giant cell formation induced by Con A stimulation of human 
monocytes was enhanced (Takeda, Tachibana et al 2003; Parthasarathy, Martin et al 2009). 
Recombinant CD63 and CD9 EC2 proteins were also shown to prevent giant cells formation, 
while there was no effect of CD81 EC2 (Parthasarathy, Martin et al. 2009). Knock-out CD9 
and CD81 mice spontaneously formed giant cells in alveolar tissue and osteoclasts in the 
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osseous tissue, suggesting that CD9 and CD81 work cooperatively to inhibit multinuclear 
cells formation (Takeda, Tachibana et al. 2003). Recent studies from our group using 
recombinant CD9/CD81 EC2 chimeras, identified a distinct region of CD9 that appears to be 
involved in regulation human monocyte fusion (Hulme, Higginbottom et al. 2014). 
 
Tetraspanin microdomains may also be important in cell fusion involved in the development 
of tumor metastasis, whereby cancer cells acquire metastatic properties. Tetraspanins 
CD81/CD9 along with GTP-binding protein, ADAM10, radixin, α13, RhoA and myosin 
regulatory light chain  where shown to be involved in colon tumor cell fusion regulation 
(Carloni, Mazzocca et al. 2012). 
 
Fusion can also occur in enveloped viral infections such as HIV-1 virus; the viral envelope 
protein (Env) attaches to the target cell surface structure and enhances penetration into the 
cell (Larsson, Bjerregaard et al. 2008). A role for tetraspanins CD81 and CD9 in HIV-1Env- 
cell membrane fusion was indicated by the finding that when the CD9 and CD81expression 
is knocked down, the formation of syncytia and viral entrance are increased  (Gordón-Alonso, 
Yañez-Mó et al. 2006). Recent overexpression and microscopy studies indicate that CD9 and 
CD63 negatively regulates HIV-induced fusion by inhibiting a particular stage of the fusion 
process (Symeonides, Lambele et al. 2014). Also, the Env viral protein is able to induce 
formation of multinuclear syncytia resulting from the fusion between infected cells and non-
infected cells, yet the syncytia forming mechanism is still poorly understood (Fanaei, Monk 
et al. 2011). In canine distemper virus (CDV) infected cells, studies using anti-CD9 antibodies 
indicate CD9 acts as a cell-cell fusion regulator by restricting access of the viral fusion 
machinery at cell: cell contact regions (Singethan, Muller et al. 2008). More recent work 
showed that tetraspanins appear to regulate fusion induced by Burkholderia bacteria 
(Elgawidi, 2016, PhD thesis, University of Sheffield). 
1.1.6.4 The role of tetraspanins in cancer  
Various studies of human tumors and cancer cell lines have shown a role for tetraspanin 
proteins in promoting or suppressing tumor adhesion, invasion, migration, angiogenesis and 
metastasis, and targeting particular tetraspanins could have value in terms of cancer treatment 
or prognosis. Their involvement in cancer appears in many cases to be related to their 
interaction with proteins involved in cell adhesion and migration (integrins, membrane 
proteases) and signaling molecules. Some tetraspanins, for instance CD151, appear to 
promote cancer development and metastasis and their expression is associated with poor 
prognosis, whereas others (e.g. CD82) are described as metastasis suppressors. A full analysis 
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of the role of tetraspanins in cancers is outside the scope of this introduction but is covered 
in recent reviews (Wang, Li et al. 2011, Sala-Valdes, Ailane et al. 2012, Hemler 2014). 
1.1.6.5 Tetraspanins and infections  
The tetraspanins have important roles in infectious disease pathology (Martin, Roth et al. 
2005, Hassuna, Monk et al. 2009, van Spriel and Figdor 2010, Monk and Partridge 2012). 
Their involvement in viral diseases has long been recognized e.g. HCV, HIV, influenza virus, 
white spot syndrome virus (WSSV), and porcine reproductive and respiratory syndrome virus 
(PRRS) (Pileri, Uematsu et al. 1998, Shanmukhappa, Kim et al. 2007, Thali 2011, Gui, Wang 
et al. 2012). However they may also be involved in prion infection (Griffiths, Heesom et al. 
2007) and roles in bacterial diseases such as  Neisseria meningitidis, Listeria monocytogenes 
(Tham, Gouin et al. 2010, Green, Monk et al. 2011, Martinez del Hoyo, Ramirez-Huesca et 
al. 2015) have been reported. They are also linked to fungal diseases such as Aspergillus and 
Candida infection (Artavanis-Tsakonas, Kasperkovitz et al. 2011) and parasitic diseases such 
as malaria, human liver fluke and Echinococcosis (Yalaoui, Huby et al. 2008, Dang, Yagi et 
al. 2012, Piratae, Tesana et al. 2012) (Figure 1.5). 
 
 
Figure 1.5: The role of tetraspanins in microbial infections explaining the possible mechanisms. I- 
Using TEMs by microbe to invade the host cell. II- The cooperative role of tetraspanins and receptors to 
kill the microbes. III- Tetraspanins modulate signaling pathway and interfere with production of cytokines. 
Figure modified with permission from Microbes and Infection (van Spriel and Figdor, 2010). 
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1.1.6.5.1 Tetraspanins and viral diseases 
The tetraspanins are involved in many stages of viral infections including attachment, 
development of syncytia and exit of the virus (Martin, Roth et al. 2005, Martin, Roth et al. 
2005, Meuleman, Hesselgesser et al. 2008, van Spriel and Figdor 2010, Monk and Partridge 
2012). As will be described below, I am going to consider the best characterized examples 
for viral infection such as HCV and HIV infection. 
  
1.1.6.5.1.1 Hepatitis C Virus (HCV) 
The hepatitis C virus is the main cause of viral hepatitis and this infection occurs in 3% of 
the global population. Chronic HCV infection is the primary cause of hepatic disease, which 
includes cirrhosis, fibrosis and hepatocellular carcinoma (Bartosch and Dubuisson 2010, 
Feneant, Levy et al. 2014). In addition, it is related to B lymphocyte proliferative disorder 
and cryoglobulinemia (Pileri, Uematsu et al. 1998). The hepatocytes are the main target of 
this RNA enveloped virus. A complex sequence of steps occurs to initiate and develop HCV 
infection in which tetraspanin CD81 takes a part (reviewed in (Feneant, Levy et al. 2014)). 
The envelope protein of HCV (E2) attaches to CD81, which acts as a virus co- receptor for 
human cells and is expressed on hepatocytes and lymphocytes (Pileri, Uematsu et al. 1998). 
Prevention of attachment between CD81 and HCV E2 is one key point to prevent virus entry 
and the basis for production of drugs for HCV disease treatment (Ziegler, Kronenberger et al. 
2009). By targeting the HCV E2 and their receptors in the cell (CD81 and low density 
lipoprotein receptor (LDLR)) via siRNAs, the number of HCV particles in infected cells is 
decreased significantly (Jahan, Khaliq et al. 2011, Jahan, Samreen et al. 2011, Davis, Harris 
et al. 2012). CD81 de-palmitoylation also reduces the sensitivity of target cells to HCV (Zhu, 
Luo et al. 2012).The interaction of HCV E2 with CD81 has also been implicated in the down-
regulation of IL-2 secretion by T-cells, by targeting the translocation of protein kinase C beta 
(which is required for IL-2 secretion) to lipid rafts. This may provide a new mechanism for 
HCV to avoid the immune response (Petrovic, Stamataki et al. 2011). The formation of 
claudin-CD81 complexes plays a role in virus trafficking and enhances virus entry (Harris, 
Davis et al. 2010, Farquhar, Harris et al. 2011, Farquhar, Hu et al. 2012). An essential role 
for CD81 residues T149, T153 and E152 in the association of claudin-1 and infection with 
HCV was found (Davis, Harris et al. 2012). 
 
1.1.6.5.1.2 Human immunodeficiency virus (HIV) 
HIV-1 is a venereal viral disease; in the early stages, it infects lymphatic tissue to set up a 
persistent infection and this tissue acts as producer and reservoir of the virus in an active 
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process which gradually exhausts the immune systems CD4+ T cells and macrophages to set 
the stage for AIDS (Haase 1999, Li, Dziuba et al. 2011). In macrophages, the tetraspanin 
CD63 seems to have an important role in production of HIV-1, either in early post invasion 
or during the reverse transcription phase (Li, Dziuba et al. 2011). Knocking-down CD63 in 
macrophages reduced infection by laboratory strains of HIV and in  CD4+ve T cells led to a 
significant decrease of virus production in these cells (Li, Endsley et al. 2014). In contrast, 
other research has found that tetraspanin CD63 expression is not essential “at least in tissue 
culture” for HIV-1 infection or replication (Ruiz-Mateos, Pelchen-Matthews et al. 2008). The 
exit of HIV-1 from T lymphocytes is reported to involve TEMs. The tetraspanins CD81, 
CD63 and to a smaller extent CD9 are inducted into the virological synapse, thus, targeting 
those tetraspanins decreases viral spread (Jolly and Sattentau 2007). Other data using 
antibodies and specific knock-down have shown TEMs in T lymphocytes, in particular CD81, 
are important in release of HIV-1 and of HIV replication (Grigorov, Attuil-Audenis et al. 
2009). As mentioned previously (1.1.6.3) CD81 and CD9 may also play a part in negatively 
regulating membrane fusion induced by the HIV-1 envelope protein Env (Gordon-Alonso, 
Yanez-Mo et al. 2006). Tetraspanin over-expression also down-regulated syncytium 
formation and this also required viral Gag, which is required for the engagement of Env to 
TEMs (Weng, Krementsov et al. 2009). In dendritic cells, HIV-1 was shown to be internalized 
into a non-lysosomal and non-conventional endocytic compartment containing tetraspanins. 
It may selectively overturn elements of the intracellular trafficking system that are needed for 
development of the dendritic cell immunological synapse to enhance its own transference and 
distribution between cells (Garcia, Pion et al. 2005). Generally, tetraspanins expression, in 
particular CD81, was shown to be decreased in cells infected with HIV-1, and it has been 
reported that the HIV-1 viral accessory protein (Vpu) is responsible for CD81 down-
regulation in HIV-1 infected T cells and increased HIV-1 virus infectivity (Lambele, 
Koppensteiner et al. 2015). 
 
1.1.6.5.1.3 Influenza virus 
Infection by influenza virus is a major world health worry causing high illness and death rates 
and economic disadvantage (Perwitasari, Yan et al. 2013). The incorporation of tetraspanins 
CD9 and CD82 into the viral envelope has been identified; β1 integrin that is associated with 
tetraspanin was also discovered. A role for the tetraspanin CD81 in influenza A virus 
uncoating and virus budding has been implicated, since CD81 depletion affected both of these 
processes; influenza trafficking was also shown to occur in CD63 positive late endosomes 
(He,Sun et al 2013). A recent study found that TEMs were involved in infection by Corona 
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viruses and low pathogenic type A influenza virus; cleavage of viral glycoproteins (priming) 
prior to virus: membrane fusion occurred in TEMs which contained virus receptors and 
priming proteases (Earnest, Hantak et al. 2015). 
 
1.1.5.5.1.4 Other viral infections 
There are many studies investigating the importance of tetraspanins in viral diseases apart 
from all those mentioned previously in this review. An association of tetraspanin CD9 in 
adeno-associated virus (AAV) infection that causes breast cancer was investigated (Kurzeder, 
Koppold et al. 2007). The relation of tetraspanin CD82 with adhesion of human T cell 
lymphotrophic virus,  type1(HTLV-1) and  the importance of  intracellular tetraspanin 
domains of CD81 and CD82 in mediation  of this virus Gag protein with TEMs is suggested 
(Pique, Lagaudriere-Gesbert et al. 2000, Mazurov, Heidecker et al. 2006, Mazurov, 
Heidecker et al. 2007). Furthermore, CD151 is reported to be associated with different stages 
of human papilloma virus (HPV) infection (reviewed in (Scheffer, Berditchevski et al. 2014). 
The tetraspanin CD151 is also suggested to participate in infection by porcine reproductive 
and respiratory syndrome virus (PRRSV) in cell culture (Shanmukhappa, Kim et al. 2007). 
 
1.1.6.5.2 Tetraspanin and prion diseases 
The term prion related protein (PrP) is used to define active infectious proteins which cause 
a spongiform encephalopathy in humans and animals (Lantos 1992, Caughey and Chesebro 
1997, Edskes and Wickner 2004). TEMs  have been implicated in  PrP (s) trafficking and 
internalization  (Griffiths, Heesom et al. 2007). In addition an interaction between 
tetraspanin-7 (CD231) and cellular prion protein has been suggested with PrP(C) binding 
with CD231 through the region in bovine PrP (154-182) containing α-helix 1(Guo, Huang et 
al. 2008). The up-regulation of tetraspanin protein CD9, usually expressed  in nervous system 
cells, may play a part in glial cells degeneration of  mice with transmissible spongiform 
encephalopathy (Doh-Ura, Mekada et al. 2000).  
 
1.1.6.5.3 Tetraspanin and fungal diseases 
Frequently opportunistic diseases are caused by fungi, which live in normal individuals 
commensally. Yet, these may be able to induce infections if the host immune status is changed 
(Bar, Gladiator et al. 2012). Various  studies have shown  interactions of fungal pattern-
recognition receptor  (F-PRRs)  and tetraspanins in a variety of antigen presenting cells such 
as B cell, monocytes,  neutrophils and macrophages (Figdor and van Spriel 2010). Dectin-1 
Chapter 1 
22 
 
molecules play an essential role in starting the immune responses against fungi and 
tetraspanins CD63 and CD37 are suggested to interact with human Dectin-1 (van Spriel and 
Figdor 2010). Another study reports that CD37-deficient mice have obviously improved 
protection against Candida albicans infection compared with wild type mice (van Spriel, Sofi 
et al. 2009). Another lethal disease in immune deficient patients is the Cryptococcus 
neoformans fungal infection (de, Fontes et al. 2016). The tetraspanin CD63 was shown to be 
recruited to phagosomes containing C. neoformans independently of MHC class II and 
LAMP-1 (Artavanis-Tsakonas, Love et al. 2006). Furthermore, CD82 was also shown to be 
recruited to Cryptococcus neoformans-containing phagosomes before it fuses with lysosomes 
(Artavanis-Tsakonas, Kasperkovitz et al. 2011). 
 
1.1.6.5.4 Tetraspanin and protozoal infection 
Protozoal diseases are one of the most fatal types of infections, in particular malaria, a disease 
that is caused by the genus Plasmodium. This protozoa causes millions of deaths annually 
(Craft 2008). The liver cells are the main initial targets from this parasite, which forms a 
parasite oophorous vesicle and is then transmitted into red blood cells as an invasive 
merozoite leading to the appearance of malarial clinical signs (Silvie, Rubinstein et al. 2003). 
The tetraspanin CD81 is essential for invasion and infection of the liver cells via sporozoites 
(Silvie, Rubinstein et al. 2003, Monk and Partridge 2012). Another study found that the 
infection with malarial parasites depends on the type of infected cells; for some cells the 
Plasmodium berghei infection does not rely on tetraspanin CD81 or membrane cholesterol of 
host cells, whilst in other cells they play an important role for this parasite infection (Silvie, 
Franetich et al. 2007). The interaction between tetraspanin CD81 and one of its partner 
proteins EWI-F in hepatocytes was found to negatively affect the function of this tetraspanin 
in P. yoelii infection (Charrin, Yalaoui et al. 2009). Recently, increasing levels of 
immunoglobulin E autoantibodies to the brain 14-3-3 epsilon protein was recognized in 
Plasmodium falciparum subclinical malaria. This protein is able to bind to tetraspanin CD81 
and IgE antibodies to it may interfere with CD81-dependent entry of the parasite at the liver 
stage of disease (Duarte, Herbert et al. 2012). 
 
1.1.6.5.5 Tetraspanin and Bacterial infection 
One of the first described examples of tetraspanins being involved in bacterial infections was 
the role of uroplakin tetraspanins in infection by uropathogenic E.coli. The four various 
uroplakins (Ia, Ib, II and III with Ia and Ib being tetraspanin members) are integral membrane 
proteins found in membrane plaques that cover the apical urinary epithelium surface of 
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mammals. The assembly of UPs into the plaques have a special barrier activity for water and 
toxic substances in urine (Lee 2011). Uropathogenic Escherichia coli accounts for 90 percent 
of total urinary tract infections in humans. The infection is initiated by bacterial adhesion to 
urothelial cells via lectin type 1-fimbria (FimH) (Katnik-Prastowska, Lis et al. 2014). Many 
uropathogenic E. coli (UPECs) showed the ability to express type 1 and P fimbriae that bind 
urothelium cell surface receptors. The recognition of two main glycoproteins of urothelial-
apical plaques (uroplakins Ia and Ib) was shown in type 1-fimbrinated UPECSs (Wu, Sun et 
al. 1996, Min, Stolz et al. 2002, Wang, Min et al. 2009, Lee 2011). The specific binding of 
FimH to mannose-rich glycans connected to Asn 169 of 1a uroplakin was demonstrated. The 
binding of the uroplakin embedded membrane and a bacterial envelope has been indicated by 
EM studies. The shedding of necrotic and/or damaged epithelial cells follows the binding of 
positive FimH Pilli bacteria and the epithelial cells of urinary bladder. This appears as a part 
of innate immune response against the infection. Survival of the bacteria may occur through 
invasion of deep layers, however, in which the bacteria are able to replicate leading to latent 
or persistent infections and antibiotic avoidance (reviewed in Monk and Partridge 2012).  
 
 The interaction of TEMs in the plasma membrane may include bacterial adhesion receptors. 
The essential role of tetraspanin proteins in bacteria adhesion to epithelial cells has been 
suggested by studying the role of tetraspanins CD9 and CD63 in the adhesion of Neisseria 
meningitidis and other species of bacteria such as Neisseria lactamica, Streptococcus 
pneumonia, Escherichia coli, and Staphylococcus aureus. It was found that the tetraspanins 
are needed for optimal bacterial adhesion (Green, Monk et al. 2011). Furthermore, other 
research using siRNA has shown the role of tetraspanin CD81 in Listeria monocytogenes 
invasion into host cells, possibly through its recruitment of Type II phosphoinositol kinases 
4 (PI4KIIβ) to entry sites (Tham, Gouin et al. 2010). Association of CD81 with Rac was also 
shown to regulate both non-specific and acquired immune responses against bacterial 
infections. Generalized Listeriosis was decreased in CD81-KO compared with WT infected 
mice; this result was shown to be correlated with high number of splenic monocytes and 
dendritic cells in CD81-KO mice. In addition, the CD81 suppresses Rac activation resulting 
in decreased expression of both TNF-α and NO in dendritic inflammatory cells (Martinez del 
Hoyo, Ramirez-Huesca et al. 2015). 
 
Chlamydia is an obligate intracellular pathogen which causes a venereal diseases, atypical 
pneumonia and eye infections This pathogen grows only in a vacuole called an inclusion 
body; and within this vacuole the bacteria acquires important survival resources from the 
host cell (Valdivia 2008). An association between Chlamydia inclusion body and selective 
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delivery of CD63 from MVBs was reported and suggested to be involved the supply of 
lipids needed for bacterial survival and infection, since treatment with anti-CD63 antibodies 
reduced Chlamydia production (Beatty 2006, Valdivia 2008). However later studies by the 
same group failed to find a direct link with CD63 (Beatty 2008). 
 
1.2 Salmonella infection  
 Salmonella is one of the Gram negative bacilli linked with human and animal diseases 
(Sánchez-Vargas, Abu-El-Haija et al. 2011) and this bacteria can grow and survive in various 
environments (Spector and Kenyon 2012). The early discovery of genus Salmonella dates 
back to 1885 when both Daniel E. Salmon and Theobald Smith (American Veterinary 
pathologist and his assistant respectively) had been searching for the causative agent of hog 
cholera that led them to discover what it so called Salmonella cholerae-suis (Fabrega and 
Vila 2013). Infection with Salmonella species is widespread (Santhi, Sunkoji et al. 2012) 
throughout Eastern and Western countries with a high death rate in poorest countries. The 
bacteria are characterized by the ability to invade phagocytic and non-phagocytic cells such 
as intestinal epithelial cells. After host cell invasion by Salmonella, these bacteria localize 
inside a membrane vesicle called the Salmonella-containing vacuole (SCVs) (Finlay, 
Ruschkowski et al. 1991, Lajarin, Rubio et al. 1996, Martinez-Lorenzo, Meresse et al. 2001, 
Sánchez-Vargas, Abu-El-Haija et al. 2011). 
1.2.1 Salmonella classification 
Classification and update of Salmonella bacteria is defined by the  Collaborating Center of 
World Health Organization (WHO) for Salmonella Reference and Research that present in 
Pasteur Institute, France, Paris, according to Kauffmann-White scheme (Issenhuth-Jeanjean, 
Roggentin et al. 2014).  Despite the complexity of Salmonella classification (Brenner, Villar 
et al. 2000), according to Kauffmann-White scheme, the Salmonella genus is classified into 
two species S. bongori, and S. enterica then sub-classified into 6 subspecies: S. enterica 
subsp. enterica, S. enterica subsp. salamae, S. enterica subsp. arizonae, S. enterica subsp. 
diarizonae, S. enterica subsp. houtenae and S. enterica subsp. indica. The S. enterica subsp. 
enterica group contains most Salmonella bacteria related to human and domestic animal 
diseases, while other S. enterica subspecies with S. bongori were found in the environment 
and in cold-blooded animals (Fabrega and Vila 2013). Otherwise, the flagellar H and O 
lipopolysaccharide (LPS) antigens are also used to classify Salmonella enterica bacteria into 
2,637 serotypes including both typhoid (human specific pathogen) and non-typhoid related 
serotypes (Issenhuth-Jeanjean, Roggentin et al. 2014, LaRock, Chaudhary et al. 2015). This 
Chapter 1 
25 
 
includes 1586 serotypes belonging to S. enterica subsp. enterica, while 22 serotypes belong 
to S. bongori species (Issenhuth-Jeanjean, Roggentin et al. 2014). 
1.2.2 Salmonella pathogenesis  
According to the World Health Organization (WHO), tens of millions of foodborne infections 
are caused by non-typhoid Salmonella (NTS) resulting in hundreds of thousand deaths each 
year (http://www.who.int/mediacentre/factsheets/fs139/en/). Different Salmonella enterica 
serovar exhibit different species specificity; Salmonella enterica serovar Typhi and 
Salmonella enterica serovar Paratyphi (A and B) affect only humans and cause a systemic 
disease called typhoid fever, that is associated with increased body temperature, headache, 
temporary diarrhea or constipation  and abdominal pain (Ohl and Miller 2001); this infection 
could lead to lethal damage in the liver, spleen,  pulmonary and/or nervous organs. The case 
fatality rate in non treated patients could reach 10-20% and drop to 1% in properly treated 
patients (Fabrega and Vila 2013). The non-typhoid serotypes (NTS) such as S. enterica subsp. 
enterica serotype Enteritidis and S. enterica subsp. enterica serotype Typhimurium have a 
wide range of specificity and cause infection in both human and animals, causing 
gastroenteritis in humans and domestic animals (LaRock, Chaudhary et al. 2015). In mice, S. 
serovar Typhimurium causes a typhoid-like systemic disease (Coburn, Grassl et al. 2007). 
However, they could also cause bacteremia and generalized infection in 
immunocompromised patients (Feasey, Dougan et al. , Gordon 2008, Dhanoa and Fatt 2009, 
Dadwal, Tegtmeier et al. 2011), in particular, in very young and older populations and rarely 
in adults individuals and animals in good health (LaRock, Chaudhary et al. 2015). Salmonella 
infections cause a various range of illness such as fever, diarrhea (with or without blood as a 
consequence of lower intestine inflammation), abdominal pain and, usually, nausea and 
vomiting, thus, it is difficult to distinguish, depending on these clinical signs, between 
gastroenteritis that is caused by enteric Salmonella from other enteric bacterial pathogens 
(Coburn, Grassl et al. 2007). 
 
Salmonella infection usually occurs by oral ingesting of contaminated food or water and 
resisting the gastric acidic environment to pass to invade epithelial cells of the intestine. Here, 
NTS strains provoke inflammatory changes in these cells, including neutrophil and fluid 
infiltration into the lumen of intestine (LaRock, Chaudhary et al. 2015). Relatively high 
numbers of bacteria, about 50,000 ingested bacteria for  6-72 hours incubaton time are needed 
to intiate Salmonella infection depending on inoculum and host susceptibility (Fabrega and 
Vila 2013). The systemic infection is generated initially by Salmonella invasion of intestinal 
epithelial cells, particularly in the distal ileum and probably the cecum at the sites covering 
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Peyer’s patches (PPs) (Carter and Collins 1974). This invasion process occurs effectively 
through luminal microfold cells (M-cells) (Jones, Ghori et al. 1994, Rescigno, Urbano et al. 
2001),  and bacteria reach the mesantric lymph node through PPs by mesantric vessels that 
allows the initiation of systemic infection. Salmonella can be  phagocytosed by different cells 
including dendritic cells (DCs), neutrophils and macrophages differentiated from 
inflammatory monocytes; the last two types of cells are aquired from blood as a response to 
inflammatary signals (Cheminay, Chakravortty et al. 2004, Johansson, Ingman et al. 2006, 
Fabrega and Vila 2013). However, DCs can directly take up Salmonella from the intestinal 
lumen by a different mechanisum, which invovles  opening epithelial cell tight junctions and 
presenting its dendrites outside the epithelium to directly contact and phagocytose bacteria 
(Rescigno, Urbano et al. 2001). Once Salmonella has invaded the intestinal epithelium, and 
is contained in salmonella-containing vesicles (SCVs);  some of these then trans-cytose to the 
epithelial basolateral membranse and cross these cells to be engulfed by phagocytes. 
Migration of these phagocytic cells through the blood stream enhances systemic infection 
(Figure 1.6) (Muller, Kaiser et al. 2012). 
  
Bacteraemia develops in approximately 5% of individuals with gastroenteritis caused by 
NTS, a severe and potentially lethal problem that occurs particularly in immunocompromised 
pationts: old and young patients, HIV infected patients and those with chronic illness. Such 
patients are more at risk of developing focal infections as well (Hohmann 2001), such as 
septic artheritis, meningitis, osteomylitis, pericarditis and endocarditis, penumonia and 
cholangitis  (Lee, Puthucheary et al. 1999, Zaidi, Bachur et al. 1999, Hohmann 2001, Gulan, 
Jotanovic et al. 2010, Lakew, Girma et al. 2013, Uygur, Reddy et al. 2013, Ortiz, Siegal et al. 
2014, Khan, Kumar et al. 2015). Furthermore, development of endarteritis particularly that 
associated with the abdominal aorta in adults is a serious complication of Salmonella 
bacteraemia (Hohmann 2001, Fabrega and Vila 2013). By contrast, the fatality rate due to 
NTS infection is about 24% in 3rd world countries, where infections by Salmonella contribute 
to diarrhea morbidity and mortality and are a common cause of hospital admissions among 
children, and a frequent cause of bacteremia.  Symptoms in children are often severe, for 
instance increased inflammation, bloody diarrhea, with longer infection times and a higher 
risk of complications arising (Mandomando, Macete et al. 2009, Mtove, Amos et al. 2010, 
Ansari, Sherchand et al. 2012).  
 
Also clinically important is the existence of a carrier state for NTS infection, which is 
evident in NTS in human and farm animals (Monack 2012, Fabrega and Vila 2013). This is 
often associated with  production of biofilms and asymptomatic carriers can act as a 
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reservoirs of infection and spreading the disease (Fabrega and Vila 2013). The carrier form 
of the disease has been investigated using serovar Typhimurium to establish a long-term 
chronic infection in a mouse model. Using a mouse strain that does not succumb to acute 
infection, Salmonella can be recovered up to 12 months after infection from systemic sites 
in symptom-free mice. Surviving bacteria, many of which may be in a non-replicative or 
latent state, were segregated inside tissue macrophages. Bacterial survival in macrophages 
may therefore enhance persistent infection (Monack 2012). 
 
1.2.3 SPIs and Salmonella infection 
 Salmonella are characterized by the ability to invade phagocytic and non-phagocytic cells 
such as intestinal epithelial cells. After the host cell invasion by Salmonella, these bacteria 
localize inside a membrane vesicle called the Salmonella-containing vacuole (SCV), where 
they can survive and replicate (Finlay, Ruschkowski et al. 1991, Martinez-Lorenzo, Meresse 
et al. 2001, Sánchez-Vargas, Abu-El-Haija et al. 2011). 
 
Following interaction between the bacterium and the host cell, entry into non-phagocytic cells 
involves cytoskeletal rearrangement, membrane ruffling and uptake. Early evidence of 
Salmonella virulence factors described a 35-40 kb area in Salmonella's DNA located at 
centisome 63 that contained the main loci coding for a type 3 secretion system (T3SS, also 
called contact dependent secretion system) (Shea, Hensel et al. 1996). This region, which 
corresponded to a pathogenicity island, encoded Salmonella virulence factors required for 
entry into non-phagocytic cells. Another Salmonella pathogenicity island (SPI-2), also 
encoding a T3SS, was shown to be required for intracellular bacterial survival (Ochman, 
Soncini et al. 1996, Hansen-Wester and Hensel 2001). The T3SS consists of a supra-
molecular structure or needle complex that spans the inner and outer membranes of S. 
Typhimurium and directs effector proteins into host cells (Kubori, Matsushima et al. 1998). 
 
The contribution of five Salmonella SPIs to the interaction with the host cell have now been 
discovered (Marcus, Brumell et al. 2000). These, together with other chromosomal and non-
chromosomal factors (such as pSLT plasmid, adhesion, flagella and biofilm formation 
essential proteins) are involved in Salmonella virulence and pathogenicity (Fig 1.6) (Fabrega 
and Vila 2013).  
 
Genes encoded by SPI-1 encode the complex and sophisticated machinery involved in 
Salmonella entrance into non-phagocytic host cells, but also other activities in the infection 
process, such as multiplication, host responses (including induction of intestinal 
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inflammation) and biofilm formation (Que, Wu et al. 2013). These effector proteins activate 
the invasion of host cells mediating the rearrangement of the actin cytoskeleton and 
enhancing internalization of bacteria. These effectors are translocated into the host cell 
through the action of the T3SS, called T3SS-1 (Fabrega and Vila 2013). SPI-1 is also 
associated with the development of SCV, the niche in which Salmonella undergo 
multiplication within the host (Que, Wu et al. 2013).  
Genes encoded by SPI-2 are generally more involved in intracellular survival. The SPI-2 
T3SS has a vital significance for intracellular Salmonella behavior and Salmonella 
pathogenicity in animal models of systemic infection (Liss and Hensel 2015). Internalized 
Salmonella use this system to translocate more than 30 proteins over the membrane of the 
SCV, which cooperatively enhance the viability and multiplication of Salmonella inside this 
organelle (Figueira and Holden 2012, Liss and Hensel 2015). SPI-2 contains two segments, 
small and large, and the large segment of SPI-2 encodes genes important in providing 
Salmonella with a suitable environment inside the SCV within epithelial and macrophage 
host cells (Fabrega and Vila 2013). It is also responsible for modulating infected host cells 
signaling pathways and altering infected cells behavior (Agbor and McCormick 2011). Less 
is known about the small segment, but the genes may confer a growth advantage over the host 
microbiota (Hensel, Nikolaus et al. 1999, Marcus, Brumell et al. 2000, Winter, Thiennimitr 
et al. 2010). 
 
Less research has been carried out on SPIs other than SPI-1 and SPI-2. SPI-3 has only four 
ORFs encoding proteins with no clear functional association between them, but it seems to 
be involved in the initial attachment, long term persistence and bacterial survival during 
systemic infection. SPI-4 also plays a role in initial contact with intestinal epithelium and has 
a probable role in long term persistent infection. SPI-5 is implicated in numerous pathogenic 
processes throughout infection (Fabrega and Vila 2013). 
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Figure 1.6: Salmonella enterica serotype Typhimurium pathogenicity model. 1. Attachment of 
Salmonella to epithelial cells mediated by SPI-3 and SPI-4 encoded proteins. 2 and 3 Salmonella invasion 
and uptake mediated by SPI-1 and SPI-5 T3SS effectors. 4: direct uptake of Salmonella by dendritic cells. 
5: intracellular Salmonella present within SCV, factors encoded by SPI-2 and the pSLT plasmid enhance 
Salmonella survival and replication within SCV. 6: Release Salmonella after transcytosis of SCVs to host 
cell basolateral membrane. 7: Salmonella are uptaken by phagocytes and present inside SCV, pSLT 
plasmid, SPI-2 and SPI-3 play a role in this process. Modified from (Fabrega and Vila 2013) 
1.2.4 Adhesion and uptake  
Salmonella bacteria have the ability to infect non phagocytic cells by a sequence of steps 
starting from adhesion of bacteria to host cells and activation of Salmonella T3SS-1, 
spreading a wave of effector proteins into the cell and triggering the rearrangement of the 
host cells actin-cytoskeleton, which is has a vital role in bacterial invasion (Misselwitz, 
Kreibich et al. 2011). Different virulence elements are involved in establishing close 
Salmonella attachment to host cells. Although the Salmonella Typhimurium genome contains 
a number of different fimbrial operons, little is known about the targets of most of these on 
host cells (reviewed in Fabrega and Vila 2013). Type-1 fimbriae are encoded by the fim genes 
and the major subunit FimA, adhesions FimI and FimH, and adaptor FimF are the main 
structural units vital to type-1 fimbriae assembly in serovar Typhimurium (Zeiner, Dwyer et 
al. 2012). These mediate attachment to the extracellular matrix through binding to 
oligomannose side chains of the laminin network, with poor adhesion to host fibronectin, 
type-1, type-3, type-4 or type-5 collagen (Kukkonen, Raunio et al. 1993). However, curli 
fimbriae (aka SEF-17) appear to be involved in the binding of S. Enteritidis to eukaryotic 
extracellular matrix protein fibronectin (Collinson, Doig et al. 1993). Pef fimbriae, encoded 
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by the pef genes on S. Typhimurium virulence plasmid, showed to bind to the trisaccharide 
Lewis X blood group antigen, which is expressed on intestinal crypt epithelial cells (Chessa, 
Dorsey et al. 2008). 
 
The Salmonella autotransporter protein MisL is an example of a Salmonella protein encoded 
by SPI-3 that may contribute to the bacterial adhesion process through binding with 
eukaryotic extracellular matrix fibronectin. This binding was found to enhance colonisation 
of intestine epithelial cells (Dorsey, Laarakker et al. 2005). The outer membrane protein PagN 
has also been shown to involve in S. Typhimurium uptake, probably through adhesion to 
heparan sulphate proteoglycans on host cells (Lambert and Smith, 2009). 
 
The host cell protein PECAM/CD31, which has a high level of mannose sugars, has been 
shown to be involved with S. serovar Typhimurium binding and also has a role in extra-
intestinal transmission of Salmonella infection to deeper tissues and controlling production 
of inflammatory cytokines by macrophages infected by Salmonella. PECAM-1 knockout 
mice were less infected with S. serovar Typhimurium with lower hepatic, splenic and 
mesenteric Salmonella, and this correlated with decreased levels of  tumor necrosis factor 
(TNF), interleukin-6 (IL-6 and monocyte chemoattractant protein (MCP). The production of 
IL-6 and TNF was also reduced in macrophages from PECAM-1 KO mice and stimulated 
with whole Salmonella, Toll-like receptor 4 (TLR-4) ligand or poly (I:C) (TLR-3 ligand) in 
vitro (Lovelace, Yap et al. 2013). 
 
As described before, effector proteins released by T3SS are translocated into the host cells to 
promote bacterial adhesion and internalization (Hansen-Wester and Hensel 2001, LaRock, 
Chaudhary et al. 2015). Membrane ruffling and actin cytoskeleton rearrangement are 
mediated by Salmonella to enhance its invasion to non-phagocytes by macropinocytosis. This 
process is dependent on SPI-1 T3SS that also reverses this action after invasion. In phagocytic 
cells such as macrophages, Salmonella uptake could be either dependent or not dependent on 
the SPI-1 system (LaRock, Chaudhary et al. 2015). Pattern recognition receptors (PRRs) 
including scavenger receptors such as CD36, the mannose receptor and members of the Toll-
like family may be involved in recognition and uptake of Salmonella by the SPI-1 
independent pathway. Opsonic receptors (e.g. complement receptors, Fc receptors) facilitate 
macrophage uptake of bacteria opsonised with complement fragments or antibodies 
(Drecktrah, Knodler et al. 2006). 
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Cytoskeletal reorganization leading to bacterial uptake is mediated mainly by translocated 
effector proteins SopB/SigD, SopE and SopE2 (Wood, Rosqvist et al. 1996, Norris, Wilson 
et al. 1998, Bakshi, Singh et al. 2000). SopB/SigD is an inositol phosphatase that as well as 
promoting actin rearrangement manipulates different cellular phospatidylinositol signaling 
pathways; for example it has an anti-apoptotic activity in epithelial cells (Knodler, Finlay et 
al. 2005) and protects SCV from cellular lysozome activity (Bakowski, Braun et al. 2010). 
Structural studies of this effector protein showed that it also interacts with the host cell Rho 
GTPase Cdc42 that plays a role in actin cytoskeleton dynamics (Burkinshaw, Prehna et al. 
2012). SopE and SopE2 also activate the Rho GTPases RAC1 and Cdc42 by stimulating 
GDP/GTP nucleotide exchange (Friebel, Ilchmann et al. 2001). These bacterial effectors, 
together with bacterial actin binding proteins SipA and SipC, promote localised actin 
polymerization and uptake of the bacteria into vacuoles (Schlumberger and Hardt 2006, 
LaRock, Chaudhary et al. 2015). 
1.2.5 Intracellular Salmonella survival  
 After that, the biogenesis and maintenance of this vacuole occurs to avoid entrance of host 
antimicrobial factors by alteration of cytoskeleton arrangement of the host cells and reduced 
vascular transport, which plays a role in Salmonella replication inside its vacuole. This 
process is controlled basically by the transporting action of T3SS-2 and its translocation 
machinery. Effectors encoded inside and outside SPI-2 are translocated to cooperate with the 
cytoskeleton of the host cells and to encourage achievement of a proper intracellular 
environment for survival and replication (Fabrega and Vila 2013). 
 
Bacterial uptake occurs quickly after the attachment process and the bacteria are contained in 
spacious phagosomes that develop into SCV (Oh, Alpuche-Aranda et al. 1996). At this stage, 
the SPI-2 T3SS effectors are involved in developing and maintaining the SCV and avoiding 
the entrance of host antimicrobial factors (Steele-Mortimer 2008). This involves changes to 
the host cell vesicular transport system (for example preventing fusion of lysosomes with the 
SCV) and cytoskeleton arrangement. Its protein and lipid components are modified and its 
morphology changed, with association of polymerized actin with the cytosolic membrane, 
which maintains and stabilizes the SCV, and vascular membrane endosomal tubules, which 
may allow movement of the SCV within the cell (Martinez-Lorenzo, Meresse et al. 2001, 
LaRock, Chaudhary et al. 2015). 
 
In the early steps of SCV biogenesis, many endosomal markers are acquired such as early 
endosomal markers Rab5 and EEA1 and then late endosomal markers such as Rab7, and the 
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lysosomal glycoproteins LAMP1, LAMP2 and LAMP3 (CD63) as well as the vacuolar 
ATPase. The involvement of these early and late endosomal markers shows the possible 
modulation of the endocytic network of the host. Salmonella may also exclude other markers 
from interacting with SCVs, such as mannose-6-phosphate receptor (M6PR). Some SPI-2-
T3SS effectors may remove host proteins form the SCV by post-translational modifications 
such as ubiquitination (LaRock, Chaudhary et al. 2015). Virulent Salmonella Typhimurium 
need to replicate within the SCVs and this requires T3SS-2 effectors, which localise to the 
SCV and some show enzymatic activities; for example SseJ modifies cholesterol and 
phospholipids in the membrane. This allows recruitment of SifA which can connect the SCV 
to microtubular network, allowing trafficking of the SCV in the cell (LaRock, Chaudhary et 
al. 2015). Host cells infected with Salmonella are characterized by the presence of Salmonella 
induced filaments (SIFs), membrane tubular structures enriched in late endosomal marker 
and formed by alteration and extension of endosomal membranes by effector proteins 
including SifA. Another pathway has also been shown in which the Salmonella causes 
formation of membrane tubules positive for trans-Golgi-network-derived Scamp3 and it is 
suggested that the host secretory pathway may also interact with SCV. Endosomal tubules 
may allow acquisition of components and nutrients needed for bacterial survival. After uptake 
and migration to the perinuclear area, most SCVs are surrounded by Golgi network 
membranes in epithelial cells, where replication occurs. The Salmonella T3SS2 effectors such 
as SseG, which localizes to the trans-Golgi is important in this process, reviewed in (da Silva, 
Cruz et al. 2012). 
Recognition of bacterial PAMPs (Pathogen-associated molecular patterns) by Toll-like 
receptors in macrophages causes acidification in phagosomes which activates SPI-2 genes 
and effector translocation (Arpaia, Godec et al. 2011, Buckner and Finlay 2011). 
 
1.3 Aims 
 
Previous studies in the laboratory investigated the role of tetraspanins in the uptake of 
Salmonella enterica serovar Typhimurium by human monocyte derived macrophages 
(MDMs). Specific monoclonal antibodies (mAbs) for various tetraspanins showed 
different effects, enhancing or inhibiting Salmonella binding to cells. The inhibition of 
Salmonella binding to MDMs was shown by using mAb to tetraspanin CD63 and 
recombinant proteins corresponding to CD63-EC2 and CD9-EC2.  In addition, the 
siRNA-mediated knockdown of CD63 also inhibited Salmonella Typhimurium adhesion. 
Immunofluorescence microscopy used in this study showed that CD63 co-localized with 
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Salmonella containing vacuoles (SCVs) at different time periods after infection. In this 
study an important role for tetraspanin CD63 in initial binding of Salmonella 
Typhimurium to macrophage was suggested (Hassuna, 2010). 
 
The aim of the present project was to further investigate the mechanism whereby tetraspanins 
are involved in Salmonella infection of macrophages and non-phagocytic cell lines.  
1. Development of a cell line model. One of the drawbacks of the previous work in the 
laboratory was that it relied on primary human derived macrophages (MDM). These are 
subject to donor variation and it is difficult to generate these in large amounts. This could be 
overcome by the use of macrophage cell lines such as J774.2 cells and RAW 247 cells. One 
problem is that these cell lines are murine and relatively few antibodies to native murine 
tetraspanins are available. It was therefore also of interest to try to develop a human 
macrophage cell line model of infection using e.g. THP-1 cells. 
2. Investigation of additional tetraspanins. Preliminary work indicated that tetraspanins CD9, 
and to some extent CD151 and CD37, also affected uptake of Salmonella by macrophages, 
but their mechanisms of action appear different to that of CD63. It was hoped to investigate 
the roles of these tetraspanins further.  
3. Co-localization of tetraspanins and Salmonella. Preliminary experiments using confocal 
microscopy suggested some co-localization of CD63 and Salmonella entering macrophages. 
It was hoped to extend these studies, also for other tetraspanins. Cell lines can more easily be 
transfected with constructs coding for GFP-tagged tetraspanins for immunofluorescence 
studies.  
4. Attempts were made to develop flow cytometry assays for investigating infections, which 
would be more objective and permit analysis of large numbers of cells than the conventional 
microscopy assay previously used. 
5. It was also of interest to determine if tetraspanins were involved in adhesion/uptake of 
Salmonella to epithelial cell lines, especially since they have been shown to play a role in 
adhesion of N. meningitidis and other bacteria, including E. coli and S. aureus, to such cells 
(Green et al. 2011).
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Chapter 2:  Materials and methods 
2.1 Materials 
2.1.1 General materials 
Unless stated otherwise, chemical and general reagents were supplied from SLS, Bio-Rad, 
Sigma and Fisher Scientific, and were analytical grade or equivalent. 
2.1.2 Water 
All the water used to prepare solutions and buffers was ultrapure deionized sterile water 
filtered from a Neptune (Purite) System. 
2.1.3 Buffers and Solutions 
Table 2.1: Buffers and solutions used.  
Type of buffer Preparation 
Store 
temperature 
1% agarose gel 
1g of agarose (MetaPhor agarose, Lonza) in 
100ml 1x TAE buffer, dissolved by heating in a 
microwave. 
 
10x blotting buffer 144g glycine plus 20.23g Tris, dissolved up to 1L 
with dH2O. 
RT 
1x blotting buffer 100ml 10x blotting buffer, 200ml methanol and 
700ml dH20 
RT 
5% blocking buffer 5g of skimmed milk powder dissolved in 100ml  
1x TBST 
4-8 °C 
 Cell dissociation 
solution 
Cell dissociation solution (SDS) was provided 
from Sigma (C5914) as 1x solution, 5ml was used 
for a T75 Flask. 
-20 °C for 
long term 
4-8 °C for 
short term 
Cell lysis buffer 
 
0.5% triton x-100 (Sigma) and 0.5% Brij 98 
(Acros Organic) in PBS with protease inhibitor 
Cocktail (Thermo Scientific, 78429). 
4-8 °C 
Coomassie de-staining 
solution   
400ml methanol, 100ml acetic acid, 500ml dH2O 
RT 
Coomassie staining 
solution 
2.5g Brilliant Blue R (Sigma), 500ml absolute 
methanol, 100ml acetic acid,  prepared up to 1L 
with dH2O 
RT 
DAPI staining solution 
0.1 % triton x-100, 0.02 % sodium dodecyl 
sulphate and 0.5 μg /ml of 4, 6-diamidino2-
phenyl-indole hydrochloride (DAPI) in PBS.  
4-8 °C 
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FACS buffer (B/B/N) 0.1% sodium azide and 0.2% bovine serum 
albumin (BSA) in HBSS.   
4-8 °C 
FIX and PERM® Fixation and permeabilisation of mammalian 
cells,  ADG, GAS-002 or Invitrogen, GAS004 
RT 
25mM glutathione 
elution buffer  
30.8mg reduced glutathione, 60.6mg Tris, volume 
brought up to 10ml with dH2O and pH adjusted to 
pH 8.0 
4-8 °C 
60% glycerol  12ml 100% glycerol, 8ml dH20. Sterilized by  
filtration.  
RT 
60% v/v glycerol stock 
solution 
60ml of 100% glycerol was mixed with 40ml 
dH2O and sterilized by autoclaving.   RT 
Halt™ Protease 
inhibitor 
Protease inhibitor (to prevent  protein 
degradation)  Thermo Scientific, OJ 190691A 4-8 °C 
Hanks buffered saline 
solution (HBSS) 
HBSS with/without Ca2+ and Mg2+ was from 
Lonza. RT 
2x Laemmle sample 
buffer (reducing 
buffer)  
50 µl β-ME added to 950 µl sample buffer 
(BioRad, 161-0737).  
RT 
Mild stripping buffer 
for nitrocellulose 
membranes  
15g glycine, 1g SDS, 10ml Tween20 pH adjusted 
to 2.2 with HCl prepared up to 1L with dH2O RT 
4X non-reducing 
protein loading buffer  
5ml 0.5M of Tris (pH adjusted to 6.8), 2ml 20%  
SDS, 4ml  glycerol, 1ml  2mg/ml bromophenol  RT 
1x PBS 100ml 10x PBS,  900ml dH20 RT 
4% paraformaldehyde 
solution  
4g of paraformaldehyde was dissolved in 50 ml 
H2O by adding 1ml of 1M solution NaOH and 
heating in a water bath for 60 minutes at 60ºC. 
After cooling, 10 ml of 10x PBS was added, the 
pH was adjusted to 7.4 and dH2O added to 100 
ml. After mixing, the solution was filtered and 
stored.  
-20 °C for 
long term 
4-8 °C for 
short term  
Permeabilising buffer 
for confocal 
microscopy 
0.1% saponin, 2% goat serum and 2% bovine 
serum albumin (BSA) in PBS 
4°C 
Phosphate buffered 
saline (PBS), 10x pH 
7.2 
NaCl 80g, KCl 2g, Na2HPO414.4g, KH2PO4 
/litredH2O RT 
Propidium iodide stain  1:1000 dilution of propodium iodide (1mg/ml, 
Sigma, P4864) in PBS 
RT 
20x SDS-PAGE 
running buffer 
EZ-Run™ running buffer ( Fisher Scientific)  
BP7700-500 RT 
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4x stacking gel buffer   6.06g Tris, 4ml 10% SDS, pH adjusted to 6.8 with 
HCl, made up to 100ml with dH2O 
4-8 °C 
SDS-PAGE stacking 
gel  
1ml H2O, 300µl 30% acrylamide, 444 µl 4x 
stacking buffer, 28μl 10% ammonium 
persulphate, 5μl TEMED  
RT 
10x TBS (Tris buffer 
saline) 
24.2g Tris, 87.66g NaCl pH adjusted to 7.6 with 
HCl prepared up to 1L with dH2O RT 
1x TBST (TBS  with 
Tween 20) 
100ml 10x TBS, 900ml dH2O and 250µl Tween20 
RT 
1x trypsin-EDTA 
solution 
This solution was prepared from 10x solution 
provided from Sigma (59418C) and was diluted 
1:10 with HBSS (without phenol red, Mg and Ca). 
4-8°C 
50X TAE (tri-acetate-
EDTA) buffer  
242g Tris base, 100ml 0.5M EDTA, 57.1 ml 
glacial acetic acid, volume adjusted to 1L. RT 
Vectashield Mountiing 
Medium 
To reduce bleaching of fluorescence. Vector 
Laboratories Inc. H 1000 4-8°C 
2.1.4 Bacterial growth media 
Table 2.2: Bacterial growth media used. 
Media and reagents Preparation 
 Lysogeny Broth (LB broth) 
10 g of tryptone (Oxoid, LP0042) + 5g of yeast extract 
(Oxoid, LP0021) + 10g NaCl /1L dH2O  
LB Agar 15g of bacteriological agar (Oxoid, LP0011) / 1L LB broth 
Super optimal broth for 
catabolite repression (SOC) 
media 
The media was from Novagen, (Cat. No. 69319)  
 
2.1.5 Antibiotics 
Table 2.3: Anti-microbial reagents used. 
Antibiotic Preparation of stock solution 
Ampicillin  Stock solution of 100mg ml-1   ampicillin in H2O, sterilized by filtration.  
Carbenicillin  Stock solution of 100mg ml-1 of carbenicillin in H2O, sterilized by 
filtration. 
Chloramphenicol  Stock solution of  34 mg ml-1  chloramphenicol in ethyl alcohol, sterilized 
by filtration.   
G418 250mg ml-1 stock solution in H2O was from Gibco (Cat. No. 11811-064). 
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Kanamycin  Stock solution of 100mg ml-1 of Kanamycin in H2O, sterilized by 
filtration.  
Puromycin 10mg ml-1 stock solution in 20 mM HEPES buffer (pH 7.2-7.5) was from 
Gibco, (Cat. No. A1113803).  
2.1.6 Commercial kits used 
Table 2.4: Commercial kits used.  
Kit name  Purpose  Origen, catalogue number 
EZNA plasmid DNA 
Mini Kit 
Small scale extraction of plasmid 
DNA. 
OMEGA, D6942-01 
HiSpeed Plasmid Midi 
Kit 
Large scale plasmid DNA 
purification  
Qiagen, 12643 
QIAquick®, gel 
extraction Kit 
Extraction and purification of PCR 
products from agarose gels 
Qiagen, 28704 
QIAquick®, PCR 
purification Kit 
Purification of PCR product Qiagen, 28104 
Qprep® Spin, 
Miniprep  Kit 
Small scale plasmid DNA 
extraction 
Qiagen, 27104 
RNeasy® Mini Kit To extract total RNA from 
mammalian cells 
Qiagen, 74104 
2.1.7 Immunological reagents used 
2.1.7.1 Primary and secondary Antibodies: 
All primary monoclonal antibodies and secondary polyclonal antibodies used are described 
in Tables 2.5 (A and B) and 2.6 respectively.  
Table 2.5 A: Primary antibodies.  
Target Host species, 
isotype 
Working 
concentration 
(μg/ml) 
Source Catalogue Number 
or reference  
Human CD9 Mouse IgG1 10 Prof. Peter Andrews, 
University of 
Sheffield 
*Clone 602.29 
(Andrews, Knowles 
et al. 1981) 
Human CD37 Mouse IgG1 10 Prof. Martin Glennie, 
University of 
Southampton 
WR-17 (Moore, 
Cooper et al. 1987) 
Human CD53 Mouse IgG1 10 AbD serotic MCA723GT 
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*Purified from hybridoma supernatants by Bioserv UK Ltd. 
 
 
Human CD63 Mouse IgG1 10 Developmental 
Studies Hybridoma 
Bank In House 
*Clone H5C6 
(Azorsa, Hyman et 
al. 1991) 
Human CD81 Mouse IgG1 10 AbD Serotec MCA1847 
Human CD81 Mouse IgG1  10 Ancell 302-820 
(preservative free) 
Human CD81 Mouse IgG1 10 BioLegend  349502 
Human CD82 Rabbit 
polyclonal 
10 AbD Serotec AHP1709 
Human CD82  Mouse IgG1 10 BioRad MCA1311 
Human CD82 Mouse IgG1 10 B & D system MAB4616 
Human CD82 Rabbit 
polyclonal 
1-10 BioRad AHP1709 
Human CD82 Mouse IgG1  10 BioLegend 342102 
Human CD151 Mouse IgG1 10 Prof. Leonie Ashman, 
University of 
Newcastle, Australia. 
*Clone 14A2 (Fitter, 
Tetaz et al. 1995) 
Human syntenin Rabbit 
polyclonal  
1-10 Abcam Ab19903 
Mouse CD9 Rat IgG2b  10 AbD Serotec MCA2749 
Mouse CD63 Rat IgG2a 10 Biolegend  143904 
Mouse CD81 Hamster, 
IgG1 
10 AbD Serotec MCA1846 
Isotype control Hamster IgG1  10 BioRad MCA2356 
Isotype control  Mouse IgG1 10 In House *Clone JC1 
(Muranova, 
Ruzheinikov et al. 
2004) 
Isotype control Rat IgG2a 10 Biolegend 400501 
Isotype control Rat IgG2b 10 Biolegend  400601 
Salmonella   Rabbit 
polyclonal  
1:80 AbD Seroteic 8209-4006 
Salmonella 
groups A, B, D, 
E1, E2, E3, E4, 
L  
Rabbit 
polyclonal 
1:20 Difco™  225341  
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Table 2.5 B: Primary conjugated antibodies. 
Target 
Host species, 
isotype 
Dilution 
µg/ml 
Label Source 
Catalogue 
Number 
GST 
Rabbit 
polyclonal  
1:5000 HRP Sigma A7340 
Human LAMP-1 
(CD107a) 
Mouse IgG1 1:100 AF® 647 BioLegend 328611 
Isotype control  Hamster IgG  10 AF® 647 AbD serotec MCA2356A647 
Isotype control  Rat IgG2a 10 AF® 647 BioLegend 400526 
Isotype control Rat IgG2b 10 AF® 647 AbD serotec MCA1125A647 
Mouse CD9 Rat IgG2a 
10 AF® 647 BioLegend 124810 
Mouse CD81 Hamster IgG 10 AF® 647 AbD serotec MCA1846A647 
Salmonella 
enteriditis, S. 
typhimurium, S. 
heidelburg     
Rabbit IgG 1:1000 FITC 
Online.com 
antibodies 
ABIN464723 
 
Table 2.6: Secondary antibodies. 
Target Host species 
Dilution 
Label Source 
Catalogue 
Number 
Mouse IgG Goat  1:250 FITC Sigma F1010 
Mouse polyclonal IgG 
fraction  
Rabbit 1:5000 HRP Sigma A9044 
Rabbit IgG Goat 1:320 FITC Sigma F9887 
Rabbit IgG 
(H and L) 
Goat 1:1000 AF® 647 Abcam Ab150083 
Rabbit IgG Goat 1:2000 HRP Sigma A6154 
Rat IgG Rabbit 1:320 FITC Sigma F9387 
Rat IgG 
(H and L) 
Goat 1:250 AF® 546 
Life 
technologies 
A11081 
Rat IgG Goat  1:5000 HRP Abcam Ab97057 
Syrian hamster IgG Goat 1:100 FITC Abcam ab6888 
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2.1.8 Cell line culture and media used 
2.1.8.1 Media for tissue culture 
Dulbecco's Modified Eagle’s Medium (DMEM) media was from Gibco or Lonza. For the 
RAW cell line DMEM with GlutamaxTM was used. For J774, HeLa syntenin KD and control, 
CD9 KO, CD81 KO and corresponding WT mouse macrophages controls, DMEM with high 
glucose (4.5 g/litre) was used. For HEC-1B and HeLa cell lines, Eagle’s Minimum Essential 
(EMEM) media (Lonza) was used. For THP-1 cells, RPMI media (Gibco) was used. All 
media were purchased as 1x solutions and heat inactivated (HI) FCS (Biowest) was added to 
a final concentration of 10%. 
2.1.8.2 Cell line types 
2.1.8.2.1 Semi-adherent phagocyte cell lines 
RAW 247 cell line: This macrophage cell line was obtained from American Type Culture 
Collection (ATCC). The cell line was originally established from a Balb/c mouse by Abelson 
leukemia virus transformation (Ralph and Nakoinz 1977).  
J774.2 cell line: This cell line is a mouse BALB/c monocyte/macrophage cell line re-cloned 
from an original ascites and solid tumor mass J774.1. (Ralph and Nakoinz 1975). This cell 
line was obtained from the European Collection of Authenticated Cell Cultures (ECACC).  
CD9-KO mouse macrophages and corresponding wild type control: The CD9 -/- 
macrophage cell line and corresponding wild type CD9 +/+ macrophage cell lines were kind 
gifts from Gabriela Dveksler (Dept. Pathology, Uniformed Services University of the Health 
Sciences, Bethesda, Maryland, USA) (Ha, Waterhouse et al. 2005). 
 
CD82-KO mouse macrophages and corresponding wild type control: The CD82 -/- 
macrophage cell line and corresponding wild type CD82 +/+ macrophage cell lines were 
kindly provided by Professor Jatin Vyas, Harvard Medical School, Boston, USA (Risinger, 
Custer et al. 2014). 
THP-1 cell line: This is an human monocyte cell line derived from a patient with acute 
monocytic leukemia (Tsuchiya, Yamabe et al. 1980). Current stocks were from ECACC. 
2.1.8.2.2 Non phagocytic cell lines 
HEC-1B cell line: This is an adherent human endometrial carcinoma epithelial cell line. This 
sub-strain of HEC-1A that was isolated in 1968 by H. Kuramoto was obtained from ATCC 
(Kuramoto, Tamura et al. 1972). 
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HeLa cell line: This is a human epithelial cell line derived from cervix adenocarcinoma (Gey, 
Coffman et al. 1952, Scherer, Syverton et al. 1953). Current stocks were from ECACC. 
HeLa syntenin knockdown (KD) and HeLa wild type (WT) cell lines: These cell lines 
were kind gifts from Professor Fedor Berditchevski (Institute for Cancer Studies, the 
University of Birmingham, Birmingham, United Kingdom). Stable knockdown of syntenin 
expression was achieved using a plasmid expressing shRNA specific for the syntenin gene, 
whereas control cells were transfected with empty vector (Fedor Berditchevski, personal 
communication). 
2.1.9 Salmonella strains used 
The bacterial strains used in the experiments were Salmonella Typhimurium NCTC 12023 
(Le Minor, Veron et al. 1982) (obtained from Professor Rob Read, Department of Infection 
and Immunity, University of Sheffield), S. Typhimurium LT2 (McClelland, Sanderson et al. 
2001) (obtained from Professor Jeffery Green, Department of Molecular Biology and 
Biotechnology). Salmonella Typhimurium SL1344 (Hoiseth and Stocker 1981) transformed 
with pNB57-mCherry was obtained from Prof Dirk Bumann/ Biozentrum/ University of 
Basel, Switzerland.  
2.1.10 Common laboratory instruments and equipment used 
All instruments and equipment used are mentioned in table 2.7. 
Table 2.7: Common laboratory instruments and equipment used.   
Instruments or equipments  Provider  
Bench type cooling lab. centrifuge Sigma  
Class II microbiological cabinet BioMAT2   
  
Electroporater (Gene Pulsar II), Capacitance 
Extender Plus and Pulse Controller Plus 
BioRad 
Flow cytometry  LSR II flow cytometer, Becton Dickinson. 
FACsAria (cells sorter), Becton Dickinson. 
Gel and western blot documentation  ChemiDoc™ MP System, BioRad 
GelDoc-lt™ imaging system, UVP  
Incubators  Scientific laboratory supplies 
Liquid Nitrogen dowers (35 HC) Statebourne BIO 36  
Magnetic stirrer with Hot plate  Stuart 
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Microcentrifuge (L 13) Sigma 
Microscopes Nikon A1 Confocal inverted system with 
EM-CCD Camera. 
Nikon Eclipse 400UV light, Digital camera 
DXM1200 
Nikon inverted light microscope. 
Olympus inverted microscope. 
Widefield imaging system (Nikon dual cam 
system) inverted Ti eclipse with Oka-lab 
environmental control chamber (for live 
imaging). 
NanoDrop® Spectrophotometer ND-1000 Labtech international  
Ori-Block® 08-1 (Heat block) Techne 
Spectrophotometer WPI  
Ultraviolet transilluminator  Comlab 
Water deionizer and sterilizer Neptune PURITE 
2.1.11 Common glassware and plasticware 
Most of the glassware and plasticware used are described in Table 2.6. 
Table 2.8: Glassware and plasticware used. 
Type of glassware and plasticware Provider 
Cryovial (1ml) Nalgene  
FluoroDish™ World Precision Instruments, Inc.20110401 
Lab-Tek II chamber slide (8 wells)  Nalgene Nunc international  
Microscope slides and coverslips Thermo scientific, SLS and VWR 
Pipette tips (20 µl, 200 µl and 1000 µl)  Starlab  
Plastic cell scraper Sarstedt 
Round bottom FACS tubes (12x75mm) Elkay 
Small FACS tubes 
(Titertube® Micro Test Tube) 
BioRad, 223-9390 
SnakeSkin® Dialysis Tubing, 3.5 MWCO, 
16 mm dry I.D.  
life technologies, 88242 
Tissue Culture Dish 10cm diameter  FALCON®, 353003 
Tissue Culture Dish 14.5 cm diameter  Greiner CELL STAR, 639160 
Tissue Culture flasks  Greiner  
2.1.12 Plasmids 
All vectors used are described in Table 2.9. 
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Table 2.9: Plasmids used. 
Plasmid symbol 
Gene 
insert/ tag 
Antibiotic resistance 
marker (bacteria) 
Antibiotic 
resistance marker 
(mammalian cells) 
Source 
pVA49/pIN29 DsRed Chloramphenicol N/A Dr Mark Thomas ( 
Department of infection and 
immunity/ University of 
Sheffield) (Vergunst, Meijer 
et al. 2010) 
pDS-Red 
Expression vector 
II (Clontech) 
DsRed Ampicillin  N/A Prof Jeffery Green 
(Department of Molecular 
Biology and Biotechnology/ 
University of Sheffield 
pBHR-1 GFP Kanamycin  N/A Dr Mark Thomas, 
Department of infection and 
immunity, University of 
Sheffield) (Stevens, Ulrich 
et al. 2005) 
pNB57 mCherry Ampicillin N/A *  Prof Dirk Bumann 
(Biozentrum/ University of 
Basel/ Switzerland)  
pGEX-KG-
mCD9-EC2-GST 
 
mCD9-
EC2-GST 
Ampicillin G418 This work  
pCMV6-AV-
mCD9-GFP 
mCD9-
GFP 
Ampicillin G418 ORIGENE (MG226288) 
pGEX-KG Sj-GST Ampicillin G418 (Guan and Dixon 1991) 
*  This plasmid is carrying the promoter for gene STM0474 is described in (Rollenhagen and 
Bumann 2006) and the GFP_ova was replaced with mCherry in this plasmid to obtain pNB57-
mCherry. 
 
2.1.13 Online tools and software 
Table 2.10: Software and online tools used.  
Imaging software: 
Software name Purpose Online link 
Fiji Image analysis http://fiji.sc/Fiji 
Lucia image 
processing 
DXM 1200 digital camera image 
capture software 
N/A 
Nikon elements 
software  
Nikon A1 confocal running and 
analyzing software 
Nikon dual cam system running and 
analyzing software 
N/A 
 
NIS-Elements 
Viewer 4.20 
Microscope image viewer  
http://www.nikoninstruments.com/en_
GB/Products/Software/NIS-Elements-
Advanced-Research/NIS-Elements-
Viewer 
FACS analysis software:  
Software name Purpose Online link 
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BD FACSDiva 7.0 LSR II flow cytometer acquisition 
and analysis of data 
N/A 
BD FACSDiva™ 
FACsAria acquisition and analysis 
software.   
N/A 
CellQuest Pro 
FACS Calibur acquisition and 
analysis of data  
N/A 
FlowJo FACS data analysis 
http://www.flowjo.com/download-
flowjo/ 
RNA Microarray analysis:  
Software name Purpose Online link 
Qlucore Omics 
Explorer 
Microarray analysis software http://www.qlucore.com/ 
Transcriptome 
Analysis Console 
(TAC) 3.0, 64bit 
Microarray analysis software from 
Affymetrix  
http://www.affymetrix.com/estore/cata
log/prod760001/AFFY/Transcriptome
+Analysis+Console+%28TAC%29+S
oftware;jsessionid=6A6246FDE91D0
BB2983675B812CCA9FC.prd01com#
1_1 
Data and graph analysis:  
Software name Purpose Online link 
Graph pad 6 Prism Data and graphs analysis  
http://www.graphpad.com/scientific-
software/prism/ 
Microsoft Office 
Excel 2010  
Data analysis  
DNA and Protein analysis: 
Tools name Purpose Online link 
EMBL-EBI Readseq 
To read and convert nucleotide 
sequences  
http://www.ebi.ac.uk/Tools/sfc/readse
q/ 
ExPASy 
To translate nucleotide sequence to 
protein sequence 
http://web.expasy.org/translate/ 
ExPASy Boxshade To shade multisequence alignment 
http://www.ch.embnet.org/software/B
OX_form.html 
MultAline 
To align and cluster multiple 
sequences 
http://multalin.toulouse.inra.fr/multali
n/multalin.html 
PDB For molecular protein structure 
http://www.rcsb.org/pdb/home/home.d
o 
Phyre2 For protein structure prediction  
http://www.sbg.bio.ic.ac.uk/phyre2/ht
ml/page.cgi?id=index 
PyMOL 
To visualize and align protein 
structure in 3D view  
https://www.pymol.org/ 
2.1.14 Materials used for Cloning 
2.1.14.1 Strains of bacteria used for cloning and protein expression 
Table 2.11: Bacterial strains used in cloning and protein expression. 
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E. coli strains Using purpose   Genotype characteristic  
DH5α (Invitrogen, 
18263-012) 
Sub-cloning F- Φ80lacZΔM15Δ(lacZYA-argF)  U169 recA1 
 endA1 hsdR17(rk-,mk+) phoAsupE44 thi-1 gyrA96 
 relA1 λ- 
Rosetta-gami B 
(Novagen, 71137).  
Tetraspanin 
EC2 expression 
F– ompT hsdSB (rB
– mB
–) gal dcm lacY1 
ahpC  (DE3) gor522::Tn10 trxBpLysSRARE (CamR, KanR, 
TetR) 
2.1.14.2 Data base sequences of cDNA and protein  
Table 2.12: Database sequences of cDNA and protein. 
Gene RefSeq mRNA 
accession 
number 
Uniport protein 
accession 
number 
Expression 
Vector 
Bioinformatics 
website  
GST 
(Schistosoma 
japonicum) 
 - P08515 pGEX-KG http://www.uniprot.o
rg/uniprot/P08515 
mCD9 NM_007657.3 P40240-1 pGEX-GST-
mCD9 EC2 
http://www.uniprot.o
rg/uniprot/P40240 
 
2.1.14.3 Primers 
Table 2.13: Forward and reverse primers used in subcloning and DNA sequencing. The specific 
targeting sequences for tetraspanins are shown in bold. 
Primer symbol Sequence  
mCD9 EC2 for 5’ATTATTGAATTCTAACCCACAAGGATGAGGTGA 3’ 
mCD9 EC2 rev 5’ATTATTAAGCTTTCAGATGTGGAACTTGTTGTTGAAG 3’ 
*pGEX-F2 5’ GAGCTGTTGACAATTAATCATCGG 3’ 
*pGEX-R1 5’ CCGGGAGCTGCATGTGTCAGAGG 3’ 
 * Primers were designed by previous lab member Mr. Ralph Hyde and generated by Genosys. Other 
primers were generated by Eurofins Genomics. 
2.1.14.4 Restriction Enzymes 
The restriction enzymes used were Eco RI-HI from (New England Biolabs) and Hind III 
from Promega. 
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2.2 Methods 
2.2.1 Mammalian cell culture methods 
2.2.1.1 Cell counting 
Cell counting was performed using an improved Neubauer hemocytometer. 
2.2.1.2 Cell freezing 
Freezing was carried out when the cells reached medium log phase. The cells were harvested 
as described below, centrifuged at 200g for 5 minutes and re-suspended at between 3-10 x106 
/ml in 1ml of freezing solution (10% DMSO and 90% FCS). Then, the mixture was 
transferred to cryovials. (All manipulations were performed on ice to avoid the toxic effects 
of DMSO). The vials were placed in a freezing plug (Jencons) for 90 minutes to allow gradual 
freezing of the cells in the nitrogen vapor in a liquid nitrogen dewar, then transferred to liquid 
nitrogen. 
2.2.1.3 Cell thawing 
After removing the cells from liquid nitrogen, they were directly transferred in to warm water 
until thawed. Then the vial was placed in ice after wiping with 70% ethanol. The vial contents 
were transferred into a sterile universal tube on ice and 9ml of medium without FCS was 
added. The cell suspension was centrifuged at 200g for 5 minutes and the cell pellet re-
suspended in fresh medium with 10% HI-FCS and transferred to a screw capped flask. Then 
the flask was incubated at 37ºC. 
2.2.1.4 Growth conditions 
All cell lines were cultured in flasks at 37º C in a humid environment. RAW247, J774.2 and 
Hela syntenin KD and Hela WT control were cultured in an atmosphere of 8% CO2, while 
HEC-1-B, HeLa, THP-1, CD9 KO and CD82 KO were incubated in 5% CO2. 
2.2.1.5 Cell harvesting and subculture 
Cells were harvested and subcultured depending on cell type. 
2.2.1.5.1 Adherent cell lines 
For cells growing in T75 flasks, the media was removed and the cells were washed once with 
10ml HBSS solution (without Ca and Mg). Then, the cells were treated with 3ml trypsin-
EDTA or with 5ml Cell Dissociation Solution for 5 to 20 minutes respectively at 37°C until 
the all cells detached from the flask surface. The trypsin was then deactivated by adding 
media with 10% HI-FCS.  
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2.2.1.5.2 Semi-adherent cell lines 
The cells were harvested once confluent by using a cell scraper to detach them from the 
surface then diluted 1:3 or 1:10 into either the same flask or into a new tissue culture flask 
with fresh media. 
2.2.1.5.3 Non-adherent cell lines 
Cells were sub-cultured by removing and replacing half of the media and cells in the flask 
with fresh media (usually the cells were sub-cultured every day to avoid cells overgrowth).  
2.2.1.6 Stimulation of THP-1 cells 
A stock solution of phorbol myristate acetate (PMA) was prepared in acetone at a 
concentration of 100µg ml-1 (160µM) and stored in aliquots at -20°C. The cells were counted 
and re-suspended at concentration of 3 x 105 ml-1   with RPMI media contain 10% HI-FCS 
and 20ng ml-1 PMA. Then the cells were cultured at 37°C for 3 days to induce differentiation 
to macrophages. After 3days, the PMA containing media was removed and cells were washed 
with HBSS and harvested as described in 2.2.1.5.1.   
2.2.2 Bacterial methods 
2.2.2.1 Salmonella transformation: 
Salmonella enteriditis serovar Typhimurium NCTC12023 and LT2 strains were transformed 
with fluorescent protein expressing vectors to generate self-fluorescent bacteria. 
2.2.2.1.1 Preparation of S. Typhimurium competent cells (for electroporation) 
To prepare the electro-competent cells, Salmonella strains NCTC12023 and LT2 were 
cultured in 5 ml LB media overnight then diluted 1:50 into 100 ml LB broth and cultured at 
37°C with shaking (250 rpm). Once the culture reached OD600 of 0.2, it was separated into 
two 50 ml pre-cooled Falcon tubes, then centrifuged at 5500g at 4°C for 10 minutes. The 
supernatant was removed by vacuum pump suction and the pellets were washed three times 
in 25 ml of pre-cooled 10% glycerol in dH2O. After the last wash, the pellets were re-
suspended in 1ml of pre-cooled 10% glycerol. The competent cells were aliquoted in 50µl 
volumes in pre-cooled 1.5 ml Eppendorf tubes and stored at -80°C.   
2.2.2.1.2 Transformation of Salmonella by Electroporation 
 The BioRad gene pulser® II electroporation system with Pulse controller was used for 
Salmonella transformation. As recommended by the manufacturer, 40µl of competent cells 
were used per electroporation with 1 µl of DNA plasmid. The cell and plasmid mixture was 
kept on ice in a 1.5 ml Eppendorf tube and then transferred to a pre-cooled electroporation 
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cuvette (gap 0.2 cm) and placed in the electroporation chamber. The voltage used was 2.4 
kv/cm, the capacitance used was 25 µF and the resistance used was 400Ω (pulse controller) 
for 1.2 msec. 200µl of LB media (without selective antibiotics) was added immediately after 
electroporation and the cuvette contents were transferred into a 1.5 ml tube and incubated for 
2 hours at 37°C with shaking (150rpm). After incubation, 50µl of the cell suspension was 
plated on LB agar contain selective antibiotics and incubated at 37°C overnight. On the next 
day, one transformed colony was re-cultured in LB agar for 24 hours for use in further 
experiments. 
2.2.2.1.3 Detecting the fluorescent protein expressing Salmonella by flow cytometry 
One single colony of transformed Salmonella was grown in 5ml LB media with selective 
reagents overnight at 37°C (without shaking). 200µl of the overnight growth was then 
cultured in 10 ml LB media with selective reagents until the OD600 reached 0.4 – 0.5. Then, 
the bacteria were cooled on ice, centrifuged at 5400g for 5 minutes, washed twice with cold 
PBS and fixed by adding 500µl of 4% PFA at RT for 15 minutes. The fixed bacteria were 
analyzed by flow cytometry using an LSR II FACS machine to determine the percentage of 
fluorescent cells and the intensity of the fluorescence compared with WT control. 
2.2.2.1.4 Detecting the fluorescent protein expressing Salmonella by fluorescence 
microscopy 
The transformed Salmonella and WT control were prepared as described above. Bacteria 
were transferred to a glass slide using a full bacteriological loop and left to dry before adding 
one small drop of Vectashield mountant with DAPI (Table 2.4). A glass coverslip was added 
then sealed with nail varnish and allowed to dry in the dark before inspection using a Nikon 
Eclipse 400UV light microscope with the appropriate filter.  
2.2.3 Flow cytometry methods 
Flow cytometry analysis was carried out using FACS machines (Table 2.7) at the Flow 
Cytometry Facility at the Medical School, Sheffield University. Mammalian cell populations 
were gated depending on their forward scatter (FSC) and side scatter (SSC) characteristics. 
2.2.3.1 Indirect immunofluorescence in tubes 
 This assay was performed using living cells under cold conditions to avoid capping, 
internalization and shedding of antigen. The cells were harvested and washed twice with cold 
washing buffer (B/B/N), then re-suspended to 0.5 x 106 in B/B/N and dispensed in 1ml 
aliquots in FACS tubes. The tubes were centrifuged at 200g for 5 minutes and the supernatant 
removed using a Pasteur pipette attached to a suction pump. The pellet was re-suspended with 
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50 μl of primary mAbs (at 10µg ml-1 or manufacturer’s recommendation in B/B/N) mixed by 
vortexing and incubated for 60 minutes on ice. Next, the cells were re-suspended and washed 
twice by adding 1ml of B/B/N and centrifuging at 200g for 5 minutes. The cell pellet was re-
suspended with 50μl of the secondary fluorescently labeled antibody and incubated for 45 
minutes on ice in the dark. Then, the cells were washed two times as described before. The 
cell pellet was re-suspended in 300μl of washing buffer on ice (if analyzed on the same day) 
or the cells were fixed by adding 300μl of 2% paraformaldehyde (if analyzed the next day). 
2.2.3.2 Direct immunofluorescence in tubes 
The method was essentially as described above except that directly labelled primary 
antibodies (50µl) were used in the first incubation. 
2.2.3.3 Indirect immunofluorescence in 96 microtiter plates 
This was carried out using V-bottomed 96 wells plates. The cells were harvested and washed 
as described previously and re-suspended to 2 x 106/ml. 100µl/well of cell suspension was 
aliquoted into the microtiter plate, which was then centrifuged at 400g for 3 minutes. The 
supernatant then was removed and the plate was placed on ice. 25µl of primary antibody was 
added (at 10µg ml-1 or manufacturer’s recommendation in B/B/N) and mixed by placing the 
plate on a vortex mixer set at low speed. The plate was incubated for 45 minutes on ice, then 
the cells were washed by adding 75µl B/B/N to the wells, and centrifuging at 400g for 3 
minutes twice. The supernatant was removed as previously and the cells were washed once 
more with 100µl B/B/N. 25µl of FITC-labelled secondary antibody was added, and mixed as 
previously and the plate was incubated on ice for 45minutes in the dark. The cells were then 
washed twice as described above and re-suspended with 200µl washing buffer (if the samples 
were analyzed the same day) or 200µl PFA 2% (if analyzed in the next 24- 48 hours). 
2.2.3.4 Direct immunofluorescence staining in 96 microtiter plates 
For direct labeling, the method was carried out as above but using 25µl of the primary labelled 
antibody only.  
2.2.3.5 Indirect immunofluorescence staining of permeabilised cells in tube 
The commercial Fix and Perm Kit™ was used (Table 2.1) to permeabilise the cells which 
allowed the antibodies to access cells by making “pores” in the cell membranes. Cells were 
harvested as described in 2.2.1.5, (0.5 – 1 x 106 cells per tube were used in this experiment).  
The cell pellet was re-suspended with 30µl solution A (fixation reagent) and incubated for 15 
minutes at room temperature (RT) then washed with 1ml PBS, in the second washing, the 
cells suspension was divided equally in to two tubes (one for permeabilisation and the other 
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not for none permeabilisation) and centrifuged 200g for 5 minutes. The supernatant was 
aspirated and the cell pellet was re-suspended by vortexing. 25µl of 20µg ml-1 of primary 
antibody was added together with either solution B (permeabilisation reagent) or 25 µl of 
B/B/N (for fixed only cells) and mixed by briefly vortexing. The suspension was incubated 
for 30 minutes at RT. The cells then were washed twice with PBS as above then the pellet 
was re-suspended with 25µl of secondary labelled antibody and the cells were incubated in 
the dark at RT. After washing the cells were re-suspended with 300µl of 1% PFA solution 
and stored at 4 °C in dark until FACS analysis. 
2.2.3.6 Indirect immunofluorescence staining of permeabilised cells in microtiter 
plates 
Cells were harvested as described previously and re-suspended at 2 x 106 ml-1 in B/B/N. 100µl 
aliquots were dispensed into each well of a “V” bottomed 96 well microtiter plate. 20µl of 
solution A was added to each well and incubated for 15 minutes RT for cell fixation. The 
fixed cells were washed by adding 100µl PBS per well, centrifuging at 400g for 3 minutes, 
the supernatant was removed, and the pellet were re-suspended by briefly vortexing. The 
washing step was repeated but with 150µl PBS. 
The cell pellet was re-suspended with 20µl of 20µg ml-1 of primary antibody, and either 20µl 
of reagent B (permeabilisation reagent) or 20µl of B/B/N (for fixed cells only). The cells were 
incubated for 30 minutes at RT the washed twice with PBS as described before. 25µl of 
secondary-labelled antibody was added to the cell pellet, mixed and incubated for 15 minutes 
in dark at RT. The cells were washed twice as previously and the pellet was re-suspended in 
200µl 1% PFA solution and the samples were transferred in to Micro Test tubes (Table 2.8) 
and were stored at 4°C in the dark (up to 48 hours) until they were analyzed by FACS. 
2.2.4 Immunofluorescence microscopy for analysis of antigen 
expression 
2.2.4.1 Immunofluorescence of cells grown on chamber slides 
This experiment was performed using Lab-Tek II™ chamber slides (8 chambers). The cells 
were harvested and re-suspended in culture medium at a density of 7x104 ml-1. Then, 0.5 ml 
of the cell suspension was aliquoted into each chamber and cultured overnight. The slides 
were examined to check cell density and the cells were washed by adding and removing 0.5 
ml BSS or PBS. Next, the cells were fixed and permeabilised by adding 0.5 ml acetone to 
each chamber and incubating for 5 min. The acetone was removed and quickly washed with 
PBS by immersing the slides into PBS, flicking to remove the PBS, and then placing the slide 
in a tank containing fresh PBS and washing for 10 min. with stirring. After that, the PBS was 
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removed from the chambers and replaced with 100 µl of an appropriate dilution of primary 
mAbs (to cover the well surface). Then, the slide was incubated at room temperature in a dark 
and humid place for 30 min. After that, the chamber was washed twice by rinsing in PBS, 
then a third time by immersing the slide in a tank containing PBS with stirring for 15 min. 
The PBS was removed and replaced with 100µl of an appropriate dilution of FITC- labeled 
secondary antibody and incubated for 30min in a dark and humid place. The chambers were 
washed as before and 100μl of 1-10 μg /ml of propidium iodide was added to each chamber 
and incubated for 3min (to stain the nucleus). The slides were washed as previously then 
flicked to remove PBS. The plastic chamber was removed according to the manufacturer's 
instructions and any remaining PBS was removed using a Pasteur pipette before adding a 
small drop of mountant to each slide section. Then, to seal the slide, a large coverslip and nail 
varnish was used. The slide was then stored at 4ºC in a dark place until examined by 
fluorescence microscopy. 
2.2.4.2 Immunofluorescence on cells grown on coverslips 
The cells were harvested and re-suspended in culture medium at a density of 1.5 x105 ml-1. 
Then, 1 ml of the cell suspension was aliquoted into the wells of a 24 well plate containing 
sterile glass coverslips (12mm no: 1.5) and the plate was incubated overnight. After checking 
cell density the cells were washed by adding and removing 1ml PBS. Next, the cells were 
fixed and permeabilised by adding 1 ml acetone to each well and incubating for 5 min. The 
acetone was removed and the coverslip quickly washed three times with PBS by adding PBS 
by plastic Pasteur pipette into the wells and removing it by suction using a vacuum pump. 
Then, 150 µl of an appropriate dilution of primary mAbs (to cover the coverslips) was added 
and the plate was incubated at room temperature in a dark and humid place for 30 min. After 
that, the plate was washed three times with PBS (as described above) and 150µl of an 
appropriate dilution of FITC- labeled secondary antibody was added and incubated for 30min 
in a dark and humid place. The plate was washed as before and 200 μl of 1µg ml-1 of 
propidium iodide was added to each well and incubated for 3min. The wells were washed 
again as previously and the coverslips were extracted using thin curved ended forceps onto 
slides that were prepared by adding one drop of Vectashield mountant (Table 2.4) for each 
coverslip. The coverslips were placed upside down (the cells facing the mountant) onto the 
slides. Then, the coverslips were sealed by nail varnish and the slides were stored in slide 
folder at 4ºC in a dark place until examined using a Nikon Eclipse 400UV light microscope 
(Table 2.7). 
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2.2.5 Infection assay 
2.2.5.1 Immunofluorescence microscopy for analysis of Salmonella infection 
 
2.2.5.1.1 Cell preparation 
HEC-1-B and HeLa cell preparation: HEC-1-B and HeLa cells (2.1.7.2.2) were harvested 
using trypsin-EDTA and counted as described in 2.2.1.5 and re-suspended in fresh culture 
medium. 1.5x105 cells were seeded in 24 well plates containing 12mm diameter sterile glass 
coverslips and cultured for 24 hours before use in the experiment. 
RAW, J774, CD9 KO and CD9 WT macrophage cell lines: Cells were harvested using a 
plastic scraper (section 2.2.1.5.2), centrifuged and re-suspended in fresh culture medium. 2 
x105 cells were seeded in 24 well culture plate onto 12mm diameter sterile glass coverslips 
and were then cultured for 24 hours before use in the experiment. 
THP-1 derived macrophages: The human monocyte cell line (2.1.8.2.2) normally grows in 
suspension and was harvested by centrifugation and re-suspended in fresh culture medium 
containing PMA 20ng ml-1 to differentiate them into macrophages. 2 x 105 cells were placed 
in wells in 24 wells plate containing 12mm sterile glass coverslips and cultured incubated for 
3 days before infection. 
2.2.5.1.2 Bacteria preparation  
 Salmonella Typhimurium used in the experiment were prepared as follows: An inoculum 
obtained from glycerol stock was plated on LB agar media overnight at 37ºC. The next day, 
2-3 colonies were picked up and inoculated in 20ml LB broth media at 37ºC overnight without 
shaking. 400 μl from the stationary phase from this growth was inoculated in 20ml LB broth 
media the next morning and incubated at 37ºC in a shaker at  250rpm to reach the mid log 
phase after 2-2.5 hours (OD600 ~ 0.4-0.5). Then, the culture was immediately centrifuged at 
5400g for 5 minutes. In order to wash the bacteria, the pellet was re-suspended with PBS and 
centrifuged again as mentioned above. The supernatant was discarded and the pellet re-
suspended again with PBS and centrifuged same as before. Then, the pellet was re-suspended 
in an appropriate amount of  cell culture media supplemented with 10% HI-FCS depending 
on the cells used in the experiment and checked again for accurate cell density (both OD600 
and viable account were obtained) and then to produce the required multiplicity of infection 
(MOI). 
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2.2.5.1.3 Infection of cultured cells 
Different MOIs and times of infection were used to optimise conditions. MOIs of 50, 100 and 
150 were used for 30, 60 and 90 minutes infection time. The mammalian cells were prepared 
before infection by removing the existent media from the wells using a Pasteur pipette, 
followed by1x washing of the cells with PBS. Cells were treated with 1ml of 5% bovine 
serum albumin (BSA) for 30 minutes to reduce non-specific attachment of bacteria to the cell 
surface (before treatment with antibodies). The BSA was removed and the wells were washed 
2x with PBS. Then, cells were incubated with 150µl of medium or medium containing the 
appropriate antibody (20µg ml-1) for 60 minutes before washing 2x with PBS. 1ml/well of 
cell media containing a suitable MOI of bacteria was added for the estimated time of 
infection. After the time course, unattached bacteria were removed and the cells washed 2x 
before fixing the infected cells with 4% paraformaldehyde. 
2.2.5.1.4 Staining procedure of infected cells 
The paraformaldehyde was removed and cells were washed 2x with PBS using a Pasteur 
pipette to prepare the cells for staining.  200 μl per well of anti-Salmonella poly A antibody 
was used at a concentration of 50µg ml-1 (diluted in PBS) for 12 minutes at room temperature 
as a primary Abs to differentiate between internal and external bacteria. Unattached Abs were 
then removed and the cells were washed twice with PBS. 200 μl/well of the secondary FITC-
conjugated anti-rabbit IgG Ab (diluted 1:320 in PBS with 0.5% goat serum) was added for 
12 minutes at room temperature. The cells were kept in the dark through the staining to 
eliminate bleaching of the fluorescence. Then, unbound Ab was removed and the cells were 
washed twice with PBS. For DNA staining in both infected cells and bacteria (internal and 
external bacteria), 400 μl/well of DAPI solution (Table 2.1) was added for 12 minutes at room 
temperature in the dark. The DAPI stain bound to nucleic acid and appeared blue when using 
the appropriate filter of a fluorescence microscope. (The excitation wavelength of DAPI is 
340 to 380 nm and the excitation wavelength of FITC is 495 to 520 nm, the green fluorescence 
of FITC was viewed using the appropriate filter). 
2.2.5.1.5 Preparation of slides for fluorescent microscopy 
After staining of the cells that were attached on the coverslip (section 2.2.5.1.4), the cells 
were washed twice with dH2O and a long sharp point forceps was used to extract the coverslip 
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from the wells. The coverslip was immersed on the slide, the cell side down, over a drop of 
Vectashield mounting medium to minimize bleaching. Then, the coverslip was fixed to the 
slide with drops of nail varnish to prevent drying and slipping of the sample. 
2.2.5.1.6 Analysis of infected cells 
A Nikon Eclipse 400UV light microscope with a Digital camera DXM1200 (2.1.10) at 1000x 
magnifying power was used for make a random count of 100 cells per replicate. After 
covering the coverslip with a drop of immersion oil, the slides were viewed under the 
microscope. Random fields were taken across the area of the coverslip to count the number 
of examined cells, number of cells associated with one or more bacteria, number of cells with 
DAPI but not FITC stained bacteria, the DAPI stained bacteria and the total number of FITC 
stained bacteria. The DAPI stained bacteria revealed both external and internal bacteria, while 
the FITC stained bacteria revealed external bacteria only. The internal bacteria could be 
counted by subtracting the FITC stained bacteria from DAPI stained bacteria. The abnormal 
cells or “Jackpot" cells (the cells which had large numbers of bacteria) were not counted. 
Parameters used to measure the difference in Salmonella uptake 
Percentage of infected cells (cells with both attached and internalized bacteria) = Number of 
cells with bacteria (DAPI stained bacteria) per 100 counted cells 
Percentage of internalization = (Number of internalized bacteria / Total number of bacteria) 
* 100 
Number of attached bacteria = Number of attached bacteria per 100 counted cells 
Number of internalized bacteria = Number of all bacteria (DAPI Stained) – Number of 
attached bacteria (FITC stained) per 100 counted cells 
    
2.2.5.2 Development of a flow cytometry procedure for analysis of Salmonella 
infection 
In this assay, the mammalian cells were infected in tubes in suspension, then the cells were 
fixed using solution A (Fix and Perm™ kit). After fixing, the cells were divided in two 
groups, one group prepared for staining with FITC-conjugated anti-Salmonella polyclonal 
Abs without cell permeabilisation (which reveals external or attached bacteria only), and the 
other group was prepared for the same staining with permeabilisation (using permeabilisation 
solution B from Fix and Perm™ Kit) (which reveals all (external and internal) cell-associated 
bacteria). After staining, the samples were analysed by flow cytometry (Figure 2.1). 
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2.2.5.2.1 Mammalian cell preparation 
The cells were harvested (2.2.1.5), using cell dissociation solution to detach the adherent cell 
lines (HEC-1-B and HeLa cell lines) while in semi-adherent cell lines, mechanical harvesting 
by plastic cell scraper was used. The cells were counted and 1x106 / ml cell suspension in 
normal cell media was prepared. The cell suspension was aliquoted in to 0.5 – 1x106 per 2ml 
Eppendorf tubes. The cells were centrifuged and then the cells were treated with 50-100µl of 
20µg ml-1 tetraspanin antibody or 500-1000nM of recombinant tetraspanin EC2 proteins for 
60 min at 37°C.  
2.2.5.2.2 Bacteria preparation 
Salmonella were prepared as mentioned in 2.2.5.1.2. 
2.2.5.2.3 Infection of the cells 
Appropriate MOIs of bacteria were used to infect the cells after treatment with anti-
tetraspanins antibody or with tetraspanins EC2 domain. 0.5 -1 ml of appropriate MOI was 
added per tube depending on the cell density to keep the cell-bacteria distribution constant 
over all the experiments. The tubes were placed in a rotating mixer and the tubes were 
incubated at 37°C for the time period stated in the experiment. The tubes were then cooled 
on ice for 5 min and centrifuged at 200g for 5 min. The infected cells were washed twice with 
B/B/N, then fixed by adding 50µl of solution A (Fix and Perm™ kit) for 15 minutes. The 
infected cells were washed with 1ml PBS and centrifuged 200g for 5 minutes. 
 Infection of the cells in 96 wells plate 
For analysis of larger numbers of samples, the experiment was carried out using sterile 96 
“U” bottom well plates instead of tubes as described in 2.2.5.2.1. Cells were aliquoted at 
concentration of 0.4-0.5 million for each well, then treated with 20µg ml-1 of anti-tetraspanin 
antibody diluted in normal media for 60 minutes at 37°C. 100µl/well of a suitable MOI of 
bacteria was added, or 100µl medium for the non-infected cell control was. The plate then 
sealed using adhesive seals (BioRad) and incubated in a shaking incubator 100rpm, 37°C for 
30 minutes. Then the plate was placed on ice for 5 minutes to stop bacterial infection and then 
centrifuged at 400g for 3 minutes. The cells were washed two times with BBN (Table 2.1). 
Cells were then fixed with 4% PFA for 15 minutes and stained as described (for non GFP 
expressing bacteria) or washed once with PBS one time and re-suspend with 1% PFA. The 
cells were kept on dark and cooled place until analysis.  
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2.2.5.2.4 Staining protocol 
The infected cells (from the previous steps) were re-suspended with 200µl PBS (second wash) 
and the contents of each tube was divided into two wells in “V” shaped 96 wells plates then 
centrifuged at 200g for 5 min. The washing solution was removed by suction (one set stained 
with permeabilisation (with solution B from Fix and Perm™ kit) other set stained without 
permeabilisation (using B/B/N instead of solution B). Using a multichannel pipette, 25µl of 
anti-Salmonella -FITC conjugate polyclonal antibodies (Table 2.5 B) at 1:500 dilution in PBS 
was added to each well. This was followed by adding 25µl of solution B to the permeabilised 
group or 25µl of B/B/N to the non-permeabilised group and the well contents were mixed by 
pipetting. In permeabilised cells, all bacteria were stained with FITC conjugated anti-
Salmonella antibody (external and internal bacteria), while in non-permeabilised cells, only 
the external bacteria were stained.  The infected cells were incubated with antibody for 15 
minutes at RT, then the stained cells were washed twice with PBS, by adding 100µl of PBS 
to each well, centrifuging at 200g for 5 min and the washing solution was removed by suction. 
The plate was then vortexed briefly at low speed, the pellets were re-suspended with 150µl 
PBS for a second wash. The pellets were re-suspended in 150µl of 1%PFA and the infected 
cells were transferred in to Micro Test tubes (Table 2.8) and kept at 4°C until were analysis 
up to 48 hours later. 
2.2.5.2.5 FACS analysis of infected cells 
An LSR II FACS machine was used to analyse infected cells. The cells were gated depending 
on forward and side scatter (FSC and SSC). 5,000 -10,000 events were acquired and the data 
analysed using BD FACSDiva 7.0 software. To calculate the cells with internalized bacteria 
only, the non-permeabilised cells (cells with attached bacteria) were subtracted from 
permeabilised cells (cells with attached and internalized bacteria). 
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Figure 2.1: Flow cytometry procedure for Salmonella infection 
 
Centrifuge and re-suspend 
the cells with anti 
tetraspanin 
Mammalian cell 
suspension (0.5 – 1 x10
6
)
 
 
Incubate 37◦C 
 
Infect the cells with suitable MOI 
of Salmonella   
Incubate 37◦ C on rotating mixer 
2X washing to remove 
unbound bacteria 
 
Non-permeabilised cells 
 (Stain attached bacteria) 
Staining the bacteria by using primary and FITC- 
secondary Abs 
Permeabilised the cells  
(Stain all infected bacteria) 
Fixing  
 
2X washing to remove 
unbound bacteria 
Analyzing the samples by FACS machine  
Chapter 2 
58 
 
2.2.5.3 Flow cytometry analysis of Salmonella infection of HeLa syntenin KD and 
control cells  
2.2.5.3.1 Preparing HeLa syntenin and HeLa control cells for infection 
The HeLa syntenin KD and WT cells control are human epithelial cells, where the former has 
been stably transfected with a plasmid encoding shRNA specific for the syntenin gene, 
whereas control  cells contain empty vector (both encoding puromycin resistance) (2.1.8.2.2). 
Cells were harvested and counted (2.2.1.5) and 3x105 cells were seeded in 12 well culture 
plates in fresh culture medium supplemented with 1.5µg ml-1 puromycin. Cells were cultured 
overnight before use in the experiment. 
2.2.5.3.2 Infection of HeLa syntenin KD and HeLa WT cells  
Bacteria were prepared as described in 2.2.4.1.2. Optimization was again carried out to find 
a suitable MOI to use in infection. After washing once with PBS, the HeLa cells were treated 
with 5% BSA for 30 minutes prior infection to reduce non-specific binding of bacteria to the 
well surface, the BSA was removed and after two further washes with PBS, 1ml of media 
(without puromycin) containing a suitable MOI of bacteria was added for for 1hr before 
washing to remove unbound bacteria and incubating in medium containing 100µg ml-1 
kanamycin for the times indicated before harvesting.  
After the time course, the cells were washed two times with HBSS (without divalent) 
followed by the addition of 0.5 ml/well trypsin-EDTA for 5 minutes. Harvested cells from 
each well were  transferred into 5ml tubes followed by centrifugation at 200g for 5 minutes 
to remove trypsin-EDTA and the cells were washed one time with PBS before fixing the 
infected cells by re-suspending the pellet with 50µl solution A (Fix and Perm™ kit,  2.1.3) 
for 15 minutes. 
2.2.5.3.3 Staining procedure 
The cells were washed 2x with 1ml PBS for the first wash and 200µl PBS for the second 
wash. In the second wash, the 200μl cells suspension was divided and transferred into two 
wells from a 96 wells plate ("V" bottomed) to prepare for staining. As described in 2.2.6.2.4, 
one group of cells was prepared for staining attached bacteria only using FITC-conjugated 
anti-Salmonella polyclonal Abs without cell permeabilisation, and the other group was 
prepared for the same staining (to stain attached and internalized bacteria) with 
permeabilisation (cell-associated bacteria). After staining, the samples were analyzed by flow 
cytometry using the LSR II flow cytometer. 10,000 events were acquired and the gate was 
adjusted depending on the non-infected cells control. 
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2.2.6 Confocal microscopy of Hela Syntenin KD and Hela WT cells 
HeLa syntenin KD cells and HeLa WT control cells (2.1.8.2.2) were used to investigate any 
differences in Salmonella co-localization within the SCV. Salmonella Typhimurium NCTC-
GFP and LT2-GFP were used for these experiments. Alexa fluor® 647-labelled anti-human 
LAMP-1 was used as an SCV marker and Alexa fluor® 568 phalloidin was used to visualize 
the cell outline by staining the actin cytoskeleton. 
2.2.6.1 Preparation of the HeLa cells  
Cells were harvested as described previously and 1.5x105 cells were seeded in culture 
medium, one day before experiment, in 24 well culture plate over 12mm diameter and 
thickness number 1.5 sterile glass coverslips. 
2.2.6.2 Infection of culture cells 
The infection was carried out using an MOI of 100 and times of infection used were 0, 1, 2, 
4, 6, 12 and 24 hours. The existent media was removed by suction using a vacuum pump, 
followed by one wash with PBS. Then, 0.5ml per well of cell media (with no puromycin) 
containing the MOI was added to each well. The attached bacteria were killed one hour post 
infection by washing the infected cells twice with pre-warmed PBS followed by adding 1ml 
per well of normal media containing penicillin and streptomycin (100U penicillin + 100g 
streptomycin/ml). After the time course, the cells were washed twice before fixing the 
infected cells with 4% paraformaldehyde for 15 minutes.  
2.2.6.3 Staining procedure 
The cells were washed twice with PBS after removing the paraformaldehyde from the wells 
by suction. 150 μl per well of Alexa Fluor 647-labelled anti-human LAMP-1 was used at 
1:100 in 0.1% saponin permeabilising buffer (Table 2.1) for 60 minutes at room temperature 
in the dark and then the cells were washed twice with PBS. 150 μl/well of the Alexa Fluor 
568 phalloidin in permeabilising buffer was then added and incubated for 20 minutes at room 
temperature in the dark and the cells were washed twice with PBS. The coverslips were 
extracted from the wells and mounted on microscope slides using Vectashield mounting 
medium with DAPI as described in 2.2.5.1.5. A Nikon A1 confocal inverted microscope with 
EM-CCD camera, (Table 2.7), with Nikon elements software was used to visualize and 
analyse the images. 
2.2.7 Mammalian cell lysis 
Lysis of mammalian cells was performed prior to detecting cellular proteins by Western 
blotting. Cells were grown in T175 flasks until they reached 60-70% confluency and then 
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harvested either by using cell scraper (in semi-adherent cells) or by treating the cells with 
trypsin-EDTA. Cells were counted, centrifuged for 5 minutes at 200g, then washed with 5 ml 
HBSS. The pellet was re-suspended with 100µl per 1 x 106 cells with  lysis solution composed 
of 0.5% Triton 100 (Sigma) and 0.5% Brij 98 in PBS containing protease inhibitor cocktail 
(Sigma P8340) at a dilution of 1:100 solution. The mixture was placed on a rotating mixer at 
4°C for 6 hours or overnight. The cell lysate was centrifuged for 15 minutes at 13,000 rpm 
using a micro-centrifuge, then the protein-containing supernatant was removed to pre-cooled 
1.5ml Eppendorf tubes and stored at -80°C.  
2.2.8 Methods used to sub-clone mouse CD9-EC2 domain 
Mouse CD9 EC2 was sub-cloned from the commercially available vector containing full-
length CD9-GFP (Origene MG226288, Table 2.9) into the pGEX-KG vector (Guan and 
Dixon 1991) (Table 2.9) so that it could be expressed as a soluble GST fusion protein, 
essentially as described previously by our group (Higginbottom, Takahashi et al. 2003).  
2.2.8.1 Purification of plasmid DNA 
Plasmid DNA was purified by using QIAprep spin Mini Kits (Table 2.4) by following the 
manufacturer’s instructions. Briefly, a single colony of transformed bacteria containing the 
relevant construct was used to inoculate 5ml LB broth (with selective antibiotics) and 
incubated in a shaking incubator at 250rpm overnight at 37°C. The bacteria were centrifuged 
at 5,400g for 10 minutes at 4°C then re-suspended in 250µl of cooled P1 buffer, then 
transferred to a 1.5 ml microfuge tube and 250µl P2 buffer and then 350µl of N3 buffer added 
and mixed by inversion.  The mixture was centrifuged at 13,000 rpm using a micro-centrifuge 
for 10 minutes. The supernatant was transferred to a QIA prep spin column and centrifuged 
for 1 minute as before. The flow through was discarded and the column washed by adding 
750µl of PE buffer and then centrifuging as previously for 1 minute. The flow through was 
discarded and the column was dried by centrifugation for 1 minute. The column was placed 
into a 1.5 ml sterile microfuge tube and the plasmid DNA was eluted by adding 50µl ddH2O 
in the center of the column. The column was left for 1 minute and centrifuged for 1 minute 
as previously. The concentration of the plasmid DNA was checked using a NanoDrop 
spectrophotometer at 260nm and the plasmid DNA was stored at -20°C. 
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2.2.8.2 PCR, digestion and ligation mixture 
Table 2.14: PCR, digestion and ligation mixture components. The Q5® High Fidelity Kit from NEB 
was used for PCR mixture components. * Amounts calculated as described in 2.2.8.11. 
PCR mixture Digestion mixture (DNA insert) 
Component  Volume (µl) Component  Volume (µl) 
Nuclease free water 22.5 Nuclease free water 32.85 
5x Q5 buffer 10 BSA 0.5 
10 mM dNTPs 1 Buffer (2 from NEB) 5 
DNA 200ng/ml 1 Eco RI-HI (NEB) 1.5 
10 µM Forward primer  2.5 Hind III (Promega)  1.5 
10 µM Reverse primer  2.5 PCR reaction (57.8 ng/µl) 8.65 (500ng) 
Q5 GC enhancer  10 Total 50 
Q5 polymerase 0.5  
Total 50 
Digestion mixture (Vector) DNA ligation mixture 
Component  Volume (µl) Component  Volume (µl) 
Nuclease free water 17.75 Nuclease free water 9 
BSA 0.25 Ligase buffer (10X) 2 
Buffer (2 from NEB) 2.5 *Vector DNA 7.3 
Eco RI-HI (NEB) 0.75 *Insert DNA 0.7 
Hind III (Promega) 0.75 Ligase 1 
Vector DNA 3 (250ng) Total 20 
Total 25  
2.2.8.3 Bacterial glycerol stock preparation 
One single colony of transformed bacteria was grown in 5ml of LB media supplemented with 
selective antibiotics overnight at 37°C in a shaking incubator (250rpm).  250µl of 60% (v/v) 
of glycerol stock solution (Table 2.1) was transferred into cryovials and mixed with 750µl of 
the overnight culture. The cryovials tube were placed at -80°C for long term storage. 
2.2.8.4 Agarose gel electrophoreses 
1% agarose gels were prepared as described (Table 2.1) and allowed to cool slightly before, 
adding 1µl of ethidium bromide per 100ml of gel and pouring into a gel tray with a comb. 
When the gel solidified, it was placed in a gel tank containing 1X TAE buffer (Table 2.1) to 
cover the gel surface. 2x loading buffer (Bioline) was used with the sample DNA at 1:1 
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dilution (10µl of each) and was loaded into each well. A hyper ladder-1 (Bioline) was loaded 
into the gel as a DNA size marker. The gels were run for 1 hour at 100V and then the DNA 
bands were visualized by UV light using a GelDoc-It™ imaging system. 
2.2.8.5 mCD9-EC2 determination 
The full sequence of mouse CD9 was obtained from a bioinformatics databases (uniProtKB 
Table 2.12) in a FASTA format and the mCD9-EC2 was identified by the same database. 
2.2.8.6 Designation of PCR primers 
After determination of the mouse CD9-EC2, primers were designed by taking first 19 to 22 
bases from the 5` and 3` ends of mCD9-EC2 and restriction sites were added that were 
compatible with the expression vector used (pGEX-KG). The primers used are described in 
Table 2.13).  
2.2.8.7 PCR amplification of mCD9-EC2 
The PCR reaction mixture was prepared as described in 2.2.8.2 in thin-walled PCR tubes. 
The mCD9-EC2 was amplified from the full length mouse CD9 in the Origene mCD9-GFP 
containing vector (Table 2.9). The optimal annealing temperatures for the forward and reverse 
primers were identified by using the Thermo Fisher Scientific Tm calculator online tool and 
it was set as the averaged melting temperature (Tm). The setting of thermal cycle reaction was 
carried out as described in Table 2.15. 
Table 2.15: Thermal cycle settings used to amplify mouse CD9-EC2 from the CD9-GFP carrying 
vector. 
Number of cycles Temperature (°C) Time  
1 Cycle 95 10  minutes 
30 Cycle 96 10 second 
60 30 second 
72 30 second 
1 Cycle 72 10 minutes 
 4 Hold 
2.2.8.8 Purification of PCR products 
 PCR product was purified either after separation on 1% agarose gels and using the QIAquick 
Gel Extraction Kit (Table 2.4), or by direct purification of DNA fragments using the QIA 
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PCR purification Kit (mentioned in 2.4). In both methods, a sufficient DNA concentration 
was obtained.  
2.2.8.9 Restriction enzyme digestion 
The purified PCR products and the expression vector pGEX-KG were double digested with 
appropriate restriction enzymes (Table 2.14) to produce 5` and 3` overhang sticky ends for 
ligation. The mixture of buffer, restriction enzymes and DNA was prepared in thin-walled 
PCR tubes followed by brief centrifugation. The mixture was incubated at 37°C for 3 hours. 
The enzymes were deactivated by heating to 80°C for 20 minutes (EcoR I-HF and Hind III-
HF). The digested samples were purified after running on 1% agarose gels and then the DNA 
concentration was determined using a NanoDrop spectrophotometer at 260nm (Table 2.7).  
2.2.8.10 DNA ligation  
After digestion and purification of both mCD9-EC2 (insert) and pGEX-KG (expression 
vector), the two fragments were ligated. The concentration of the insert and the vector were 
determined by NanoDrop (Table 2.14) and all components in the calculated amounts were 
mixed in small Eppendorf tubes and incubated for 1-3 hours at 25°C. 
The amount of insert and the vector DNA were determined according to the following 
equation: 
𝑉𝑒𝑐𝑡𝑜𝑟 𝑎𝑚𝑜𝑢𝑛𝑡 (𝑛𝑔)𝑥 𝐼𝑛𝑠𝑒𝑟𝑡 𝑠𝑖𝑧𝑒 (𝑏𝑝)
𝑆𝑖𝑧𝑒 𝑜𝑓 𝑣𝑒𝑐𝑡𝑜𝑟 (𝑏𝑝)
 𝑥 𝑚𝑜𝑙𝑎𝑟 𝑟𝑎𝑡𝑖𝑜 𝑖𝑛𝑠𝑒𝑟𝑡: 𝑣𝑒𝑐𝑡𝑜𝑟
= 𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑖𝑛𝑠𝑒𝑟𝑡 (𝑛𝑔) 
A 3:1 molar ratio of vector: insert was used here. 
 2.2.8.11 Plasmid amplification 
1µl of complete ligation reaction was used to transform 20µl DH5α competent cells following 
the protocol described in 2.2.9.1. Half of 10 single colonies were picked and grown overnight 
in 5 ml LB media with selective antibiotics at 37°C and 250 rpm shaking followed by DNA 
plasmid purification (2.2.8.1) and PCR amplification, as described in 2.2.8.4, using mCD9 
EC2 forward and reverse primers (Table 2.13), as well as the forward (pGEX-F2) and reverse 
(pGEX-R1) primers for the vector (Table 2.13). 
2.2.8.12 DNA sequencing 
After the results of the PCR described above, DNA from 4 chosen clones were sequenced 
using forward and reverse vector primers (pGEX-F2 and pGEX-R1 respectively, (Table 
2.13). Sequencing was carried out using the Core Genomic Facility, DNA Sequencing 
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Service at the in University of Sheffield, using an Applied Biosystems 3730 DNA analyser 
and BigDye v3.1 protocol. 
2.2.9 Bacterial protein expression 
2.2.9.1 Transformation of DH5α and Rosetta gami competent cells 
This method was used for cloning of vector (using DH5α cells) or protein expression (using 
Rosetta gami B, Novogen). 50µl of competent cells were defrosted on ice and 1µl of plasmid 
of interest was added and mixed by tapping the tube gently. The mixture was incubated on 
ice for 30 minutes, then placed in a floating pad in a water bath at 42°C for 45 seconds (heat 
shock).  The cells were left for a further 2 minutes on ice before adding 250µl SOC medium. 
The cells were then incubated with shaking (150 rpm) for 30 minutes. 50µl from this culture 
was plated on agar plates containing appropriate selection agents. 
2.2.9.2 Expression of protein in Rosetta gami 
Rosetta gami cells were transformed with pGEX-GST-CD9-EC2 as described above. One 
single colony was picked into 5ml LB broth containing carbenicillin (100µg ml-1) using a 
sterile pipette tip. The cells were incubated overnight at 37°C and 250 rpm in a shaking 
incubator. Next day, the culture was diluted in 500ml LB broth (in a 2 litre conical flask) 
containing carbenicillin at 100µg ml-1. The flask was incubated for 5-8 hours until the OD600 
reached 0.7, and at this point expression was induced by adding 50µl of 1M IPTG solution 
(0.1mM final concentration) and left for a further 4 hours incubation to express the protein. 
500ml tubes were used for centrifugation of the cultures after recording the weight for each 
tube (to calculate the weight of the bacterial pellet after subtracting the weight of the tube 
from the total) and filled to a maximum volume of ~330ml per tube. The tubes were 
centrifuged at 4500g for 20 minutes, the supernatants discarded and the pellets were stored 
in -80°C until the next step. 
2.2.9.3 Bacterial cell lysis 
The frozen tubes were defrosted on ice and the pellets were re-suspended with cooled PBS 
contain 1:100 protease inhibitor cocktail (Table 2.4) at a ratio of 5ml PBS per 1gram of 
bacterial pellet. The re-suspended pellet was transferred into 20 ml autoclaved pre-cooled 
Beckman tubes, which were placed in a 500ml plastic beaker containing ice to keep the 
bacterial suspension cool during sonication. The sonicater was set for 15 micron and the 
sonication was performed five times for 15 seconds with 2 minute intervals between each 
round, and the suspension was mixed after two rounds of sonication. The bacterial lysate was 
Chapter 2 
65 
 
centrifuged at 16,000g for 30 minutes and the supernatant transferred into pre-cooled 15 ml 
Falcon tubes and kept on ice.  
2.2.9.4 Protein purification  
Glutathione agarose beads, (Sigma, G4510) were prepared at a concentration of 0.1ml of 
beads for every 1 gram of bacterial pellet by taking double the volume of the beads from the 
stock (as 50% of the supplied volume is ethanol). The ethanol was removed by centrifugation 
at 500g for 5 minutes at 4°C, and the beads were washed 3 times by re-suspending with 5x 
beads volume of pre-cooled PBS before mixing with the cell lysate. 
The mixture of beads and cell lysate was incubated at room temperature on a blood mixer for 
2 hours, then centrifuged at 500g for 5 minutes (4°C) and the supernatant discarded. The 
beads were washed three times with 5 column volumes of pre-cooled PBS (to wash the beads 
and remove unbound proteins) by re-suspending the beads gently with pre-cooled PBS and 
then centrifuging as before (one fraction was taken for analysis from each step of the 
washing). After the final wash, the bound protein was eluted using glutathione elution buffer 
(Table 2.1) and incubating with gentle rotation for 20 minutes. The beads were centrifuged 
as previously and the supernatant containing the expressing protein was transferred in to new 
pre-cooled microfuge tube. The elution process was repeated, as before and fractions were 
taken at each elution step for analysis by Western blot. 
2.2.9.5 Determination of protein concentration and dialysis 
The protein concentration was determined by using the NanoDrop spectrophotometer at 280 
nm and the purified protein either stored in -80°C or dialyzed the same day. The required 
length of 16mm SnakeSkin dialysis tubing with 3.5K molecular weight (Life Technologies) 
(Table 2.8) cut-off with an additional 1-2 inches (for tube closure) was used and the tubing 
was cleanly cut at a 90° angle.  The tubing was briefly dipped into PBS (dialysis buffer) and 
knotted securely at one end. The eluted protein was added into the open end and it was 
securely knotted at the other end. An appropriate container and dialysis buffer (about 300 
times the volume of samples of PBS) were used for dialysis at 4°C with slow stirring for 8-
12 hours (the dialysis buffer was changed twice during dialysis process). After dialysis the 
dialyzed protein was transferred into sterile 1.5ml pre-cooled tubes and stored at -80°C. The 
expressed protein and fractions were checked by SDS-PAGE followed by either staining with 
Coomassie blue or the proteins were transferred onto nitrocellulose membrane for Western 
blotting. 
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2.2.9.6 SDS-PAGE electrophoresis 
Sodium dodecyl sulphate -polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
using a Mini-Protein Cell system from BioRad following the manufacturer’s instructions. 
Briefly, EZ-Run™ 12.5% Protein Gel Solution (Fisher BioReagent) was used to prepare the 
resolving gel after 30µl of freshly made APS and 7.5µl of TEMED for each 5 ml of the gel 
solution (enough for one gel) were added. A 5% stacking gel was prepared as described in 
Table 2.1. For non-reducing SDS-PAGE, the protein samples were boiled with 4x non 
reducing buffer (Table 2.1) at 95°C for 10 minutes using a heating block (Table 2.7). 5-10µl 
of colored protein marker (all Blue Precision Plus, Biorad) was used and 10-20µl of protein 
sample was loaded per well. Gels were run using 1x EZ-Run™ running buffer (Table 2.1) at 
80V for approximately 20 minutes (until the proteins passed through the stacking gel) and 
then at 120V for 60-90 minutes. 
2.2.9.7 SDS-PAGE staining and de-staining 
Gels were extracted from the casting glasses and stained with Coomassie stain (Table 2.1) for 
20 minutes on a rocking table. To remove the non-protein bound stain, gels were incubated 
in de-stain solution (Table 2.1) for 4-6 hours at room temperature then the de-stain solution 
was replaced with distilled water and incubated overnight on a rocking table at room 
temperature.  
2.2.9.8 Western blotting 
After preparing the SDS-PAGE as described above, a wet Western blotting system was used. 
The gel sandwich was assembled composed of, from negative to positive electrodes, sponge,  
blotting filter paper, SDS-PAGE gel,  0.45µm nitrocellulose membrane 
(Amersham™Protran,10600003), blotting filter paper and sponge. All elements of the gel 
sandwich were soaked with blotting buffer to moisturize before assembly. After that, the 
sandwich was placed in the blotting module with the nitrocellulose membrane facing the 
positive electrode. To cool the module, a freezing block was placed in the tank of blotting 
system. The proteins were transferred at 100V for 1 hour or at 20V overnight. Then the 
membrane was extracted and placed in a 50ml Falcon tube with 5% blocking solution (Table 
2.1) for 30 minutes at RT to block the membrane for any non-specific binding of antibodies. 
The blocking solution was replaced with 5ml of an appropriate primary antibody in 5% 
skimmed milk blocking solution (Table 2.1) and incubated overnight on a rotating mixer at 
4°C. The membrane was then washed three times with TBST (Table 2.1) for 5 minutes for 
each, followed by staining with HRP-conjugated secondary antibodies for 2 hours on a 
rotating mixer at RT. The membrane was then washed three times as described above. Finally, 
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the membrane was incubated with Super Signal West Pico Chemiluminescent substrate (from 
Thermo Scientific or BioRad) for 1-5 minutes at RT, then, the extra reagent was removed by 
holding the membrane vertically over tissue paper (to absorb the extra amount of the reagent) 
before placing it in the ChemiDoc™ MP system (BioRad) to visualize and capture the 
proteins bands. 
2.2.10 Mammalian cells transfection 
2.2.10.1 Selective reagent kill curve 
This method was performed to determine the optimal selective antibiotic concentration for 
obtaining stable transfected cells. Different concentrations, starting from 0.1 to 2 mg ml-1 of 
G418 in DMEM media were prepared. The cells were seeded in 24 wells plates at 105 /well. 
The next day, the media was removed and replaced with media containing the appropriate 
G418 concentration in duplicate. The cells were observed every day for 7 days and the media 
was replaced every 3 days. The optimal antibiotic dose was determined after 7 days and is 
defined as the lowest antibiotic concentration that is able to kill all the cells after this time. 
2.2.10.2 Transfection of J774 cells by electroporation 
The transfection of J774 cells with the mCD9-GFP carrying vector (Table 2.9) was carried 
out using a Gene Pluser® II with capacitance extender plus (BioRad). The cells were grown 
in a T75 flask overnight 2.2.1.4) then harvested using trypsin-EDTA for 5 minutes (2.2.1.5). 
5 x106 cells were centrifuged and the cell pellet re-suspended with 250µl of DMEM 
supplemented with 10% HI-FCS. 20µg of plasmid DNA was mixed with the cell suspension 
in a 0.4cm gap electroporation cuvette. The mixture was incubated on ice for 15 minutes 
before electroporation. The electroporation system setting was: voltage 0.2 kv, capacitance 
950 µF. After the cells were transfected, they were diluted into 30ml DMEM media 
supplemented with 10% HI-FCS and penicillin streptomycin 100U penicillin + 100g 
streptomycin/ml),  then separated into 3 10cm culture dishes (Table 2.8) and cultured under 
standard conditions. The cells were observed using a fluorescence inverted microscope after 
24 hours. After 48-72 hours post transfection, the medium was replaced with 10% HI-FCS 
DMEM supplemented with penicillin, streptomycin and 400µg/ml G418 (selective reagent) 
for 3 days and thereafter with 200µg/ml G418 containing media for maintaining the 
transfected cells. The G418 resistant cells were tested by flow cytometry to evaluate the 
percentage of mCD9-GFP expressing cells. The cells were sorted using a FACS Aria cell 
sorter depending on their GFP expression. 
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2.2.11 RNA Microarray analysis 
Microarray analysis was performed to compare the mRNA expression profiles of macrophage 
cell lines derived from CD9 KO or corresponding WT mice (section 2.1.8.2.1) 
2.2.11.1 RNA extraction 
RNA was extracted using the RNAeasy Mini Kit (Qiagen, Cat. No. 74104) according to the 
manufacturer’s instructions. The total RNA concentration was determined by NanoDrop 
spectrophotometer and the samples were stored at -80 °C until used for the GeneChip® 3’IVT 
Express labeling assay. 
2.2.11.2 RNA purity and integrity analysis 
RNA purity and integrity of extracted RMA were analysed by using Agilent RNA 6000 Nano 
Kit by microfluidic analysis using the Agilent 2100 bioanalyser following the manufacturer’s 
instructions. The analysis was carried out at the SITraN Microarray facility at the University 
of Sheffield. 
2.2.11.3 RNA amplification and labelling 
Amplification was performed using the Affymetrix GeneChip 3’ IVT express kit following 
manufacturer’s instructions and will be covered, briefly, in the following section. 
Poly-A RNA control:  A positive RNA control was prepared to monitor the effectivity of the 
reagents that were used (all reagents needed were included with the kit). The poly-A RNA 
controls were also prepared to monitor the whole target labeling procedure. The Poly-A RNA 
kit included several probe sets of Bacillus subtilis genes (lys, phe, thr and dap); these set of 
genes are absents in eukaryotic cells and are synthesized in vitro. The stock poly-A control 
was diluted with poly-A control dilution buffer. The poly-A RNA dilution was prepared for 
100ng total RNA by adding 2µl of poly-A RNA stock control to 38µl of poly-A control buffer 
to obtain (1:20) the first dilution and 2µl from this dilution was mixed with 98µl of poly-A 
control buffer to obtain the second (1:50) dilution. As in the previous step, 2µl from the 
second dilution was added to 98µl of buffer to obtain the third (1:50) dilution, 2µl from the 
third dilution was added to 18µl of buffer to have the fourth (1:20) and working dilution.  
The total RNA/poly-A RNA control mixer was prepared by adding 100ng (in 1µl) of total 
RNA to 2µl from fourth dilution (from the previous step) of poly-A RNA control with 3µl 
of nuclease free water to reach 5µl total volume.  
First strand cDNA synthesis: Following the previous step, the first strand cDNA was 
synthesized following the manufacturer’s instruction (GeneChip® IVT Express Kit). Briefly, 
Chapter 2 
69 
 
to prepare the first strand master mix, 4µl of first strand buffer mix was mixed with 1µl of 
first strand enzyme mix (for each reaction), the mixture then briefly centrifuged and placed 
on ice, 5µl of total RNA/poly-A control mixture (from the previous step) was added to 5µl 
first-strand master mix for 10µl final volume, then mixed, centrifuged and placed on ice. Then 
the mixture was incubated for 2hr at 42ºC in a thermal cycler, then briefly centrifuged and 
placed on ice to proceed to the next step.  
 Second strand cDNA synthesis: The second strand master mix was prepared by mixing 13µl 
of nuclease free water, 5µl second strand master mix and 2µl second strand enzyme mix (total 
volume 20µl). This was mixed and briefly centrifuged. 10µl of cDNA (from the previous 
step) was added to 20µl of second strand master mix and the mixture was mixed, briefly 
centrifuged and placed on ice. Then the mixture was incubated in thermal cycler at 16ºC for 
1 hr followed by 65ºC for 10 minutes. Then, the product was briefly centrifuged (to collect 
double stranded cDNA). The double stranded cDNA product was placed immediately on ice 
or stored at -20ºC.      
In vitro transcription to synthesize labeled aRNA: In brief, the IVT master mix was prepared 
for each sample at RT in a nuclease free tube as follows: 4µl of 3` IVT biotin label was mixed 
with 20µl IVT buffer and 6µl of IVT enzyme. This was briefly mixed and centrifuged. Then, 
this was mixed with 30µl of double stranded DNA (from the previous step) and the mixture 
was briefly centrifuged, followed by 16 hr incubation at 40ºC using thermal cycler 
programmed for Transcription aRNA synthesis. The tubes were either kept on ice for labeled 
aRNA purification or stored at -20 ºC.  
aRNA purification: The aRNA was purified by adding 100µl of purification bead mix for 
each 60µl aRNA (from the previous step), mixed and transferred to a well of a “U” bottomed 
96 well plate, then mixed several times by pipetting followed by 10 minutes incubation at 
RT. The plate was moved to a magnetic stand for aRNA binding bead capture for about 5 
minutes. The supernatant was aspirated and discarded and the beads were washed with 100µl 
aRNA washing solution for each sample followed by shaking for 1 minute. The plate was 
returned to the magnetic stand and the washing step was repeated twice more. After washing, 
the plate was allowed to dry for 5 minute to evaporate the remaining ethanol from the washing 
buffer. The aRNA was eluted by adding 50µl of pre-warmed (65ºC) nuclease free water to 
each sample followed by shaking the plate for 3 minutes. Then, the plate was returned to the 
magnetic stand and the RNA binding bead captured. The eluted aRNA (supernatant) was 
transferred to a nuclease-free PCR tube and stored at -20ºC.  The concentration of aRNA was 
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determined by measuring (2µl of sample) absorbance at 260 nm using NanoDrop and Agilent 
Bioanalyser and an RNA6000 nano kit was used to analyse the aRNA size and distribution. 
Fragmentation of labeled aRNA: The fragmentation of labeled aRNA was carried out by 
preparing the fragmentation mixture on ice and adding 15µg aRNA (1-32 µl) to 8µl 
fragmentation buffer (the volume was adjusted to 40µl by adding nuclease free water). The 
mixture was briefly centrifuged then incubated for 35 minutes at 95ºC. The tubes was briefly 
centrifuged and immediately replaced on ice. The Agilent bioanalyser using RNA6000 Nano 
kit was used to determine the size of fragments.     
Hybridization: The array hybridization was carried out by using the GeneChip® Mouse 
Genome 430.2.0 array (Affymetrix, part. no. 900495). The hybridization cocktail was 
prepared for single probe array following manufacturer’s instruction (GeneChip® 3`IVT 
Express kit user manual). Briefly, 12.5µg (33.3µl) of fragmented and labeled aRNA was 
mixed with 4.2 µl control oligonucleotide B2 (3nM), 12.5µl of 20x hybridization controls 
(bioB, bioC, bioD and cre), 125µl 2x hybridization mix, 25µl DMSO and 50µl nuclease free 
water. The hybridization cocktail was incubated for 5 minutes at 99ºC then for 5 minutes at 
45ºC using the thermal cycler hybridization cocktail program. Meanwhile, the array was 
wetted with 200µl of pre-hybridization mix and incubated at 60 rpm rotation for 10 minutes 
at 45ºC. The hybridization cocktail was centrifuged for 5 minutes. Then, the pre-hybridization 
mix was extracted from the array and re-filled with an appropriate volume of hybridization 
cocktail and the array was incubated for 16hr at 45ºC with 60 rpm rotation.  
After incubation, the hybridization cocktail was extracted from the array chip and the chip 
was loaded with wash buffer. The chip washing process was carried out using the Affymetrix 
Fluidics System 450. The GeneChip 30007G scanner was used to scan the chip. The 
microarray analysis work was carried in collaboration with Dr. Paul Heath in the Microarray 
facilities in SITraN, University of Sheffield. 
2.2.11.4 Data analysis 
 After obtaining the gene expression data, the difference between CD9 KO mouse 
macrophages and WT mouse macrophage controls was analysed by using Qlucore Omics. 
Data from gene expression profiles were analysed using principal component analysis (PCA), 
a mathematical algorithm which trims data diminutions where the data set retains most 
variation. This  trimming is  achieved by determining directions, or so-called principal 
components (PC), in which a few components could represent thousands of variables that 
could be visualized as a plot to estimate sample similarity and variation and possible sample 
clustering (Ringner 2008). In addition to PCA analysis and plots, this software provided other 
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functions such as investigating any structure in the data by combining PCA with variant 
filtering and enhancing the results by performing statistical filtering using ANOVA. This 
classifies data and creates a gene list depending on selected statistical testes such as T-test, 
F-test or regression; it identifies subgroups by using hierarchical clustering or PCA and finds 
correlation and networks between selected genes by working with PCA plots 
(http://qlucore.com/ProdOverviewGeneExpression.aspx?cache=0).                     Transcriptome 
Analysis Console v3.0 (Affymetrix) software was also used 
(http://www.affymetrix.com/estore/browse/level_seven_software_products_only.jsp?produc
tId=prod760001#1_1). This software has the same functionality as in Qlucore Omics except 
for a few differences in the statistical analysis and data analysis output format, since the fold 
changes is based on linear values while in Qlucore this value in log2 format.  Multiple T-tests 
with p values of 0.05, 0.01 and 0.001 were applied in order to evaluate the variably regulated 
genes and the gene ontology was analysed by using the bioinformatics tool DAVID. 
2.2.12 Co-localisation experiments 
2.2.12.1 Mouse CD9 and Salmonella co-localisation in J774 cells  
Both J774 cells and Salmonella bacteria were prepared as described in 2.2.5.1.1 and 2.2.5.1.2 
respectively, then cells were infected as described in 2.2.5.1.3. After fixation, 5% bovine 
serum albumin (BSA) blocking solution in PBS was used for 10 minutes to prevent non-
specific binding followed by washing twice with PBS. The fixed cells were then stained by 
adding 150µl/well of primary antibodies anti-mCD9 and anti-Salmonella (Table 2.5 A) at 
concentration of 10 µg ml-1 and 50µg ml-1 respectively in (0.5 % goat serum in PBS) for 45 
minutes. Then, cells were washed twice with PBS and stained with secondary antibodies anti- 
rat Alexa fluor 546 and anti-rabbit Alexa fluor 647 (Table 2.5 B) at manufacturers 
recommended concentration (in 0.5% goat serum PBS) to stain cell surface mCD9 and 
external Salmonella respectively for 30 minutes. Cells were then washed twice with PBS 
followed by staining of cells and bacterial DNA by DAPI stain, 400 μl/well of DAPI solution 
(Table 2.1) was added for 12 minutes at room temperature in the dark. Cells were then 
prepared for confocal microscopy as described in 2.2.5.1.5. Images were acquired using 60x 
objective. A Nikon A1 confocal inverted microscope with EM-CCD camera (Table 2.7), with 
Nikon elements software was used to visualize and analyse the images. 
2.2.12.2 CD9 co-localization in mCD9-GFP J774 transfected cells 
The J774 cells were transfected with mCD9-GFP as described in 2.2.10.1. and the transfected 
cells were infected with pNB57-mCherry (Table 2.9) transformed Salmonella Typhimurium 
NCTC12023 as described in 2.2.2.1.2. at MOI of 50 for 0, 5, 10, 15, 30, 60, 90 and 120 
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minutes as described in 2.2.5.1.3. The cells were washed and fixed with 4% PFA for 15 
minutes RT. Then, the slides were prepared as described in 2.2.5.1.5. using Vectashield 
mounting medium with DAPI to minimize the bleaching and stain cells and bacterial DNA 
with DAPI stain (blue). Then, the coverslip was fixed to the slide with drops of nail varnish 
to prevent drying and slipping of the sample. Samples were analysed and visualized using 
inverted Nikon confocal microscopy system as mentioned above. 
2.2.12.3 Live imaging microscopy 
J774 cells transfected with mCD9-GFP grown on glass bottom FluoroDish™ (Table 2.8) at 
a concentration of 3 x 105 were infected with 50 MOI of Salmonella Typhimurium NCTC 
self-expressing of red fluorescent protein (RFP). A Widefield imaging system (Nikon dual 
cam system) inverted Ti eclipse with Oka-lab environmental control chamber (Table 2.7) 
controlled by Nikon elements software (NIS) (Table 2.10) was used for live imaging and the 
100x objective was used. The microscope and images were adjusted and prepared choosing 
the appropriate filter for GFP and RFP. The old media was removed and the cells were washed 
one time with pre-warmed PBS and 1ml of appropriate MOI in phenol red free DMEM media 
containing 10% FCS was added. Then, the images were acquired every 5-10 seconds, the 
images then analysed using ImageJ software.
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Chapter 3:  Investigation of tetraspanin protein 
expression in mammalian cell lines 
 
3.1 Introduction 
Screening of tetraspanin proteins on the cell lines was essential to confirm the presence and 
distribution of tetraspanin proteins prior to studying the role of tetraspanin proteins in 
Salmonella infection using FACS and immunofluorescence microscopy. In addition, this 
chapter also details the transformation of fluorescent protein carrying vectors into Salmonella 
enterica serovar Typhimurium NCTC12023 and LT2 strains. These were generated as such 
strains could enhance and facilitate assessing mammalian cells that associated with bacteria 
by FACS without needing to stain Salmonella  and could help to investigate the role of 
tetraspanins using live or fixed cells microscopic imaging. 
 
3.1.1 Tetraspanin protein expression 
Tetraspanin proteins are broadly expressed on mammalian cells, but whilst some  members 
are widely distributed,  the expression of others is limited to particular cells (Boucheix and 
Rubinstein 2001). For  example, the uroplakins UP1a and UP1b are expressed specifically in 
urothelium cells; the photo-receptor tetraspanin peripherin/RDS and ROM-1 is expressed in 
the photoreceptor outer segment and is required optimum membrane fusion (Boesze-
Battaglia, Stefano et al. 2007); tetraspanins CD37 and CD53 are mainly expressed by 
leukocytes (Virtaneva, Angelisova et al. 1993); tetraspanins Tspan-5 and NET are expressed 
in mouse macrophages (RAW264.7) and involved in osteoclastogenesis (Iwai, Ishii et al. 
2007). 
 
3.1.2 Flow cytometry in tetraspanins screening 
Flow cytometry offers a quick method to detect and quantify fluorescent signals of cells 
labelled with fluorochrome (Van Dilla, Trujillo et al. 1969). Since its development, flow 
cytometry has been widely used for classifying and studying the expression intensity of 
different molecules on the cell surface and cytosolic organelles. The synchronised analysis of 
various fluorescent parameters offers a comprehensive study of signalling, receptor, effector 
and co-expressed structural molecules (O'Donnell, Ernst et al. 2013). 
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3.1.3 Cell line models 
Different phagocytic and non-phagocytic cell lines were used in this study and screened for 
tetraspanin expression on the cell surface and associated with intracellular compartments. For 
macrophages, firstly, the mouse macrophage-like J774 cell line was used, since these cells 
show an intrinsic ability for phagocytosis (Ralph and Nakoinz 1975). This cell line has been 
used as an E. coli infection model to understand internalized bacterial survival (Stevenson, 
Baillie et al. 1984) and to understand diarrhogenic E. coli in cell toxicity and apoptosis post 
infection (Lai, Xu et al. 1999). Importantly, J774 cells have also been widely to investigate 
various aspects of S. Typhimurium infection, including studies carried out in this department 
(Tang, Guest et al. 2004, Gilberthorpe, Lee et al. 2007). Another well-known mouse 
macrophage cell line was also used: the RAW264.7 cell line that was originally established 
from a Balb/c mouse by Abelson leukaemia virus transformation (Ralph and Nakoinz 1977). 
This cell line has also been widely used to investigate Salmonella Typhimurium infection 
(Govoni, Canonne-Hergaux et al. 1999, Lahiri, Das et al. 2008, Ipinza, Collao et al. 2014). 
However, both of these cell lines are of mouse origin, and few monoclonal antibodies that 
target the native tetraspanin proteins are commercially available compared with antibodies to 
the human tetraspanin proteins. The human monocyte cell line, THP-1, derived from a patient 
with acute monocytic leukaemia (Tsuchiya, Yamabe et al. 1980), can be induced to 
differentiate into macrophage-like cells by treating the cells with  phorbol myristate acetate 
(PMA) (Tsuchiya, Kobayashi et al. 1982). The cells become adherent, stop dividing and 
become phagocytic with upregulation of certain cell surface proteins including CD14 and 
CD11b, and particularly proteins that are associated with cell structure and metabolism after 
differentiation to macrophages (Schwende, Fitzke et al. 1996, Zhang, Liu et al. 2015). 
Differentiated THP-1 like macrophage-like cells have also been used for models of S. 
Typhimurium infection (e.g. (Sly, Guiney et al. 2002).  
As an epithelial cell model, the HEC-1-B cell line was included. This is an adherent human 
endometrial carcinoma epithelial cell line produced as a sub-strain of HEC-1A that was 
isolated in 1968 by Kuramoto (Kuramoto, Tamura et al. 1972). Since then, these cells have 
been used in different infection assays, including those from our group (Griffiss, Lammel et 
al. 1999, Green, Monk et al. 2011). In addition to HEC-1-B, the well-known human epithelial 
cell HeLa cell line was also used. This is a human epithelial cell line derived from cervix 
adenocarcinoma that was the first cultured human cells showing immortality (Gey, Coffman 
et al. 1952). Later on, these cells were shown to be highly susceptible to  poliomyelitis virus 
infection and first used to develop polio vaccine  (Scherer, Syverton et al. 1953) and the full 
genomic sequences of the cells was firstly published in 2013 (Landry, Pyl et al. 2013). HeLa 
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cells were suggested for use as a cell model for Salmonella invasion based on the fact that 
Salmonella bacteria have the ability to infect non-phagocytic cells (Giannella, Washington et 
al. 1973) and have been widely used with S. Typhimurium. 
3.1.4 Fluorescent protein expressing Salmonella 
The green jelly fish (Aequoea victoria) fluorescent protein (GFP) has been developed as a 
main indicator to observe gene expression by cell transformation, protein tracking and 
lineages of cells (Sirerol-Piquer, Cebrian-Silla et al. 2012). The fluorescent signal can be 
detected by flow cytometry in GFP-expressed bacteria, both in bacteria alone or in bacteria 
associated with different host cells. This provides a potential tool to investigate bacterial 
pathogenicity either by bacterial visualisation or bacterial quantification (Valdivia, 
Hromockyj et al. 1996). 
The expression of GFP protein can be achieved by transforming bacteria with a plasmid 
vector encoding the GFP alone or fused with gene of interest that is then inserted into bacterial 
chromosomal DNA to provide a single copy and stable GFP expression (Hautefort, Proenca 
et al. 2003, Thone, Schwanhausser et al. 2007, Clark, Martinez-Argudo et al. 2009). 
No effect has been observed on bacterial viability and growth rate (Ma, Zhang et al. 2011) or 
bacterial invasion ability in GFP expressed Salmonella Typhimurium (Valdivia, Hromockyj 
et al. 1996). However, high expression levels of GFP could affect Salmonella virulence and 
it has been suggested that the range of 7000-200,000 molecules per bacterium are enough for 
detection by FACS and do not affect Salmonella pathogenesis (Wendland and Bumann 2002). 
Nevertheless, others found that the antibiotic resistance gene used for selection could affect 
Salmonella invasiveness;  chloramphenicol resistance had the strongest effect on Salmonella 
invasion, whereas the kanamycin resistance gene was the safest to use as an antibiotic marker, 
it was concluded that increase the size of the plasmid DNA could affect normal bacterial 
functions (Clark, Martinez-Argudo et al. 2009). 
3.2 Aims 
The main aim of this chapter, initially, was screening the tetraspanin protein expression that 
is associated in cells surface and cytoplasmic compartments prior to investigating tetraspanin 
roles in Salmonella uptake. A second aim was generate fluorescent-self-expressing 
Salmonella strains that would facilitate the investigation. 
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3.3 Results 
3.3.1 Expression of tetraspanin proteins on different cell types 
Prior to investigating the role of tetraspanin proteins in Salmonella infection on cell lines it 
was important to confirm the presence and expression levels of tetraspanin proteins on the 
cells that were used. FACS and immunofluorescence microscopy were used for screening. In 
the FACS method, the population of mammalian cells was gated depending on FSC and SSC 
parameters (approximately related to cell size and cell granularity, respectively). To confirm 
presence of tetraspanins immunofluorescence microscopy was carried out by using indirect 
immunofluorescence staining of cell lines that were seeded on chamber slides. 
3.3.1.1 Tetraspanin proteins expression in the J774 cell line 
The quantitative estimation of tetraspanin cell surface expression on the mouse macrophage 
J774 cell line was performed by FACS, as described in 2.2.3.1. The population of cells was 
gated depending on FSC and SSC parameters (Figure 3.1. A). High surface expression of 
CD81 and CD9 was observed, whilst the expression of CD63 was not detectable above the 
isotype control (Figure 3.1 B). 
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Figure 3.1: Analysis of tetraspanin expression in J774 cells by flow cytometry: The primary 
monoclonal antibodies used were appropriate isotype controls, anti CD9, anti CD63 and anti CD81 (Table 
2.5 A). The secondary antibodies were a FITC-conjugated anti-rat IgG (for CD9 and CD63) and anti- 
hamster IgG (for CD81) A: The dot plot shows J774 cells gated according to forward scatter (FSC) and 
side scatter (SSC), the histograms plot shows the FCS overlap of isotype and anti-tetraspanins treated cells. 
B: MFI of tetraspanin CD9, CD63 and CD81 expression. Bars describe means, while error bars describe 
standard error means. n=3 in duplicate, MFI= median of fluorescent intensity. 
A 
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Immunofluorescence microscopy analysis of tetraspanin expression of J774 cells was 
consistent with data obtained by flow cytometry. High expression of CD9 and CD81 was 
observed compared with isotype controls; however, CD63 was poorly expressed in these 
cells, with staining similar to that obtained with the isotype control (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Analysis of tetraspanin expression in J774 cells by immunofluorescence microscopy. Cells 
were cultured on chamber slides and fixed and permeabilised as described in 2.2.4.1, then stained with 
primary monoclonal antibody anti CD9, anti CD63 and anti CD81 or appropriate isotype controls at 10 
µg/ml followed by FITC-conjugated anti-rat  IgG (for CD9 and CD63) or anti- hamster IgG (for CD81) as 
described in 2.1.7.1. Nuclei were counter-stained with propidium iodide. These images were obtained by 
using the 100x objective.  
 
3.3.1.2 Tetraspanin expression in the RAW247 cell line 
Screening of tetraspanin expression on the mouse macrophage RAW247 cell line was 
performed as described above 3.3.1.1. There is a high expression of tetraspanins CD81 and 
CD9, while the tetraspanin CD63 expression is lower, but present (Figure 3.3).
Rat IgG2b  
Rat IgG2a  
Hamster IgG  
CD9 
CD63 
CD81 
Chapter 3 
78 
 
 
 
 
 
 
R
a
t-
Ig
G
 2
b
C
D
9
 
R
a
t-
Ig
G
 2
a
C
D
6
3
 
H
a
m
s
te
r  
Ig
G
1
 
C
D
8
1
 
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
2 5 0 0
M
F
I
B
 
Figure 3.3: Analysis of tetraspanin expression in RAW247 cells by flow cytometry: The primary 
monoclonal antibody used were appropriate isotype controls, anti CD9, anti CD63 and anti CD81 (Table 
2.5 A). The secondary antibodies were a FITC-conjugated anti-rat IgG (for CD9 and CD63) and anti- 
hamster IgG (for CD81) A: The dot plot shows RAW247 cells gated according to forward scatter (FSC) 
and side scatter, the histograms plot shows the FCS overlap of isotype and anti-tetraspanins treated cells.  
B: MFI of tetraspanin CD9, CD63 and CD81 expression. Bars describe means, while error bars describe 
standard error of means. n=3 in duplicate, MFI= median of fluorescent intensity.  
 
 
Indirect immunofluorescence microscopy was used to visualize the tetraspanin proteins as 
described in 3.3.1.1. The images shows obvious membrane staining of CD9 and high 
expression of CD9 shows in cell-cell attached membranes. As expected, CD63 (which is 
known to be associated mainly with intracellular vesicular compartments) showed strong 
intracellular staining (Figure 3.4). 
A 
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Figure 3.4: Analysis of tetraspanin expression in RAW247 cells by immunofluorescence microscopy. 
Cells were cultured on chamber slides and fixed and permeabilised as described in 2.2.4.1, then stained 
with primary monoclonal antibody (mAbs) anti CD9 and anti CD63 or appropriate isotype controls at 10 
µg/ml followed by FITC-conjugated anti-rat  IgG as described in 2.1.7.1. Nuclei were counter-stained with 
DAPI. These images were obtained by using the 100x objective. 
 
3.3.1.3 Tetraspanin expression in stimulated and non-stimulated THP-1 cells 
As described in 2.1.8.2.1, THP-1 is a human monocyte cell line obtained from a human 
leukaemia (Tsuchiya, Yamabe et al. 1980). These cells can be differentiated to macrophage-
like cells by treating the cells with phorbol ester (PMA), as described in 2.2.1.6. 
Undifferentiated THP-1 cells were grown in suspension and were stimulated by treating the 
cells with 20ng ml-1 of PMA for 1, 2 and 3 days. After 24 hours in PMA, the cells showed 
Tetraspanin-FITC Overlap 
Isotype 
CD9 
Isotype 
CD63 
DNA-DAPI 
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changes in their phenotype and became adherent. Cells were harvested as described in 
2.2.1.5.1. The cell population was gated depending on cell size and granulation revealed by 
FSC and SSC respectively. Changes in the FSC and SSC profile of the cells showed obvious 
differences in the properties of the cells after PMA stimulation, with the cells becoming more 
scattered with changes in their size (Figure 3.5 A). There were also differences in tetraspanin 
expression compared with non-stimulated cells. A dramatic increase in expression of CD63 
and CD81 was apparent, while CD82 showed an increase, but not significant, of surface 
expression one day post stimulation, but this decreased after two and three days post 
stimulation. CD9 increased significantly after one day of stimulation, but did not increase 
further thereafter. CD53 increased up until two days post stimulation. No significant changes 
were noticed in surface expression of CD37 and CD151 after stimulation (Figure 3.5 B). 
Tetraspanin expression was also visualised by immunofluorescence microscopy of 
permeabilised cells. High total expression of CD63, CD81, CD82 and, to a lesser extent, 
CD53, was observed in THP-1 derived macrophages after three days PMA stimulation. Low 
staining of CD9, CD37 and CD151 was observed compared with the isotype control (Figure 
3.6). The low staining of CD9 and CD37 was rather unexpected from FACS data. This might 
be related to high sensitivity of the epitopes recognised by the monoclonal antibodies to the 
fixative used. As expected, CD63 seen on granular staining, consistent with its known 
location in the endosomal compartment (Pols and Klumperman 2009). 
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Figure 3.5: Analysis of tetraspanin expression in THP-1 cells by flow cytometry: THP-1 cells were 
treated with 20ng ml-1 PMA for 1-3 days. The primary monoclonal antibody (mAbs) used were JC1 (isotype 
control), anti CD9 (602.29), anti CD37 (WR17), anti CD53 (MEM-53), anti CD63 (H5C6), anti CD81, anti 
CD82 and anti CD151 (14 A2) (Table 2.5 A). The secondary Abs was a FITC-conjugated anti-mouse. A: 
The dot plot shows THP-1 cells gated according to forward scatter (FSC) and side scatter, the histograms 
plot shows the FCS overlap of isotype and anti-troponins treated cells.  B: MFI of tetraspanins expression. 
Bars describe means, while error bars describe standard error. n=4 in duplicate, MFI= median of 
fluorescence intensity. Data was analysed by Two-way ANOVA comparing means for each sample. **** 
p ≤ 0.0001 *** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05 and ns is non-significant 
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Figure 3.6: Analysis of tetraspanin expression in THP-1 cells by immunofluorescence microscopy. 
THP-1 cells treated with 20ng ml-1 PMA for 3 days. Cells were cultured on 12mm cover slides placed in 
24 wells plate and fixed as described in 2.2.4.2. The primary monoclonal antibody (mAbs) used were JC1 
(isotype control), anti CD9 (602.29), anti CD37 (WR17), anti CD53 (MEM-53), anti CD63 (H5C6), anti 
CD81, anti CD82 and anti CD151 (14 A2) (Table 2.5 A) at 10 µg/ml followed by FITC-conjugated anti-
mouse IgG as described in 2.1.7.1. Nuclei were counter-stained with propidium iodide. These images were 
obtained by using the 100x objective. 
3.3.1.4 Tetraspanin expression in the HEC-1-B cell line 
HEC-1-B cell line is human epithelial cell line model obtained from human endometrial 
carcinoma (Kuramoto, Tamura et al. 1972) as described in 2.2.3.1. Analysis by flow 
cytometry showed high expression of  CD9 and CD81 with relatively low expression of  
CD63 and CD151 and little expression of cell surface CD82 (Figure 3.7). 
CD37 
CD9 
CD53 
NCD63 CD81 
CD151 CD82 
Isotype 
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Immunofluorescence microscopy showed high expression of CD63 in patches in the cell 
cytoplasm as expected since CD63 is known to be associated with intracellular endosomal-
lysosomal compartments. High expression of CD81 was observed in contrast to CD9, CD82 
and CD151 that were poorly stained in permeabilised HEC-1-B cells (Figure 3.8). 
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Figure 3.7: Analysis of tetraspanin expression in HEC-1-B cells by flow cytometry: The primary 
monoclonal antibody (mAbs) used were JC1 (isotype control), anti CD9 (602.29), anti CD63 (H5C6), anti 
CD81, anti CD82 and anti CD151 (14 A2) (Table 2.5 A). The secondary Abs was a FITC-conjugated anti-
mouse. A: The dot plot shows HEC-1-B cells gated according to forward scatter (FSC) and side scatter, the 
histograms plot shows the FCS overlap of isotype and anti-troponins treated cells. B: MFI of tetraspanins 
expression. Bars describe means, while error bars describe standard error. n=3 in duplicate, MFI= median 
of fluorescent intensity. 
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Figure 3.8: Analysis of tetraspanin expression in HEC-1-B cells by immunofluorescence microscopy. 
Cells were cultured on 12mm cover slides placed in 24 wells plate and fixed as described in 2.2.4.2. The 
primary monoclonal antibody (mAbs) used were JC1 (isotype control), anti CD9 (602.29), anti CD63 
(H5C6), anti CD81, anti CD82 and anti CD151 (14 A2) (Table 2.5 A) at 10 µg/ml followed by FITC-
conjugated anti-mouse IgG as described in 2.1.7.1. Nuclei were counter-stained with propidium iodide. 
These images were obtained by using the 100x objective. 
3.3.1.5 Analysis of tetraspanin expression in HeLa cells 
In flow cytometry analysis, HeLa cells showed high surface expression CD9, CD63, CD81 
and CD151, with slightly lower expression of CD82 (Figure 3.9). Immunofluorescence 
microscopy of permeabilised cells showed strong staining for CD63, some staining for 
CD151 and low staining for CD9, CD81 and CD82 (Figure 3.10).   
Isotype CD9 
CD63 CD81 
CD82 CD151 
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Figure 3.9: Analysis of tetraspanin expression in HeLa cells by flow cytometry: The primary 
monoclonal antibody (mAbs) used were JC1 (isotype control), anti CD9 (602.29), anti CD63 (H5C6), anti 
CD81, anti CD82 and anti CD151 (14 A2) (Table 2.5 A). The secondary Abs was a FITC-conjugated anti-
mouse. A: The dot plot shows HeLa cells gated according to forward scatter (FSC) and side scatter, the 
histograms plot shows the FCS overlap of isotype and anti-troponins treated cells. B: MFI of tetraspanins 
expression. Bars describe means, while error bars describe standard error. n=3 in duplicate, MFI= median 
of fluorescent intensity. 
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Figure 3.10: Analysis of tetraspanin expression in HeLa cells by immunofluorescence microscopy. 
Cells were cultured on chamber slides and fixed and permeabilised as described in 2.2.4.1. The primary 
monoclonal antibody (mAbs) used were JC1 (isotype control), anti CD9 (602.29), anti CD63 (H5C6), anti 
CD81, anti CD82 and anti CD151 (14 A2) (Table 2.5 A) at 10 µg/ml followed by FITC-conjugated anti-
mouse IgG as described in 2.1.7.1. Nuclei were counter-stained with propidium iodide. These images were 
obtained by using the 40x objective. 
3.3.1.6 Tetraspanin protein expression in CD82-KO cell line  
Since anti-mouse CD82 is commercially unavailable, CD82 knockout macrophages 
generated from CD82-KO mice (Risinger, Custer et al. 2014) could offer an alternative to 
investigate the role of this tetraspanin in infection. The effect of CD82 knockout on 
expression of tetraspanins CD9, CD63 and CD81 was assessed by flow cytometry. No 
significant difference was indicated in surface expression of CD9 in CD82-KO cells 
compared with corresponding WT mouse macrophages; high expression of CD9 was 
observed in both CD82-KO and WT control. Nevertheless, surface expression of CD63 was 
significantly upregulated in CD82-KO cells compared with WT control, but was relatively 
low in WT mouse macrophages, as had previously been observed in J774 and RAW 
macrophages. Furthermore, CD81 was also significantly upregulated in CD82-KO mouse 
macrophages compared corresponding WT mouse macrophages (Figure 3.11). 
Isotype CD9CC
D9 
CD63I
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 Figure 3.11: Analysis of tetraspanin expression in CD82 KO and WT mouse macrophages by flow 
cytometry: This work was carried out in our lab by a 3rd year project students S. Howard and V. Rose 
(under my supervision). The primary monoclonal antibody (mAbs) used were appropriate isotype controls, 
anti CD9, anti CD63 and anti CD81 (Table 2.5 A). The secondary antibodies were a FITC-conjugated anti-
rat IgG (for CD9 and CD63) and anti- hamster IgG (for CD81) A: The dot plot shows CD82 KO cells gated 
according to forward scatter (FSC) and side scatter, the histograms plot shows the FCS overlap of isotype 
and anti-troponins treated cells.  B: MFI of tetraspanins. Bars describe means, while error bars describe 
standard error means. N=4 in duplicate, MFI= median of fluorescent intensity. Data was analysed by T-test 
comparing means for each sample. ** p ≤ 0.01, * p ≤ 0.05 and ns is non-significant. 
3.3.2 Salmonella Typhimurium expressing green fluorescent protein 
(GFP) 
Salmonella expressing fluorescent proteins have been increasingly employed (Haidinger, 
Szostak et al. 2001, Thone, Schwanhausser et al. 2007, Robijns, Roberfroid et al. 2014), either 
in cell infection studies (Thone, Schwanhausser et al. 2007) or to investigate particular 
virulence associated proteins throughout bacterial infection (Bumann 2002). Salmonella cells 
competent for electroporation transformation were prepared as described in 2.2.2.1.1. and the 
bacterial transformation using electroporation was carried out as described in 2.2.2.1.2. 
Optimisation of transformation for Salmonella NCTC12023 and LT2 were carried out using 
different vectors carrying GFP or RFP encoded genes to be expressed in Salmonella (Table 
2.9). The broad host range (pBHR-1) vector (Szpirer, Faelen et al. 2001) carrying the GFP 
encoding gene (kindly donated from Dr. Mark Thomas, Medical school, University of 
Sheffield) was successfully transformed into both Salmonella strains and sufficient and stable 
A 
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GFP protein expression was obtained for detection by flow cytometry and fluorescence 
microscopy using appropriate filters. In flow cytometry, the GFP positive Salmonella 
population was completely segregated with high percentages (~ 90-99 %) and high 
fluorescent intensity (Figure 3.12). Fluorescence microscopy visualisation of the GFP and 
WT Salmonella is shown in Figure 3.13. No significant changes in percentage of Salmonella 
expressing GFP was observed in overnight culture compared with 2 hours culture in both 
strains. No significant MFI difference was also observed in the LT2 strain between overnight 
culture and 2 hours culture; however, overnight cultures of NCTC12023 expressing GFP 
seemed to be more highly expressing GFP compared with 2 hours culture, although high 
expression of GFP was observed here also (Figure 3.12). 
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Figure 3.12: GFP expression by Salmonella Typhimurium transformed with plasmids encoding GFP. 
Salmonella Typhimurium strains were transformed with the pBHR-GFP vector as described in 2.2.2.1.2. 
Bacteria were prepared and analysed by LSR-II flow cytometer as described in 2.2.2.1.3. Both FSC and 
SSC parameters were used to plot the cells on a log10 scale and 105 events were acquired. Positive cells 
were detected using the 530-30 A filter of a LSR-II flow cytometer machine from the FSC-SSC gated cells 
population. Salmonella NCTC12023 and LT2 wild types were included as negative control A: Overlap 
histogram of FSC of Salmonella NCTC12023 WT and GFP expressing strain. B: Overlap histogram of 
FSC of Salmonella LT2 WT and GFP expressing strains. C: Percentage of positive cells compared with 
non-transformed WT Salmonella. D: MFI of transformed Salmonella compared with WT strain. n=3.  MFI= 
median of fluorescent intensity, data was analysed by Two-way ANOVA comparing between means for 
each sample. **** p ≤ 0.0001, ** p ≤ 0.01, * p ≤ 0.05 and ns is non-significant.  
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Figure 3.13: Immunofluorescence images of S. Typhimurium transformed with pBHR1-GFP 
plasmid. Bacteria were prepared as described in 2.2.2.1.4 A: Salmonella Typhimurium NCTC12023 
transformed with pBHR1-GFP vector (green), and bacterial DNA stained with DAPI (blue) and visualised 
using the appropriate filter compared with WT control. B: LT2 strain transformed with pBHR1-GFP vector 
(green), and bacterial DNA stained with DAPI (blue) and visualised using appropriate filter. These images 
obtained using the 100x objective. 
Salmonella-FITC DNA-DAPI 
A 
NCTC12023 
WT 
NCTC12023 
GFP 
B 
LT2-WT 
LT2-GFP 
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3.3.3 Salmonella Typhimurium expressing red fluorescent protein 
(RFP) protein 
As mentioned above, RFP expressing Salmonella could provide advantages for investigating 
bacterial infection either for imaging or quantitative studies (Valdivia, Hromockyj et al. 
1996). Furthermore, RFP expressing Salmonella could facilitate live imaging when combined 
with tetraspanin-GFP expressing cells. Salmonella were transformed with a DsRed carrying 
vector pAV49 (Table 2.9). Transformation was successful, as bacteria grew on antibiotic 
selective plates, but no expression of DsRed in either Salmonella strains was found (data not 
shown). However, successful but unstable expression of DsRed was observed in NCTC12023 
strain transformed with another DsRed expressing vector (pDS-Red Expression vector II 
(Table 2.9)). In addition, the expression of DsRed was affected by the concentration of 
selective antibiotic used and culture conditions. 200µg ml-1 ampicillin gave more stable 
expression of DsRed grown on LB agar, while weak expression of DsRed was shown in 
Salmonella grown in LB broth containing the same concentration of selective antibiotic 
(Figure 3.14). Few colonies expressing DsRed in the LT2 strain transformed with pDS 
expression vector II were observed. In addition, a significant variation in the percentage of 
positive cells and intensity of fluorescence (MFI) was observed in NCTC12023-pDs-Red in 
2 hour bacterial cultures compared with overnight culture (Figures 3.15 and 3.18 A-D). 
Salmonella expressing low levels of DsRed protein are difficult to detect either by 
fluorescence microscope or by FACS. Since all infection experiments were carried out using 
bacteria in mid log growth phase (about 2 hours incubation); high DsRed protein expression 
seems to need a longer incubation time by which the bacteria enter stationary phase. 
Furthermore, a high percentage of Salmonella expressing DsRed protein was also detected in 
the GFP flow cytometer filter (Figure 3.18 A-D). This high overlap of DsRed protein with 
the GFP filter could prevent the usefulness of DsRed expressing Salmonella with tetraspanin-
GFP expressing cells since both GFP and DsRed would show by the same filter. In addition, 
this overlap was also observed in wide field microscopy, making it difficult to investigate 
tetraspanin GFP-Salmonella localisation using live imaging (data not shown). 
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Figure 3.14: Effect of different growth conditions and ampicillin concentration on DS-RED 
expression. I: NCTC12023-pDS-Red strain subcultured in 200µg ml-1 ampicillin LB agar. A: Primary 
culture from frozen glycerol stock. B: One colony from “A” sub-cultured into 200µg ml-1 ampicillin LB 
agar. C: One single colony from “B” sub-cultured into 200µg ml-1 ampicillin LB agar.  II: NCTC12023-
pDS-Red strain grown in different ampicillin concentrations in LB agar. A: 50µg ml-1 B: 200µg ml-1. C: 
300µg ml-1. D: 400µg ml-1 overnight culture. 
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Figure 3.15: Flow cytometry analysis of pDS-Red transformed Salmonella Typhimurium. 
NCTC12023 and LT2 strains were transformed with pDS-Red vector as described in 2.2.2.1.2, and the 
bacteria were prepared and analysed using LSR-II flow cytometer using 488 blue laser with the 610-20A 
filter (as recommended for RFP) as described in 2.2.2.1.3. A: Percentage of positive cells compared with 
non-transformed WT Salmonella. B: MFI of transformed Salmonella compared with WT strain. Bars 
describe means, while error bars describe standard errors. n=3, MFI= median of fluorescent intensity, data 
was analysed by Two-way ANOVA comparing between means for each sample. ** p ≤ 0.01, * p ≤ 0.05 
and ns is non-significant. 
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Figure 3.16: Immunofluorescence images of S. Typhimurium NCTC12023 transformed with pDS-
Red plasmid. Bacteria were cultured and prepared for microscopic imaging as described in 2.2.2.1.4. A: 
NCTC12023-WT control stained with DAPI (blue) visualised using appropriate filter compared with WT 
control. B: NCTC12023-pDSRed (red) 2 hours culture visualised using appropriate filter. C: NCTC-12023-
pDsRed (red) overnight culture visualised using appropriate filter. These images were obtained using the 
100x objective. 
 
 Therefore, mCherry expressing Salmonella could be better to use with tetraspanin-GFP 
expressing cells.  
A mCherry carrying plasmid pNB57 (Table 2.9) was successfully transformed into both 
Salmonella strains and the mCherry protein was successfully and stably expressed in both 
strains (Figure 3.17). Flow cytometry analysis showed a high percentage of positive cells, 
however, as observed for DsRed, both the percentage of mCherry expressing Salmonella and 
MFI was significantly higher in overnight cultures compared with 2 hour cultures (Figure 
3.18). In spite of these variations in mCherry expression, the positive population of 
Salmonella expressing mCherry was only detected in the red fluorescence channel, with no 
overlap in the GFP channel (Figure 3.18 A-D). 
DNA DsRed 
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Figure 3.17: Salmonella strains transformed with pNB57-mCherry vector.  A: S. Typhimurium 
NCTC12023 wild type strain grown on LB agar. B: S. Typhimurium LT2 wild type strain grown on LB 
agar. C: S. Typhimurium NCTC12023-pNB57-mCherry strain grown on LB agar with 100µg ml-1 
ampicillin. D: S. Typhimurium LT2-pNB57-mCherry strain grown on LB agar with 100µg ml-1 ampicillin.  
A B 
C D 
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Figure 3.18: Flow cytometry analysis of mCherry transformed Salmonella Typhimurium. 
NCTC12023 and LT2 strains were transformed with pNB57-mCherry vector as described in 2.2.2.1.2, and 
the bacteria were prepared and analysed using LSR-II flow cytometer using 488 blue laser with the 610-
20A filter (as recommended for RFP) as described in 2.2.2.1.3. Both FSC and SSC parameters were used 
to plot the cells on a log10 scale and 105 events were acquired. Positive cells were detected using the 530-
30 A and 610-20 A filters of a LSR-II flow cytometer from the FSC-SSC gated cells population. Salmonella 
NCTC12023 and LT2 wild types were included as negative control A: Overlap histogram of FSC of 
Salmonella NCTC12023 WT, DsRed and mCherry expressing strain 2 hours incubation culture and 
overnight incubation culture (B). C: Overlap histogram of FSC of Salmonella LT2 WT, DsRed and 
mCherry expressing strain 2 hours incubation culture and overnight incubation culture (D). E: Percentage 
of mCherry positive cells compared with non-transformed WT Salmonella. F: MFI of pNB57- mCherry 
transformed Salmonella compared with WT strain. n=3.  MFI= median of fluorescent intensity, data was 
analysed by Two-way ANOVA comparing between means for each sample. **** p ≤ 0.0001, *** p ≤ 0.001 
** p ≤ 0.01 and * p ≤ 0.05.  
WT 
DsRed (pDS-Red) 
mCherry (pNB57) 
A B 
D C 
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Figure 3.19: Immunofluorescence images of S. Typhimurium LT2 transformed with pNB57-mcherry 
plasmid. Bacteria were cultured and prepared for microscopic imaging as described in 2.2.2.1.4. A: 
NCTC12023-WT control stained with DAPI (blue) visualised using appropriate filter. B: NCTC-12023-
mCherry (red) overnight culture visualised using appropriate filter. C: LT2-mCherry (red) overnight culture 
visualised using appropriate filter. These images were obtained using the 100x objective. 
 
Similar results were evident from fluorescence microscopy of the pDS-Red transformed 
NCTC12023 strain. The DsRed expression was observed in overnight bacterial cultures, but 
only in a few cells after 2 hours culture (Figure 3.16).  
 
3.4 Discussion 
The level of tetraspanins expression was screened as an initial step to investigate the role of 
these proteins in Salmonella infection. Two different cell species were used, mouse and 
human, although few anti-tetraspanin antibodies that recognise the native protein are 
commercially available for the mouse proteins, in contrast to anti-human tetraspanins. The 
monoclonal antibodies were used to determine tetraspanins expression, since mAbs provide 
DNA mCherry 
A 
DAPI 
 
C 
B 
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a highly specific tool to detect specific antigens (Kohler and Milstein 1975). As reported in 
many studies, the tetraspanin proteins are expressed in all human cell types, with some 
tetraspanin members (including CD9 and CD81) expressed in most mammalian cells (Hemler 
2005) while others are  seen in specific cell types and associated with particular functions, as 
mentioned previously. CD9, CD53, CD63 and CD81 are expressed in normal MDMs and 
macrophages (Tippett, Cameron et al. 2013). In RAW and J774, the expression of CD9 and 
CD81, was observed in using flow cytometry and the results supported by 
immunofluorescence images. These tetraspanins were found mainly on the cell surface. High 
expression of CD9 and CD81 was observed with low surface expression of CD63; this could 
be because the tetraspanin CD63 is associated mostly with intracellular vesicular 
compartments (late endosomes and lysosomes) (Zhang, Kotha et al. 2009). 
 
The human cell lines derived from human monocytic leukaemia (THP-1) (Tsuchiya, Yamabe 
et al. 1980) was also used in Salmonella infection. These cells could be differentiated to 
become macrophages by treating the cells with phorbol ester (PMA).  Compared  with other 
human monocyte cell lines, this THP-1 cells were shown to be more similar to primary 
MDMs  (Auwerx 1991). The differentiation of THP-1 by phorbol ester could be mediated by 
protein kinase C (PKC) resulting in suppression of the G1 phase of the cell cycle (Traore, 
Trush et al. 2005). High concentrations of phorbol ester could lead to affect the differentiated 
cells responses (e.g. to IL10) therefore a minimum concentration of PMA is required for THP-
1 stimulation without affecting macrophage functionality (Maess, Wittig et al. 2014). 
Different markers have been shown to be expressed post THP-1 differentiation,  particularly 
CD11b and CD14 (Schwende, Fitzke et al. 1996). In the THP-1 cells model, most of the 
tetraspanins were upregulated within one day of PMA stimulation (apart from CD37, and 
CD151). The cellular phenotype was changed to become adherent, flat and stopped dividing 
after stimulation, consistent with previous reported observations (Tsuchiya, Kobayashi et al. 
1982). Although CD63 is associated with endosomal-lysosomal compartments (Zhang, Kotha 
et al. 2009), high surface expression of CD63 was noticed one day after stimulation and 
dramatically increased to reach the highest level compared with other tetraspanins. Neither 
CD37 nor CD151 showed changes in expression after THP-1 differentiation, while CD9 was 
upregulated by one day post THP-1 stimulation and was stabilised by day 2 and 3 of 
stimulation. This is in contrast to reports that CD9 increased after 24 hours post differentiation 
by PMA at 40ng/ml and continued to increase until 72 hours of stimulation (Tsukamoto, 
Takeuchi et al. 2014). Furthermore, human monocyte derived macrophages (MDMs) showed 
a higher expression of CD9 compared with monocytes while CD81 remained at the same 
level of expression during maturation and surface CD53 decreased after differentiation, 
Chapter 3 
97 
 
although intracellular levels increased (Tippett, Cameron et al. 2013), which may relate to the 
development of the endosomal-lysosomal system in differentiated macrophages (de Winde, 
Zuidscherwoude et al, 2015). However, THP-1 derived macrophages shown increases in 
CD53 and CD81 compared with un-stimulated THP-1 cells. Nevertheless, previous studies 
here also showed that CD53 increased after THP-1 differentiation (Hassuna, 2010, thesis, 
University of Sheffield). 
 
In the HEC1-B cell line, high expression of CD9 and CD81 was observed by FACS. By 
contrast, CD63, CD82 and CD151 seem to be lowly expressed compared with isotype control 
(Figure 3.7). Nevertheless, CD151 showed the highest expression amongst the tetraspanins 
in another epithelial cell line, HeLa cells (Figure 3.9). CD151 is known to be associated with 
cancer cells proliferation and high expression of CD151 correlates with bad prognosis in 
cancer (Hemler 2014). CD63 and CD82 were also shown to be significantly expressed in 
HeLa cells compared with isotype control. These results demonstrate that, different patterns 
of tetraspanin expression could be seen depending on the cell type and origin. In HEC-1-B, 
the immunofluorescence microscopy results shows highly intense staining of CD63 
distributed as patches on cells, with more intensive staining localised close to the nucleus, 
whilst no strong staining was observed for  CD9, CD82 and CD151. In contrast, Hela cells 
present a strong staining of CD151and to a lesser extent CD81 and CD82; however, the CD63 
staining localisation shows same pattern observed in HEC-1-B cells. These results support 
the previous finding using flow cytometry in which low expression of CD151 and CD82 were 
observed in HEC-1-B in contrast to HeLa cells. Nevertheless, CD63 was highly expressed 
and showed the same localisation pattern in both cell lines. The presence of patches of 
staining could be related to the high expression of CD63 in intracellular compartment 
particularly endosomal lysosomal system (Pols and Klumperman 2009). 
 
Tetraspanin CD82 and also named KAI1 is widely distributed in different cells types 
including haemopoietic and non-haemopoietic cells (Martin, Roth et al. 2005) and in different 
cancers (Huang, Taki et al. 1997) acts as a tumour suppressor which supresses cancer cells 
motility, invasion and metastasis (Liu and Zhang 2006, Hemler 2014, Feng, Huang et al. 
2015). Furthermore, it is associated with HTLV-1 (human T-cells leukaemia virus type 1) 
infection and viral cell-cell transmission (Pique, Lagaudriere-Gesbert et al. 2000). Antibodies 
targeting mouse CD82 are not commercially available, therefore, CD82-KO mouse 
macrophages could offer a suitable mouse cell model to study the contribution of CD82 either 
in cancers (Hemler 2014) or in infections, although many genes shown to be either 
upregulated or down regulated in mRNA level as a consequence of CD82 gene disruption 
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(Risinger, Custer et al. 2014). Downregulation of CD63 and CD81 was observed in CD82-
KO mouse macrophages compared with corresponding macrophages control (Figure 3.11). 
In contrast, no change in CD9 expression was noticed in these cells. As for CD63, CD82 is 
also known to be localised within the endosomal-lysosomal system (Xu, Zhang et al. 2009). 
In addition, CD82 associates with CD63 and both tetraspanins are found in MHC class-II 
compartments (Hammond, Denzin et al. 1998). A number of  studies have shown association 
of various integrins, including α3β1, α4β1, α5β1 and α6β1,with CD82 to form CD82-
integrins complex in different cells types, reviewed in  (Berditchevski 2001), notwithstanding 
the direct association of CD63 with α3β1 and α6β1 (Berditchevski, Bazzoni et al. 1995). 
Furthermore, association of CD81 and/or CD82 with α4β1 integrin in hemopoietic cells has 
also been observed (Mannion, Berditchevski et al. 1996). These tetraspanin-tetraspanin and 
tetraspanin-integrin association could have a direct or indirect impact in alteration of certain 
tetraspanins expression in absence of CD82. 
 
Bacteria self-expressing fluorescent proteins such as GFP and RFP offer a good tool to better 
understand bacterial pathogenesis and bacteria behaviour in a natural environment by 
employing live cell visualisation (Lagendijk, Validov et al. 2010). GFP has been increasingly 
used as a fluorescent marker in different applications, in particularly pathogenicity of bacteria 
to host cells in both imaging and quantification studies (Valdivia, Hromockyj et al. 1996). 
Two different vectors carrying the GFP gene sequence were used, and although both plasmids 
expressed GFP in E. coli, the pBHR1-GFP vector was most successfully used to express GFP 
in both S. Typhimurium NCTC12023 and LT2 strains. However, the LT2 strain seemed to be 
express more GFP compared with the NCTC12023 strain. GFP-positive Salmonella were 
detected by flow cytometry (Figure 3.12), since this sensitive and reliable tool has been used 
to detect different Salmonella serotypes using fluorescent-tag mAbs either in food 
contaminated with Salmonella or from cultured bacteria (Pinder and McClelland 1994). Both 
Salmonella-GFP alone and cells associated with Salmonella (as described in chapter 4) were 
detected by flow cytometry using 488nm laser and fluorescence microscopy (Figure 3.13). 
Therefore, the GFP expressing Salmonella could be used to identify Salmonella infected host 
cells and discriminate these cells from non-infected cells by flow cytometry (Salcedo, 
Noursadeghi et al. 2001). In addition, with high GFP expression, the overall GFP signal could 
reveal the number of bacteria associated with host cells (Thone, Schwanhausser et al. 2007). 
However, some studies noted that Salmonella infectivity could be affected by either high 
expression of GFP protein (Wendland and Bumann 2002) or the antibiotic resistance gene 
used in construction of  the GFP carrying plasmid; a GFP-plasmid with the chloramphenicol 
resistance gene affected Salmonella invasion, whereas a kanamycin-resistance gene did not 
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(Clark, Martinez-Argudo et al. 2009). Since the pBHR1-GFP plasmid used has the kanamycin 
resistance gene, the GFP expression level is less likely to interfere with Salmonella-host cells 
association. 
 
As it will be described in chapter 6, J774 cells were successfully transfected with a mouse-
CD9-GFP vector. The GFP-CD9 was expressed and localised to the cell membrane and 
detected by both flow cytometry and fluorescent microscopy. These cells offer a valuable tool 
for live imaging of any CD9-Salmonella interactions; however, the self- fluorescent 
expressing Salmonella strains that have been generated in current study have the GFP marker. 
Hence, it was considered worth trying to generate Salmonella self-expressing RFP for dual 
colour live imaging. This could enhance studying the live imaging of tetraspanin-Salmonella 
associations and also in fixed samples overcome some of the drawbacks of using different 
primary and secondary antibodies. In that case red fluorescent proteins were thought to be 
suitable. DsRed is a 28 kDa red fluorescent protein with 583 nm maximum emission that was 
cloned from the coral genus Discosoma and has been shown to be less susceptibility to pH 
(4.5-12) and more resistant to an acidic environment than GFP, as well as being less sensitive 
to photo-bleaching (Baird, Zacharias et al. 2000). Nevertheless, different plasmids (Table 2.9) 
were tested with no success regarding the level of DsRed expression, fluorescent protein 
maturation and stability, despite these DsRed carrying vectors giving stable and detectable 
RFP expression in an E. coli system, even though both bacterial genuses belong to the same 
family. It has been reported that a long time is needed to obtain DsRed maturation and also 
that  DsRed shows a high oligomerisation and occurs as a tetramer (Baird, Zacharias et al. 
2000). However, Different mutations generated in DsRed fluorescent protein have been 
shown to enhance its properties (Sorensen, Lippuner et al. 2003) and to decrease the green 
signal and increase protein solubility (Bevis and Glick 2002). 
 
Thus, a vector carrying the mCherry gene, pNB57-mCherry, was used to generate Salmonella 
expressing mCherry fluorescent protein. The mCherry fluorescent protein was found to be 
relevant in bacterial investigations and combined with GFP in dual staining to investigate 
bacterial pathogenicity and live imaging (Lagendijk, Validov et al. 2010). Both Salmonella 
strains expressed stable mCherry that was detected using flow cytometry and fluorescence 
microscopy. The mCherry transformed Salmonella showed a high percentage of positive 
mCherry bacteria and nicely shifted as a positive population using appropriate filter without 
overlapping in the GFP channel after incubation of the Salmonella for 24 houses in LB broth 
with selective antibiotic. Nevertheless, NCTC12023-mCherry strain showed a lower 
percentage of positive cells (about 50%) after two hours culture. In contrast, the transformed 
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LT2-strain had a higher percentage of positive cells under the same conditions. This suggests 
that expression of different levels of fluorescent proteins could also be related to incubation 
time and bacterial strains.  
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Chapter 4:  The effect of tetraspanins on Salmonella 
uptake 
 
4.1 Introduction 
The antibiotic resistance of bacteria has become a problematic issue which is increasingly 
distributed worldwide and a cause of high infection and fatality rates. Many alternative 
treatments have emerged to target either particular bacterial proteins that are responsible for 
bacterial virulence and invasion (Gu, Zhou et al. 2015) or targeting certain proteins that act 
as a bridge between bacteria and host cells to enhance infection (Parker, Sando et al. 2010).  
In Salmonella infection, targeting the effector proteins that are released from bacteria by 
T3SS could prevent Salmonella infection rather than targeting bacteria themselves. For 
example, a type of salicyliden acylhydrazide, INP0403, showed an inhibitory effect on 
Salmonella T3SS without affecting the viability and growth of the Salmonella (Hudson, 
Layton et al. 2007). This compound reduced the transcription of genes that are involved in 
T3SS production (Layton, Hudson et al. 2010). Another possibility is to disrupt the bacterial 
adhesion to the host cells (anti-adhesion therapy), reviewed in (Krachler and Orth 2013). As 
an example of this strategy, a high glycosylated mucin-1 (Muc-1) in cow’s milk was shown 
to be effective in supressing adhesion of common gastrointestinal disease related pathogens, 
including Salmonella Typhimurium, and E. coli to the epithelial cell line, Caco-1, and to some 
extent Gram positive bacteria including Bacillus subtilis and Staphylococcus aureus. Sialic 
acid, D-mannose and L-fucose also inhibited adhesion of S. Typhimurium and sialidase 
abrogated the inhibitory action of Muc-1, showing the importance of sialic acid in bacterial 
adhesion (Parker, Sando et al. 2010). 
 
The crucial role of host cell pathways recruited by intracellular bacteria to facilitate invasion 
is reviewed by Bhavsar et al. (2007) and was described in Chapter 1. Different host cell 
functions have been shown to be recruited by Salmonella such as rearrangements of host cell 
cytoskeleton, signal transduction, and trafficking of Salmonella containing vacuoles. 
Understanding of  bacterial-host cell interaction mechanisms could lead to finding new 
strategies for bacterial treatments, as reviewed in (Finlay and Cossart 1997). Important for 
our present research is the targeting of particular host proteins that are shown to be involved 
in bacterial adhesion and invasion such as the tetraspanins  (Green, Monk et al. 2011). In 
bacterial infections, the role of tetraspanins is becoming more obvious, despite relatively few 
studies, as described in Chapter 1 and reviewed in Monk and Partridge (2012). 
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Using Salmonella enterica serovar Typhimurium as a model of bacterial infection has certain 
advantages, as the bacterium has a highly sophisticated invasion machinery that allows it to 
invade both phagocytic and non-phagocytic cells, reviewed in (LaRock, Chaudhary et al. 
2015). This therefore offers a good tool to investigate the role of tetraspanin proteins in 
bacterial infection in different cell lines. Previous studies from this laboratory investigated 
the role of tetraspanins in Salmonella infection of primary human MDMs. The disadvantages 
of using primary cells are that the cells are subject to donor variation and it may be difficult 
to obtain sufficient numbers for some experiments (Hassuna, 2010, PhD thesis, University of 
Sheffield). 
 
Many tools have become available to investigate the functions of tetraspanins such as specific 
monoclonal antibodies (mAbs), recombinant EC2 proteins, knockdown of tetraspanin 
expression by siRNA and tetraspanin gene knockout in experimental animals  (Hemler 2008). 
In bacterial infections, anti-tetraspanin antibodies to CD9, CD63 and CD151 reduced 
Neisseria meningitides adhesion to epithelial cells (Green, Monk et al. 2011); anti-CD63 also 
reduced Salmonella Typhimurium uptake by human primary MDMs (Hassuna, 2010, PhD 
thesis, University of Sheffield). 
4.1.1 Flow cytometry and bacterial –host interactions  
Flow cytometry analysis has been shown to be useful in investigating bacterial pathogenicity 
and to study the bacterial-host interaction (Valdivia and Falkow 1998, Pils, Schmitter et al. 
2006). It offers a quick and appropriate method to analyse the bacterial-host invasion and has 
been reported to accurately differentiate between external associated and internalised 
bacteria; moreover results obtained from flow cytometry were shown to be comparable with 
other analysis methods (Pils, Schmitter et al. 2006). In most of these studies, groups have 
labelled bacteria for analysis; a fluorochrome-labelled version of vancomycin was used to 
label peptidoglycan and to investigate attached and internalised Staphylococcus aureus to 
host cells (Trouillet, Rasigade et al. 2011). However, direct labelling of Salmonella may 
potentially interfere with bacterial binding and invasion, depending on the level of fluorescent 
protein expression. High GFP expression showed an effect on Salmonella invasion 
(Wendland and Bumann 2002). In contrast, other researchers have suggested that the plasmid 
construct, not the level of fluorescent protein expression, could has effects on Salmonella 
invasion; and plasmids encoding chloramphenicol resistance seemed to have this impact 
(Clark, Martinez-Argudo et al. 2009). Other workers have used bacteria expressing 
chromosomal GFP. For example, this approach was shown to be useful in differentiating 
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between host cell subpopulations infected with few (1 or 2) or many salmonella, and the 
accuracy of these results were confirmed by confocal microscopy (Thone, Schwanhausser et 
al. 2007). 
 
4.2 Aims 
The primary aim in this Chapter was to investigate the possible role of tetraspanin proteins in 
Salmonella uptake by phagocytic (mouse and human macrophage) and non-phagocytic 
(human epithelial) cell lines. Finding a suitable cell line model could overcome the main 
drawback of a previous study that was dependent on primary human MDMs, which are 
known to be subject to donor variation and difficult to generate in large numbers for the 
experiments. The relative merits of human and mouse cell line is more antibody reagents are 
available for human, but the macrophages derived from these cell line are less mature 
compared with  the more  “macrophage- like” murine J774 cell line. The epithelial cell lines 
were chosen as a model of non-phagocytic cells with different modes of uptake, and these 
cell lines had not previously been studied. As discussed in Chapter 1, whilst Salmonella may 
be taken up passively by macrophages through phagocytosis, uptake by epithelial cells 
generally requires expression of the Type 3 secretion system. 
The second aim emerged during the experiments that were initially dependent on 
immunofluorescence microscopy for counting and estimating the rate of cell infection. This 
method can be subjective and prone to variations arising from human error. We therefore 
tried to develop a method for assessing bacterial infection by using flow cytometry that would 
be more objective. In addition such a method is less time consuming, increases the number 
of infected cells assessed and reduces the amount of expensive antibody reagents that are 
needed. In brief, instead of infecting, staining and counting cells seeded on coverslips, the 
cells were infected in suspension, then either fixed (to determine external bacteria) or fixed 
and permeabilised (to determine total bacteria) before staining with FITC-conjugated anti-
Salmonella antibody and analysis by flow cytometry (Figure 4.1). As an alternative, 
potentially faster method, Salmonella were transformed with a GFP carrying vector. 
Successful, stable expression of GFP in both Salmonella strains was achieved (as described 
in Chapter 3) and these GFP strains were investigated in the infection assay and their infection 
rate was assessed by flow cytometry. 
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Figure 4.1: Outline of the flow cytometry procedure developed for assessing Salmonella infection of 
mammalian cells. 
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4.3 Results 
4.3.1 Effect of anti-tetraspanin antibodies on Salmonella Typhimurium 
uptake analysed by immunofluorescence microscopy 
Tetraspanin expression by the cell lines that would be used in the experiments has been 
described previously (chapter 3). Other initial experiments included studying the Salmonella 
growth curve to find the log phase that would be used. Different multiplicities of infection 
(MOI) and infection times were investigated to establish those that were most suitable. A 
growth curve was plotted by growing Salmonella in 20 ml LB broth and measuring both 
optical density (OD600) and viable bacterial counts (colony forming unit (CFU)) through 
different time periods (1 - 24 hours). This experiment was repeated three times and the mid-
log phase chosen from the average to use for the Salmonella infection assay (OD600 ≈ 0.4-0.5, 
time ≈ 2-2.5 hours and CFU≈ 7-8 x107) respectively (data not shown). For further 
confirmation, the CFU was measured separately for each experiment. To optimise the MOI 
and infection time, the various mammalian cell lines were infected at different MOIs (30, 50, 
100 and 150) and for different infection times (30, 60 and 90 minutes). Cells were fixed, 
stained and counted, as described in 2.2.5.1. High MOIs and longer infection times gave high 
infection rates and high numbers of bacteria that made counting difficult, whilst shorter times 
gave low rates of infection with less bacterial internalisation. Suitable MOIs were chosen 
therefore as follows: in J774 cell line, a 30 MOI for 30 minutes: in THP-1 derived 
macrophages, a 30 MOI for 30 minutes; in HEC-1-B, a 100 MOI for 60 minutes (optimisation 
data not shown). 
4.3.1.1 Effect of anti-tetraspanin antibodies on Salmonella Typhimurium 
NCTC12023 uptake by the J774 cell line 
The mouse macrophage-like J774 cell line was chosen first to investigate the effect of 
tetraspanin antibodies in Salmonella infection, since this cell line is an immortal cell line and 
has high expression of surface CD9 and CD81 (Chapter 3, section 3.3.1.1). This cell line has 
been used successfully here to investigate infection by Salmonella Typhimurium (Tang, 
Guest et al. 2004, Gilberthorpe, Lee et al. 2007). However, few anti-mouse tetraspanin mAbs 
are commercially available. Furthermore, the anti-tetraspanins mAbs that were used to block 
the surface tetraspanins antigens will bind non-specifically with Fc receptors (FcR) that are 
expressed by these cells. To take account of nonspecific binding of mAbs to FcR, appropriate 
isotype controls were included in all experiments and the results were compared with these. 
The effect of anti-tetraspanin antibodies on infection of J774 cells with Salmonella 
Typhimurium NCTC12023 was assessed using saturating concentrations of antibody (20µg 
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ml-1) as described in 2.2.5.1.3. (Figure 4.2). The antibody effects were measured by four 
parameters:  the percentage of cells with associated bacteria, the total number of cell-
associated bacteria, the number of attached (external) bacteria and the percentage of 
internalized bacteria (2.2.5.1.6). The results showed a significant reduction in the percentage 
of cells with bound bacteria (to ~59% of control) and in the number of bacteria per 100 cells 
for anti-CD9 pre-treated cells compared with the isotype control. No differences were 
observed in the number of external bacteria or percentage of bacteria internalised, or for all 
four infection parameter in the non-treated control compared with the isotype (Figure 4.3). 
 
 
 
 
 
 
 
 
Figure 4.2: Immunofluorescence microscopy of J774 cells infected with Salmonella Typhimurium 
NCTC12023. Following infection at 50 MOI for 30 minutes, cells were fixed and stained, as mentioned in 
2.2.5.1.4.using primary rabbit anti-Salmonella polyvalent antibody followed by secondary anti-rabbit –
FITC and   DAPI staining (combined with permeabilising buffer).The cell and bacterial DNA are stained 
with DAPI (blue) stain and the external bacteria are stained with FITC (green). A: J774 cells infected with 
S. Typhimurium, with both bacterial and J774 cell DNA stained blue (DAPI) using correct fluorescence 
filter B: FITC (green) stain that reveals the external bacteria. C: Phase contrast image merged with FITC 
image shows external bacteria stained green (FITC) stain and the outline of the J774 cells. Arrows point to 
bacteria. Images were captured using a Nikon Eclipse E400 fluorescence microscope using the oil 
immersion objective (x100). 
Salmonella 
FITC 
DNA-DAPI PH + FITC A B C 
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Figure 4.3: Effect of anti-CD9 mAbs on Salmonella uptake by J774 cells at 30 MOI for 30 minutes. 
J774.2 cells were pre-treated with anti-CD9 or isotype control before Salmonella Typhimurium NCTC 
12023 strain infection as described Figure 4.2. A: J774 cells associated with Salmonella. B: Number of 
bacteria per 100 cells. C: Number of external or attached bacteria. D: The percentage of internalized 
bacteria, E and F: Corresponding raw data (average of non-normalised) for normalised A and B only. Bars 
show means, while error bars show standard errors.  n=3 in triplicate, graphs A and B data was analysed by 
One Sample T-test comparing with isotype control, graphs C, D, E and F data was analysed by Ordinary 
one-way ANOVA Holm-Sidak's multiple comparisons test, significance * P ≤ 0.05 while ns is non-
significant. 
 
Work subsequently carried out in our lab by a 4th year project student (under my supervision) 
investigated the effect of other anti-tetraspanin antibodies (anti-CD63 and anti-CD81) on 
Salmonella NCTC12023 strain uptake by J774 cells. The results showed a significant 
reduction in the percentage of cells associated with bacteria (to ~ 78%) and in the number of 
bacteria per 100 cells in anti-CD81 pre-treated cells compared with the isotype control. No 
differences were observed in the number of external bacteria or percentage of bacteria 
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internalisation, or for all four infection parameter in anti-CD63 pre-treated cells no significant 
changes were observed compared with isotype control (Figure 4.4).  The lack of an effect 
with anti-CD63 antibodies may be due to the very low expression levels of this tetraspanin 
on J774 cells (chapter 3). 
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Figure 4.4: Effect of anti-CD63 and anti-CD81 mAbs on Salmonella uptake by J774 cells at 30 MOI 
for 30 minutes. J774.2 cells were pre-treated with anti-CD63, anti-CD81 or corresponding isotype control 
before Salmonella Typhimurium NCTC 12023 strain infection. A: J774 cells associated with Salmonella. 
B: Number of bacteria per 100 cells. C: Number of external or attached bacteria. D: The percentage of 
internalized bacteria, E and F: Corresponding raw data (average of non-normalised) for normalised A and 
B only. Bars show means, while error bars show standard errors.  n=3 in triplicate,  graphs A and B data 
was analysed by One Sample T-test comparing with isotype control, graphs C, D, E and F data was analysed 
by Ordinary one-way ANOVA Holm-Sidak's multiple comparisons test, significance * P ≤ 0.05, while ns 
is non-significant. 
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4.3.1.2 Effect of anti-tetraspanins antibodies in Salmonella Typhimurium uptake 
by macrophages derived from the human THP-1 cell line 
Although the work with the mouse macrophage cell line confirmed a role for tetraspanins in 
Salmonella infection of macrophages, there are some significant differences between the 
results obtained here and those reported for human MDM (Noha Hassuna, PhD thesis 2010); 
for example anti-CD9 antibodies had little effect on S. Typhimurium uptake by MDM. In 
addition, there are relatively few antibody reagents for mouse tetraspanins. As human MDM 
are subject to donor variation and difficult to generate in large numbers (as mentioned before), 
using macrophages derived from monocyte cell lines such as THP-1 cell line could offer an 
alternative human macrophage cell model. Undifferentiated THP-1 cells show significant 
expression of tetraspanins CD37, CD53, CD63 and CD81 and most of these tetraspanins are 
significantly increased after stimulation of THP-1 cells with phorbol myristate acetate (PMA) 
to differentiate to macrophages in particular CD9, CD53, CD63 and CD81 (as described in 
Chapter 3). These cells are non-adherent, making analysis by immunofluorescence 
microscopy difficult and even when induced to adhere by coating surfaces with poly-L-lysine, 
take up bacteria inefficiently (Noha Hassuna, personal communication). 
  
 
 
 
 
 
 
 
 
 
  
Figure 4.5: Immunofluorescence microscopy of THP-1 derived macrophages cell line cells infected 
with Salmonella Typhimurium at 30 MOI for 30 minutes. THP-1 cells that had been stimulated with 
20ng ml-1 of PMA for 3 days (Chapter 3.3.1.3) were infected with Salmonella Typhimurium NCTC 12023, 
fixed and stained as described in Figure 4.2. A and C: Stimulated THP-1 cells with S. Typhimurium, with 
both bacterial and cell DNA stained blue (DAPI) under the correct fluorescence filter, B and D: FITC 
(green) stain that reveals the external bacteria. Arrows point to bacteria. The images were captured using 
Nikon Eclipse E400 fluorescence microscope using oil immersion (100x) objective. 
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Figure 4.6: Effect of anti-tetraspanin mAbs on Salmonella NCTC12023 strain uptake by 
macrophages derived from THP-1 cells at 30 MOI for 30 minutes. THP-1 cells treated with 20ng ml-1 
PMA for 3 days and  cells were pre-treated with JC1 (control isotype), anti CD9 (602.29), anti CD63 
(H5C6), anti CD81 and anti CD151 (14, A2) at 20μg ml-1 before Salmonella Typhimurium NCTC12023 
strain infection as described Figure 4.5. A: Cells infected with Salmonella. B: Number of bacteria per 100 
cells. C: Number of external or attached bacteria. D: The percentage of internalized bacteria, E and F: 
Corresponding raw data (average of non-normalised) for normalised A and B only. Bars show means, while 
error bars show standard errors.  n=4 in duplicate, graphs A and B data was analysed by One Sample T-test 
comparing with isotype control, graphs C, D, E and F data was analysed by Ordinary one-way ANOVA 
Holm-Sidak's multiple comparisons test, significance *** p ≤ 0.001, ** P ≤ 0.01 and * P ≤ 0.05, ns is non-
significant. 
The same parameters and infection protocol as described in 4.3.1.1 were used to investigate 
the Salmonella infection of phorbol ester treated THP-1 cells. Using 30 MOI for 30 minutes, 
the percentage of THP-1 derived macrophages cells associated with Salmonella 
Typhimurium NCTC12023 and the number of bacteria per 100 cells showed a significant 
reduction when the cells were pre-treated with anti-CD63, anti-CD81 and anti-CD151. 
However, no significant change was observed for cells treated with anti-CD9 before infection. 
No significant changes were observed in the number of external or attached bacteria and 
percentage of internalised bacteria for any of the antibody treatments (Figure 4.5 and 4.6).  
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Since Salmonella Typhimurium NCTC12023 strain is a low virulence laboratory strain, a 
different strain was also introduced in the infection experiments, Salmonella enterica serovar 
Typhimurium LT2 strain. Cells infected with Salmonella Typhimurium LT2 strain showed 
no significant reduction in infection when treated with anti-CD9 and anti-CD63 (Figure 4.7). 
There appeared to be some obvious reduction with anti-CD81 and CD151 antibodies, but this 
was not significant. No significant changes were observed in cells treated with isotype control 
compared with non-treated cells control. No changes were observed in cells treated with anti-
tetraspanin mAbs compared with isotype control (JC1) in number of external cells per 100 
counted cells and percentage of internalisation.
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Figure 4.7: Effect of anti-tetraspanin mAbs on Salmonella LT2 strain uptake by macrophages 
derived from THP-1 cells at 30 MOI for 30 minutes. THP-1 cells treated with 20ng ml-1 PMA for 3 days 
and cells were pre-treated with JC1 (control isotype), anti CD9 (602.29), anti CD63 (H5C6), anti CD81 and 
anti CD151 (14, A2) at 20μg ml-1) before Salmonella Typhimurium LT2 strain. A: Cells infected with 
Salmonella. B: Number of bacteria per 100 cells. C: Number of external or attached bacteria. D: The 
percentage of internalized bacteria, E and F: Corresponding raw data (average of non-normalised) for 
normalised A and B only. Bars show means, while error bars show standard errors.  n=3 in duplicate, graphs 
A and B data was analysed by One Sample T-test comparing with isotype control, graphs C,D, E and F data 
was analysed by Ordinary one-way ANOVA Holm-Sidak's multiple comparisons test, significance ** p ≤ 
0.01 and * P ≤ 0.05, ns is non-significant.  
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4.3.1.3 Effect of anti-tetraspanin antibodies on Salmonella uptake by the HEC-1-B 
cell line 
 Salmonella has the ability to invade and replicate in various cell types within the host 
(Haraga, Ohlson et al. 2008). It also has the ability to attach to and invade different phagocytic 
and non-phagocytic cell lines, as shown by many researchers (Finlay, Ruschkowski et al. 
1991, Mills and Finlay 1994, Lajarin, Rubio et al. 1996, Rosales-Reyes, Perez-Lopez et al. 
2012). The ability to invade non-phagocytic cells can be mediated by T3SS-1 (Rosselin, Abed 
et al. 2011) (discussed in detail in 1.2.3). The human epithelial cell line, HEC-1-B, was 
therefore chosen as cell model of non-phagocytic cell line to investigate the tetraspanins 
effect on Salmonella Typhimurium NCTC12023 strain uptake. In addition, when these cells 
were treated with either anti-tetraspanin antibodies (CD9, CD63 and CD151) or recombinant 
EC2 domains a reduction in the adhesion of another gram negative bacterium, Neisseria 
meningitidis, was observed (Green, Monk et al. 2011). HEC-1-B cells were infected, fixed 
and stained as described previously (2.2.5.1) (Figure 4.8). From optimisation experiments, 
100 MOI for 60 minutes infection time was chosen as this gave a suitable number of bacteria 
that could analysed (data not shown). As shown in the previous chapter (3.3.1.4), high surface 
expression of tetraspanins CD9, CD63, CD81 and CD151were observed in HEC-1-B cells. 
No significant changes were observed in HEC-1-B cells pre-treated with anti-CD9, anti-
CD37, anti-CD63, anti-CD81, and anti-CD82 or anti CD-151 compared with JC1 isotype 
control in all four parameters used to indicate assess cell infection (Figure 4.8 and 4.9).
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Figure 4.8: Immunofluorescence microscopy of HEC-1-B cell line cells infected with Salmonella 
Typhimurium NCTC12023 at 100 MOI for 60 minutes. HEC-1-B cells were infected with Salmonella 
Typhimurium NCTC 12023, fixed and stained as described in Figure 4.2.  A and C: HEC-1-B cells with 
S. Typhimurium, with both bacterial and cell DNA stained blue (DAPI) under the correct fluorescence 
filter, B and D:  FITC (green) stain that reveals the external bacteria. Arrows point to bacteria. The images 
were captured using Nikon Eclipse E400 fluorescence microscope using oil immersion (100x) objective. 
DNA-DAPI Salmonella-FITC 
DNA-DAPI Salmonella-FITC 
A 
  
B 
C 
  
D 
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Figure 4.9: Effect of anti-tetraspanin mAbs on Salmonella NCTC12023 strain uptake by HEC-1-B 
cells at 100 MOI for 60 minutes. HEC-1-B cells were pre-treated with JC1 (control isotype), anti CD9 
(602.29), anti CD63 (H5C6), anti CD81 and anti CD151 (14, A2) at concentration of (20μg ml-1) before 
Salmonella Typhimurium NCTC 12023 strain infection as described Figure 4.8. A: Cells infected with 
Salmonella. B: Number of bacteria per 100 cells. C: Number of external or attached bacteria. D: The 
percentage of internalized bacteria, E and F: Corresponding raw data (average non-normalised) data for A 
and B respectively. Bars show means, while error bars show standard errors.  n=3 in duplicate, graphs A 
and B data was analysed by One Sample T-test comparing with isotype control, graphs C, D, E and F data 
was analysed by Ordinary one-way ANOVA Holm-Sidak's multiple comparisons test, ns is non-significant. 
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4.3.2 Effect of anti-tetraspanin antibodies on Salmonella Typhimurium 
uptake analysed by flow cytometry  
As described in (4.1), a flow cytometry method was developed to analyse the infected cells 
instead of using the ordinary immunofluorescent microscopy method (2.2.5.2). Bacteria were 
prepared for infections as previously (2.2.5.1.2). The main difference in the procedure 
afterwards was that cells were harvested, and  treated with antibody in tubes and then infected 
with the cells and bacteria maintained in suspension (2.2.5.2.3). Optimisation experiments 
were carried out for each cell line and for both Salmonella strains. Interestingly, the overall 
optimisation  results showed that a lower  MOI was needed to give sufficient infected cells 
for both macrophage and epithelial cell lines using this infection method (optimisation data 
not shown). 
 
4.3.2.1 Salmonella uptake by J774 cell line 
 J774 cells were infected with Salmonella NCTC12023 strain at 5 MOI for 30 minutes after 
treatment with anti-tetraspanin antibodies using the flow cytometry protocol for infection and 
staining as described in detail in 2.2.5.2 and outlined in Figure 4.10. The cells were analysed 
using the LSR-II flow cytometer and 10,000 events were acquired. The cells were gated 
depending on forward and side scatter (FSC and SSC respectively) and for detecting cells 
associated with bacteria, the 530-30 filter was used to detect the FITC signal (Figure 4.9 A), 
which was clearly above the auto-fluorescent background signals from the cells. The 
percentage of positive cells reveals the cells with associated bacteria whilst the MFI indicates 
the intensity of bacterial infection. To estimate the percentage of internalised bacteria, the 
number of infected cells that were stained without permeabilization was subtracted from 
permeabilized infected cells (total cell associated bacteria). The flow cytometry method 
shows a significant reduction in infection rate by S. Typhimurium of J774.2 cells treated with 
anti-CD9 antibodies, similar to that observed with the immunofluorescence microscopy 
method. Anti-CD81 antibodies also showed inhibition, whereas anti-CD63 antibodies 
showed no significant change in Salmonella uptake (Figure 4.10 B). However, no significant 
changes in MFI was observed (data not shown). No significant changes were observed in the 
percentage of cells with internal bacteria (subtracting cells associated with attached bacteria 
(non-permeabilised) from cells associated with bacteria (permeabilised)) or cells associated 
with external bacteria (Figure 4.10 C and D), despite some reduction in the number of cells 
associated with internalised bacteria but this was not statistically significant. The results 
obtained by the flow cytometry assay therefore appear consistent with the data obtained with 
the microscopy assay described in 4.3.1.1. 
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Figure 4.10: Effect of tetraspanin mAbs on Salmonella uptake by J774 cells at 5 MOI for 30 minutes 
analysed by flow cytometry.  J774.2 cells were harvested, placed in Eppendorf tubes and pre-treated with 
anti-tetraspanin mAbs or isotype control (20µg ml-1 for 60 minutes) before infection with Salmonella 
Typhimurium NCTC12023 as described in 2.2.5.2.1. The cell-bacteria suspension was placed on a rotating 
mixer and was incubated at 37°C for 30 minutes. The cells were washed and fixed or fixed and 
permeabilised as described in 2.2.5.2.4 and stained using primary rabbit anti-Salmonella polyvalent 
antibody followed by secondary anti-rabbit –FITC. Cells were kept in 1% PFA until analysis using an LSR-
flow cytometer. A: Dot plot from FACS analysis showing how the values shown in B were obtained (LH 
graph shows the gated population of cells analysed based on forward and right angle scatter, the middle and 
RH graph show fluorescent staining of infected cells pre-incubated with isotype control and anti-CD9, 
respectively, with uninfected control cells depicted in red. B: Percentage of J774 cells infected with 
Salmonella normalized to 100% isotype control. C: Percentage of cells with external bacteria normalised 
to 100% isotype control. D: Percentage of cells with internal bacteria (subtracting the percentage of cells 
with external bacteria from all infected permeabilized cells). E: Raw data before normalisation. Bars 
describe means, while error bars describe standard error means.  n=3 in duplicate, data was analysed by 
Ordinary one sample T test comparing with isotype control, significance **** p ≤ 0.0001 and ** P ≤ 0.01.  
ns is non-significant.  
A 
Isotype  CD9 
Cells control 
Salmonella infected cells  
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4.3.2.2 Salmonella Typhimurium uptake by HEC-1-B cell line 
Since the NCTC12023 strain has been shown to be less invasive to epithelial cells compared 
with other strains, the LT2 strain was also included here. Both Salmonella strains and HEC-
1-B cells were prepared and harvested as described in 2.2.5.2.  No significant effects were 
shown in total infected cells, cells with attached bacteria and cells with internalised bacteria 
in HEC-1-B cells infected with S. Typhimurium NCTC12023 strain (Figure 4.11 A and B)  
and LT2  strains (Figure 4.11 C and D). No significant changes in MFI were observed (data 
not shown). This result is consistent with that observed by fluorescence microscopy. The LT2 
strain did appear to give slightly higher rates of infection, as might be expected (comparing 
Figure 4.11 E and F and G and H). The results obtained with the flow cytometry assay are 
consistent with those obtained with the microscopy assay described in 4.3.1.3. 
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Figure 4.11: Effect of tetraspanin mAbs on Salmonella strain uptake by HEC-1-B cells at 50 MOI for 
60 minutes analysed by flow cytometry. HEC-1-B cells were harvested non-enzymatically and pre-treated 
with anti-tetraspanin antibody or isotype control before infection and staining of permeabilised or non-
permeabilised cells as described in Figure 4.10. NCTC12023 strain (A) or LT2 strain (C) normalised to 
100% permeabilised isotype control (described in 2.2.5.2). Percentage of cells with internal bacteria, 
NCTC12023 strain (B) or (D) LT2 strain normalised to 100 isotype control. E-H: Corresponding raw data 
for A-D respectively. Bars show means, while error bars show standard error. n=3 in duplicate, the data 
was analysed using One Sample T-test (A-D) and Ordinary one-way ANOVA Holm-Sidak's multiple 
comparisons test (E-H) compared with isotype control,  ns is non-significant.  
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4.3.3 Effect of anti-tetraspanins antibodies on Salmonella 
Typhimurium-GFP uptake analysed by flow cytometry 
It was postulated that using GFP expressing bacteria might provide a good tool to allow a 
more direct, faster method of assessing infections by flow cytometry without the need to stain 
using anti-Salmonella antibodies. As described previously (3.3.2), GFP was successfully 
expressed in S. Typhimurium NCTC12023 and LT2 strains. 
4.3.3.1 Effect of anti-tetraspanin antibodies on S. Typhimurium-GFP uptake by 
J774 cells analysed by flow cytometry 
Salmonella-GFP strains were prepared as described in (2.2.5.1.2) in media contain 100µg/ml 
kanamycin and the J774 cells were infected at 5 MOI for 30 minutes as described previously 
(Figure 4.10). The cells with associated Salmonella-GFP were clearly segregated from the 
non-infected cells (Figure 4.12 A). The results considered represent percentage of total J774 
cells with associated bacteria (both attached and internalised Salmonella). As previously 
(Figure 4.10),  a significant reduction in percentage of Salmonella NCTC12023-GFP strain 
uptake in cells treated with anti- mouse CD81 prior infection was observed (Figure 4.12 B), 
although this was less significant than previously (the percentage of cells associated with 
bacteria). However, unexpectedly, although there appeared to be a slight reduction in uptake 
by cells treated with anti-CD9 relative to the isotype control, this was not statistically 
significant. In addition, anti-CD63 mAb had no effect on uptake. No significant reduction in 
Salmonella uptake was apparent with any of the mAb for cells infected with Salmonella LT2-
GFP strain using normalised data (Figure 4.12 C), but anti-CD81 did show an effect when 
the raw (non-normalised) data were analysed. It is notable from comparing the raw flow 
cytometry data for WT NCTC12023 (Figure 4.10 E) with GFP-NCTC12023 (Figure 4.12 E) 
that the infection rate of the GFP strain is lower (~ 40% of J774 cells are associated with WT 
bacteria compared with ~ 20% for the GFP bacteria).  
Control samples of Salmonella-GFP strain and wild type bacteria were included in each 
experiment, confirming that GFP was highly expressed (over 90% of bacteria were GFP 
positive for both strains used) indicating that GFP expression was stable (data not shown). 
As noted previously, the LT2 strain showed higher GFP expression, as indicated by a higher 
MFI, as shown previously (3.3.2). 
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Figure 4.12: Effect of tetraspanin mAbs on Salmonella-GFP uptake by J774 cells at 5 MOI for 30 
minutes analysed by flow cytometry.  J774.2 cells were harvested and pre-treated with mAbs or isotype 
control before infecting with GFP-expressing Salmonella as described in 4.10. After washing the infected 
cells were fixed with 4% PFA for 15 minutes, washed once with PBS and suspended in with 1% PFA before 
analysis using the LSR-II flow cytometer (2.2.5.2.3). 10,000 events were acquired and the cells were gated 
according to FSC and SSC parameters. The GFP signal was detected using 530-30A filter and 530nm 
maximum emission 488nm blue laser. A: Dot plot from FACS analysis showing how the values shown in 
B-E were obtained. Percentage of J774 cells infected with S. Typhimurium normalized to isotype control 
(B) NCTC12023-GFP or (C) LT2-GFP. D and E: Raw data for B and C respectively. Bars describe means, 
while error bars describe standard errors.  n=6 in (B) and n=4 in (C), in duplicate. The data  was analysed 
by One sample T test comparing with isotype control in B and C and Ordinary one-way ANOVA Holm-
Sidak's multiple comparisons test compared with  isotype control in D and E, significance * P ≤ 0.05, ns is 
non-significant. 
4.3.3.2 Salmonella Typhimurium uptake by RAW264 cell line 
Alongside the experiments with J774 cells, uptake of Salmonella-GFP strains by another 
mouse macrophage cell line, the semi-adherent RAW264 cell line, were carried out. 
Optimisation experiments indicated that an MOI of 20 and an infection time of 30 were 
suitable. The results considered represent the total RAW264 cells with associated bacteria 
(both attached and internalised Salmonella). Here, a significant reduction in the cells 
A 
NCTC12023-
GFP 
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associated with Salmonella-GFP was observed on pre-treatment with anti-CD9 and anti-
CD81, but not anti-CD63, for both Salmonella-GFP strains (Figure 4.13 A and B).   
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Figure 4.13: Effect of tetraspanin mAbs on Salmonella expressing GFP uptake by RAW264 cells at 
20 MOI for 30 minutes analysed by flow cytometry. RAW264 cells were harvested and pre-treated with 
antibodies in U-bottomed 96-well plates prior to infection with bacteria on a shaking incubator then washed 
and fixed as described in 2.2.5.2.3 and Figure 4.12. Cells were analysed using the LSR-II flow cytometer, 
as previously and 5,000 events were acquired. Percentage of RAW264 cells infected with S. Typhimurium 
normalized to isotype control (A) NCTC12023-GFP or (B) LT2-GFP. C and D: Raw data for A and B 
respectively. Bars describe means, while error bars describe standard errors.  n=5 in (A) and n=6 in (B), in 
duplicate. The data  was analysed by One sample T-test comparing with isotype control in A and B and 
Ordinary one-way ANOVA Holm-Sidak's multiple comparisons test compared with  isotype control in C 
and D, significance ** P ≤ 0.01,* P ≤ 0.05, ns is non-significant. 
 
4.3.3.3 Salmonella Typhimurium uptake by non-differentiated THP-1 cell line 
The human monocyte cell line (THP-1) was also used to investigate the effect of anti-
tetraspanins antibodies on Salmonella-GFP strain uptake. The undifferentiated cells were 
used in the flow cytometry method because it was too difficult to harvest sufficient numbers 
of viable cells, as they become more adherent. From optimisation  experiments 50 MOI and 
infection for 60 minutes was chosen as showing sufficient numbers of cells with associated 
bacteria for  analysis; this compares with 30 MOI and 30 minutes infection for PMA-
stimulated THP-1 (4.3.1.2), indicating that the undifferentiated cells are more difficult to 
infect. The cells were harvested, pre-treated with antibodies and infected with Salmonella-
GFP as described in the preceding section, before analysis by flow cytometry. Variations in 
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the effects of anti-tetraspanin antibodies on uptake of GFP-transfected bacteria were observed 
depending on the Salmonella strain used. Anti-CD81 reduced bacterial association of cells 
infected with the NCTC12023-GFP strain, whilst no significant effects were noticed with any 
other anti-tetraspanin treatments (Figure 4-14 A and C). However, none of the anti-
tetraspanin antibodies tested reduced association of cells infected with LT2-GFP strain 
(Figure 4.14 B). By contrast, THP-1 cells pre-treated with anti-CD151 appeared to show some 
increase in bacteria association, with a high median of fluorescent intensity (MFI) compared 
with isotype cells control. (Figure 4-14 D). 
 
4.3.3.4 S. Typhimurium-GFP strains uptake by HeLa cell line 
As described in 4.3.2.2. no effect of tetraspanin antibodies were observed in the human 
epithelial cell line HEC-1-B. Here, another epithelial cell line was introduced, since Hela 
cells offer a useful epithelial cell model to investigate Salmonella infection (Giannella, 
Washington et al. 1973, Jones, Richardson et al. 1981). This cell line was used to investigate 
the effect of anti-tetraspanins antibodies on Salmonella-GFP strain uptake. The tetraspanin 
expression of these cells was described previously in Chapter (3.3.1.5) and high expression 
of CD151 was observed in addition to that of other tetraspanins including CD9, CD63 and 
CD81. From initial optimising experiments the 50 MOI for 60 minutes was chosen (data not 
shown). Cells were harvested, pre-treated with antibody, infected with GFP-expressing 
strains of Salmonella as described previously (4.3.2.2). The anti-CD81 treated cells were 
shown to have more associated Salmonella NCTC12023-GFP compared with the isotype 
control, whereas no significant changes were noticed for the other anti-tetraspanin treatments 
(Figure 4-15 A). None of the anti-tetraspanins antibodies affected association of the cells with 
the LT2-GFP strain (Figure 4.15 B). No significant changes in MFI was observed (data not 
shown).
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Figure 4.14: Effect of tetraspanin mAbs on Salmonella expressing GFP uptake by THP-1 cells at 50 
MOI for 60 minutes analysed by flow cytometry. THP-1 cells were harvested and pre-treated with 
antibodies in U-bottomed 96-well plates prior to infection with bacteria on a shaking incubator then washed 
and fixed as described in 2.2.5.2.3 and Figure 4.12. Cells were analysed using the LSR-II flow cytometer, 
as previously and 5,000 events were acquired. Percentage of THP-1 cells infected with S. Typhimurium 
normalized to isotype control (A) NCTC12023-GFP or (B) LT2-GFP. And median of fluorescent intensity 
(MFI) (C) NCTC12023-GFP or (D) LT2-GFP. E-H: Corresponding raw data for A-D respectively. Bars 
describe means, while error bars describe standard errors.  n=3 in duplicate. The data  was analysed by One 
sample T-test comparing with isotype control in A-D and Ordinary one-way ANOVA Holm-Sidak's 
multiple comparisons test compared with  isotype control in E-H, significance * P ≤ 0.05, ns is non-
significant.  
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Figure 4.15: Effect of tetraspanin mAbs on Salmonella expressing GFP uptake by HeLa cells at 50 
MOI for 60 minutes analysed by flow cytometry. HeLa cells were harvested and pre-treated with 
antibodies in U-bottomed 96-well plates prior to infection with bacteria on a shaking incubator then washed 
and fixed as described in 2.2.5.2.3 and Figure 4.12. Cells were analysed using the LSR-II flow cytometer, 
as previously and 5,000 events were acquired.  Percentage of HeLa cells infected with S. Typhimurium 
normalized to isotype control (A) NCTC12023-GFP or (B) LT2-GFP. C and D: Corresponding raw (non-
normalised) data for B and C respectively. Bars describe means, while error bars describe standard errors.  
n=3 in duplicate. The data  was analysed by One sample T-test comparing with isotype control in A and B 
and Ordinary one-way ANOVA Holm-Sidak's multiple comparisons test compared with  isotype control in 
C and D, significance * P ≤ 0.05, ns is non-significant. 
 
4.4: Discussion 
Previous work from our lab has indicated that tetraspanins are involved in S. Typhimurium 
infection of human monocyte-derived macrophages (MDMs). The initial aim of this work 
was to develop cell line models to investigate the role of tetraspanins in Salmonella infection. 
In this study, different cell lines including mouse macrophage cell lines (J774.2 and 
RAW247), human macrophage-like cells (derived from human monocytes THP-1) and a 
human epithelial cell lines (HEC-1-B and HeLa cell lines) were infected with Salmonella 
strains. Initial infection experiments were carried out to optimise the conditions for infection 
of cell lines with Salmonella including the multiplicity of infection (MOI) and the time of 
infection.  
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Salmonella can infect and replicate in various cell types within the host (Haraga, Ohlson et 
al. 2008). As well, it has the ability to attached and invade different phagocytic and non-
phagocytic cell lines (Finlay, Ruschkowski et al. 1991, Mills and Finlay 1994, Lajarin, Rubio 
et al. 1996, Rosales-Reyes, Perez-Lopez et al. 2012). In the present study, the results show 
the ability of Salmonella to invade non-phagocytic cells (HEC-1-B, HeLa epithelial cell lines) 
as well as phagocytic cell lines (RAW, J774 mouse macrophages and THP-1 derived 
macrophages). The ability to infect non-phagocytic cells can be mediated by T3SS-1 
(Rosselin, Abed et al. 2011).  
The mouse like macrophages J774 and RAW cell lines were used as a macrophage models to 
investigate the effect of anti-tetraspanin antibodies on Salmonella uptake. Furthermore, THP-
1 derived macrophages were also used, since this cell line is of human origin and might more 
closely resemble the primary human MDM used in the previous study. The THP-1 cells were 
differentiated to macrophages – like cells using phorbol ester (PMA) as mentioned in chapter 
3. As reviewed in (Auwerx 1991), the THP-1 cell line offers a close human model for MDMs. 
Initially a conventional immunofluorescence microscopy manual counting technique was 
used to investigate the effects of anti-tetraspanins on Salmonella infection. This method has 
routinely been used in our lab to indicate bacterial infection in both human macrophages 
(Hassuna, 2010, PhD thesis, University of Sheffield) and epithelial cell lines (Green, Monk 
et al. 2011); (Cozens, 2015, PhD  thesis, University of Sheffield).  
As shown in (Figure 4.3), a significant reduction in Salmonella NCTC12023 uptake was 
shown in J774 cells treated with anti-mouse CD9 prior Salmonella infection compared with 
isotype control. This is in contrast to previous studies on human MDM, where no inhibition 
with anti-CD9 mAbs was observed; however recombinant soluble CD9 EC2 proteins 
inhibited association of Salmonella with human MDM, suggesting involvement of CD9 in 
this process (Hassuna, PhD thesis, University of Sheffield 2010). Anti-CD81 antibodies 
showed a more modest inhibitory effect, consistent with previous data on human MDM. 
However anti-CD63 antibodies showed no effect; this may relate to the extremely low levels 
of CD63 on the surface of J774 cells (chapter 3). In contrast, the THP-1 derived macrophages 
and human MDMs both showed high levels of CD63 (Chapter 3) and (Hassuna, 2010, PhD 
thesis, University of Sheffield). 
 
By contrast, for human cells, no inhibition by anti-CD9 mAb in THP-1 derived macrophages 
was noticed when using the same anti-CD9 antibody that blocked adhesion in the human 
MDM experiments. The differences in the effects of the anti-CD9 antibodies between mouse 
and human cells may relate to differences in the particular antibodies used, or differences in 
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CD9 between the mouse and human cells.  Also in agreement with previous studies on human 
MDM, anti-CD63 and anti-CD81 antibodies inhibited association of Salmonella NCTC12023 
to THP-1 derived macrophages. However anti-CD151 antibodies caused inhibition of 
infection of  THP-1 macrophages, whereas no effect was seen with human MDM. The 
differing effects the antibodies here may relate to differences in expression of the tetraspanins, 
as human MDM were shown to express low levels of CD151 (only slightly higher than the 
isotype control (Hassuna, PhD thesis, University of Sheffield 2010). No significant effects 
were seen on the number of internalised bacteria, so it appears that the antibodies are acting 
at a stage prior to this. The infection of THP-1 derived macrophages by another Salmonella 
strain, LT2, which is reported to be more virulent (Professor Jeff Green, personal 
communication) and suggested in the present study (when the bacteria were used at mid log 
phase of growth) was also investigated. This difference could probably relate to differences 
in SPI-1 expression of certain T3SS components depending on Salmonella strains. It has been 
found that Salmonella Typhimurium NCTC12023 has less ability to invade epithelial cell 
lines, which may relate to low expression of prgH that is shown to be important to instruct 
needle complex formation in other Salmonella Typhimurium strains (Clark, Perrett et al. 
2011).  With the LT2 strain, anti-CD9 and anti-CD63 antibodies had no significant effect on 
adhesion to THP-1 macrophages and although some reduction was observed with anti-CD81 
and anti-CD151 antibodies, this did not reach significance. Interestingly, anti-CD151 
antibodies were previously found to reduce Neisseria meningitidis adhesion to human 
epithelial cells  (Green, Monk et al. 2011). 
  
It was of interest to investigate any potential role for tetraspanins in the infection of non-
phagocytic cells by Salmonella, as the uptake of bacteria by these cells is likely to be primarily 
through the Type 3 secretion system (Finlay, Ruschkowski et al. 1991, Mills and Finlay 1994, 
Lajarin, Rubio et al. 1996, Rosales-Reyes, Perez-Lopez et al. 2012). As shown in (Figure 4.8) 
Salmonella were attached to and internalised into HEC-1-B cells after one hour incubation. 
Nevertheless, no significant effects were observed in these cells after treatment with anti-
tetraspanins antibodies, either for the total cells associated with bacteria or in attached and 
internalised bacteria (Figure 4.9). This finding was in contrast to the reduction that was found 
in cells associated with attached Salmonella NCTC12023 in HEC-1-B cells that had been 
pre-treated with recombinant EC2 proteins corresponding to CD9, CD63 or CD151 prior to 
infection (Green, 2010, PhD thesis, University of Sheffield). The effect of antibodies was not 
assessed individually in the previous study. It could be that EC2 proteins have an effect 
whereas antibodies do not; in retrospect, it would have been useful to see if the previous 
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findings with EC2 proteins could be replicated here. Alternatively, it could be that 
tetraspanins are not involved in Salmonella uptake that is mediated by T3SS. Interestingly, 
infection of MDMs by Salmonella induced to express high level of T3SS was less affected 
by anti-CD63 antibodies (Noha Hassuna, PhD thesis 2010). 
 
As stated previously, another aim of the work described in this Chapter was to develop a flow 
cytometry assay for assessing infection, which would be comparable with the microscopy 
assay but should be faster, permit analysis of more events and give more objective results. As 
mentioned earlier in this chapter (4.1.1), flow cytometry has been applied to study bacterial 
pathogenicity to host cells and bacterial-host interaction (Valdivia and Falkow 1998, Pils, 
Schmitter et al. 2006). Additionally, it was reported to be comparable with other ordinary 
infection assays and provide a quick and appropriate method to differentiate between external 
associated and internalised bacteria (Pils, Schmitter et al. 2006, Trouillet, Rasigade et al. 
2011). The J774 cell line infection results that were obtained from this method, where bacteria 
were stained using antibodies after infection, were very comparable with the results from the 
fluorescence microscopy method (Figures 4.3, 4.4 and 4.10). In both methods anti- CD9 and 
anti CD81 antibodies similarly reduced Salmonella uptake significantly. Additionally, anti-
mouse tetraspanins CD63 showed no effect on Salmonella/cells association, as in the 
microscopy assay. Interestingly, a lower MOI was necessary to achieve similar level of 
infections in the flow cytometry assay; it is possible that incubation of cells with bacteria in 
suspension may facilitate greater binding compared to cells adhered to coverslips. Also as 
found in the microscopy based method (Figure 4.9), no significant changes in total cells 
associated with bacteria, cells associated with external bacteria and cells associated with 
internal bacteria was found in HEC-1-B human epithelial cell line infected with Salmonella 
Typhimurium NCTC12023 and LT2 strains. 
It was speculated that the generation of stable GFP expressing Salmonella strains could have 
advantages for both flow cytometry and for confocal microscopy. After optimising 
experiments using different vectors carrying either GFP or RFP proteins (as mentioned in 
chapter, 3.3.2 ), a broad host range plasmid (pBHR-1) carrying the GFP expression sequence 
was used to induce a stable, highly expressed GFP that was detected by flow cytometry and 
fluorescent microscope using appropriate filters. The pBHR1vector is derived from pBBR1 
(Szpirer, Faelen et al. 2001) that was firstly isolated from Bordetella bronchiseptica-S87 
(Antoine and Locht 1992). Bacteria expressing GFP have been employed in bacterial 
pathogenicity studies (Valdivia, Hromockyj et al. 1996) and it has been reported that GFP 
expression does not interfere with Salmonella invasion (Valdivia, Hromockyj et al. 1996, Ma, 
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Zhang et al. 2011). In contrast, high expression levels of GFP seems to affect Salmonella 
virulence (Wendland and Bumann 2002). In the present study, the Salmonella-GFP strains 
were successfully detected by flow cytometry using appropriate filter either alone (described 
in previous chapter, Figure 3.12) or associated with host cells in different cell lines. Also the 
population of bacteria infected cells was nicely segregated from the non-infected cell 
population by FACS analysis (Figure 4.12 A). Unexpectedly, J774 cells treated with anti-
CD9 antibodies showed no significant change in cells associated with Salmonella 
NCTC12023-GFP and LT2-GFP strain, although some reduction was still seen with anti-
CD81 antibodies. This could be related to the sensitivity of detecting fluorescence signal by 
flow cytometry which seems to be lower in GFP-expressing bacteria compared with bacterial 
immunostaining. To further investigate CD9 and CD81 in mouse macrophages, another 
mouse macrophages cell line was introduced. With the RAW 264.7 cell line, a small but 
significant reduction in Salmonella uptake in cells treated with anti-mouse CD9 and CD81 
(but not in CD63) prior Salmonella NCTC and LT2 strains infection was observed. However 
a higher MOI was required to obtain sufficient cell infection (20 MOI), which could be 
because the RAW cells are less phagocytic than J774 cell line. Attempts to use the flow 
cytometry method to assess infection in THP-1 derived macrophages cells (stimulated for 
three days stimulation using PMA) were unsuccessful. This could be because these cells seem 
to become more fragile after harvesting, as a high concentration of cells debris was apparent 
in flow cytometry when the cells were infected in suspension; this could affect the flow 
cytometry analysis accuracy. PMA-stimulated THP-1 cells are very strongly adherent, and 
may have been damaged during harvesting prior to infection. Therefore, undifferentiated 
THP-1 cells were also assessed using the flow cytometry method. A high MOI was required 
to achieve infection of these cells, similar to that used for the epithelial cell lines. 
Interestingly, the undifferentiated THP-1 cells behaved differently depending on the 
Salmonella strains used. Cells treated with anti-human CD81 prior to S. Typhimurium 
NCTC12023-GFP infection showed a slight but significant reduction in cells associated with 
bacteria, but this was not observed with the LT2-GFP strain. None of the other antibodies 
used reduced infection. In contrast, a significant increase in the fluorescence (MFI) of cells 
treated with CD151 prior to infection with the LT2 strain was observed (Figure 4.14), 
suggesting that in this case the antibody may actually enhance bacterial uptake. The 
differences in anti-tetraspanin mAb action between non-differentiated and differentiated 
THP-1 cells might be related to the differences in tetraspanins expression and/or non-
differentiated THP-1 cells are weakly phagocytic compared with high phagocytic activity of 
differentiated THP-1. A higher MOI was needed to obtain sufficient infection rate in non-
differentiated THP-1 cells. Another epithelial cell model, the well-known HeLa cell line was 
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also used to assess infection by the GFP-expressing strains. Again no inhibition of infection 
was observed with any of the anti-tetraspanin antibodies used, but anti-CD81 treated Hela 
cells seemed to show slightly enhanced infection with Salmonella-NCTC12023-GFP, but not 
with the LT2-GFP. This contrasts with studies by Tham, et al (2010), where the anti-CD81 
treated HeLa cells showed lower susceptibility to infection by another Gram negative bacteria 
Listeria monocytogenes, and CD81 has been shown to be regulated immunity against this 
bacterial infection (Martinez del Hoyo, Ramirez-Huesca et al. 2015). This diversity in 
tetraspanin mAb response could be related to the differences in bacterial types and strains 
that used, where some bacterial strains seem to be more dependent on cell surface proteins 
than others. 
Overall, the results obtained in this Chapter are consistent with previous studies showing that 
tetraspanins are involved in Salmonella infection of mononuclear phagocytes (mouse or 
human), although some differences were observed in the involvement of individual 
tetraspanins; this may relate to varying expression levels of the tetraspanins or differences in 
the immortalised cell lines used here. However, in the studies using specific antibodies, there 
was little evidence to suggest that tetraspanins are involved in Salmonella infection of non-
phagocytic cells. 
A flow cytometry assay was developed for monitoring Salmonella infection that gave very 
comparable results with the microscopy assay when antibody staining was used to detect 
bacteria. However, a flow cytometry assay using GFP-expressing bacteria gave rather 
different results, with generally no or less effects being seen when using anti-tetraspanin 
antibodies. It could be that expressing GFP protein affected the infectivity of the bacteria in 
some way or that the GFP bacteria were not as well detected by FACS. Is it possible that if 
bacteria were internalised, the GFP signal may have been lost/reduced. Because of this, 
thereafter in this work, the antibody-staining method was used to detect Salmonella infection 
by flow cytometry.
Chapter 5 
129 
 
Chapter 5:  Effect of soluble tetraspanins EC2 proteins 
on Salmonella Typhimurium uptake by J774 cells and 
generation of soluble mouse CD9 EC2. 
 
5.1 Introduction 
The large extracellular loop (LEL or EC2 domain) of tetraspanins has the most variable 
sequence between family members, but contains a highly conserved CCG motif  that indicates 
the tetraspanin signature, together with another 2, 4 or 6 cysteine residues that form 2, 3 or 4 
disulphide bonds respectively (Seigneuret, Delaguillaumie et al. 2001). The EC2 regions of 
tetraspanins have been shown to be involved in many cell functions including fusion (Fanaei, 
Monk et al. 2011), egg-sperm fertilisation (Zhu, Miller et al. 2002, Hemler 2003), migration 
(Powner, Kopp et al. 2011), multinucleated giant cell formation (Takeda, Tachibana et al. 
2003, Hulme, Higginbottom et al. 2014) and adhesion (Reyes, Monjas et al. 2015). 
5.1.1 Tetraspanins EC2 and infections 
Soluble recombinants EC2 proteins of several tetraspanins including CD9, CD63, CD81 and 
CD151 were shown to inhibit CXCR4-HIV-1 viral invasion in to macrophages (Ho, Martin 
et al. 2006). Also, as motioned previously (Chapter 1, Chapter 4) cells treated with tetraspanin 
EC2 recombinant proteins prior to infection reduced bacterial adhesion to epithelial cells 
(Green, Monk et al. 2011) and Salmonella Typhimurium uptake by MDMs (Noha Hassuna, 
2010. PhD Thesis). 
 
5.1.2 Recombinant proteins expression systems 
 Success in achieving a high level of recombinant protein expression is subject to different 
factors including the characteristics of cell growth, level of expression, endogenous or 
exogenous expression, post-translational protein modification and functional activity of 
expressed proteins and the overall cost of expression system (Makrides 1996, Yin, Li et al. 
2007). Recombinant protein expression system is chosen according to the size and complexity 
of expressed proteins; the bacterial system is useful for expressing relatively small proteins, 
while eukaryotic systems such as yeast, mammalian cells, insect cells and plant cells are 
relevant to express large, complex and glycosylated proteins (Demain and Vaishnav 2009). 
Two main yeast systems are commonly used to express recombinant proteins including 
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Saccharomyces cerevisiae and Pichia pastoris. A high level of recombinant proteins (of more 
than 50 kDa) could be produced by this system with many advantages, in particular of 
glycosylated proteins, with the advantage of low cost (Demain and Vaishnav 2009). The 
mammalian cell system, however, is another popular system to express recombinant proteins, 
specifically glycosylated proteins, and the Chinese hamster ovary cells (CHO) cells have 
become the most widely used here. These cells can produce a high level of recombinant 
protein, with correct post-translational modifications for mammalian proteins, reviewed in 
(Kim, Kim et al. 2012). For more complex proteins, mainly proteins that require post 
translational modification, the baculoviral-insect system could also be a choice (Demain and 
Vaishnav 2009). Nevertheless, the high cost of this system compared with other eukaryotic 
recombinant protein expression systems could be considered as a main disadvantage 
(Gecchele, Merlin et al. 2015). In addition to all of the eukaryotic systems that are described 
above, plants have been shown to be important and effective expression system for 
recombinant proteins production (Wilken and Nikolov 2012), with advantages of flexibility, 
costs and protein quality; however, not all recombinant proteins are suitable for this system  
(Gecchele, Merlin et al. 2015). The plant Arabidopsis thaliana and other plants are commonly 
used to produce recombinant proteins (Demain and Vaishnav 2009). 
 
The prokaryotic recombinant protein expression by E. coli offers a low cost, high level of 
recombinant protein production. Despite  the advantage of E coli, it is not the system of choice 
for certain genes, which  could relate to many factors such as complex structural features, 
mRNA stability and translation efficiency, miss-folding of proteins, protein degradation by 
host enzymatic activity and the toxicity of the expressed protein to host cells (Makrides 1996, 
Yin, Li et al. 2007). Understanding the basics  of E. coli transcription, translation and folding 
of proteins and genetic improvement led to enhancing the efficiency of this system to express 
complicated eukaryotic proteins (Baneyx 1999). Folding of recombinant proteins, 
particularly complex and cysteine rich proteins, are the main issue of concern to obtain host 
native protein features. The size and complexity of host proteins affects their folding and 
formation of functional native proteins. Generally, large and complex recombinant proteins 
are less likely to reach the native conformation efficiently, and assistance is usually needed 
compared with small (<100 residues) and single host proteins. The unfolded or misfolded 
recombinant proteins are therefore often aggregated in inclusion bodies or degraded by the 
action of host cells enzymes (Baneyx and Mujacic 2004). This aggregation could be as a 
result of the presence of a strong promoter and high concentration of inducer that leads to the 
production of high levels of recombinant protein and, consequently, aggregation of insoluble 
proteins to form inclusion bodies (Baneyx and Mujacic 2004, Sorensen and Mortensen 2005). 
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A strong promoter is required in an expression vector to regulate the high levels of gene 
expression and the presence of a repressor leads to decreased basal transcription in the 
absence of an inducer. The promoter could be induced thermally or chemically, and the main 
chemical that is used for promoter induction is isopropyl-beta-D-thiogalactopyranoside 
(IPTG) (Sorensen and Mortensen 2005), which binds to the lac repressor, allowing 
transcription from the lac operon. The formation of inclusion bodies could be considered as 
main disadvantage of using E coli systems compared with other expression systems 
(Gecchele, Merlin et al. 2015). As much as 50-95% of  insoluble proteins have been found in 
inclusion bodies that are usually degraded by host cell proteases, reviewed in (Sorensen and 
Mortensen 2005). One strategy that could prevent aggregation of recombinant proteins is by 
using a molecular chaperone that regulates the protein folding processes and prevents 
aggregation of misfolded proteins, reviewed in (Schlieker, Bukau et al. 2002). Alternatively 
re-solubilisation of the insoluble recombinant proteins can be carried out by using urea and 
guadinium hydrochloride detergent (Sorensen and Mortensen 2005). 
 
Since the N-linked glycosylation system of Campylobacter jejuni has been successfully 
transferred into E. coli, it has now become possible to produce glycosylated proteins in E. 
coli even though there is structural variation between bacterial and eukaryotic glycans 
(Wacker, Linton et al. 2002). More recently, the glycosyltransferase pathway from yeast 
Saccharomyces cerevisiae was also transferred into the glycosylation modified E. coli system 
to enable this modified bacteria to produce lipid linked trimannosyl-chitobiose (Man3-
GlcNAc2) and mannosyl-chitobiose (Man-GlcNAc2) that are seen essential in eukaryotic 
glycosylation (Srichaisupakit, Ohashi et al. 2015). 
 
A polypeptide fusion protein called an affinity tag is widely used to enhance recombinant 
proteins purification and detection, and is also used to increase protein production, folding 
and solubility. As well it can used to express toxic proteins and it could save the tagged 
proteins from degradation, reviewed in (Costa, Almeida et al. 2014). Different tags have been 
commonly used depending on the protein of interest and popular choices include His-tag, 
thioredoxin, Strep-tag, SBP-tag, Nus-tag, Arg-tag, cellulose-binding domain, calmodulin-
binding peptide, c-myc-tag, DSb A and glutathione S-transferase (GST) (Terpe 2003). A 26 
kDa GST of Schistosoma japanicum was cloned into an E. coli expression plasmid and the 
expressed proteins could be purified from host cell lysates using affinity chromatography on 
fixed glutathione. Binding  GST protein could be eluted using 10mM reduced glutathione 
under non-denaturation conditions and  the expressed GST protein is commonly found 
soluble in aqueous solution and forms dimers and it could be detected easily by enzymatic 
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and immunological methods. However, the GST-tagged proteins can be insoluble and this 
could be associated with the presence hydrophobic regions in the tagged protein. GST can be 
inserted either at the C or N terminus of proteins and can be used in different expression 
systems (Terpe 2003). The GST tag has been shown to stabilise the linked protein better 
compared with His-tag. It has been shown that the E. coli acetohydroxyacid synthase-I 
isozymes large subunit (AHAS-I-LSU) that is tagged with GST (GST-LSU) was more stable 
compared with the His-tagged protein (His-LSU) that was unstable (Li, Liu et al. 2015).  
 
In our group, the E. coli system has been shown to be competent to produce tetraspanins 
extracellular domains, EC2s tagged with GST. As described before, the tagged proteins were 
shown to be stable and the GST did not interfere with fused protein functions as indicated in 
previous study in our group. The system reliably expresses EC2 domains with correct folding 
and formation of the disulphide bonds that are crucial to EC2 function. Despite this, a high 
proportion of the proteins may be in inclusion bodies as insoluble form that could be as result 
of high levels of recombinant proteins expression (Fanaei, PhD thesis, University of 
Sheffield, 2013). 
 
5.2 Aims 
In present study, targeting tetraspanins CD9 and CD81with specific antibodies in the mouse 
macrophage cell line J774 reduced Salmonella uptake. There was no effect with anti-CD63 
antibodies, which is not surprising as these cells express very low levels of CD63 on their 
surface (Chapter 3). From a previous study in our lab, MDMs treated with antibodies to CD63 
and recombinant CD63-EC2 showed a significant reduction in Salmonella uptake (Hassuna, 
PhD thesis, University of Sheffield 2010). In the same study, CD9-EC2 also inhibited 
bacterial adhesion. Furthermore, another study showed a significant reduction in adhesion of 
various bacteria to epithelial cells that treated with tetraspanins EC2-GST recombinant 
proteins prior infection (Green, PhD thesis, University of Sheffield 2010) (Green, Monk et 
al. 2011). Here, we investigated the effect of human tetraspanins EC2 recombinant protein 
on mouse J774 cells prior to Salmonella infection. In addition, mouse CD9-EC2 was 
generated, and its effects on Salmonella uptake by J774 cells investigated.  
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5.3 Results 
 
5.3.1 Effects of recombinant EC2 fragments on J774 cells infected with 
S. Typhimurium NCTC 12023 (flow cytometry) 
Previous studies using human monocyte-derived macrophages (MDM) showed that 
recombinant versions of the large extracellular domains (EC2s) of tetraspanins CD9 and 
CD63 inhibited S. Typhimurium uptake by approximately 50% (Hassuna, PhD thesis, 
University of Sheffield 2010). The recombinant proteins also inhibited adhesion of N. 
meningitidis and other bacteria to human epithelial cell lines (Green et al., 2011). Since 
antibodies to CD9 and CD81 had an inhibitory effect on S. Typhimurium infection of J774 
cells, it appeared appropriate here to test the effect of the corresponding soluble EC2 proteins. 
The human versions of these recombinant proteins were expressed as GST-fusion proteins in 
E. coli and had been prepared by another member of the laboratory (Marzieh Fanaei). These 
proteins were shown to be correctly folded in Western blots with conformation-sensitive 
antibodies (Marzieh Fanaei, PhD thesis University of Sheffield, 2013) and also showed 
biological activity in a number of other assays carried out concurrently with the experiments 
described here, including inhibition of adhesion of bacteria to epithelial cells lines and 
inhibition of multinucleated giant cell formation in J774 cells induced by infection with 
Burkholderia thailandensis (D. Cozens PhD thesis University of Sheffield 2015, A. Elgawidi, 
personal communication). 
The effect of tetraspanin EC2 proteins was tested by flow cytometry as described in 2.2.5.2 
using direct staining with FITC conjugated anti-Salmonella polyclonal antibody (Figure 5.1). 
No significant changes in the percentage of cells infected or in the median fluorescence 
intensity (MFI), which gives an indication of the level of infection, were shown when 
recombinant human CD9 EC2 and CD81 EC2-GST fragments were used to pre-treat J774 
cells prior to infection with S. Typhimurium at 500 and1000 nM protein concentrations 
compared with the GST control., However, a minor significant change in MFI was  observed 
with  CD9-EC2 for cells  treated with 500nM of recombinant EC2 protein compared with 
non-treated cells. 
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Figure 5.1: Effect of tetraspanin EC2 recombinant protein on Salmonella NCTC-12023 uptake by 
J774 cells analysed by flow cytometry.  J774.2 cells were harvested, placed in Eppendorf tubes and pre-
treated with CD9 and CD81 EC2-GST at concentration of 500nM (B and C) and 1000nM (D and E) for 60 
minutes before infection with Salmonella Typhimurium NCTC12023 at 5 MOI for 30 minutes as described 
in 2.2.5.2.1. The cells-bacteria mixture was placed on a rotating mixer and was incubated at 37°C for 30 
minutes. The cells were washed and fixed or fixed and permeabilised as described in 2.2.5.2.4 and stained 
using FITC conjugated anti-Salmonella polyvalent antibody. Cells were kept in 1% PFA until analysis 
using an LSR-II flow cytometer. A: Dot plot from FACS analysis showing how the values shown in B-E 
were obtained B: Percentage of J774 cells infected with Salmonella normalized to 100% isotype control. 
C: MFI of J774 cells infected with Salmonella normalized to 100% isotype control. D: Percentage of cells 
infected with Salmonella NCTC12023 E: MFI of J774 cells infected with Salmonella normalized to 100% 
isotype control. F-I: Raw data before normalisation. Bars describe means, while error bars describe 
standard error means. MFI is the median of fluorescence intensity, n=5 in B and C and n=3 in D and E in 
duplicate, data was analysed by Ordinary one sample T-test comparing with non-treated cells and GST 
treated control (B-E), graphs (F-I) data was analysed by Ordinary one-way ANOVA Holm-Sidak's multiple 
comparisons test, significance * P ≤ 0.05. ns is non-significant. 
.  
GST hCD9-EC2 
A 
Non infected 
GST 
Non infected 
hCD9-EC2-GST 
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5.3.2 Generation of soluble mouse CD9-EC2 
Human tetraspanin EC2s have previously been shown to be active on mouse cells in other 
types of assay (sperm: egg fusion (Higginbottom et al 2003; B. thailandensis-induced fusion 
of J774 cells, Atiga Elgawidi, personal communication). However, their lack of an effect on 
Salmonella infection might be due to sequence differences between the human and mouse 
CD9 EC2 proteins, which show 76% identity. 
 
5.3.2.1 Mouse CD9-EC2 sequence and alignment 
The full length of the CD9 protein sequences were obtained from online bioinformatics 
database UniProt (http://www.uniprot.org/), and the domain sequences were chosen as 
indicated in this online tool. The sequences were aligned using online multi-sequences 
alignment, MultAline, (http://multalin.toulouse.inra.fr/multalin/) and BoxShade (http://www. 
ch.embnet.org/software/BOX_form.html) where the sequences identities expressed as 
percentages were obtained using BLAST 2 sequences alignment (http://blast.ncbi.nlm. 
nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome).The mouse, rat and human CD9 
protein sequence were aligned using a combination of these tools (Figure 5.2).  The tetrasp-
anin mouse CD9 shown about 95% identity to rat CD9 and 89% with Homo sapiens CD9. 
However, the mouse EC2 shows about 87% homology with rat CD9-EC2 and 77% homology 
with Homo sapiens CD9. 
CD9-Homosapian    1 MPVKGGTKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQETNNNNSSFYTGV 
CD9-RAT           1 MPVKGGSKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQE--TNHSSFYTGV 
CD9-mouse         1 MPVKGGSKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQE--NNHSSFYTGV 
consensus         1 ******.*****************************************   * ******* 
                      N-tail                                  TM-1                                           EC1 
 
CD9-Homosapian   61 YILIGAGALMMLVGFLGCCGAVQESQCMLGLFFGFLLVIFAIEIAAAIWGYSHKDEVIKE 
CD9-RAT          59 YILIGAGALMMLVGFLGCCGAVQESQCMLGLFFGFLLVIFAIEIAAAVWGYTHKDEVIKE 
CD9-mouse        59 YILIGAGALMMLVGFLGCCGAVQESQCMLGLFFGFLLVIFAIEIAAAVWGYTHKDEVIKE 
consensus        61 ***********************************************.***.******** 
                           TM-2                       SIL                              TM-3 
 
CD9-Homosapian  121 VQEFYKDTYNKLKTKDEPQRETLKAIHYALNCCGLAGGVEQFISDICPKKDVLETFTVKS 
CD9-RAT         119 LQEFYKDTYQKLRNKDEPQRETLKAIHMALNCCGIAGGVEQFISDICPKKQVLESFQVKS 
CD9-mouse       119 LQEFYKDTYQKLRSKDEPQRETLKAIHMALDCCGIAGPLEQFISDTCPKKQLLESFQVKP 
consensus       121 .********.**. ************* ** ***.** .****** **** .**.* **  
                                                   EC2 
 
CD9-Homosapian  181 CPDAIKEVFDNKFHIIGAVGIGIAVVMIFGMIFSMILCCAIRRNREMV 
CD9-RAT         179 CPDAIDEVFHSKFHIIGAVGIGIAVVMIFGMIFSMILCCAIRRSREMV 
CD9-mouse       179 CPEAISEVFNNKFHIIGAVGIGIAVVMIFGMIFSMILCCAIRRSREMV 
consensus       181 **.** ***  ******************************** **** 
                                              TM-4            C-tail 
 
Figure 5.2: Mouse, rat and human CD9 proteins sequence alignment.  All three full CD9 sequence 
were obtained from UniProt (http://www.uniprot.org/). The large extracellular domain (EC2) sequences is 
shown boxed and in yellow letters. The transmembrane domains (TMs) are underlined. EC1: Is the small 
extracellular domain. SIL: Is the small intracellular loop. All domains sites were chosen as it indicated in 
UniProt. MultAline, (http://multalin.toulouse.inra.fr/multalin/) and BoxShade (http://www.ch.embnet 
.org/software/BOX_form.html) were used to align these sequences. 
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5.3.2.2 Mouse CD9-EC2 theoretic structure alignments 
The online protein structure prediction tool, Phyr2, was used to build a 3D model protein 
structure and  shows the putative ligand binding sites and amino acid differences  (Kelley, 
Mezulis et al. 2015) of mouse, rat and human CD9, since these protein structures have not 
yet been solved . A combination of this online tool with the PyMOL Molecular graphic 
system, Version 1.7.4 Schrödinger, LLC. Software (https://www.pymol.org/), was used to 
visualised the 3D structure predicted using the Phyr2 tools. The CD9-EC2 of mouse was 
predicted and aligned with the predicted rat and human CD9-EC2 structures (Figure 5.3). 
And as described previously, the online tools MultAline and BoxShade were used also to 
show differences and homology of mouse CD9-EC2 compared with rat and Homo sapient 
(Figure 5.2).   
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Figure 5.3: The predicted structure, sequence comparison and alignment of mouse, human and rat 
CD9-EC2 (large extracellular domain). The grey colour in (1) shows the position of SFQ residues found 
in mouse and rat but not in human CD9-EC2 and shown to be needed in mouse gametes fusion (Zhu, Miller 
et al. 2002). The yellow colour in (3) represents the sites of differences between human or in rat compared 
with mouse. 1A: The predicted structure of mouse CD9-EC2 obtained by Phyre2 (Kelley, Mezulis et al. 
2015), the structure was edited and visualised using The PyMOL Molecular Graphics System, Version 
1.7.4 Schrödinger, LLC (https://www.pymol.org/).  1B: Space-filling model of the predicted mouse CD9- 
EC2 structure. 2:  Mouse and human sequence alignment, both  full length sequences obtained from the 
UniProt online database (http://www.uniprot.org/uniprot/P40240) (http://www.uniprot.org/uniprot/ 
P21926) and  aligned using MultAline (http://www.sacs.ucsf.edu/cgi-bin/multalin.py) and BoxShade 
(http://embnet.vital-it.ch/software/BOX_form.html).  2A: The predicted structure of human CD9-EC2. 2B: 
Space-filling model of the predicted human CD9-EC2 structure. 2C: Mouse and human aligned structures 
of predicted CD9-EC2 showing the structural homology. 3: Mouse and rat aligned sequences, the rat full 
length sequence was obtained from UniProt (http://www.uniprot.org/uniprot/P40241). 3A: The predicted 
structure of rat CD9-EC2. 3B: Space-filling model of predicted rat CD9-EC2. 3C: Mouse and rat predicted 
CD9-EC2 aligned structures showing the structural homology.  
 
5.3.2.3 Cloning of Mouse recombinant CD9-EC2 
The expression of mouse CD9-EC2-GST was therefore undertaken to find out the role of 
mouse CD9-EC2 in Salmonella uptake. The sequence corresponding to the EC2 was PCR-
amplified from a full-length mouse CD9-GFP construct (Origene) (Figure 5.4) using forward 
and reverse primers designed to be complementary to 5` and 3` of mCD9-EC2 and 
incorporating EcoR-l and Hind-lll restriction sites to allow cloning in to corresponding sites 
of the pGEX-KG vector, as described in 2.2.8.6 The PCR products were analysed by agarose 
gel electrophoresis (Figure 5.5). 
 
Figure 5.4: Mouse CD9 in pCMV6-AV-GFP (MG226288) vector. The image was obtained from the 
plasmid supplier’s website (http://www.origene.com/mouse_orf_clone/NM_007657/MG226288/Cd9. 
aspx) showing the vector construct and the inserted mouse CD9 fused with GFP DNA sequence and the 
cloning sites.    
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Figure 5.5:  PCR amplification of mouse CD9-EC2 from pCMV-AC-GFP mouse CD9. The mCD9-
EC2 was amplified from CD9-GFP using the conditions described in 2.2.8.7. 4µl of PCR product was 
mixed with 1µl of 5x DNA loading buffer (BioRad) and loaded for each well of a 1% agarose gel, 5µl of 
DNA ladder (hyper ladder 1, Bioline) was used as a marker to indicate the DNA size (H). E1 and E2: 
Amplified mCD9-EC2 DNA segments [252 bp] taking into consideration the extra bp in forward and 
reverse primers and the restriction sites 
 
The amplified mCD9-EC2 DNA was shown to be pure and the expected size in relation to 
the DNA ladder. The amplified mCD9-EC2 was extracted from the gel (2.2.8.8) then double 
digested by EcoR-l and Hind-III restriction endonuclease enzymes (2.2.8.9). The same 
procedure was applied to the pGEX-KG plasmid to produce overhanging ends, then the 
restricted PCR purified product was ligated with the pGEX-KG vector to generate a mouse 
CD9-EC2-GST construct, as described in 2.2.8.10 and shown in (Figure 5.6). The ligation 
product was transformed into DH5α cells which were grown in selective media contain 100µg 
carbenicillin to select transformed bacteria. 
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Figure 5. 6: Plasmid map for mouse CD9-EC2 in pGEX-KG-GST vector. SnapGene® 2.8 software 
was used to draw the plasmid map.  
 
To confirm the presence the mCD9-EC2 in the pGEX-KG vector, different transformed 
colonies were taken and grown in selective LB broth followed by plasmid extraction (2.2.8.1). 
The extracted plasmids were double digested with EcoR-l and Hind-III to excise the EC2 
segment from the plasmid and also PCR amplification was carried out using the same primers 
used previously to amplify the mCD9-EC2 as well as using primers designed to amplify the 
mCD9-EC2 along with the GST-tag (2.1.14.3). Plasmids obtained from two colonies were 
shown to be contain the full length inserted DNA fragment by both restriction digest and PCR 
amplification. Other colonies analysed gave fragments of unexpected size on double 
digestion, but appeared to contain mCD9-EC2 as determined by PCR (Figure 5.7).
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Figure 5.7: Detection of the presence of mCD9-EC2 DNA fragment in the pGEX-KG plasmid: A: 
Double digestion of plasmid DNA extracted from different colonies transformed with pGEX-KG 
mCD9EC2 ligation products to excise the inserted mCD9-EC2 (shown in 1 and 2 in red box). B: PCR 
amplification of mouse CD9-EC2 from plasmid DNA extracted as for (A). C: PCR amplification of mouse 
CD9-EC2-GST from plasmid DNA extracted as for (A). Samples were run on a 1% agarose gel as described 
in Figure 5.5. H=Hyper ladder (Bioline), 1-4 = colony number selected post ligation. 
Colonies 1 and 2 were expanded and DNA from these sequenced to confirm presence of the 
correct mCD9-EC2 construct using the foreword and reverse primers, pGEX-F2 and pGEX-
R1 respectively described in 2.2.8.12. The sequencing confirmed the presence of mCD9-EC2 
and that no mutation had been introduced.  
 5.3.3 Expression and purification of recombinant mouse CD9-EC2 
protein in E. coli Rosetta-Gami strain 
The confirmed pGEX-mCD9-EC2 and pGEX-GST control vectors were separately used to 
transform Rosetta Gami competent cells (2.2.9.1) followed by expression of recombinant 
protein in 500ml bacterial cultures (2.2.9.2). After induction of protein expression, the 
bacteria were harvested, lysed and the mCD9-GST and GST control proteins were purified 
from the soluble lysate fraction as described in 2.2.9.3 (Figure 5.8), essentially following the 
methods described previously (Higginbottom, Takahashi et al. 2003) as described in (2.2.9.4). 
Fractions taken from each step of the protein purification were checked by SDS-PAGE and 
western blotting using primary rat anti-mouse CD9 antibodies followed by HRP conjugated 
anti-rat secondary antibodies (Figure 5.9) or HRP tagged anti GST (Figure 5.10). The protein 
concentration was estimated by measuring the absorption at 280 nm using a Nano drop 
(2.2.9.5). 
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Figure 5.8: Analysis of purification of mCD9-GST and GST control by SDS-PAGE and Western 
blotting.  Lysates were prepared from E. coli cells transformed to express GST-mCD9 or GST control as 
described in 2.2.9.1. The insoluble fractions were retained after lysis and re-suspended in PBS buffer for 
analysis by SDS-PAGE. Soluble lysate fractions were used for glutathione affinity chromatography. 
Samples were taken at each stage of the purification and run on a 12.5% PAGE gel under non-reducing 
conditions before staining with Coomassie blue (A). 1: precision plus protein standards. 2,4: GST 
expression: insoluble and supernatant fractions, respectively, 3,5 :  CD9-EC2-GST expression : insoluble 
and supernatant fractions, respectively, 6,8: GST: first and second elution of bound protein from glutathione 
beads, respectively, 7,9: CD9-EC2: first and second elution of bound protein from glutathione beads, 
respectively. B: Western blot of the proteins described in (A) detected using anti-mouse CD9 primary Ab 
followed by anti-rat-HRP secondary Ab (2.2.9.8). 
 
The exposure time in Western blot was increased to visualise the protein bands and see if 
mCD9 multimers could be detected (Figure 5.9). The results show the presence of one small 
band at the higher exposure time. A relatively high level of insoluble proteins was shown 
after treatment of the insoluble fraction with 2M urea solution to re-solubilise the insoluble 
proteins. 
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Figure 5.9: Expression and purification of t GST-mCD9-EC2 analysed by SDS-PAGE and Western 
blotting. Lysates from E. coli induced to express pGEX GST-mCD9 were used in glutathione affinity 
chromatography (2.2.9.4). Fractions from each step were selected for analysis by SDS-PAGE and western 
blot. Samples were run on 12.5% SDS-PAGE gels. A; Total protein stained with Coomassie stain. B: 
Western blot using anti-mouse CD9 and anti-rat-HRP secondary Abs (2.2.9.8), exposure time (5 second 
exposure). C: (9.5 second exposure) high exposure time period. M: Protein marker, 1: Insoluble fraction 
obtained post-lysis (re-suspended with 2M urea buffer). 2: Soluble fraction obtained post-lysis (applied to 
glutathione column. 3: second wash flow through after application of soluble lysate to column, 4: protein 
eluted with glutathione.  
As shown by Western blotting (Figure 5.10) the purified mCD9-EC2 was successfully 
detected with anti-GST-HRP; however, different bands were present in the mCD9- GST 
preparation compared with one single band in the GST protein control.  The band at 25 kD 
corresponds to some free GST, whereas the band at 37 kD is the expected size for CD9EC2-
GST. The higher molecular weight bands could be due to the presence of CD9 multimers and 
this has been noted by other workers (Higginbottom et al 2003). Interestingly, the Western 
blot obtained using anti-mCD9 antibody (Figure 5.9) showed a clear single band of mCD9 
located in correct position; this could be because the anti-GST antibody gave a stronger signal 
and bound more strongly to GST. Overall the results of Western blotting show the mCD9 
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was successfully expressed and has correct disulphide bond formation (the mCD9-EC2 was 
specifically identified by specific anti-mouse CD9 mAb under non-reducing condition), GST 
tagged and purified.  
 
 
 
 
 
 
 
 
Figure 5.10: Analysis of recombinant GST-tagged mouse CD9-EC2 protein and GST control by 
western Blotting after affinity purification Samples of purified mouse CD9EC2-GST and purified GST 
were run under non-reducing conditions on 12.5% SDS-PAGE gels and then transferred to nitrocellulose 
membrane. GST was detected using primary HRP conjugated anti-GST antibody. 1: mCD9-GST. 2: GST.  
Further investigation was carried out to determine whether there is any cross reactivity 
between mouse, rat and human CD9-EC2. Different primary antibodies were used targeting 
mouse, rat and human CD9 against mouse and human CD9-EC2 recombinant proteins 
(Figure 5.11). No cross reactivity between mouse and human CD9-EC2 was observed by 
using anti-mouse CD9 and anti-human CD9, while anti-rat CD9 reacted with human CD9-
EC2 but not mouse CD9-EC2 recombinant proteins. Taken together, the results show that 
mouse CD9-EC2 recombinant protein was identified successfully by anti-mouse CD9 
antibody and was not identified by anti-rat or anti-human CD9 antibodies. 
 
 
 
 
 
 
Figure 5.11: Detection of recombinant GST-tagged mouse and human CD9-EC2 protein by Western 
blot using anti-human, anti-mouse and anti-rat primary Abs. A: Western blotting using anti-rat CD9 
primary Abs and anti-mouse HRP tagged secondary Abs. B: Western blotting using anti-mouse CD9 
primary Abs and anti-rat HRP tagged secondary Abs. C: Western blotting by using anti-Human CD9 
primary Abs and anti-Mouse HRP tagged secondary Abs. M, purified  mouse CD9-EC2-GST, H, human 
CD9-EC2-GST. Purified recombinant proteins were run on 12% SDS-PAGE gels under non-reducing 
conditions prior to transfer to nitrocellulose prior to Western blotting. 
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5.3.4 Effect of Mouse CD9-EC2 domain in Salmonella Typhimurium 
uptake 
The mouse version of CD9-EC2 recombinant protein was successfully produced and used in 
infection experiments. Infection by Salmonella NCTC12023 and LT2 strains of J774 cells 
pre-treated with mouse CD9-EC2 showed no significant reduction in Salmonella uptake 
compared with the GST control, using 500 and 1000nM of recombinant proteins; however a 
slight but significant reduction in the percentage of cells pre-treated with 1000nM CD9-EC2 
with S. Typhimurium NCTC12023 compared with non-treated cells were observed (Figure 
5.12).  No significant changes were observed for the same cells treated with mouse CD9-EC2 
infected with S. Typhimurium LT2 strain. The infected cells were analysed by the flow 
cytometry method as previously described (Figure 5.13).
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Figure 5.12: Effect of mouse tetraspanin CD9-EC2 recombinant protein on Salmonella NCTC12023 
uptake by J774 cells analysed by flow cytometry.  J774.2 cells were harvested, placed in Eppendorf tubes 
and pre-treated with mCD9 EC2-GST at concentration of 500nM (B and C) and 1000nM (D and E) for 60 
minutes before infection with Salmonella Typhimurium NCTC12023 at 5 MOI for 30 minutes as described 
in 2.2.5.2.1. The cells-bacteria mixture was placed on a rotating mixer and was incubated at 37°C for 30 
minutes. The cells were washed and fixed or fixed and permeabilised as described in 2.2.5.2.4 and stained 
using FITC conjugated anti-Salmonella polyvalent antibody. Cells were kept in 1% PFA until analysis 
using an LSR-II flow cytometer. A: Dot plot from FACS analysis showing how the values shown in B-E 
were obtained B: Percentage of J774 cells infected with Salmonella normalized to 100% isotype control. 
C: MFI of J774 cells infected with Salmonella normalized to 100% isotype control. D: Percentage of cells 
infected with Salmonella NCTC12023 E: MFI of J774 cells infected with Salmonella normalized to 100% 
isotype control. F-I: Raw data before normalisation. Bars describe means, while error bars describe 
standard error means. MFI is the median of fluorescence intensity, n=5 in B and C and n=4 in D and E in 
duplicate, data was analysed by Ordinary one sample T-test comparing with non-treated cells and GST 
treated control, significance ** P ≤ 0.01.  Ns is non-significant. 
GST mCD9-EC2-GST 
A 
GST 
Non-infected  
mCD9-EC2-GST 
Non-infected  
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Figure 5.13: Effect of mouse tetraspanin CD9-EC2 recombinant protein on Salmonella LT2 uptake 
by J774 cells analysed by flow cytometry.  J774.2 cells were harvested, placed in Eppendorf tubes and 
pre-treated with mCD9 EC2-GST at concentration of 500nM (A and B) and 1000nM (C and D) for 60 
minutes before infection with Salmonella Typhimurium LT2 at 5 MOI for 30 minutes as described in 
2.2.5.2.1. The cells-bacteria mixture was placed on a rotating mixer and was incubated at 37°C for 30 
minutes. The cells were washed and fixed or fixed and permeabilised as described in 2.2.5.2.4 and stained 
using FITC conjugated anti-Salmonella polyvalent antibody. Cells were kept in 1% PFA until analysis 
using an LSR-II flow cytometer. A: Percentage of J774 cells infected with Salmonella normalized to 100% 
isotype control. B: MFI of J774 cells infected with Salmonella normalized to 100% isotype control. C: 
Percentage of cells infected with Salmonella LT2. D: MFI of J774 cells infected with Salmonella 
normalized to 100% isotype control. E-H: Raw data before normalisation. Bars describe means, while error 
bars describe standard error means. MFI is the median of fluorescence intensity,  n=3 in A and B and n=4 
in C and D in duplicate, data was analysed by Ordinary one sample T test comparing with non-treated cells 
and GST treated control (A-D) and graphs (E-H) data was analysed by Ordinary one-way ANOVA Holm-
Sidak's multiple comparisons test, significance. ns is non-significant. 
 
Chapter 5 
148 
 
5.4 Discussion 
This chapter details studies investigating the role of the large extracellular domain of 
tetraspanins CD9 and CD81 in Salmonella uptake by mouse macrophages cell line model 
J774. Soluble, recombinant human versions of both tetraspanins that had previously been 
produced in our lab were first used at two different concentrations (500nM and 1000nM) to 
treat J774 cells prior to Salmonella infection. Despite the reduction by antibodies to both 
tetraspanins on Salmonella uptake by J774 cells (chapter 4), no clear effect of either 
tetraspanin recombinant protein on Salmonella infection was seen when compared with the 
GST control (Figure 5.1). As mentioned previously, the recombinant EC2s used here had 
been shown to be correctly folded using conformation sensitive antibodies and had shown 
biological activity in other assays, including inhibition of adhesion of N. meningitidis to 
human HEC-1B epithelial cells (Daniel Cozens, PhD thesis, University of Sheffield 2015). 
Human CD9-EC2 is highly homologous with the mouse version (77%) and the recombinant 
protein used here was effective in inhibiting giant cell formation induced by Burkholderia 
thailandensis in J774 cells (Atiga Elgawidi, personal communication). However, species 
differences may be important in some functions; for example human but not mouse CD9-
EC2 reduced giant cell formation in human MDMs induced by Con-A (Parthasarathy, Martin 
et al. 2009, Hulme, Higginbottom et al. 2014). The mechanism of action of recombinant CD9-
EC2 proteins is not fully understood as yet. However, a previous study indicated that the 
CD9-EC2 could be associating with leukocyte integrin receptors VCAM-1 and ICAM-1 that 
were shown to be included in TEMs that act as a “docking structure” on endothelial cells 
during leukocyte firm adhesion (Barreiro, Zamai et al. 2008). Soluble GST tagged CD9-EC2 
proteins inhibited leukocyte adhesion to endothelial cells and were shown to decrease the 
clustering of ICAM-1 and VCAM-1 receptors and interrupt their scattering pattern. It was 
suggested that the CD9-EC2-GST competed with the native membrane CD9-EC2 for its 
heterophilic and homophilic protein associations, interfering with its action (Barreiro, Zamai 
et al. 2008). The EC2 domain of CD9 also exhibited an inhibitory effect on adhesion mediated 
by LFA-1 and LFA-1 dependent leukocyte cytotoxicity. The effect of CD9 on LFA-
1appeared to be through altering its aggregation (Reyes, Monjas et al. 2015). Furthermore, 
the human recombinant EC2 fusion proteins for CD9, CD63 and CD151 showed a strong 
effect in inhibiting adhesion of bacteria to human epithelial cells (Green, Monk et al. 2011). 
Here it was also speculated that the soluble EC2s were acting by disrupting interactions of 
native membrane tetraspanins in TEMs, which were proposed to form “adhesion platforms” 
for the bacteria. In contrast, in HCV infections, a study showed the mouse CD81 EC2-GST 
recombinant protein failed to suppress viral infection, whilst cells expressing the full length 
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mouse CD81 supported infection, leading to suggestion that CD81-EC2 lacks the ability to 
fully mimic the native CD81 (Flint, von Hahn et al. 2006). Taken together, it was postulated 
that the lack of effect of human CD9 and CD81 soluble EC2 proteins on Salmonella infection 
of J774 might be due to the fact that we were using mouse cell line, although the EC2s of 
human and mouse CD9 are 77% identical, while mouse and human CD81-EC2 are 80.2% 
identical. 
To investigate if this lack of an effect was due to species differences, mouse CD9-EC2 was 
cloned and successfully expressed as a GST fusion protein. However, J774 cells treated with 
mCD9-EC2-GST prior to Salmonella NCTC12023 strain showed no significant effect on 
Salmonella infection relative to the GST control. The mouse CD9-EC2 produced here was 
detected using specific monoclonal antibodies in immunoblotting and has been shown to be 
biologically active in another system as it inhibited fusion of J774 cells induced by 
Burkholderia thailandensis (Atiga Elgawidi, personal communication).  
As mentioned before, a previous study in our lab showed that human CD9 EC2-GST reduced 
Salmonella uptake by MDMs, whereas no reduction in uptake, was observed with anti-CD9 
antibody. This difference in results could be subject to different mechanism of action between 
antibodies and recombinant proteins. It is known that the antibody binds directly to antigen, 
whilst the mechanism of tetraspanin recombinant proteins is not fully understood yet. It has 
been suggested that it could compete with the native proteins or disrupted its association 
within TEMs (Noha Hassuna, 2010, thesis). This will be discussed further in Chapter 8. 
The generated mCD9-EC2-GST was expressed in E. coli (Figure 5-8 to 5-9) an important 
host system for protein expression (Baneyx 1999, Baneyx and Mujacic 2004). A relatively 
thick and clear band of about 35kD molecular weight (predicted size of CD9-GST) was 
observed with lower molecular weight band down to 26 kDa that bound with anti-GST 
antibody but not anti mCD9. This band corresponded to free GST that had been in some way 
cleaved or degraded from the full length protein or possibly production of the full length 
protein was terminated early in protein translation (Fanaei, PhD thesis, 2013, University of 
Sheffield). In addition, degradation by bacterial proteases has been observed, particularly, on 
misfolded or partial folded proteins (Baneyx and Mujacic 2004, Sorensen and Mortensen 
2005), or aggregated insoluble forms particularly as inclusion bodies. Furthermore, proteins 
that have several disulphide bonds seems to be more affected (Georgiou and Valax 1996). 
Although the recombinant proteins was identified by a specific anti-CD9 monoclonal 
antibody, the recombinant CD9-EC2 protein was not glycosylated as native CD9-EC2, since 
E. coli lacks the  protein glycosylation machinery present in eukaryotic cells. As mentioned 
previously (5.1) the glycosylation machinery from Campylobacter jejuni was successfully 
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transferred to E. coli expression system, and this system  seems to be promising although this 
molecularly engineered E.coli system was relatively inefficient for complicated and large 
proteins (Jaffe, Strutton et al. 2014). Hence, the eukaryotic expression system such as 
mammalian cells, yeast and baculoviral system seems to be more compatible to produce 
proteins that need glycosylation.  Amongst these more complex systems, yeast  appears to be 
more similar to E. coli, yielding sufficient amounts of protein at low expense (Demain and 
Vaishnav 2009). Using mammalian cells seems to be more relevant for CD9-EC2 expression. 
Nevertheless, attempts to express GST-CD9-EC2 and other tetraspanins using Chinese 
hamster kidney (CHO) and  mammalian human embryonic kidney cells (HEK293) by our 
group were unsuccessful (John Palmer, 2016, thesis, University of Sheffield). More recently, 
the yeast, S. cerevisiae, expression system was successfully used to express tetraspanin 
proteins and the expressed protein was aggregated in endoplasmic reticulum membrane or in 
yeast cells as granules or present in cell membrane  (Skaar, Korza et al. 2015).
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Chapter 6:  Salmonella uptake by CD9 knockout 
macrophages 
6.1 Introduction 
Tetraspanin CD9 or Tspan29, also known as p24, is a 24 kD molecular weight protein 
originally identified as a protein expressed on leukocytes and the expression of p24/CD9 was 
also observed in normal platelets and several neoplastic cell types (Hercend, Nadler et al. 
1981, Jones, Borowitz et al. 1982). An antibody to CD9 appeared to cause platelet activation 
(Jennings, Crossno et al. 1994). 
CD9 is now known to be widely expressed on a variety of cell types and tissues (Charrin, 
Jouannet et al. 2014) CD9, together with CD81 and CD151, was recently shown to be highly 
expressed on blood and lymphatic endothelial cells (Iwasaki, Takeda et al. 2013). CD9 is also 
expressed on haematopoietic stem cells and different levels of CD9 expression could be used 
as a tool to separate haematopoietic stem cell into different sub-population (Karlsson, Rorby 
et al. 2013). Tetraspanin CD9 has also been shown to be expressed in different types of 
tumour; it is expressed in basal and squamous cell carcinomas in the skin and actinic 
keratosis. Different levels of CD9 expression were observed by using immuno-histochemical 
staining of the cell membrane and cytoplasm, with differences in CD9 localization according 
to the type of tumour (Ach, Ziemer et al. 2010). 
CD9 has been shown to be involved in various cell functions; notably it has been shown to 
play an important role in mouse egg fertilization (Rubinstein, Ziyyat et al. 2006), and 
described in more detail in Chapter 1. 
6.1.1 CD9 and partner proteins 
Partner proteins that interact directly with CD9 are described in Yanez-Mo M., et al. 2009. 
Of note, integrins are known to be a close CD9 partner (Radford, Thorne et al. 1996, Halova, 
Draberova et al. 2013). CD9 was shown to be associated directly to β2 integrin (LFA-1) in a 
variety of leukocytes (Reyes, Monjas et al. 2015), and with α3, α5 integrins (Hirano, Higuchi 
et al. 1999), β1integrin (Kohmo, Kijima et al. 2010) and α6 β1 integrins (Park, Inoue et al. 
2000). It has been shown the CD9 and CD81 associated directly with α3β1 integrin without 
needing this integrin to be connected with other tetraspanins. As the integrin β1 is linked 
directly with the membrane cofactor protein, CD46, this protein has been detected as an 
indirectly associated partner to CD9 (Lozahic, Christiansen et al. 2000, Gustafson-Wagner 
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and Stipp 2013). Tspan-4 (previously known as NAG-2) also associates with CD9 and CD81 
in an interaction that also includes α6β1 integrin protein (Tachibana, Bodorova et al. 1997).  
A direct and strong interaction of CD9 and CD81 has been observed with the human EWI-2 
Ig superfamily protein (which  shows 91% homology with mouse EWI-2 protein) (Stipp, 
Kolesnikova et al. 2001). A clear association with another Ig superfamily member 
(prostaglandin F2α receptor regulatory protein (FPRP), also known as CD9P-1 or EWI-F) 
with CD9 and/or CD81 also has been reported (Charrin, Le Naour et al. 2001, Stipp, Orlicky 
et al. 2001). 
CD9 also interacts with the metalloprotease, ADAM17, and negatively regulated the 
sheddase enzyme (Gutierrez-Lopez, Gilsanz et al. 2011). ALCAM also associated with CD9 
in surface protein complexes in leukocytes that also contain ADAM17/TAGE (Gilsanz, 
Sanchez-Martin et al. 2013). Furthermore, LR11 (low density lipoprotein receptor family 
candidate) mediated shedding by ADAM17 was shown to be modulated by tetraspanin CD9 
in different leukocyte tumour cell lines, where CD9 suppresses LR11 shedding mediated by 
ADAM17 (Tsukamoto, Takeuchi et al. 2014).  By using co-immunoprecipitation, an 
association between CD9 and CD10, another metalloprotease, has recently been identified. 
The C- terminal region of CD9 and EC2 domains were required for the CD9 -CD10 
association, and CD9 was shown to enhanced the amount of release of CD10 in exosomes 
(Mazurov, Barbashova et al. 2013). 
A physical association of CD9, CD63 and CD81 with c-kit receptor tyrosine kinase has been 
observed (Anzai, Lee et al. 2002) and it was suggested that the tetraspanins may modulate its 
activity. As mentioned in Chapter 1, the tetraspanin proteins have also been shown by co-
immunoprecipitation to be associated with protein kinase C (PKCs) and may recruit PKC to 
integrins. In Jurkat T cells, PKCα has been shown to be strongly associated with CD9, CD81 
and CD82 (Zhang, Bontrager et al. 2001). 
The type 2 scavenger receptor, CD36, has also shown to be directly associated with CD9 in 
platelets (Miao, Vasile et al. 2001) and macrophages (Huang, Febbraio et al. 2011), and 
integrins were also involved in this interaction. 
 
6.1.2 CD9 Knockout mouse macrophages 
The CD9 gene was knocked out at the embryonic stage to generate CD9 +/- mice by the 
Boucheix researcher group (Le Naour, Rubinstein et al. 2000). Following the method that 
was described in (Capecchi 1989),  the CD9 gene was disrupted by CD9 gene targeting in 
embryonic stem cells in which the CD9 promoter and exon-1 were replaced by a G418 
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(Neomycin) resistance gene and southern blotting was used to confirm this Flow cytometry 
and immunohistochemistry analysis confirmed absence of surface CD9 in homozygote mice 
(Le Naour, Rubinstein et al. 2000). J2 transforming retrovirus (Cox, Mathieson et al. 1989) 
was used to generate the immortal CD9KO and wild type macrophage cell lines used in the 
present study by Ha and co-workers. Briefly, bone marrow derived macrophages (BMDM) 
were collected and purified from the femur and tibia of CD9-KO and wild type C5BL/6 mice 
and transfected with J2 transforming retrovirus to generate immortal cell lines. The CD9KO 
and corresponding WT control were kindly donated by Dr. Gabriela Dveksler, Dept. 
Pathology, Uniformed Services University of Health Sciences, Bethesda, MD, US (Ha, 
Waterhouse et al. 2005). 
6.1.3 Microarray analysis method 
Microarray analysis of mRNA provides analysis of thousands of gene expression sets, leading 
towards a better understanding of cell physiology. This technique has been used to investigate 
different diseases and tumour mechanisms, with support provided from bioinformatics data 
bases and statistical analysis (Margalit, Somech et al. 2005, Jeffery, Higgins et al. 2006). 
 
6.2 Aims 
Since CD9 antibodies appeared to show a significant effect on Salmonella uptake in J774 
cells (Chapter 4), it was of interest to examine uptake in a macrophage cell line derived from 
a mouse in which the CD9 gene had been knocked out, with the corresponding wild 
macrophage cell line as a control (Ha et al, 2005).Therefore the aims of this chapter were to 
investigate the uptake of Salmonella Typhimurium NCTC and LT2 strains by CD9-KO 
mouse macrophages compared with corresponding WT cells. In addition, the expression of 
tetraspanins by these cells was studied. Differences in the expression of a wide range of 
proteins at the mRNA level in CD9-KO and WT mouse macrophages control were 
investigated by microarray analysis. Attempts were also made to rescue the CD9-/- 
macrophages and to establish a stable macrophage cell line expressing GFP-CD9. 
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6.3 Results 
6.3.1 Tetraspanin protein expression in CD9KO and wild type mouse 
macrophages 
6.3.1.1 Western blot analysis 
Initially, Western blotting was used to verify that the macrophage cell line derived from the 
CD9KO mouse did not express CD9 protein (Figure 6.1). As expected, no CD9 expression 
was detected in lysates prepared from CD9-KO mouse macrophages whilst CD9 protein band 
(at 24kd) was clearly detected in WT mouse macrophages.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Western blot analysis of lysates prepared from CD9 KO mouse macrophages and WT 
control. Cells were lysed with cell lysis solution (2.2.7) and the lysate was run on 12.5% SDS gels under 
non-reducing condition and transferred to nitrocellulose as described in 2.2.9.6. The blot was developed 
using rat anti-mouse CD9 primary Ab followed by anti-rat-HRP conjugated secondary Abs as described 
in 2.2.9.8. M: Protein marker (Table 2.1). 
6.3.1.2 Immunofluorescence Microscopy analysis  
Immunofluorescence microscopy was also performed on the CD9KO cells and corresponding 
WT mouse macrophages. As expected, no surface expression of CD9 in CD9KO cells was 
observed compared with high surface expression of CD9 in WT mouse macrophages. In 
addition, low expression of CD63 in CD9KO compared with WT control was observed. 
CD81 showed little surface expression on either cell type, possible due to sensitivity of the 
epitope to the fixation process (Figure 6.2). These results are further confirmed by FACS as 
described in the following section.
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Figure 6.2: Immunofluorescence microscopy of mouse CD9 -/- and WT control macrophages. Cells 
were cultured on chamber slides and fixed as described in 2.2.4.1, then stained with primary monoclonal 
antibody (mAbs) anti CD9, anti CD63 and anti CD81 or appropriate isotype controls at 10 µg/ml as 
described in 2.1.7.1. The secondary Abs was a FITC-conjugated anti-Rat Ab (for CD9 and CD63) and anti- 
Hamster Abs (for CD81primary anti-tetraspanin antibodies). Nuclei were counter-stained with propidium 
iodide, Rat IgG2a and IgG2b were used as an isotype controls for CD9 and CD63 respectively, hamster 
IgG was used as a control for CD81. These images were obtained by using the 40x objective.  
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6.3.1.3 Flow cytometry (FACS analysis) 
Immunofluorescence microscopy showed a clear difference in CD9 expression in WT and 
CD9 KO cells, but the differences in CD63 and CD81 levels were less clear. Therefore, FACS 
analysis was used to investigate total levels of tetraspanins (permeabilised cells) and cell 
surface levels (non-permeabilised) cells. As shown in figure 6.3, high expression of CD9 was 
observed in WT cells compared with CD9KO cells. Most of the CD9 is found on the cell 
surface as there is little difference in levels between permeabilised and non-permeabilised 
cells. Both CD9KO and WT show considerable CD63 expression in permeabilised cells by 
FACS, as expected since CD63 is known to predominantly associate with intracellular 
vesicles. Relatively low, but not significantly, expression of CD63 was observed in CD9KO 
cells. Significant changes were observed in CD81 expression between CD9KO and WT 
mouse macrophages, in both permeabilised and non permeabilised cells; the percentage of 
positive cells and the median of fluorescent intensity (MFI) were significantly lower in 
CD9KO compared with WT control cells. To summarise, CD9 and CD81 were highly 
expressed on cell surface of WT mouse macrophages, whereas most of the CD63 was 
intracellular. CD81 was shown to be significantly downregulated in the absence of CD9.
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Figure 6.3: Tetraspanin expression in CD9KO and WT mouse macrophages by flow cytometry: The 
primary monoclonal antibody (mAbs) used were isotype (control) anti CD9, anti CD63 and anti CD81. The 
secondary Abs was a FITC-conjugated anti-Rat Ab (for CD9 and CD63) and anti- Hamster Abs (for CD81, 
I: Shows tetraspanins expression in CD9KO and WT control (isotype control values were subtracted) A: 
Percent of positive cells expressed tetraspanins .B: MFI of tetraspanins expression. Bars describe means, 
while error bars describe standard error means. II: Shows the raw FACS data in the form of dot plots for 
isotype control and anti-CD81 that were used to obtain the values shown in (A and B), line segregate 
between negative and positive cells, A and B: cells were stained without permeabilisation. C and D: cells 
were stained with permeabilisation. W and K reveals to wild type and CD9-KO mouse macrophage 
respectively, P and N reveals to permeabilised and non-permeabilised respectively). n=2 (CD9) and n=3 
(CD63 and CD81) in duplicate, the significant difference was analysed by T test compared between means 
for each sample. *** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05 and ns is non-significant. 
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6.3.2 Salmonella uptake by wild type and CD9-KO mouse 
macrophages 
6.3.2.1 Immunofluorescence Microscopy 
Using the immunofluorescence microscopy assay (2.2.5.1), no difference in infection of the 
CD9 KO macrophage cell line was shown for the NCTC12023 strain (at MOIs of 10 and 30) 
compared to the wild type in any of the categories used to assess infection (Figures 6.4 and 
6.5). However, the CD9 KO macrophages showed some increase in the percentage of cells 
associated with the LT2 strain at an MOI of 30 and this became significant after the data was 
normalised to 100% WT cells control (Figure 6.4). No significant differences were apparent 
in the other parameters used to assess infection after such normalisation (data not shown). 
Interestingly, the LT2 strain was less associated with WT macrophages than the NCTC12023 
strain and this became significant at 10 MOI (Figure 6.5 A and B).  
6.3.2.2 Flow cytometry method 
Since there appeared to be a slight but significant difference in infection of  CD9KO and WT 
mouse macrophages by the LT2 strain, infection was also analysed using the flow cytometry 
method,  (2.2.5.2), as this method is more objective than microscopy. After optimisation, 5 
MOI for 30 minutes infection time was chosen for these experiments since this gave a 
sufficient number of infected cells. As noted previously in Chapter 4,  it seems that a lower  
MOI is needed when the cells are infected in suspension compared to when they are adherent 
to coverslips. Again, no significant differences were observed in CD9KO compared with WT 
control for the NCTC12023 strain. However, CD9KO cells again were more susceptible to 
Salmonella infection with the LT2 strain (Figure 6.6). Also, as noticed in previously (Figure 
6.4 and 6.5), the LT2 strain was significantly less associated with macrophages than the 
NCTC12023 strain (Figure 6.6). 
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Figure 6.4: Salmonella Typhimurium uptake by CD9 KO (-/-) and wild type mouse macrophage at 
30 MOI analysed by fluorescent microscopy. Cells were infected with S. Typhimurium strains 
NCTC12023 and LT2 for 30 minutes as described in 2.2.5.1.3.  A: Percentage of cells with associated 
bacteria. B: Number of bacteria per 100 cells C: Number of external or attached bacteria per 100 cells. D: 
The percentage of internalized bacteria E: Percentage of cells with associated bacteria normalised to 100 
CD9-KO cells, Bars describe means, while error bars describe standard error .n=3, performed in triplicate 
Data were analysed by T-test (A-D) and One Sample T-test in E, * p ≤ 0.05 and ns is non-significant. 
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Figure 6.5: Salmonella Typhimurium uptake by CD9 KO (-/-) and wild type mouse macrophage at 
10 MOI analysed by fluorescent microscopy. Cells were infected with S. Typhimurium strains 
NCTC12023 and LT2 for 30 minutes as described in 2.2.5.1.3.  A: Percentage of cells with associated 
bacteria. B: Number of bacteria per 100 cells C: Number of external or attached bacteria. D: The percentage 
of internalized bacteria. Bars describe means, while error bars describe standard error .n=3, performed in 
triplicate. Data were analysed by T-test, ** p ≤ 0.01,  * p ≤ 0.05 and ns is non-significant. 
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Figure 6.6: Salmonella Typhimurium uptake by CD9 KO (-/-) and wild type mouse macrophages 
analysed by flow cytometry. Cells were infected at 5 MOI with S. Typhimurium strains NCTC12023 and 
LT2 for 30 minutes as described in 2.2.5.2 and analysed using an LSRII flow cytometer, capturing 10,000 
events per sample. The graph shows percentage of cells with associated bacteria. Bars describe means, 
while error bars describe standard error means. n=7 in NCTC and n=4 in LT2 in duplicate. Data were 
analysed by T-test, ***p≤ 0.001, * p≤ 0.05 and ns is non-significant. 
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As expected, anti-CD9 antibodies showed no effect on infection of CD9KO macrophages, 
but inhibited infection of WT cells significantly (Figure 6.7). Overall the results of this section 
show Salmonella uptake in CD9KO mouse macrophages differed compared with WT, but 
this was dependent on the Salmonella strain. Surprisingly the CD9KO cells appeared   more 
susceptible to the LT2 strain.  
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Figure 6.7: Effect of anti-CD9 antibodies on Salmonella Typhimurium NCTC12023 uptake by CD9 
KO (-/-) and wild type mouse macrophages. Cells were  treated with rat IgG2a (isotype control) or  anti-
CD9 antibody at 10µg ml-1 for 60 minutes prior to infection with an MOI of 5 for 30 minutes and analysed 
by flow cytometry as described in Figure 6.6. A: Percentage of CD9 KO cells infected with NCTC12023 
(normalised to isotype control). B: Percentage of WT cells infected with NCTC12023 (normalised to 
isotype control). C and D: Raw data for A and B respectively. Bars describe means, while error bars 
describe standard error.  n=4 in duplicate, the data was analysed by One Sample T-test (A and B) and One 
way ANOVA (C and D), * p ≤ 0.05 and ns is non-significant.  
 
6.3.3 CD9-KO and WT mouse macrophages RNA microarray analysis 
As mentioned in 6.1, microarray analysis is widely used to investigate the broad spectrum of 
gene expression in different types of cells including mouse macrophages (Eskra, Mathison et 
al. 2003, Cheng, Liu et al. 2010). Since there appeared to be changes in expression of proteins 
other than CD9 in the KO macrophage cell line, it was of interest to compare mRNA 
expression between the cell lines. It was thought that this might also give information on the 
apparent differences in susceptibility of the CD9KO and wild type macrophages to infection 
by the LT2 strain of Salmonella. Microarray analysis was carried out on RNA extracted from 
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each cell line in three independent experiments. The expression profiles of 45101 genes for 
CD9 KO cells were compared with that of WT mouse macrophages; this work was carried 
out in collaboration with Dr. Paul Heath, Sheffield Institute for Translation Neuroscience 
(SITraN), University of Sheffield. 
6.3.3.1 RNA Quality 
Testing RNA purity and integrity was carried out in all samples of extracted RNA as this can 
affect the efficiency of RNA amplification. RNA quality was analysed by using Agilent RNA 
6000 Nano Kit as described in 2.2.11.2. The results that were obtained for extracted RNA for 
all 6 samples (3 preparations from CD9KO and WT cells)  showed high integrity with an 
RNA integrity number (RIN) of greater than 9.9 in all cases (Schroeder, Mueller et al. 2006). 
The RNA was of a sufficiently a high concentration and the level of contaminants was very 
low (Figure 6.8). The electropherograms indicate that the 28S rRNA was full length in a 
single peak that corresponds to high integrated non-degraded RNA and double the intensity 
of 18S rRNA band. Based on the 28S and 18S rRNA ratio, the mRNA was likely to be intact 
and full length.  
  
 
 
  
 
Figure 6.8: Analysis of total RNA extracted from mouse CD9-KO and WT macrophage cell lines. 
Electropherograms were obtained using the Agilent RNA 6000 Nano Kit. Graphs show the total RNA 
analysis from CD9 KD and WT cells.  The total RNA concentration and integrity are shown in the tables 
attached to the graphs. The two small peaks to the left of the graphs reveal to marker used, while the two 
large peaks reveal 18S and 28S rRNA.  
6.3.3.2 Comparison of gene expression in CD9-KO and WT mouse macrophage 
cell lines 
The GenChip® Mouse Genome 430 2.0 arrays from Affymetrix were used to examine gene 
expression in the two macrophage cell lines. The profiles showed some significant consistent 
Wild type mouse macrophages CD9-KO mouse macrophages 
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changes in expression for CD9-KO cells compared with WT control. By using QLUCORE 
OMICS explorer software to analyse and cluster the variable gene expression, principle 
components analysis (PCA) of all three experiments (three arrays of WT and three arrays of 
CD9-KO cells) demonstrated a clear separation between the two groups of samples. The 
variables of all three arrays of WT and the three arrays of CD9-KO showed high 
interrelationship with 77% in PCA analysis (2.2.11.5) (Figure 6.9). At a significance value of 
P≤0.05, 1037 genes show either higher expression (252 genes) or lower expression (787 
genes) in CD9-KO compared with WT cells. Furthermore, at P≤0.01, 194 genes showed 
changes in expression, with up-regulation (47 genes) or down-regulation (147 genes) in CD9 
KO macrophages compared to WT. (Table 6.1). 9 genes were either downregulated in 
CD9KO (6 genes) or upregulated in CD9KO (3 genes) compared with WT considering 1.5 
fold-changes and p≤0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9: Principle Component Analysis (PCA) of mRNA microarray expression results. The 
analysis was performed using QLUCORE OMICS explorer in RMA normalised data. The blue and yellow 
spheres show 3 separate arrays for CD9-KO and WT mouse macrophages, respectively. The PCA of the 
variables was analysed by multi comparison T-test compare the variable of three separate arrays of CD9-
KO cells with WT mouse macrophage cells control. n=3, p≤0.05.  
77 % 
6 % 7 % 
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Figure 6.10: The hierarchical clustering and heat map of gene expression of CD9-KO and WT mouse 
macrophage cell lines. Hierarchical cluster analysis was performed using 6 arrays (3 for CD9 KO and 3 
for WT). The data were analysed using QLUCORE OMICS explorer on RMA normalised data. Red 
indicates upregulated gene expression and green indicates downregulated gene expression. 
 
Table 6.1: Summary of significant differences in gene expression between CD9 KO and WT 
macrophage cell lines.  
 
Fold changes 
P Value 
Two groups comparison by WT mouse macrophages 
Number of  
genes 
analysed 
Number of 
genes with 
changed 
expression 
Number of  
up-regulated 
genes  
Number of down-
regulated genes 
Fold changes 
1  
P ≤ 0.05 
45101 
1037 252 787 
P ≤ 0.01 194 47 147 
P ≤ 0.001 19 6 13 
Fold changes 
1.5  P ≤ 0.05 
 
9 3 6 
Genes whose expression was up-regulated or down-regulated in CD9KO compared with WT mouse 
macrophages were analysed using QLUCORE OMICS explorer, n=3, multiple comparison T test. The fold-
change in gene expression is also shown. 
Table 6.2 describes genes that show a 1.5 fold change in expression between CD9KO and 
WT macrophage cell lines at p ≤ 0.05. As expected, CD9 is significantly downregulated in 
CD9KO macrophages, along with other genes including inactive X specific transcripts (Xist), 
cyclin-dependent kinase inhibitor 2A (Cdkn2a), sphingomyelin phosphodiesterase acid like 
3A (Smpdl3a). 
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Table 6.2: List of genes with significant changes in expression at p ≤ 0, 05 and Fold changes greater 
than 1.5 (log2).  
 Cluster ID Gene 
Symbol 
Gene Title 
Mean (gene 
expression (log 2) 
WT 
Mean  (gene 
expression log 
2) CD9KO 
p-value (T test) differences 
1427263_at 
Xist 
inactive X specific 
transcripts 
8.771663333 3.536686667 0.00340875 
expression 
in CD9-
KO 
Low  
1416066_at Cd9 CD9 antigen 11.92996667 6.679943333 0.009066419 
1436936_s_at 
Xist 
inactive X specific 
transcripts 
10.27028667 5.590026667 0.014852971 
1427262_at 
Xist 
inactive X specific 
transcripts 
7.97583 3.265586667 0.02585763 
1416635_at 
Smpdl3a 
sphingomyelin 
phosphodiesterase, acid-like 
3A 
9.593803333 5.10127 0.028010708 
1450140_a_at 
Cdkn2a 
cyclin-dependent kinase 
inhibitor 2A 
10.62583 5.919296667 0.041311694 
1437534_at  
---  * --- 3.71228 6.01991 0.039206261 
High 
expression  
in CD9-
KO 
1423331_a_at 
Pvrl3 poliovirus receptor-related 3 4.157093333 6.969106667 0.045487168 
1430567_at 
Spink5 
Serine protease inhibitor 
kazal-type 5 
4.53532 7.037873333 0.045806818 
Genes whose expression was up-regulated or down-regulated in  CD9KO compared with WT mouse 
macrophages were analysed using QLUCORE OMICS explorer, multiple comparison T test, n=3. The 
mean of  WT and CD9-KO values correspond to normalised expression levels expressed as log to the base 
2 (log 2).* Mouse hypothetical protein full sequence cDNA target probe identified from whole body cDNA. 
Tables 6.3 and 6.4 show the top 20 genes with lower and higher expression in CD9KO cells 
compared with WT control, respectively.  
Table 6.3: List of top 20 downregulated genes in CD9KO compared with WT mouse macrophages.  
Gene id Gene Symbol Gene Title 
p-value 
 (T test) 
Fold change 
Mean WT (log 
2) 
Mean CD9 KO 
(log 2) 
1427263_at Xist inactive X specific transcripts 0.0034088 0.410772 8.7716633 3.5366867 
1427262_at Xist inactive X specific transcripts 0.0258576 0.431587 7.97583 3.2655867 
1416635_at Smpdl3a 
sphingomyelin phosphodiesterase, acid-
like 3A 
0.0280107 0.529539 9.5938033 5.10127 
1436936_s_at Xist inactive X specific transcripts 0.014853 0.554648 10.270287 5.5900267 
1450140_a_at Cdkn2a cyclin-dependent kinase inhibitor 2A 0.0413117 0.557509 10.62583 5.9192967 
1416066_at Cd9 CD9 antigen 0.0090664 0.559064 11.929967 6.6799433 
1449195_s_at Cxcl16 chemokine (C-X-C motif) ligand 16 0.0384578 0.766257 9.1632133 6.9701733 
1438498_at N/A N/A 0.038851 0.784942 6.5227133 5.09923 
1428367_at Ndst1 
N-deacetylase/N-sulfotransferase 
(heparan glucosaminyl) 1 
0.0226324 0.78663 7.07705 5.5451233 
1443783_x_at N/A N/A 0.0063796 0.793061 3.29521 2.6150667 
1438858_x_at N/A N/A 0.0268185 0.840707 6.7662 5.6961367 
1430672_at N/A N/A 0.0367112 0.849284 7.46829 6.3399767 
1455741_a_at Ece1 endothelin converting enzyme 1 0.0300922 0.849423 7.80457 6.6259233 
1442218_at N/A N/A 0.0148969 0.850929 4.92839 4.19017 
1440413_at N/A N/A 0.0364437 0.851115 3.7763433 3.2087833 
1452388_at Hspa1a heat shock protein 1A 0.0117909 0.85863 7.9276267 6.8083233 
1439475_at N/A N/A 0.041715 0.85957 6.6055333 5.66356 
1452431_s_at H2-Aa 
histocompatibility 2, class II antigen A, 
alpha 
0.0305783 0.862184 6.3508767 5.4692933 
1447494_at D7Bwg0826e 
DNA segment, Chr 7, Brigham & 
Women's Genetics 0826 expressed 
0.0131046 0.867507 3.85747 3.3472 
1432723_at N/A N/A 0.0020257 0.872652 3.78802 3.3045367 
The expression value data were analysed using T test, QLUCORE OMICS explorer software, n=3, P ≤ 0, 
05. 
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Table 6.4: List of top 20 upregulated genes in CD9KO compared with WT mouse macrophages.   
Gene id 
Gene 
Symbol 
Gene Title p-value Fold change 
Mean WT 
(log2) 
Mean KO 
(log2) 
1423331_a_at Pvrl3 poliovirus receptor-related 3 0.045487 1.69633 4.157093 6.969107 
1437534_at --- --- 0.039206 1.63258 3.71228 6.01991 
1430567_at N/A N/A 0.045807 1.58347 4.53532 7.037873 
1417398_at Rras2 
related RAS viral (r-ras) 
oncogene homolog 2 
0.034543 1.4263 5.082387 7.237393 
1455869_at --- --- 0.036756 1.41965 6.37495 9.062807 
1415965_at Scd1 
stearoyl-Coenzyme A desaturase 
1 
0.045557 1.40215 5.70242 7.950387 
1425708_at Rnf17 ring finger protein 17 0.030104 1.34886 4.214657 5.682737 
1449484_at Stc2 stanniocalcin 2 0.045969 1.34773 4.94744 6.718833 
1456226_x_at Ddr1 
discoidin domain receptor family, 
member 1 
0.030232 1.30163 3.40317 4.431883 
1427673_a_at Sema3e 
sema domain, immunoglobulin 
domain (Ig), short basic domain, 
secreted, (semaphorin) 3E 
0.025358 1.29009 5.069307 6.508393 
1436501_at N/A N/A 0.015441 1.26409 4.001333 5.069983 
1419417_at Vegfc 
vascular endothelial growth 
factor C 
0.029201 1.2509 3.761343 4.707927 
1440739_at N/A N/A 0.003451 1.23823 4.548617 5.638523 
1425906_a_at Sema3e 
sema domain, immunoglobulin 
domain (Ig), short basic domain, 
secreted, (semaphorin) 3E 
0.048039 1.22191 4.91507 6.00677 
1429462_at N/A N/A 0.028464 1.21682 4.095197 4.968653 
1421193_a_at Pbx3 pre B cell leukemia homeobox 3 0.039064 1.21246 5.637947 6.816113 
1439489_at N/A N/A 0.039913 1.21164 5.04427 6.121793 
1426411_a_at Strbp 
spermatid perinuclear RNA 
binding protein 
0.037228 1.20429 6.137743 7.37052 
1428402_at Zcchc3 
zinc finger, CCHC domain 
containing 3 
0.025575 1.2038 5.644963 6.780513 
1426605_at Brcc3 
BRCA1/BRCA2-containing 
complex, subunit 3 
0.03085 1.19821 4.11993 4.925937 
Data were analysed using T test, QLUCORE OMICS explorer software, n=3, P ≤ 0.05. 
As expected, the CD9 gene expression is significantly lower in CD9-KO cells compared with 
WT macrophages and the CD9 expression showed the highest up-regulated fold change in 
WT cells. In contrast, no significant changes were seen with other tetraspanins (Figure 6.11 
and Table 6.5). In particular CD81, which was significantly reduced in protein expression as 
determined by flow cytometry in CD9-KO (Figure 6.3), showed no significant change at the 
mRNA level. The data were collected manually from the main microarray expression data set 
for all three experiments and the mean expression levels were taken to represent the mRNA 
levels of the tetraspanins. These results show the highest mRNA expression were for CD53 
and CD9 followed by tetraspanin SAS (Tspan 31), CD81, CD63, Tspan 4, Tspan 3, CD82, 
Tspan 32, Tspan 13 and CD37. As previously described (6.3.1.1) the CD9, CD81 and CD63 
protein expression level look compatible with mRNA expression level (in terms of the level 
of expression). As expected, CD53 shows a high level of expression in these cell lines as this 
protein is particularly expressed in white blood cells, along with CD37 (Figure 6.11). It was 
not possible to observe the expression of other tetraspanins at the protein level due to the lack 
of availability of monoclonal antibodies specific for mouse tetraspanins. 
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Figure 6.11: Tetraspanin mRNA expression in CD9 KO mouse macrophages and WT control as 
determined by RNA microarray analysis. The graph shows the level of mRNA expression in both CD9-
KO and WT mouse macrophages. CD9 was significantly down regulated in CD9KO cells compared with 
WT cells control. Data were analysed using multiple comparison T test, **p ≤ 0.001, Qlucore Omics 
explorer software, n=3. 
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Table 6.5: Tetraspanin mRNA expression in CD9 KO mouse macrophages and WT control as 
determined by RNA microarray analysis.  
The table shows the level of mRNA expression in both CD9-KO and WT mouse macrophages. CD9 is 
significantly down regulated in CD9KO cells compared with WT cells control. Data were analysed using 
multiple comparison ANOVA test, Transcriptome Analysis Console v3.0 (Affymetrix) software, n=3. 
CD9 is known to be involved in cell adhesion and cell:cell fusion and studies by another 
member of the laboratory have shown that the CD9 KO macrophages show an enhanced 
ability to fuse when infected with Burkholderia thailandenesis (Atiga Elgawidi, personal 
communication). It was therefore of interest to examine changes in expression of genes 
related to adhesion and cell-cell fusion. The Database for Annotation, Visualization, and 
Integrated Discovery (DAVID) was used to identify, annotate, and summarise a list of 
significantly variable genes that were obtained from Qlucore Omics explorer microarray data 
analysis software to summarise adhesion related proteins (Table 6.6). Some proteins that are 
involved in adhesion show changes in their expression, either up- or down-regulated, 
Transcript 
Cluster ID 
Gene 
Symbol 
WT Bi-weight 
Avg Signal 
(log2) 
CD9KO Bi-
weight Avg 
Signal (log2) 
WT Standard 
Deviation 
CD9KO 
Standard 
Deviation 
Fold Change 
(linear) (WT 
vs. CD9KO) 
ANOVA p-
value (WT vs. 
CD9KO) 
1448617_at Cd53 13.4 13.57 0.93 0.54 -1.12 0.562474 
1416066_at Cd9 12.26 6.57 1.66 1.06 51.34 0.009897 
1416556_at Tspan31 11.88 11.86 0.54 0.47 1.01 0.961661 
1416330_at Cd81 11.56 11.09 0.55 0.5 1.38 0.148905 
1417057_a_at Cd63 11.21 11.52 0.45 0.74 -1.25 0.403789 
1430029_a_at Tspan31 10.98 11.05 0.34 0.29 -1.04 0.971217 
1448276_at Tspan4 10.8 10.58 0.5 0.37 1.16 0.818489 
1416009_at Tspan3 10.43 10.44 0.56 0.38 -1 0.793574 
1416401_at Cd82 10.38 10.38 0.43 0.6 1.01 0.782086 
1418398_a_at Tspan32 10.26 10.64 1.2 1 -1.3 0.620637 
1418643_at Tspan13 9.76 9.26 1.09 1.6 1.42 0.68876 
1419206_at Cd37 9.27 9.55 1.75 1.23 -1.21 0.883932 
1423924_s_at Tspan14 8.92 8.59 0.26 0.08 1.26 0.119316 
1437670_x_at Cd151 8.75 8.78 0.32 0.49 -1.02 0.838355 
1424093_x_at Cd151 8.47 8.56 0.23 0.28 -1.06 0.79979 
1431289_at Tspan32 8.36 8.32 0.39 0.03 1.03 0.575533 
1449611_at Cd82 7.98 7.8 0.28 0.13 1.13 0.708419 
1417179_at Tspan5 7.49 8.16 0.36 0.46 -1.6 0.286094 
1431530_a_at Tspan5 7 7.78 0.44 0.54 -1.72 0.269263 
1427525_at Cd151 6.99 6.96 0.21 0.15 1.02 0.236338 
1424334_at Tspan17 6.97 6.67 0.1 0.35 1.23 0.633919 
1424649_a_at Tspan8 6.84 7.02 1.39 0.81 -1.13 0.51709 
1424653_at Tspan15 6.81 6.46 0.41 0.22 1.28 0.282095 
1428197_at Tspan9 6.7 6.66 0.06 0.14 1.03 0.638838 
1425736_at Cd37 6.35 6.37 0.3 0.04 -1.01 0.870017 
1441968_at Tspan9 6.32 6.24 0.14 0.05 1.06 0.567916 
1426588_at Tspan10 6 5.97 0.05 0.13 1.03 0.305498 
1420017_at Tspan8 5.83 5.72 0.24 0.46 1.08 0.612396 
1442174_at Tspan18 5.56 5.48 0.12 0.13 1.06 0.505433 
1420921_at Cd151 5.49 5.36 0.17 0.05 1.09 0.30413 
1432417_a_at Tspan2 5.34 5.26 0.14 0.23 1.06 0.124232 
1417957_a_at Tspan1 5.33 5.37 0.04 0.06 -1.02 0.238855 
1425157_x_at Tspan33 5.27 5.04 0.22 0.18 1.17 0.575588 
1441776_at Tspan11 5.19 5.22 0.12 0.04 -1.02 0.674501 
1417502_at Tspan7 5.11 5.23 0.24 0.16 -1.09 0.74318 
1430310_at Tspan11 5.04 5.02 0.16 0.23 1.01 0.767338 
1417958_at Tspan1 5.02 4.89 0.19 0.01 1.09 0.301564 
1424568_at Tspan2 4.94 5.04 0.09 0.12 -1.07 0.675034 
1416872_at Tspan6 4.54 4.55 0.13 0.28 -1.01 0.953296 
1429856_at Tspan18 4.28 4.14 0.11 0.23 1.11 0.081541 
1436626_at Tspan11 4.01 4.13 0.1 0.12 -1.08 0.650124 
1437095_at Tspan18 3.93 3.84 0.33 0.18 1.06 0.409074 
1448737_at Tspan7 3.87 3.88 0.02 0.18 -1 0.482717 
1420019_at Tspan8 3.77 3.63 0.27 0.13 1.1 0.163325 
1424567_at Tspan2 3.47 3.28 0.14 0.15 1.14 0.371873 
1445860_at Tspan11 3.3 3.46 0.17 0.04 -1.12 0.524847 
1420018_s_at Tspan8 3.13 3.26 0.23 0.27 -1.1 0.963114 
1448501_at Tspan6 2.77 2.77 0.04 0.04 1 0.275909 
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particularly integrin β3 that has been shown to be associated with CD9 (Indig, Diaz-Gonzalez 
et al. 1997) and was downregulated in CD9KO cells. In addition, the integrin β6, another 
tetraspanin partner protein, was also downregulated in CD9KO mouse macrophages. 
Claudin-1, another CD9 partner protein (Kovalenko, Yang et al. 2007), was also 
downregulated in CD9KO cells. 
Table 6.6: Expression of adhesion related genes in CD9 KO and WT macrophages.  
Gene id Gene 
Symbol 
Gene Title p-value 
(T test) 
Difference Fold change 
(Log2) 
average 
CD9KO (log2) 
Average 
WT (Log2) 
1456226_x_at Ddr1 discoidin domain receptor family, 
member 1 
0.0302315 0.380319 1.30163 4.43 3.40 
1449764_x_at Ssx2ip synovial sarcoma, X breakpoint 2 
interacting protein 
0.0386983 0.166595 1.12241 3.01 2.68 
1431611_a_at Cadm1 cell adhesion molecule 1 0.0434334 0.166575 1.12239 8.58 7.65 
1421614_at Zan zonadhesin 0.0433298 0.107517 1.07737 5.52 5.13 
1416133_at Efr3a EFR3 homolog A (S. cerevisiae) 0.0396587 0.059217 1.0419 9.74 9.35 
1446332_at Pcdhgc protocadherin gamma subfamily 
A, 8; protocadherin gamma 
subfamily A, 9; protocadherin 
gamma subfamily B, 4; 
protocadherin gamma subfamily 
C, 3; protocadherin gamma 
subfamily C, 5; protocadherin 
gamma cluster; protocadherin 
gamma subfamily C, 4; 
protocadherin gamma subfamily 
A, 2; protocadherin gamma 
subfamily A, 3; protocadherin 
gamma subfamily A, 11; 
protocadherin gamma subfamily 
A, 12 
0.0131914 0.0304663 1.02134 3.54 3.46 
1444317_at Pcdh15 protocadherin 15 0.0031688 -0.037897 0.974074 2.82 2.89 
1429072_at RIKEN 
cDNA 
1110001D15 
gene 
RIKEN cDNA 1110001D15 gene 0.0252886 -0.0399849 0.972665 5.46 5.61 
1441706_at, 
1432196_a_at 
dscam1 Down syndrome cell adhesion 
molecule-like 1 
0.0298455 -0.0521435 0.964502 4.01 4.16 
1435349_at Nrp2 neuropilin 2 0.0245295 -0.0531348 0.96384 10.17 10.55 
1450922_a_at Tgfb2 transforming growth factor, beta 2 0.0440474 -0.0549237 0.962645 2.97 3.09 
1426997_at Thra thyroid hormone receptor alpha 0.0346426 -0.056231 0.961773 7.10 7.38 
1416357_a_at Mcam melanoma cell adhesion molecule 0.0160792 -0.0621606 0.957829 4.25 4.44 
1422590_at Cdk5 cyclin-dependent kinase 5 0.0415928 -0.0695461 0.952938 5.94 6.23 
1432281_a_at Itgb6 integrin beta 6 0.0262944 -0.0703539 0.952404 3.55 3.72 
1438662_at ajap1 adherens junction associated 
protein 1 
0.032503 -0.0730263 0.950642 4.34 4.57 
1447825_x_at Pcdh8 protocadherin 8 0.0060953 -0.0786623 0.946935 3.07 3.24 
1433413_at Nrxn1 neurexin I 0.0016809 -0.0798047 0.946186 5.96 6.30 
1435190_at N/A N/A 0.0347286 -0.0804348 0.945773 2.97 3.14 
1419423_at Stab2 stabilin 2 0.0342327 -0.0836406 0.943673 5.28 5.59 
1445798_at dlg1 discs, large homolog 1 
(Drosophila); similar to Discs, 
large homolog 1 (Drosophila) 
0.0290769 -0.0857195 0.942315 2.92 3.10 
1460412_at Fbln7 fibulin 7 0.0370743 -0.0857738 0.942279 3.77 4.01 
1421511_at Itgb3 integrin beta 3 0.0423281 -0.0872572 0.941311 5.09 5.41 
1450341_at Pcdhb8 protocadherin beta 8 0.0328162 -0.0905556 0.939161 4.75 5.06 
1437932_a_at Cldn1 claudin 1 0.0034232 -0.0965702 0.935254 3.52 3.76 
1421633_a_at Hapln1 hyaluronan and proteoglycan link 
protein 1 
0.0259266 -0.0973429 0.934753 3.08 3.30 
1418664_at, 
1441361_at 
Mpdz multiple PDZ domain protein 0.0003761 -0.112017 0.925293 4.65 5.02 
1449586_at Pkp1 plakophilin 1 0.0461386 -0.117819 0.92158 3.95 4.29 
1445731_at N/A N/A 0.0385795 -0.119602 0.920442 4.65 5.05 
1450199_a_at Stab1 stabilin 1 0.0242771 -0.133711 0.911484 7.41 8.13 
1419527_at Comp cartilage oligomeric matrix 
protein 
0.0425262 -0.13966 0.907733 5.32 5.87 
1421723_at Pcdhb18 protocadherin beta 18 0.022168 -0.145366 0.90415 3.05 3.38 
1416066_at Cd9 CD9 antigen 0.0090664 -0.838915 0.559064 6.68 11.93 
Variably expressed genes were annotated using DAVID online annotation software from analysed p≤0.05 
significant value by multiple T test in Qlucore Omix explorer software. n=3. 
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6.3.4 Transfection of mCD9-GFP in J774 mouse macrophage cells 
The pCMV6-AV construct obtained from Origene (Table 2.9) carrying mouse CD9-GFP was 
used initially to try to rescue mCD9 in CD9-KO cells. This would also provide the 
opportunity to visualise CD9 by microscopy without the need for antibody staining. However, 
despite using different transfection techniques (including chemical transfection, conventional 
and nucleofector electroporation, data not shown) the transfections were unsuccessful. The 
pCMV6-AV vector carries G418 resistance, but the CD9-KO mouse macrophages already 
have the G418 resistance gene from the CD9 knock down experiment (Le Naour, Rubinstein 
et al. 2000, Ha, Waterhouse et al. 2005). Attempts to select for transfectants by co-transfection 
using a second plasmid carrying puromycin resistance were therefore also carried out but 
were unsuccessful.  
Instead, attempts were made to over express mCD9 in J774 cells by transfecting the cells with 
the CD9-GFP vector using electroporation as described in 2.2.10.2. mCD9-GFP was 
successfully expressed and localised in cell membrane of transfected J774 cells (Figure 
6.12), with most cells shown to be expressed mCD9-GFP after cell sorting. 
 
 
 
 
 
 
 
Figure 6.12: Expression of mCD9-GFP transfected J774 cells. Cells were transfected with the mCD9-
GFP construct (Table 2.9) by electroporation as described in 2.2.10.2. followed by selection of transfected 
cells using G418 containing media. GFP expressing cells were sorted by flow cytometry. The sorted cells 
were visualised using an inverted florescent microscope. 
Screening for expression of tetraspanins CD9 and CD81 was carried out using appropriate 
antibodies labelled with Alexa fluor and flow cytometry. CD9 expression was about two 
times higher in mCD9-GFP transfected cells compared with non-transfected cells (Figure 
6.13 B). As described previously in fluorescence microscopy, most transfected cells 
expressed CD9-GFP (Figure 6.13 A). A significant reduction in CD81 expression was 
detected in mCD9-GFP transfected cells compared with non-transfected cells (Figure 6.13 
C). 
mCD9-GFP Phase 
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Figure 6.13: Tetraspanin CD9 and CD81 expression in mCD9-GFP transfected J774 cells. 
A: Dot plot showing the main parameters that were used in the experiments. B, C: Surface expression of 
CD9 and CD81, respectively, in CD9-GFP transfected J774 compared with non-transfected cells. Anti-
mouse tetraspanin primary mAbs or appropriate isotype controls conjugated with Alexa fluor® 647 were 
used (Table 2.5.B). Data were analysed by BD FACSDiva 8.0.1. The gate was set depending on the non-
treated cells control (washing buffer was added to the cells instead of antibody). The experiment was done 
in duplicate, MFI =Median fluorescent intensity. N=3 in duplicate, the significant difference was analysed 
by Two ways ANOVA, Sidak`s multiple comparisons test, significance **** p ≤ 0.0001 and * P ≤ 0.05, ns 
is non-significant.  
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6.3.5 Localisation of CD9 during Salmonella infection in mCD9-GFP 
transfected J774 cells 
A permanent mCD9-GFP transfected cell line was successfully generated, which provides an 
important tool to study CD9 localisation during Salmonella infection by taking advantage of 
having mCherry expressing Salmonella. The mCD9-GFP transfected J774 cells were 
prepared and infected with Salmonella NCTC12023-mCherry and then fixed and prepared 
for confocal microscopy at different time points. The results showed that CD9-GFP was 
aggregated and surrounded Salmonella at phagocytosis sites and some CD9 appears to be 
present on the membrane of the phagosomes containing internalised Salmonella at 15 minutes 
post- infection. By 120 minutes post infection, internalised bacteria do not co-localise CD9 
(Figure 6.14). 
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Figure 6.14: Confocal microscopy of mCD9-GFP transfected J774 cells infected with Salmonella Typhimurium 
NCTC12023-mCherry. J774 cells were infected with NCTC12023-mCherry strain (magenta) at 50 MOI for 0, 5, and 
10. 15, 30, 60 and 120 minutes, as described in (2.2.12.2). The cells then were fixed then cellular and bacterial DNA 
were stained blue (DAPI) stain (blue). Images were visualised using Nikon A1 Confocal inverted system with 
EM-CCD camera and 60x objectives. 
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6.4 Discussion 
CD9 is one of most important tetraspanin family members encoded by a gene that was found 
on chromosome12 in humans (Maecker, Todd et al. 1997) and chromosome 6 in mouse 
(Elliott and Moore 1996). Tetraspanin CD9 (Tspan29) has been detected in a variety of 
mammalian cells such as basophils, macrophages, eosinophils, epithelial cells, fibroblasts, 
neurons, oocytes, different cancer cells and cancer cell lines (Zhang, Kotha et al. 2009).  
 
 In the current study, we have shown high expression of CD9 in mouse macrophages at both 
mRNA (microarray analysis results) and protein expression level (immunofluorescence and 
flow cytometry). CD9 has been shown to be involved in bacterial adhesion to human 
epithelial cell lines (Green, Monk et al. 2011) and mouse macrophages cell lines (Chapter 4). 
To further investigate the role of CD9 in infection of mouse macrophages by Salmonella, 
macrophage cell lines derived from CD9KO and corresponding wild type mice were used.  
There was no difference in the infection of CD9KO or WT macrophages by the NCTC12023 
strain of Salmonella, but surprisingly, CD9KO macrophages were more susceptible to 
infection by the LT2 strain. This might also relate to the effects of CD9 gene knock out on 
other tetraspanin members (as there was significant reduction in expression of CD81 in CD9 
KO cells) or on other proteins relevant to infection. It has been found that Salmonella 
Typhimurium NCTC12023 is less able to invade epithelial cell lines compared with 
Salmonella Typhimurium SL1344 strain because it is deficient in some of the T3SS proteins 
(Clark, Perrett et al. 2011). Furthermore, T3SS is also important for Salmonella survival after 
uptake by macrophages (Cirillo, Valdivia et al. 1998). In addition, the differences in 
Salmonella strains uptake could relate to differences in uptake mechanism, with  LT2 seeming 
to be more resistant to phagocytosis than Salmonella strain NCTC12023, as described in 
6.3.2.   
  
Western blot, immunofluorescence and FACS analysis with anti-CD9 antibodies showed 
strong expression of CD9 in wild type control and no expression of CD9 in CD9KO. 
However, a very slight shifting of the cells to the positive gated region (based on the isotype 
control) was observed for the CD9KO cells in flow cytometry analysis. As no expression was 
apparent by Western blotting, it is likely that this was due to slightly higher non-specific 
binding of the anti-CD9 antibody to the cells compared to the isotype control. CD81 showed 
a significant reduction at the protein level, but not in mRNA expression, in the CD9KO cells. 
CD63 protein expression also appeared lower in the CD9KO cells, although this was, not 
statistically significant from flow cytometry analysis and high levels of CD63 mRNA were 
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observed in both cell types in microarray analysis. CD9 and CD81 are known to interact at 
the protein level, but the effect of knock down or knock out of CD9 on expression of other 
tetraspanins seems to vary depending on cell type. Knockdown of CD9 or CD81 in human 
dermal lymphatic endothelial cells (HDLEC) led to increased protein expression of the other 
tetraspanin without affecting the CD151 expression levels (Iwasaki, Takeda et al. 2013). 
However, in the same study, siRNA knockdown of CD9 in human umbilical vein epithelial 
cells (HUVEC) had little effect on CD81 expression and blood or lymphatic endothelial cells 
from CD9 KO mice showed little change in CD81 protein expression compared to wild type. 
In another study, no changes in CD81 and CD151 mRNA and protein expression levels were 
noticed after knocking down CD9 by lentiviral shRNA in vascular smooth muscles, although 
the CD9-KD cells showed a different phenotype (Herr, Mabry et al. 2014). It is possible that 
knockdown of CD9/CD81 leads to compensatory changes in expression of the other 
tetraspanin in some cell types but not others. Interestingly, CD81 protein expression was also 
down regulated in mouse macrophage J774 cells transfected to over-express CD9, as 
described in 6.3.4. As far as we are aware, the expression of other tetraspanins on macrophage 
cell lines derived from CD9KO mice has not been investigated at the protein expression level 
because of the limited number of anti-mouse tetraspanin antibodies available. The fact that 
CD81 expression seems to be downregulated either in CD9KO macrophages or CD9 
overexpressing J774 mouse macrophages may be related to the role of CD9 in the proper 
trafficking of CD81 in these cells. 
 
Microarray analysis has emerged and developed since it was used for graphic evaluations of 
results, to more sophisticated algorithmic comparisons of gene expression used in many types 
of biological research (Allison, Cui et al. 2006). The quality of the extracted RNA in gene 
expression experiments has a vital role in microarray analysis and  high sensitivity of several 
microRNAs to the method of RNA isolation used has been demonstrated  (Podolska, 
Kaczkowski et al. 2011). The extracted RNA should not contain any contaminants such as 
proteins, cell debris and DNA; in addition, the RNA samples should not contain RNA 
extraction related materials such as salts, phenol and ethanol. These contaminants could lead 
to a decrease in the efficiency of reverse transcription and reduce amplification levels. The 
RNA full length integrity is another important factor that affects RNA quality as a degraded 
RNA will produce cDNA with missing portions of the transcripts that are complemented with 
probes in the array (Podolska, Kaczkowski et al. 2011). Testing RNA purity and integrity 
were carried out in all samples of extracted RNA (Figure 6.8), confirming that it was of high 
quality. 
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Different methods have been developed to evaluate the significance of changes in gene 
expression; T test analysis was shown to be powerful in microarray analysis of a range of 
different sizes of gene sets (Jeffery, Higgins et al. 2006). Here, two different software 
analyses were used: QLUCORE OMICS explorer that uses T-Test analysis, and Affymetrix® 
Transcriptome Analysis console (TAC) software that uses the ANOVA test. Despite some  
differences in the results that were obtained from these two types of microarray analysis tools 
, a highly significant reduction of CD9 mRNA in CD9KO cells was shown (p≤0.01combined 
with 1.5 log2 fold change). Three genes shown to be also highly down regulated in CD9KO 
mouse macrophages were Xist, Cdkn2a and Smpl3a. The Xist gene (X-inactive specific 
transcript) is an RNA gene that has a role X chromosomal inactivation (XCI), and mainly 
functions to genetically suppress one of two feminine X chromosomes (Brockdorff, Ashworth 
et al. 1991). It is expressed in both somatic and germ cells (McCarrey and Dilworth 1992) 
and has also been shown to be involved in embryo development (Hartshorn, Rice et al. 2002). 
Cdkn2a (cyclin-dependent kinase 2a) was firstly identified as being mutated in melanoma, 
but mutations in this gene were soon shown to be related to different non melanoma tumors. 
Cdkn2a codes for two different tumor suppressors p16 (INK4a) and p19 (ARF) that have 
roles in regulating cell proliferation and cancer malignancy, reviewed in (Aoude, Wadt et al. 
2015). It has been shown that p19 (ARF) is important in the p53 tumor suppressor pathway 
(Herzog, Noh et al. 1999); furthermore, p53 is involved in cancer adhesion and metastasis. 
CD9 is shown to be upregulated in p53R248 mutants of ovarian cancer cells in both whole 
genome sequence microarray and RT-PCR along with several adhesion related proteins (Lee, 
Ahn et al. 2015). The p53 gene was also shown to be significantly downregulated (p≤0.05 
and fold change not considered) in CD9KO mouse macrophages compared with WT control. 
The Smpdl3a (encoding the sphingomyelin phosphodiesterase, acid-like 3A protein) was 
another gene that was shown to be downregulated at the mRNA level, in CD9KO cells.  In 
primary human macrophages Smpdl3a expression is shown to be regulated by cholesterol and 
by liver X receptor (LXR and cyclic AMP (cAMP) (Traini, Quinn et al. 2014). Regulation of 
CD9 expression by the cAMP/PKA signaling pathways has been observed (Muroi, Sakurai 
et al. 2009). 
Three genes were shown to be upregulated in CD9KO cells (p ≤0.05 and 1.5 fold changes). 
Of note, the poliovirus receptor-related 3 (Pvrl3) gene encodes the poliovirus receptor-related 
3 protein (also known as Nectin 3) and is known to be associated in cell-cell adhesion (Satoh-
Horikawa, Nakanishi et al. 2000). The Pvrl3 gene was shown to be associated in human eye 
development through its involvement in cell-cell adhesion that mediated by Nectin (Lachke, 
Higgins et al. 2012). Nectin is thought to co-operate with E-cadherin in the development of 
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cell: cell adhesion junctions, in human epithelial cells (Peng, Mandai et al. 2002). 
Interestingly, tetraspanins including CD9 have been reported to co-localise with E-cadherin 
(Yanez-Mo, Mittelbrunn et al. 2001). 
 
In contrast to the results reported here for macrophage cell lines, embryonic stem cell (ESC) 
lines established from CD9-/- (3 cell lines) and WT (2 cell lines) mouse ESCs were shown 
by microarray analysis to have globally similar (but not identical) expression patterns. The 
cell lines were phenotypically similar and no difference in CD81 protein expression was 
observed. Also, no differences were observed in predicted tetraspanins expression (mRNA 
level) or CD9 associated proteins between CD9KO ESCs and WT control (Akutsu, Miura et 
al. 2009). 
  
The online tools DAVID ( The Database for Annotation, Visualization and Integrated 
Discovery) were used to cluster, annotate and extract functional genes from gene list to 
understand functional analysis and annotation of variable genes (Huang da, Sherman et al. 
2009). The CD9 associated proteins, integrin α3 (Indig, Diaz-Gonzalez et al. 1997)  and 
claudin-1(Kovalenko, Yang et al. 2007)  were down regulated in CD9KO cells (Table 6.6).  
 
Attempts to rescue the CD9 -/- macrophages with CD9-GFP were unsuccessful, but a stable 
J774 cell line expressing CD9-GFP was established, which is useful for fluorescence 
microscopy. The results showed that transfected CD9 behaved, in term of distribution, 
similarly to cells expressing native CD9. As shown in (Figure 6.12), CD9-GFP was correctly 
distributed on the plasma membrane while no obvious cytoplasmic CD9 was detected. An 
obvious co-localisation of CD9 and Salmonella was observed during the phagocytic process 
by J774 macrophages; however, this co-localisation was not clear after Salmonella 
internalisation. It could be that the CD9 was affected by degradation in internalised bacterial 
phagosome or could it be that CD9 is not present in the endosomal compartments where 
Salmonella is found at the later stages of infection. Attempts were made to visualise the CD9 
distribution and association with Salmonella during infection in live imaging using J774 
overexpressing CD9-GFP and mCherry expressing Salmonella. However, it was difficult to 
analyse the results using available imaging analysis software because of high background 
signals that made it difficult to observe any association.  
Other workers have reported that cancer cell motility was decreased after introducing CD9-
GFP in small cell lung cancer (SCLC) (Funakoshi, Tachibana et al. 2003). Overexpression of 
CD9-GFP was also used to investigate cell membrane fusion induced by HIV-1 virus 
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infection (Gordon-Alonso, Yanez-Mo et al. 2006). The stably transfected GFP-CD9 J774 
macrophage cell line generated here may be useful for further functional studies in the future.
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Chapter 7:  Investigation of the effects of syntenin 
knockdown on Salmonella Typhimurium uptake 
7.1 Introduction 
Previous studies from this laboratory indicated an important role for tetraspanin CD63 in the 
association of Salmonella Typhimurium with human MDMs (Noha Hassuna, PhD, thesis, 
University of Sheffield, 2010). Binding of S. Typhimurium to MDM was shown to be 
inhibited by antibodies to CD63, which induced internalisation of cell surface CD63, and by 
siRNA knockdown. During the course of present studies, a HeLa cells that had been stably 
knocked-down for the expression of syntenin, a partner of CD63 involved in its trafficking 
(Latysheva et al, 2006), became available; it was therefore of interest to investigate S. 
Typhimurium uptake by these cells. 
7.1.1 Syntenin-1 
Syntenin-1 is a scaffolding protein containing two PDZ domains, which was originally shown to 
link syndecan (a family of transmembrane heparin sulphate proteoglycans) to the cytoskeleton. It 
co-localised with syndecan at the plasma membrane and at intracellular vesicles (Grootjans, 
Zimmermann et al. 1997). The PDZ domain shows homology with domains found in yeast, 
plant and bacteria (Ponting 1997) (Kennedy 1995). Syntenin is expressed in various cell types 
and cell lines and is found at sites of cell-cell adhesion, microfilaments and the nucleus (Stier, 
Totzke et al. 2000, Zimmermann, Tomatis et al. 2001, Meerschaert, Bruyneel et al. 2007). It 
is also known as melanoma differentiation association gene-9 (mda-9) because of its role in 
regulating melanoma metastasis (Boukerche, Su et al. 2005). 
7.1.2 Syntenin functions 
As a scaffolding or adaptor protein, syntenin is involved in various cell functions including 
membrane-cytoskeletal organisation (Grootjans, Zimmermann et al. 1997), adhesion, where  
it was originally shown to  play a role in adherence  junction formation by regulating cell 
membrane kinetics  (Zimmermann, Tomatis et al. 2001) and protein trafficking 
(Zimmermann, Zhang et al. 2005). Mice knocked out for the syntenin-1 gene appeared normal 
but had elevated levels of intestinal immunoglobulins, suggesting that syntenin negatively 
regulates their production. (Tamura, Ikutani et al. 2015).  In the nervous system, syntenin is 
involved in regulating nerve cell maturation and formation of synapses in central nervous 
system (CNS) (Hirbec, Martin et al. 2005). In cancers, syntenin promotes angiogenesis (Das, 
Bhutia et al. 2013) and metastasis, migration and invasion (Lee, Kim et al. 2011, Das, Bhutia 
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et al. 2012, Das, Bhutia et al. 2012, Zhong, Ran et al. 2012, Hwangbo, Tae et al. 2015) and 
is upregulated in metastases in a number of cancers including  melanoma (Helmke, 
Polychronidis et al. 2004) (Boukerche, Su et al. 2005). Syntenin is also expressed in exosomes 
and has been implicated in their biogenesis (Friand, David et al. 2015, Roucourt, Meeussen 
et al. 2015). It has also been shown to negatively regulate HIV-1 invasion of T cells (Gordon-
Alonso, Rocha-Perugini et al. 2012).  
7.1.3 Syntenin structure 
The  PDZ domains are the main feature of syntenin structure, consisting of 80-100 residues 
organized in six β strand and two α helices (Kegelman, Das et al. 2015). The functional 
syntenin-1 is made up of 298aa consisting of 2 PDZ domains, with PDZ-1 positioned at a.a. 
114-193 and PDZ-2 positioned at a.a.198-273 and N and C-terminal tails (http://www.uniprot 
.org/uniprot/O00560). The human syntenin crystal structure has been solved, showing that 
the two PDZ domains are structurally quite similar (Figure 7.1) (Kang, Cooper et al. 2003). 
Both PDZ domains are required for syntenin functions (Zimmermann, Tomatis et al. 2001) 
and it has been suggested that PDZ2 acts as the main syndecan binding domain while PDZ1 
acts as an auxiliary binding domain to syndecan (Grootjans, Reekmans et al. 2000). 
Nevertheless, both PDZ domains in syntenin have a crucial role in mediating the interaction 
between syntenin and syntenin-associated proteins (Sarkar, Boukerche et al. 2004). 
 
 
Figure 7.1: Structure of PDZ tandem of Syntenin-1. The structure 1N99 (Kang, Cooper et al. 2003) was 
obtained from PDB data base (http://www.rcsb.org/pdb/explore/explore.do?structureId=1N99) and was 
visualised using the PyMOL molecular graphic viewer. A: A cartoon diagram shows the two PDZ domains. 
B: A surface diagram showing the two PDZ domains that compose syntenin-1 protein. 
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7.1.4 Syntenin protein associations 
 Syntenin was initially shown to interact with the heparin sulphate proteoglycan syndecan 
through the FYA sequence in the C-tail of syndecan (Grootjans, Zimmermann et al. 1997). It 
also interacts with a wide range of other proteins including schwannomin (sch-1) 
(Jannatipour, Dion et al. 2001),  the glycine transporter protein2 (GlyT2) (Ohno, Koroll et al. 
2004), the type I membrane glycoprotein CD6 (Gimferrer, Ibanez et al. 2005), the  c-Src 
proto-oncogene (Boukerche, Su et al. 2008), type 1 membrane protein NG2 (Chatterjee, 
Stegmuller et al. 2008), TRAF6 (Chen, Du et al. 2008), frizzled 7 receptor (Luyten, Mortier 
et al. 2008), lysyl-tRNA synthetase (Meerschaert, Remue et al. 2008), PIP2 (Zimmermann, 
Meerschaert et al. 2002, Zimmermann, Zhang et al. 2005), IL-5 receptor (Beekman, Verhagen 
et al. 2009) and Notch ligand Delta-1 (Estrach, Legg et al. 2007). Importantly for this study, 
it has also been shown to interact with tetraspanin CD63 and was suggested to be a component 
of TEM (Latysheva, Muratov et al. 2006). The interaction between tetraspanin CD63 with 
syntenin-1 was direct and no association of CD9 or CD81 was detected by 
immunoprecipitation. The tetraspanin CD63 C-terminus is crucial to the association with 
Syntenin-1 as deletion of the last two C-terminal amino acids abolished the interaction. The 
interaction occurred through the PDZ domain of syntenin but the syntenin C-terminus also 
stabilized this association as removing this abolished the interaction. Over-expression of 
syntenin slowed internalisation of CD63, and CD63 internalisation was arrested in cells 
expressing mutant syntenin-1 lacking the N-terminal 100 amino acids (Latysheva, Muratov 
et al. 2006). As mentioned previously (Chapter 1) CD63 has an internalization/lysosomal 
targeting motif at its C-terminus that facilitates interaction with AP-2 complexes that promote 
its internalisation (Rous, Reaves et al. 2002). It has therefore been suggested that syntenin 
competes with AP-2 mediated internalisation of CD63 to regulate endocytosis (Latysheva, 
Muratov et al. 2006).  
7.1.5 HeLa syntenin –KD cells 
The Hela syntenin knock down cell line was generated using a pLKO-sh Syntenin clone, 
while the control cell line was transfected with pLKO-puro vector (Fedor Berdichevski, 
personal communication). Both Hela syntenin-KD and control cell lines were kindly provided 
by Fedor Berditchevski (Institute for cancer studies, the University of Birmingham, 
Birmingham, United Kingdom). 
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7.2 Aims 
Since syntenin directly associates with CD63, which has previously been implicated in 
association of S. Typhimurium with human MDM, it was of interest to investigate association 
of the bacteria with cells that had been stably knocked down for syntenin expression. 
Furthermore, as mentioned previously, anti-CD63 antibody inhibition of this association was 
mediated by CD63 internalisation, which may be affected by syntenin (Latysheva, Muratov 
et al. 2006).  
 
7.3 Results  
7.3.1 Investigation of expression of syntenin-1 protein in syntenin-1 KD 
and control HeLa cells 
Syntenin-1protein has been shown to be expressed in different cell types and cell lines 
(Meerschaert, Bruyneel et al. 2007), including HeLa cells (Latysheva, Muratov et al. 2006). 
Western blot and immunofluorescence microscopy were performed to investigate differences 
in syntenin protein expression on HeLa syntenin KD cells and HeLa cells control. 
7.3.1.1. Western blot of HeLa-syntenin KD and control cell lysates 
 To independently verify knock-down of syntenin-1 expression in the cell line provided by 
Professor Berditchevski, Western blotting was used to detect syntenin-1 in syntenin KD and 
control HeLa cells. As expected, no expression of syntenin was shown in HeLa syntenin KD 
cells compared with a clear protein band in HeLa control cells (Figure 7.2) at ~33kd, the 
expected size of syntenin. 
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Figure 7.2: Western blot of lysates prepared from HeLa Syntenin KD and control cells. Cells were 
lysed with 0.5% Brij 98 and 0.5% Triton 100X as described in 2.2.7 and the lysate was run on 12.5% SDS-
PAGE gels under reducing conditions before transfer to nitrocellulose membrane. The membrane was 
probed with anti-human syntenin followed by anti-rabbit-HRP. M, protein markers; KD and C, lysate from 
syntenin KD and control cells respectively.  
 
 7.3.1.2 Immunofluorescence microscopy analysis of syntenin expression in KD and 
control HeLa cells  
 Immunofluorescence microscopy was performed to investigate the total level of syntenin-1 
protein expression and distribution in HeLa syntenin-KD cells and control cells as described 
in 2.2.4.1. The results showed low expression of syntenin protein in syntenin-KD HeLa cells 
compared with WT cells control (Figure 7.3).  Slight background staining was observed in 
isotype treated cells control indicating some non-specific binding of the rabbit IgG or the 
secondary antibody. 
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Figure 7.3: Immunofluorescence microscopy of syntenin KD and control HeLa cells stained for 
syntenin. Hela cells were seeded in 8-well chamber slides, fixed and permeabilised and stained with 
primary anti-syntenin or rabbit IgG control (10µg ml-1) (Sigma) followed by anti-rabbit-FITC as described 
in 2.2.4.1 Nuclei were counter-stained with propidium iodide. These images obtained using 20 x, 40x and 
100x oil immersion objective lenses. 
7.3.2 Investigation of tetraspanin protein expression in syntenin-KD 
and control HeLa cells 
 The expression of tetraspanin proteins was investigated in syntenin-KD cells and control 
HeLa cells by flow cytometry and immunofluorescence microscopy. The flow cytometry 
was carried out on both live, fixed (for surface expression only) and fixed and 
permeabilised cells (for surface and cytoplasmic protein expression). Staining was also 
carried out on live cells here to address the possibility that the fixation reagent used 
(paraformaldehyde) might be itself be causing some permeabilisation. In live cell staining, 
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the surface expression (MFI) of CD151 showed a significant reduction in syntenin KD cells 
compared with control cells. No significant changes were observed for other tetraspanins 
(Figure 7.4, A and B). Nevertheless, the tetraspanin protein expression showed some 
differences after fixing and permeabilising the cells prior to staining. A significant increase 
in total CD63 expression and, to a lesser extent CD81, was observed in syntenin-KD cells 
compared with control cells (Figure 7.4, C). The percentage of CD63 and CD81 positive 
cells also increased. Although the MFI did not increase, the percentage of CD9 and CD151 
positive cells was increased in fixed and permeabilised syntenin KD cells (data not shown).  
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Figure 7.4: Tetraspanin expression in syntenin KD and control HeLa cells determined by flow 
cytometry. HeLa cells were stained with primary anti-tetraspanin mAbs or isotype control (JC1) as 
described in 2.2.3.6 followed by FITC-conjugated anti mouse antibody. MFI =Median fluorescent intensity. 
A: MFI of live cell stained.  B: The percentage of live cells stained, Figure A and B work was carried out 
in our lab by a 3rd year project students S. Howard and V. Rose (under my supervision). C: MFI of fixed 
or fixed and permeabilised cells stained. n=4 in duplicate, the data was analysed by Two ways ANOVA 
Tukey's multiple  comparisons test comparing with isotype control,  significance *** P ≤ 0.001, ** p ≤ 0.01 
and * P ≤ 0.05,  ns is non-significant. 
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In immunofluorescence microscopy, the tetraspanins CD9, CD63 and CD81 staining of 
fixed, permeabilised cells also appeared stronger in the syntenin-KD cells compared with 
control cells (Figure 7.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5: Immunofluorescence microscopy of syntenin KD and control cells stained for 
tetraspanins. Cells were prepared and fixed as described in Figure 7.3 before staining with anti –
tetraspanin antibodies or isotype control  Nuclei were counter-stained with propidium iodide. These images 
were obtained by fluorescence microscopy using the 40x objective.
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7.3.3 HeLa cells integrin expression 
The expression of integrin proteins α3, α6 and β1 was also investigated in syntenin-KD cells 
and control HeLa cells by flow cytometry, since CD151 expression on syntenin-KD cells was 
significantly reduced and CD151 is known to associate with integrins (Figure 7.4 A).  This 
work was carried out by a 4th year project student under my supervision. The flow cytometry 
was carried out using live cells to investigate the surface expression of these proteins. The 
surface expression (MFI) of β1 integrin showed a significant reduction in syntenin KD cells 
compared with control cells. No significant changes were observed for other integrins (α3 and 
α6) (Figure 7.6).  
J
C
1
-C
J
C
1
-K

3
-C

3
-K

1
-C

1
-K

6
- i
s
o
ty
p
e
 C

6
- i
s
o
ty
p
e
 K

6
-C

6
-K
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
2 5 0 0
 M
F
I
n sn s*n sn s
 
Figure 7.6: Integrins expression in syntenin KD and control HeLa cells determined by flow 
cytometry. Integrin expression assay carried out by M. Jones. Briefly, HeLa cells were stained with 
primary anti-α3, anti-β1 and anti-α6 mAbs or corresponding isotype control followed by FITC-conjugated 
anti mouse antibody. MFI =Median fluorescent intensity. n=3 in duplicate, the data was analysed by T- test 
comparing Syntenin-KD HeLa cells (K) with cells control (C), significance * P ≤ 0.05, while ns is non-
significant. 
  
7.3.4 Salmonella uptake by HeLa-Syntenin KD cells compared with 
WT control 
HeLa syntenin KD and WT control were infected by Salmonella Typhimurium NCTC12023 
and LT2 strains at MOI 100 for 1 hr. The cells were then washed and incubated in antibiotic 
containing medium to kill extracellular bacteria before analysis at various time periods post-
infection, as described in (2.2.5.3.2). As noticed in chapter 4 (Figure 4.15), the HeLa cells 
were more susceptible to infection by the LT2 strain compared to NCTC12023 strain 
(comparing figure 7.7. A and B, E and F). It was noticeable that at all time points and for both 
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strains, the syntenin KD cells appeared to have more bacteria associated with them than the 
control cells, although this only reached significance at certain time points when considering 
total cell associated bacteria and cells with internalised bacteria for the LT2 strain. However, 
for the NCTC12023 strain, the percentage of cells with internalised bacteria was significant 
at all time points. 
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Figure 7.7: Salmonella Typhimurium uptake by syntenin KD or control HeLa cells at 100 MOI for 
different time periods analysed by flow cytometry. HeLa cells were infected with S. Typhimurium as 
described in 2.2.5.3.2 for 1hr before washing to remove unbound bacteria and incubating in medium 
containing 100µg ml-1 kanamycin for the times indicated before harvesting, fixing and permeabilising and 
staining with FITC-conjugated anti-Salmonella antibodies and analysis by flow cytometry as described in 
2.2.5.3.2. A: Total percentage of cells infected with NCTC12023 strain (permeabilised cells) or B: LT2 
strain (permeabilised cells). C: Percentage of cells with attached bacteria NCTC12023 strain or D: LT2 
strain. E: Percentage of cells with internalised bacteria NCTC12023 strain or F: LT2 strain. (The percentage 
of cells with internalised bacteria was determined by subtracting the value obtained for non-permeabilised 
cells form that of permeabilised cells). Bars describe means, while error bars describe standard errors. n=5 
in A, C and E and n=3 in B, D and F in duplicate, the data was analysed by T test to compare the mean 
between WT and KD infected cells, ** p≤ 0.01, * p≤ 0.5 and ns is non-significant.   
 
To investigate possible differences in bacterial adhesion to syntenin KD and control cells, 
both cell lines were infected at MOI 100 for shorter time periods and the number of non-
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permeabilised cells with attached bacteria determined (Figure 7.8). (In the experiments 
described above, the principle aim had been to investigate any differences in internalisation 
of bacteria. In the previous protocol it would be expected that most attached bacteria would 
be killed by the antibiotic treatment used after infection and removed during washing and 
harvesting as described in 2.2.5.3.2 and (Figure 7.7). The present experiment was carried out 
to observe cells with attached bacteria infected in suspension as described in 2.2.5.2. There 
was no significant difference in adhesion of the NCTC12023 strain to KD or control cells but 
at the earlier time points, the percentage of KD cells with attached LT2 bacteria was lower 
than for the control cells. 
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Figure 7.8: Adhesion of Salmonella Typhimurium to syntenin KD and control HeLa cells at 100 MOI 
for different time periods (analysed by flow cytometry). HeLa cells infected with S. Typhimurium. 
NCTC12023 and LT2 strains in tube and stained with anti-Salmonella-FITC conjugated antibody, as 
described in (2.2.5.2) without permeabilisation to observe attached bacteria only. A: Percentage of cells 
with attached NCTC12023 or B: LT2 strain. Bars describe means, while error bars describe standard errors. 
n=3 in duplicate, the data was analysed by two ways ANOVA test Sidak’s multiple comparison test to 
compare the mean between WT and KD infected cells, ** p≤ 0.01, * p≤ 0.5 and ns is non-significant.  
 
7.3.5 Confocal microscopy analysis of Syntenin KD cells and WT cells 
control infected with Salmonella 
Syntenin KD cells appeared to be more susceptible to infection by both strains of Salmonella, 
but this did not appear to correlate with any difference in bacterial adhesion. Confocal 
microscopy studies were therefore undertaken in an attempt to see if there were any obvious 
differences in trafficking of Salmonella between the cell lines. The confocal microscopy was 
performed as described in (2.2.6). Different fluorescent stains were used to indicate 
Salmonella-containing vacuoles (SCVs), the nucleus, and the cell boundary and to investigate 
Salmonella localisation within the cells cytoplasm. LAMP-1 (or  CD107a) is described as a 
SCV marker (Brumell, Tang et al. 2002) and it co-localises with SCV at different stages of 
Salmonella infection  (Rajashekar, Liebl et al. 2014). Anti-LAMP-1-AF®647 conjugate was 
Chapter 7 
191 
 
therefore used to detect SCV within the cytoplasm and give a good indication of Salmonella 
internalisation, survival and replication inside the infected cells. To track Salmonella bacteria 
inside infected cells, a GFP expressing Salmonella strain was used as described in 2.2.6. 
Cellular actin was stained by Alexa Fluor®568 phalloidin, to indicate the cell boundary. 
Preliminary experiments using flow cytometry showed similar, but slightly lower expression 
of LAMP-1 in syntenin-KD cells compared with controls (Figure7.9). 
The LAMP-1-Salmonella co-localisation experiment showed an obvious increase in 
Salmonella with time after infection, as shown previously by flow cytometry (7.3.4). Syntenin 
KD cells showed relatively more bacteria within the cytoplasm niche compared with control 
cells in both Salmonella strains, particularly at the 24 hours post-infection time point.  LAMP-
1 started to co-localise with Salmonella at 2 hours post infection, indicating SCV biogenesis. 
This LAMP-1-Salmonella association decreased from 6 hours post infection, correlating with 
intracellular bacterial replication. Most of the bacteria accumulated in one place within the 
cell cytoplasm and no obvious differences were observed between HeLa syntenin-KD and 
control cells in terms of bacterial accumulation and distribution. At earlier time points (1 hour 
infection time point) it was difficult to determine whether the bacteria were simply attached 
to cells or internalised. However, localisation of LAMP-1 with bacteria revealed internalised 
Salmonella, although this could not be observed in earlier stages of infection (Figure 7.10, 
7.11 and 7.12). Attempts were made to quantitate co-localisation of GFP-bacteria with 
LAMP-1 using Fiji software (Figure 7.12). For the LT2 strain, there was significant co-
localisation at 2- 6 hr post-infection in both cell lines. The same pattern was apparent for 
NCTC strain in the syntenin-KD cells, but co-localisation was not significant at 2 hr for 
control cells and was also slightly reduced at 4 hr. This suggests that knock-down of syntenin 
may promote uptake of the NCTC strain, which is broadly in agreement with the observations 
made previously from flow cytometry (Figure 7.7). 
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Figure 7.9: LAMP-1 expression in syntenin KD and control HeLa cell lines determined by flow 
cytometry. Permeabilised cells were incubated with anti-LAMP-1 AF® 647 antibody before analysis by 
flow cytometry using LSR-II flow cytometer as described in 2.2.3.5. Bars describe means, while error bars 
describe standard errors.  
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Figure 7.10: Confocal microscopy of syntenin KD or control HeLa cells infected with Salmonella 
Typhimurium NCTC12023-GFP. HeLa cells were infected at 100 MOI for 1 hour, as described in (2.2.6), 
then incubated with 100 Ut penicillin, 100µg streptomycin /ml for the time period indicated. The cells then 
were fixed and stained with anti-LAMP-1 AF®647 (red) followed by AF®568 Phalloidin (magenta, to stain 
actin), and cellular and bacterial DNA stained blue (DAPI) stain. K= HeLa syntenin-KD cells, C= Control 
cells. 1, 2, 4, 6, 12 and 24 reveals to time points for Salmonella infection, while 0 depicts non infected cells.  
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Figure 7.11: Confocal microscopy of syntenin KD or control HeLa cells infected with Salmonella 
Typhimurium LT2-GFP. HeLa cells were infected at 100 MOI for 1 hour, as described in (2.2.6), then 
incubated with 100 Ut penicillin, 100µg streptomycin /ml for the time period indicated. The cells then were 
fixed and stained with anti-LAMP-1 AF®647 (red) followed by AF®568 Phalloidin (magenta, to stain actin), 
and cellular and bacterial DNA stained blue (DAPI) stain. K= HeLa syntenin-KD cells, C= Control cells. 
1, 2, 4, 6, 12 and 24 time points for Salmonella infection, while 0 mean non infected cells. 
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Figure 7.12: Analysis of confocal microscopy images of syntenin KD or control HeLa cells infected 
with Salmonella Typhimurium-GFP strains. HeLa cells were infected at 100 MOI for 1 hour, as 
described in (2.2.6), then incubated with 100 U penicillin, 100µg streptomycin /ml for the time period 
indicated. The cells then were fixed and stained with anti-LAMP-1 AF®647. Images were analysed using 
Fiji analysis software using Manders coefficients test to quantify co-localisation of Salmonella (GFP/green) 
NCTC12023 (A) and LT2 (B) and LAMP-1 (AF®647/far red). The co-localisation analysis value is between 
0 (no co-localisation) to 1 (optimum co-localisation).  K= HeLa syntenin-KD cells, C= Control cells. 1, 2, 
4, 6, 12 and 24 reveals to time points for Salmonella infection. 
 
7.4 Discussion 
The 33 kd scaffolding protein, syntenin-1, is broadly expressed in different cell types and 
tumours and is involved in regulating membrane and cytoplasmic protein signalling pathways 
(Yang, 2007). It has been shown to form a direct and stable association with tetraspanin CD63 
and is postulated to be a constituent of TEM (Latysheva, Muratov et al. 2006). Syntenin-1 
expression regulated CD63 internalisation and overexpression of syntenin-1 reduced 
internalisation of CD63. In the present study, we investigated HeLa cells that had been stably 
knocked down for syntenin expression by transfection with a plasmid encoding shRNA 
specific for syntenin. Knockdown of syntenin expression was verified independently by 
Western blotting compared to control HeLa cells transfected with empty vector. Analysis by 
flow cytometry showed no significant differences in cell surface CD63 expression between 
syntenin-KD and control cells (Figure 7.4), but there were slight but significantly higher 
levels of CD63 in permeabilised KD cells indicating higher intracellular levels of this 
tetraspanin. Since Latysheva and co-workers showed that overexpression of syntenin-1 
reduced CD63 internalisation (Latysheva, Muratov et al. 2006), knock down of syntenin-1 
might increase CD63 internalisation that could, consequently, increase expression of CD63 
to compensate. A slight, but significant increase in total CD81, was also observed, and this 
tetraspanin was shown by Latysheva and co-workers to associate with syntenin indirectly, 
probably through its interaction with CD63.  
Chapter 7 
198 
 
CD151 was the only tetraspanin investigated that showed a difference in cell surface 
expression, with a slight but significant decrease in the level on unfixed syntenin-1 KD cells 
relative to controls. A possible interaction between cell surface CD151 and syntenin-1 was 
not reported in the previous study (Latysheva, Muratov et al. 2006). It would be interesting 
to determine if CD151 and syntenin could be co-immunoprecipitated from whole cell lysates 
of HeLa cells. Interestingly, CD151 is known to be strongly associated with integrins 
including α3β1, α6β1, α6β4 and α7β1 integrins (Hemler 2014) and syntenin is reported to 
facilitate the assembly of β1 integrin signalling complexes on the plasma membrane 
(Hwangbo, Park et al. 2011). Syntenin also strongly associates with syndecan, which also has 
been shown to be involved with β1 integrin cell adhesion (Gama-de-Souza, Cyreno-Oliveira 
et al. 2008). Thus, integrins (α1, α6 and β1) expression in both cell lines were also investigated, 
as shown in (Figure 7.6). A significant reduction of β1 integrin in syntenin-KD cells was 
observed compared with control cells, however, no significant change in either α3 or α6 
integrin surface expression was observed. This suggested, therefore, the reduction in CD151 
expression in syntenin-KD cells may be linked to its integrin β1 association. This could be 
affected by knock-down of syntenin or through syndecan. 
As discussed previously in this thesis, Salmonella Typhimurium has the ability of to infect 
mammalian non phagocytic cells by a sequence of steps starting from bacterial adhesion to 
host cells, activation of Salmonella T3SS-1 and spreading a wave of off effector proteins to 
trigger the rearrangement of the host cells actin-cytoskeleton (Misselwitz, Kreibich et al. 
2011). Here, both control and syntenin-1 knock down HeLa cells were infected by S. 
Typhimurium. The infection rate was relatively low, but comparable with that seen in wild 
type HeLa cells (Figure 4.15) and again the LT2 strain showed greater infectivity than the 
NCTC strain. Infection of syntenin-1 KD cells was consistently higher compared to control 
cells and this showed greatest significance in the increased number of NCTC bacteria 
internalised by the syntenin-1 KD cells (Figure 7.7 E). Analysis of images obtained of GFP-
bacteria taken up by the two cell lines also suggested increased uptake by the syntenin-1 KD 
cells and co-localisation of NCTC bacteria and LAMP-1 occurred earlier in the syntenin-1 
KD cells (Figures 7.12). However, there were no significant differences in adhesion of the 
bacteria to the cell lines after 1 hour (the time period used for infection) (Figure 7.8).  
These studies were undertaken since previous data on human MDM indicated that surface 
expression of CD63 is important in adhesion of S. Typhimurium to these cells. Syntenin-1 
has previously been shown to regulate internalisation of CD63 (Latysheva, Muratov et al. 
2006), but surprisingly there was no significant change in surface levels of CD63 between 
control and syntenin-1 KD cells. Interestingly, however, preliminary results from stochastic 
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optical resolution microscopy (STORM), have shown a significant change in cell membrane 
CD63 distribution and clustering between the cell lines.  In brief, clusters of CD63 are smaller 
in terms of diameter and area in syntenin KD cells compared with control HeLa cells (Megan 
Jones, MSc student project, 2016). This, together with the observed decrease in CD151 
expression, suggests some disruption of TEM on the syntenin KD cells; however, there is no 
clear relationship between the increased infection in the syntenin-1 KD cells and the 
tetraspanins. As reported in chapter 4, antibodies to tetraspanins, including CD63, had no 
effect on infection of Salmonella Typhimurium by wild type HeLa cells. The differences in 
infection may therefore relate to the interactions of syntenin with other partner proteins 
involved in plasma membrane/cytoskeletal proteins signalling. As mentioned previously, 
syntenin-1 binds syndecans, a family of proteoglycans with heterogeneous heparan sulphate 
chains (Grootjans, Zimmermann et al. 1997). Interestingly, it has been shown that S. 
Typhimurium can utilise heparan sulphate as a means of adhering to and invading host cells. 
This is mediated by PagN, a bacterial outer membrane protein (Lambert and Smith 2009). It 
is possible that alterations in syndecan organisation or trafficking in the syntenin-1 KD cells 
has some effect on infection of the Hela cells by S. Typhimurium. Syndecan-1 and syndecan-
4 have been shown to have a role in Neisseria gonorrhoeae adhesion and uptake; over 
expression of syndecan-1 and 4 in HeLa cells led to increased Neisseria gonorrhoeae uptake 
compared with WT control and it was concluded that syndecan may serve as a receptor for 
Neisseria gonorrhoeae (Freissler, Meyer auf der Heyde et al. 2000). Furthermore, Syndecan-
1 KO epithelial cells show more resistance to Staphylococcus aureus infection (Hayashida, 
Amano et al. 2011). 
The intracellular Salmonella survive through disrupting and arresting the maturation pathway 
of the invasion vacuole and, consequently, this provides a safe place for Salmonella 
replication  (Brumell and Grinstein 2004). The SCV is found to acquire lysosomal membrane 
glycoprotein Lamp1, CD63 and vacuole ATPase (Martinez-Lorenzo, Meresse et al. 2001). In 
addition to these lysosomal markers, the host proteins Rab5, EEA1 and late Rab7 endosomal 
marker are also acquired during the early steps of SCV biogenesis. The involvement of early 
and late endosomal markers presents the potential for host/SCV interaction along with the 
action of T3SS effectors such as SifA (required for SCV membrane stability) to provide 
Salmonella Typhimurium an intracellular niche to replicate. Maturation of the SCV occurs 
by specific interactions with the endocytic pathway, in which most of the SCVs are 
surrounded by Golgi network membranes after invasion of epithelial cells (da Silva, Cruz et 
al. 2012) and as discussed in Chapter 1. The T3SS effector protein SipC is involved in 
acquiring LAMP-1 protein through its association with the host cell protein Syntaxin6 
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(Madan, Rastogi et al. 2012).  Loss of SCV integrity has been shown to lead to increased 
cytosolic Salmonella replication in HeLa cells and this could arise by targeting either the SCV 
effectors involved or the cells endosomal system (Brumell, Tang et al. 2002). It is suggested 
that maintaining SCV in epithelial cells may prevent antigen presentation via MHCI and 
activation of proinflammatory responses. LAMP-1 has been shown to be a good SCV marker, 
so this protein was used for confocal microscopy. Preliminary experiments showed a 
noticeable reduction in LAMP-1 expression in syntenin-KD cells by flow cytometry (Figure 
7.9).  However, no noticeable differences in LAMP-1 association with Salmonella was 
observed in syntenin-KD compared with control cells. A highly significant association of 
LAMP-1 with replicating intracellular Salmonella was observed after 2 hours infection and 
this increased at 4 to 6 hour. Nonetheless, this association decreased after 12 to 24 hours post 
infection at the time when the internalized bacteria show a high level of replication.  
In macrophages, Salmonella could overcome lysosomal action by containing every single 
bacterium in a single SCV resulting in increased SCVs and Salmonella replication inside the 
cells. This is reported to deplete the number of acidic lysosomes in infected cells as a result 
of increasing Salmonella multiplication as the cell cannot produce enough acidic lysosomes 
to target the rising number of SCVs (Eswarappa, Negi et al. 2010).
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Chapter 8:  General discussion 
Tetraspanins are increasingly observed to be of importance in various cell activities and have 
attracted the interest of many researchers due to their role in infections (Hassuna, Monk et al. 
2009, van Spriel and Figdor 2010, Green, Monk et al. 2011, Monk and Partridge 2012). 
Nevertheless, relatively little research has been published describing the association of 
tetraspanins with bacterial infection processes. Work from our group indicates that certain 
tetraspanins are involved in bacterial adhesion and uptake; mAb specific for CD9, CD63 and 
CD151, the corresponding recombinant EC2 domains and siRNA knockdown of each of these 
tetraspanins reduced Neisseria meningitidis adhesion to human epithelial cells (Green, Monk 
et al, 2011; Cozens, 2015, PhD thesis, University of Sheffield). In addition, tetraspanins were 
implicated in the adhesion of a range of other bacteria (Neisseria lactamica, Streptococcus 
pneumonia, Escherichia coli, Staphylococcus aureus) to epithelial cells (Green, Monk et al, 
2011), suggesting a general bacterial adhesion mechanism involving TEM. More recently, 
reagents targeting CD9 have been shown to reduce adhesion of Staphylococcus aureus to 
human keratinocytes and a 3-D model of human skin (Ventress, PhD thesis, University of 
Sheffield 2016; Ventress et al., manuscript submitted). Of particular relevance to this work, 
anti-CD63 mAb, siRNA CD63 knockdown and recombinant tetraspanin EC2 proteins also 
reduced Salmonella Typhimurium uptake by human primary MDMs (Hassuna, 2010, PhD 
thesis, University of Sheffield). However, more studies are needed to understand this 
association.  
The ability of Salmonella to attach to, invade and replicate in wide range of host cells and 
cell lines representing either phagocytic on non-phagocytic cell types (Finlay, Ruschkowski 
et al. 1991, Mills and Finlay 1994, Lajarin, Rubio et al. 1996, Haraga, Ohlson et al. 2008, 
Rosales-Reyes, Perez-Lopez et al. 2012) make this bacteria ideal as a model to investigate 
the involvement of tetraspanin proteins in the infection process. As previously discussed, the 
ability to invade non-phagocytic cells is mediated by T3SS-1 (Rosselin, Abed et al. 2011), 
whereas macrophage infection can also be mediated by phagocytosis (Aderem and Underhill 
1999). Salmonella is able to survive in macrophages and these cells may play an important 
role in bacterial survival and spread (Lathrop, Binder et al. 2015). In the present study, 
different cell lines, representing mouse and human macrophages as well as human epithelial 
cells, were used to investigate the potential effect of tetraspanin proteins on Salmonella 
infection. 
Previous studies in the laboratory investigated the role of tetraspanins in the uptake of 
Salmonella enterica serovar Typhimurium by human monocyte derived macrophages 
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(MDMs). Specific monoclonal antibodies (mAbs) for various tetraspanins showed 
different effects, enhancing (CD37) or inhibiting (CD63) Salmonella binding to cells. The 
inhibition of Salmonella binding to MDMs was shown by using recombinant proteins 
corresponding to CD63-EC2 and CD9-EC2.  In addition, the siRNA-mediated 
knockdown of CD63 also reduced Salmonella Typhimurium adhesion (Hassuna, PhD 
thesis, University of Sheffield 2010) 
Immunofluorescence microscopy showed that CD63 co-localized with Salmonella 
containing vacuoles (SCVs) at different time periods after infection. Overall from this 
study an important role for tetraspanin CD63 in the initial binding of Salmonella 
Typhimurium to macrophages was suggested, with the likely involvement of other 
tetraspanins (Hassuna, PhD thesis, University of Sheffield 2010). However, one of the 
drawbacks of relying on MDMs are donor variation and the difficulty of generating these 
cells in large amounts. Therefore, using macrophage cell lines such as J774.2 and RAW 247 
could overcome this problem. However, these cell lines are of murine origin and relatively 
few antibodies to native murine tetraspanins are available. Thus, we also aimed to develop a 
human macrophage cell line model of infection using human THP-1 cells to investigate the 
role of tetraspanins in Salmonella infection. In parallel, tools were developed including 
Salmonella self-expressing fluorescent proteins and a flow cytometry assay to assess 
Salmonella infection, which could help to obtain rapid and objective results. Approaches used 
to investigate the function of tetraspanins included the use of specific monoclonal antibodies, 
recombinant EC2 proteins and a stable CD9 knock-out macrophage cell line. Furthermore, 
the role of the CD63 tetraspanin partner protein, syntenin, on Salmonella infection of HeLa 
cells was also studied. 
 
Screening surface expression of the tetraspanin proteins showed a similar pattern for the 
mouse macrophage cell models J774, RAW (Figures 3.1 and 3.3) and WT mouse 
macrophages (Figure 6.3), with highest expression for CD9 followed by relatively high levels 
of CD81, while CD63 showed lower expression in RAW and WT mouse macrophages with 
no expression on J774. By contrast, macrophages derived from human THP-1 cells, showed 
higher expression of CD63 than CD9, with relatively high expression of CD81 compared 
with the mouse macrophage cell lines (Figure 3.5). Differences in expression patterns were 
also observed in the epithelial cell lines used, HEC-1-B and HeLa; although both cell lines 
showed high expression of CD9 and CD81, higher expression of CD151 was observed in 
HeLa cells (Figure 3.9) with only low expression of this tetraspanin on HEC-1-B (Figure 3.7).  
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Chapter 3 also describes attempts to generate fluorescent bacteria to try to enhance and 
facilitate assessing Salmonella infection. Different vectors carrying the GFP or RFP genes 
were used. The GFP protein seems to be stably expressed and detected in both Salmonella 
strains by FACS (Figure 3.12), either as Salmonella-GFP alone or in cells associated with 
Salmonella-GFP. A 28 kDa DsRed fluorescent protein that shows less susceptibility to pH 
(4.5-12), more resistance to an acidic environment than GFP and less sensitive to photo-
bleaching (Baird, Zacharias et al. 2000) could offer a good Salmonella detector particularly 
with tetraspanin-GFP tagged protein. However, in contrast to GFP, generating high and stable 
self-expressing RFP Salmonella seemed to be more difficult, despite the fluorescent protein 
being well-expressed in E. coli. The percentage of positive cells and fluorescence intensity 
for Salmonella expressing DsRed were unstable and varied depending on Salmonella strains, 
time period of incubation and concentration of selective antibiotic (Chapter 3, section 3.3.3). 
This could be related to more time being needed to obtain dimerization and maturation (Baird, 
Zacharias et al. 2000). Therefore, choosing another RFP protein, mCherry was recommended. 
The expression of mCherry in Salmonella was successful, although lower expression of this 
florescent protein was observed after 2 hours incubation compared with overnight cultures. 
mCherry has the advantage of no overlapping in emission detected either by fluorescence 
microscopy or by FACS, in contrast to DsRed (as described in section 3.3.3). The mCherry 
fluorescent protein was found to be relevant for bacterial investigations combined with GFP 
expressing cells or FITC-labelled antibodies for fluorescence microscopy. 
8.1 Development of tools to assess Salmonella infection 
 Flow cytometry analysis has the potential to offer a rapid and appropriate method to study 
bacteria-host invasion. Other workers have reported it to be comparable with other methods 
for investigating bacterial pathogenicity and bacterial: host interaction, particularly when 
combined with self-fluorescence expressing bacteria (Valdivia and Falkow 1998, Pils, 
Schmitter et al. 2006, Trouillet, Rasigade et al. 2011). Nevertheless, high levels of fluorescent 
protein expression or features of the plasmid construct used could interfere with Salmonella 
invasion properties (Wendland and Bumann 2002, Clark, Martinez-Argudo et al. 2009). Here, 
a flow cytometry assay was developed for assessing infection, and shown to be comparable 
with the microscopy assay with the advantage of giving more objective results. In assays 
where antibodies were used to stain Salmonella after infection, the results were very 
comparable with the conventional fluorescence microscopy method (Chapter 4, comparing 
the results shown in Figure 4.3 and 4.4 with Figure 4.10; Figure 4.9 with 4.11). Interestingly, 
a lower MOI was needed to reach similar infection levels in the flow cytometry assay, and 
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we speculate that when cells are incubated with bacteria in suspension, bacterial binding may 
be facilitated compared to cells adhered to coverslips. 
8.2 Tetraspanins effects on Salmonella uptake 
 The overall results show a significant reduction in Salmonella NCTC12023 infection after 
treating the mouse macrophage cell model with anti-CD9 and CD81 prior to Salmonella 
infection (Figure 4.3, Figure 4.4, Figure 4.10, and Figure 6.7 B). This contrasts with previous 
studies on human MDM, where no inhibition with anti-CD9 mAbs was observed; however 
recombinant soluble CD9-EC2 proteins inhibited Salmonella association with human MDM 
suggesting that this tetraspanin is involved in this process (Hassuna, PhD thesis, University 
of Sheffield 2010), and it has been found that anti-CD9 antibody inhibited adhesion of 
bacteria to human epithelial cell lines (Green, PhD thesis, University of Sheffield 2010). 
Interestingly, in the present study, no effect on cell associated bacteria in human THP-1 
derived macrophages was noticed (Figure 4.5) when these were pre-treated with the same 
anti-CD9 antibody used in the human MDM experiments, where it also showed no effect. 
The differences in the effects of the anti-CD9 antibodies may relate to differences between 
mouse and human cell CD9 or the relative levels of CD9 expression compared with other 
tetraspanins including CD63, (as described in chapter 3, Figure 3.1, 3.3 and 3.5 ) that may 
affect TEMs structure and organisation. There were no effects with anti-CD63 in contrast to 
previous studies, but this is likely to be due to the apparent absence of CD63 on the mouse 
macrophage cell line used. As found in the previous studies on human MDM, anti-CD63 
antibodies inhibited association of Salmonella NCTC12023 to THP-1 derived macrophages. 
In contrast, anti-CD81 and anti-CD151 antibodies caused inhibition of infection of THP-1 
macrophages, whereas no effect was seen with human MDM. The level of tetraspanin 
expression (chapter 3) may account for the differences in cell-bacteria association,  since low 
levels of CD151 were shown to be expressed in human MDMs (Hassuna, PhD thesis, 
University of Sheffield 2010). Interestingly, anti-CD151 antibodies were previously found to 
reduce Neisseria meningitidis adhesion to human epithelial cells (Green, Monk et al. 2011) 
and found to be required for Listeria monocytogenes invasion of the human epithelial HeLa 
cell line (Tham, Gouin et al. 2010). 
Different patterns of results were seen in some cases for cells infected with the Salmonella 
LT2 strain compared to NCTC12023 post anti-tetraspanin treatment (comparing Figure 4.6 
with 4.7; Figure 4.14 in macrophages derived THP-1 and in undifferentiated THP-1 
respectively). In macrophages derived from THP-1 by phorbol ester treatment, the inhibitory 
effect of anti-CD63, anti-CD81 and anti-CD151 antibody pre-treatment is more pronounced 
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in cells infected with Salmonella NCTC12023 than for the LT2 strain. Also no reduction by 
anti-CD81 was observed for undifferentiated THP1 cells infected with LT2, in contrast to the 
NCTC12023 strain. Higher rates of infection were observed for the LT2 strain compared with 
NCTC12023 in epithelial cell lines (Figure 4.11 E and F and G and H (HEC-1-B); Figures 
7.7 and 7.8 (HeLa cells). This could perhaps relate to differences in SPI-1-T3SS expression 
depending on Salmonella strains. It has been reported that S. NCTC12023 has less ability to 
invade epithelial cell lines, which may be due to low expression of prgH that is important for 
needle complex formation in other Salmonella Typhimurium strains (Clark, Perrett et al. 
2011). As expected, Salmonella were attached to and internalised by HEC-1-B and HeLa 
cells after one hour incubation (results described and discussed in chapter 4 and chapter 7). 
However, no significant change in cells associated with bacteria on pre-treatment with anti-
tetraspanin antibodies was observed in HEC-1-B cells infected with either of the Salmonella 
strains (Figures 4.9 and 4.11). This finding appears to contrast with a previous study that 
showed a reduction in cells associated with attached Salmonella NCTC12023 in HEC-1-B 
cells that had been pre-treated with a combination of all three antibodies (CD9, CD63 and 
CD151) before infection (Green, 2010, thesis, University of Sheffield). Using a combination 
of all three antibodies could have a greater effect on TEMs by disrupting wider areas and 
affecting various tetraspanin associated proteins within the structure of TEMs. The results 
presented here could also indicate less involvement of tetraspanins and uptake mediated by 
Salmonella T3SS. Interestingly, infection of MDMs by Salmonella induced to express high 
levels of T3SS was less affected by anti-CD63 antibodies (Noha Hassuna, PhD thesis 2010). 
This also contrasts with results reported that anti-CD81 reduced Listeria meningitidis uptake 
by HeLa cells (Tham, Gouin et al. 2010). Different bacterial types, strains and mode of uptake 
might cause this diversity in tetraspanins responses. 
8.3 Recombinant EC2 domain effects on Salmonella uptake 
As previously discussed, recombinant tetraspanin EC2s, including CD9-EC2, have been 
shown to inhibit bacterial binding to human epithelial cells (Green, Monk et al 2011; Daniel 
Cozens, PhD thesis University of Sheffield 2015). It was suggested that the soluble EC2s 
were disrupting interactions of native membrane tetraspanins in TEMs that were proposed to 
act as “adhesion platforms” for the bacterial adhesion.  This was similar to the finding that 
CD9-EC2 inhibited attachment of human leukocytes to endothelial cells. Here, the suggested 
mechanism, supported by electron microscopy and fluorescence imaging, was that this 
recombinant protein competed with the native membrane CD9-EC2 and interfered with its 
action for its heterophilic and homophilic protein associations (Barreiro, Zamai et al. 2008). 
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Also as previously reported soluble recombinant CD9 EC2 inhibited adhesion of Salmonella 
Typhimurium to human MDM (Noha Hassuna, PhD thesis, University of Sheffield 2010). 
Therefore, a recombinant version of the EC2 of tetraspanin CD9 was also used in the present 
study to investigate the role of this tetraspanin in Salmonella uptake by J774 cells as described 
in Chapter 5. Soluble, recombinant versions of human CD9 (hCD9) that had previously been 
produced in our lab were first used, since there is high homology between human and mouse 
CD9-EC2 (77% identity). In addition, hCD9-EC2 was functionally active in inhibiting giant 
cell formation induced by Burkholderia thailandensis in J774 cells (Atiga Elgawidi, personal 
communication).  
No significant change in cells associated with bacteria was seen, even in cells pre-treated with 
high concentrations of EC2 (1000nM) prior to infection. This was surprising, since as 
described in chapter 4, a significant reduction in cells associated with bacteria on anti-CD9 
pre-treatment of in J774 cells was demonstrated (Figure 5.1). The same preparation of EC2 
had been shown to be correctly folded and detected using conformation-sensitive antibodies. 
It also had biologically activity in other assays, inhibiting N. meningitidis adhesion to human 
HEC-1B epithelial cells (Dan Cozens, PhD thesis, University of Sheffield 2015) and giant 
cell formation induced by B. thailandensis in J774 cells as described above. Nonetheless, 
species variation may be important in some functions. DNA corresponding to mouse CD9 
EC2 was therefore cloned and used successfully to generate recombinant mouse CD9-EC2-
GST. This was produced and purified and detected by monoclonal antibodies targeting mouse 
CD9 (chapter 5, Figure 5.8, 5.9 and 5.11 B) but not human CD9 (Figure 5.11 C). Pre-
treatment of J774 with mCD9-EC2-GST before Salmonella NCTC strain infection again 
showed no significant effect compared with the GST control. However, this preparation of 
mCD9-EC2 was biologically active in another assay involving mouse macrophages, as it 
suppressed J774 fusion induced by Burkholderia thailandensis (Atiga Elgawidi, personal 
communication). 
The differences in results between cells treated with antibodies or with recombinant EC2 
domain may indicate that Salmonella binding to J774 cells is not dependent on TEMs and the 
antibodies are acting in a different way here. Alternatively, it could relate to the differences 
in methods used to assess bacterial infection (the flow cytometry method was carried out in 
the current study while Green et al (2011) used immunofluorescence microscopy, although 
the methods appeared very comparable when the effects of antibodies were investigated). If 
time had permitted, it would have been useful to investigate the effects of the CD9-EC2 
proteins on bacterial adhesion to epithelial cell lines using flow cytometry. Alternatively, it 
could be that the recombinant EC2 lacks some feature needed for activity in this particular 
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instance. It may have been interesting to look at other tetraspanin EC2s, for instance CD81, 
since antibodies to this tetraspanin also affected Salmonella infection of mouse macrophages. 
Further investigation is also needed to gain insight into the dynamics of action of EC2 and/or 
antibodies in Salmonella infection, such as electron microscopy or super resolution 
microscopy and using labelled EC2 protein to investigate its binding to cells. Unlike N. 
meningitidis, little is known about “receptors” for Salmonella. 
To further investigate the role of CD9 in infection of mouse macrophages by Salmonella, 
macrophage cell lines derived from CD9 KO and corresponding wild type mice were used, 
as detailed in Chapter 6. There was no difference in the infection of CD9KO or WT 
macrophages by the NCTC12023 strain of Salmonella, but surprisingly CD9KO 
macrophages were more susceptible to infection by the LT2 strain. However, the 
corresponding wild type macrophages were less susceptible to infection by the LT2 strain 
compared with the NCTC12023 strain. This contrasts with human epithelial cells, where as 
described above, the LT2 strain showed greater infectivity. This might be related to the 
differences in Salmonella Typhimurium strains T3SS effector protein expression, as 
mentioned previously (Clark, Perrett et al. 2011). Moreover, it has been indicated that the 
T3SS is also important for Salmonella survival after uptake by macrophages (Cirillo, Valdivia 
et al. 1998). The differences in Salmonella strains uptake could also relate to differences in 
the uptake mechanism, with the LT2 strain seeming to be more resistant to infection by the 
phagocytosis route than the Salmonella strain NCTC12023 in the wild type macrophage cell 
line.  
 
CD9 gene knock out also affected protein expression of other tetraspanin members; a 
significant reduction in cell surface expression of CD81 in CD9 KO cells was found. CD9 
and CD81 are known to associate with one another (Gustafson-Wagner and Stipp 2013) and 
this suggests a role for CD9 in correct trafficking of CD81 in these cells. In RNA microarray 
analysis, expression of several genes were found to be highly and significantly (p≤0.05 and 
1.5, log2, fold change) affected after knocking-out CD9, either downregulated (including Xist, 
Cdkn2a and Smpl3a) or upregulated (including Pvrl3 and Spink5). These results present the 
possible role of CD9 in the expression of these proteins at mRNA level. Further study may 
be needed to confirm these changes using qPCR and their protein expression levels using 
antibodies. 
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8.4 Syntenin and Salmonella infection in HeLa cells 
A direct association of syntenin-1 with tetraspanin CD63 has been shown and the protein is 
postulated to be a constituent of TEM and affect CD63 internalisation (Latysheva, Muratov 
et al. 2006). CD63 involvement in Salmonella uptake has shown previously using MDMs 
(Hassuna, PhD thesis, University of Sheffield 2010) and in the present study anti-CD63 
antibodies reduced S. Typhimurium NCTC12023 association with THP-1 derived 
macrophages (Chapter 4). It was therefore of interest to investigate a direct or indirect role 
for syntenin-1 in Salmonella infection using HeLa cells stably knocked down for syntenin 
expression. As described in chapter 7, (Figure 7.4), there was little difference in  cell surface 
expression of CD63 although higher cytosolic levels of CD63 were observed in syntenin KD 
HeLa cells; this could relate to the role of syntenin in CD63 internalisation (as discussed in 
7.4). However, interestingly, preliminary STORM microscopy results have shown that 
surface CD63 distribution and clustering were significantly changed between the cell lines 
(described in chapter 7, 7.4) (Megan Jones, MSc student project, 2016). Furthermore, a 
reduction of CD151 expression was observed in syntenin KD cells. CD151 is directly 
associated with integrins including α3, α6β1, α6β4 and α7β1 integrins (Hemler 2014), and 
enhances their signalling complex assembly on cell membranes (Hwangbo, Park et al. 2011). 
The β1integrin subunit expression, but not α3 and α6 subunits, was significantly decreased 
on the syntenin KD cells. An association of syntenin with syndecan that is also associated 
with β1 integrin cell adhesion molecules has been reported (Gama-de-Souza, Cyreno-Oliveira 
et al. 2008). Salmonella infection was assessed by flow cytometry and the results supported 
by immunofluorescence imaging of infected cells; the S. LT2 strain showed a higher infection 
rate compared with NCTC12023 strain, and in both strains, syntenin KD cells were more 
susceptible to infection than control cells (chapter 7, Figure 7.7). However, no significant 
changes were observed in the early stages of Salmonella adhesion, even though, from 
previous studies, CD63 appeared to be important to Salmonella adhesion into MDMs. Also, 
as reported in Chapter 4, antibodies to CD63 had no effect on uptake of GFP-Salmonella by 
wild type HeLa cells. The results with the reduction of CD151 and β1 expression in syntenin 
KD cells, together with preliminary STORM microscopy, suggested disruption of TEM in 
syntenin KD cells. However, there is no clear link here between TEM and bacterial adhesion 
as was found previously for human macrophages. As discussed in Chapter 7, the effects of 
syntenin knock down may therefore relate to its interaction with other partner proteins such 
as syndecan. Syntenin-1 is an adaptor protein that is known to be involved receptor trafficking 
(Beekman and Coffer 2008) and may be involved in actin remodelling (Gordon-Alonzo et al 
2012). These processes could be important in Salmonella entry into non-phagocytic cells by 
the T3SS system. 
Chapter 8 
209 
 
8.5 Other future directions 
Using murine cell lines have many advantages as cell model; however there are limited 
numbers of commercial antibodies currently available to native mouse versions of the 
tetraspanins. Despite this, some antibodies against mouse tetraspanins are becoming 
commercially available, but these are often raised against peptides or recombinant proteins. 
Such antibodies against mouse CD37 and CD151 were tested but did not recognize native 
tetraspanins on the surface of mouse macrophages cell lines. It may be worth testing 
additional commercially available antibodies to mouse tetraspanins to investigate their roles 
in Salmonella infection. The commercially available antibodies may be useful for looking at 
levels of expression of different tetraspanins in Western blotting, but they cannot be used for 
functional studies if they do not recognise native proteins. 
The CD9KO mouse macrophages cells that were generated from CD9KO mice (Le Naour, 
Rubinstein et al. 2000) showed no difference in Salmonella NCTC12023 infection; however, 
interestingly CD9 KO mouse macrophages was more susceptible to S. LT2 strain. Hence, 
more experiments are needed to understand the cells behavior in relation to strain variation, 
particularly in long term infection and whether there are any differences in tetraspanin 
expression related with the Salmonella strains and time periods of infection. Also, regarding 
the stable CD9-GFP expressing J774 cell line that was generated in this study, it would be 
worth investigating the effect of overexpression of CD9 on Salmonella infection. Since CD81 
was downregulated in CD9 overexpressing cells, it would be worth checking the expression 
of other tetraspanins by western blotting. In addition, many tetraspanin KO mice (CD37, 
CD81 or CD151) have been generated in different studies (Gartlan, Belz et al. 2010, 
Makkawi, Moheimani et al. 2015, Martinez del Hoyo, Ramirez-Huesca et al. 2015), and it 
would be useful to try generate immortal bone marrow derived macrophages from these mice. 
It would also be interesting to use these tetraspanin-KO mice to investigate the immune 
response following systemic infection with Salmonella. Also, using primary renal and hepatic 
cells from these KO mice could offer a good tool to obtain a better understanding of the 
infection process in the absence of particular tetraspanins. A similar study has been published 
more recently that investigated the effect of knockout of CD81 in mice infected with Listeria 
monocytogenes (Martinez del Hoyo, Ramirez-Huesca et al. 2015). As mentioned previously, 
such CD81 -/- mice were more susceptible to infection and a role for CD81in negatively 
regulating the immune response was demonstrated. Also, knocking out tetraspanins in cell 
lines using the CRISPR-Cas9 system could offer another good way to generate tetraspanin-
KO cell lines. 
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Studying the expression of tetraspanins at the mRNA level offers a good tool to investigate 
the differences in tetraspanin expression profile in a wider context. RNA microarray analysis, 
increasingly, has been applied in many studies (Margalit, Somech et al. 2005, Jeffery, Higgins 
et al. 2006). This method could be used to investigate global changes in many different 
proteins, including tetraspanin and partner proteins, at the mRNA level. The gene responses 
to bacterial infection at the mRNA level was investigated in RAW264.7 mouse macrophages 
infected with Brucella abortus bacteria using microarray analysis (Eskra, Mathison et al. 
2003). It will be useful to try screening the possible changes, at the transcription level, of 
gene expression during the infection process and in persistent infection with Salmonella. 
Co-immunoprecipitation trials with CD9, CD81 and other possibly associated tetraspanins or 
tetraspanin partner proteins, particularly integrins, was within the initial aims in this study. 
However, time limitation prevented this being possible. These types of experiment could help 
to detect possible interactions between tetraspanins and putative Salmonella receptors since 
little is known about these.
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